data_5t42_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5t42 _Structure_validation_residue.Date_analyzed 2017-08-25 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 631' ' ' SER . . . . . 0.418 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -102.85 -48.51 4.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.688 0.28 . . . . 0.0 110.875 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.596 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 12.4 t70 -136.3 -96.85 0.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.861 0.362 . . . . 0.0 111.32 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.62 -41.39 63.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.24 -22.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.148 0.499 . . . . 0.0 112.288 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.491 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.1 tm? 177.66 -58.56 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.281 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 10.6 Cg_endo -57.64 -20.26 41.42 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.668 1.579 . . . . 0.0 110.585 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.596 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 1.9 p-10 30.52 40.64 0.01 OUTLIER 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.396 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 44.01 54.46 5.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.359 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -132.86 -46.18 0.12 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.4 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -99.52 -27.06 13.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 0.0 110.844 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 1.6 t-20 -148.05 69.74 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -94.8 -27.47 15.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.048 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.6 -21.05 66.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.096 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . 0.416 ' HA ' ' CE2' ' A' ' 648' ' ' TRP . 1.2 p-90 -48.43 -29.59 4.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.773 0.32 . . . . 0.0 111.242 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -137.03 14.64 3.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.595 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 3.6 t -156.57 24.76 0.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.715 0.293 . . . . 0.0 111.446 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -143.42 -90.52 0.13 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.307 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.42 ' O ' HG13 ' A' ' 652' ' ' ILE . 37.9 p-90 -73.0 -20.9 60.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.614 0.245 . . . . 0.0 111.043 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . 0.474 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 4.0 ttt-85 -85.79 -15.44 42.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 110.284 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -24.4 63.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.789 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -159.18 59.06 0.41 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.498 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 0.5 OUTLIER -65.45 -47.88 67.96 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.8 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 41.1 Cg_endo -89.02 -76.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.975 2.45 . . . . 0.0 112.732 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 167.95 88.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.577 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.53 47.71 1.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.552 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.517 ' CA ' ' HA3' ' A' ' 660' ' ' GLY . 10.2 tp -114.48 -33.86 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.327 . . . . 0.0 111.187 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . 0.413 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -131.37 -48.04 0.12 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.737 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . 0.425 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 10.7 p -69.54 -43.29 80.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.246 0.546 . . . . 0.0 109.892 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.577 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 22.3 m -118.6 -15.85 9.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.677 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . 0.517 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.4 -51.05 4.51 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.345 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.435 ' CG1' HG11 ' A' ' 665' ' ' VAL . 43.1 t -82.62 -61.72 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 110.775 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 658' ' ' VAL . 40.0 t -41.79 -33.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.591 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.3 tt -75.98 -37.54 34.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.545 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.49 -24.95 36.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.173 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.435 HG11 ' CG1' ' A' ' 661' ' ' VAL . 5.2 m -84.51 -43.41 17.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.313 0.577 . . . . 0.0 110.478 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.425 ' N ' ' CG2' ' A' ' 665' ' ' VAL . 18.9 mm -67.35 -36.71 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.565 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.22 -35.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.976 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 3.4 tp -84.9 -63.03 1.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.873 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -26.89 10.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.755 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -70.07 -23.71 63.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.983 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 11.4 mt -85.96 -35.35 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.158 0.504 . . . . 0.0 110.88 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -61.11 -32.97 72.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.509 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -17.9 27.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.566 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -88.59 -35.08 17.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.467 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 36.6 t -96.77 -19.21 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.354 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 676' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.848 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.08 -44.15 15.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 110.855 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.643 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 64.2 t0 -136.92 -97.91 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.405 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -42.96 63.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.469 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.32 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.47 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.2 tm? 178.9 -59.42 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.316 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 15.0 Cg_endo -59.36 -20.13 54.45 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.702 1.601 . . . . 0.0 110.283 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.643 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 0.4 OUTLIER 36.31 -160.4 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.152 178.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -108.36 76.96 1.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.044 0.449 . . . . 0.0 111.027 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 179.48 -35.15 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.348 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.88 -29.28 23.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.752 0.311 . . . . 0.0 110.925 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.2 42.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.219 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -56.84 -22.37 36.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.145 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . 0.427 ' HB3' ' CD1' ' A' ' 648' ' ' TRP . 92.4 m-20 -52.99 -19.83 2.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.039 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . 0.412 ' HA ' ' CD ' ' A' ' 649' ' ' ARG . 25.9 p-90 -48.27 -28.32 3.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.908 0.385 . . . . 0.0 111.126 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.97 24.84 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.982 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 6.3 t -156.21 21.58 0.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.427 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -149.77 -124.92 1.31 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.848 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.427 ' CD1' ' HB3' ' A' ' 643' ' ' ASN . 64.7 p-90 -61.89 -21.05 64.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.655 0.264 . . . . 0.0 111.445 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . 0.482 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 3.3 ttt180 -86.17 -15.93 39.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.876 0.369 . . . . 0.0 110.474 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -73.62 -14.64 61.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.509 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 651' ' ' TRP . 2.3 p-90 -158.9 50.84 0.38 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.687 0.28 . . . . 0.0 111.503 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.482 ' CG1' ' HA ' ' A' ' 649' ' ' ARG . 0.7 OUTLIER -63.89 -48.61 78.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.357 . . . . 0.0 110.552 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 30.6 Cg_endo -94.46 -76.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.488 2.792 . . . . 0.0 112.485 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 167.31 96.1 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.624 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.59 42.3 2.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.323 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.426 ' CA ' ' HA3' ' A' ' 660' ' ' GLY . 9.1 tp -114.48 -39.6 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.706 0.289 . . . . 0.0 111.696 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -134.06 -53.68 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.738 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.51 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.352 0.596 . . . . 0.0 109.843 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.499 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 23.3 m -119.68 -17.81 8.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.992 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . 0.426 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.28 -51.57 4.34 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.623 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.408 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 53.1 t -82.78 -59.65 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.093 0.473 . . . . 0.0 110.567 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.446 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 62.0 t -42.19 -31.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.417 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.7 tp -80.85 -35.98 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.648 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.6 -26.86 34.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.498 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 2.1 p -84.69 -34.3 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 121.122 0.487 . . . . 0.0 110.356 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 45.8 mt -81.46 -38.32 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.267 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.13 -32.41 0.26 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.398 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.57 -63.17 1.38 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.97 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -54.04 -25.96 24.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.06 0.457 . . . . 0.0 110.357 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -67.99 -22.08 65.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.932 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 7.2 mt -85.5 -37.1 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.134 0.492 . . . . 0.0 111.051 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.3 -31.77 71.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.563 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 -17.87 27.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.754 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -92.65 -34.17 14.09 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.155 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -94.15 -11.06 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.396 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.48 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.831 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 631' ' ' SER . . . . . 0.401 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.5 OUTLIER -119.59 -45.0 2.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.706 0.289 . . . . 0.0 110.889 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.595 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 18.8 t70 -137.99 -95.65 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.362 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -52.53 -42.14 64.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.189 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.52 -20.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.483 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.1 tm? 177.79 -58.93 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.364 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 11.2 Cg_endo -58.03 -20.51 45.74 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.724 1.616 . . . . 0.0 110.544 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.595 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 1.4 p-10 30.24 39.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.6 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 636' ' ' PRO . 9.0 mt-30 51.5 98.78 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.163 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -170.12 -40.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.337 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -80.85 -39.96 25.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 110.731 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -178.78 92.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.51 -19.09 62.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -53.88 -20.3 5.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.098 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -48.31 -28.89 3.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.791 0.329 . . . . 0.0 111.163 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -147.62 20.82 1.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 6.9 t -155.6 24.91 0.4 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.771 0.32 . . . . 0.0 111.212 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -151.82 -79.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.655 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -86.13 -21.46 27.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.587 0.232 . . . . 0.0 111.287 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . 0.424 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 1.3 ttp85 -86.44 -15.75 39.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.317 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -71.22 -18.23 62.47 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.177 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -167.54 59.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.591 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.554 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 2.1 mt -60.33 -54.88 50.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.771 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 37.5 Cg_endo -69.13 -64.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.265 1.977 . . . . 0.0 112.378 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 168.39 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.494 0.664 . . . . 0.0 110.281 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.453 ' HA2' ' CG1' ' A' ' 658' ' ' VAL . . . 103.64 38.35 2.8 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.705 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.552 ' O ' ' HA3' ' A' ' 660' ' ' GLY . 0.4 OUTLIER -73.5 -17.68 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.245 0.545 . . . . 0.0 110.515 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -106.52 -35.39 2.87 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . 0.453 ' CG1' ' HA2' ' A' ' 655' ' ' GLY . 13.9 p -82.29 -31.65 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.254 -0.473 . . . . 0.0 110.6 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.565 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 70.9 m -123.47 -20.26 5.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.755 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.2 -44.54 7.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.908 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 96.5 t -82.62 -62.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.205 0.526 . . . . 0.0 110.413 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.488 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 44.0 t -42.05 -32.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.543 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.565 ' HB ' ' O ' ' A' ' 659' ' ' THR . 0.3 OUTLIER -79.27 -34.87 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.689 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.0 -27.23 35.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.285 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.488 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 1.8 p -84.64 -33.98 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 121.285 0.565 . . . . 0.0 110.154 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 662' ' ' VAL . 25.4 mm -82.84 -37.97 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.341 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.13 -32.65 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.342 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.4 tp -84.53 -63.1 1.4 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.821 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -53.86 -25.2 18.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.516 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -69.08 -22.65 63.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 16.1 mt -86.01 -36.3 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.113 0.482 . . . . 0.0 111.082 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -61.44 -33.16 73.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.543 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -17.9 27.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.716 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -91.46 -34.23 14.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.164 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.494 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -95.19 -11.29 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.302 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.494 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.18 -0.915 . . . . 0.0 110.792 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.1 m -120.92 -40.85 2.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.61 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 16.3 t70 -141.88 -99.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.349 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -39.07 60.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.441 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.46 -23.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.236 0.541 . . . . 0.0 112.007 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.614 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 173.1 -52.98 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.923 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 35.8 Cg_exo -55.96 -23.54 43.7 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.714 1.609 . . . . 0.0 110.489 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.61 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.0 p-10 27.28 48.93 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.539 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 43.01 73.54 0.14 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.593 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -134.66 -44.53 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.554 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -97.22 69.03 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 110.986 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 3.4 t30 62.28 86.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -63.86 -23.82 67.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.19 -17.06 9.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.891 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -48.25 -40.27 24.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.724 0.297 . . . . 0.0 111.251 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -131.89 16.39 4.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.385 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 9.5 t -152.48 23.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.794 0.331 . . . . 0.0 111.093 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.41 -96.72 0.28 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.112 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.497 ' O ' ' HB ' ' A' ' 652' ' ' ILE . 57.8 p-90 -64.77 -22.04 66.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.092 0.473 . . . . 0.0 110.697 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.45 -24.07 25.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . 0.416 ' HB3' ' CD1' ' A' ' 651' ' ' TRP . 3.6 tt0 -91.38 -32.93 15.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.207 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . 0.42 ' O ' ' CE3' ' A' ' 651' ' ' TRP . 25.0 p-90 -175.4 67.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.03 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.574 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 9.1 tp -64.3 -33.14 8.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 33.3 Cg_endo -93.82 -74.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.536 2.158 . . . . 0.0 112.442 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 178.67 70.34 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.439 0.638 . . . . 0.0 110.317 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.454 ' CA ' HG13 ' A' ' 658' ' ' VAL . . . 103.62 45.04 1.59 Allowed Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.565 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.479 ' O ' ' HA3' ' A' ' 660' ' ' GLY . 0.4 OUTLIER -73.08 -18.6 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 110.102 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . 0.441 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -106.12 -33.87 3.34 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . 0.454 HG13 ' CA ' ' A' ' 655' ' ' GLY . 13.0 p -82.13 -30.55 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.999 0.428 . . . . 0.0 110.589 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.551 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 99.5 m -124.82 -23.38 4.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.931 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.14 -44.64 7.46 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.156 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.441 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 74.5 t -82.67 -61.67 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.191 0.52 . . . . 0.0 110.574 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.403 ' HA ' HG21 ' A' ' 665' ' ' VAL . 40.1 t -43.05 -33.2 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.461 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 659' ' ' THR . 5.0 tt -77.47 -35.5 22.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.176 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.63 -25.19 35.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.844 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 666' ' ' ILE . 2.8 m -84.38 -42.21 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.301 0.572 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.431 ' N ' ' CG2' ' A' ' 665' ' ' VAL . 45.0 mt -70.82 -37.09 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.437 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -39.85 -34.58 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.117 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.83 -63.15 1.38 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.88 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.15 -26.77 12.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.617 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -69.35 -24.7 63.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.971 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 16.8 mt -86.1 -36.06 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.124 0.487 . . . . 0.0 110.879 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.79 -32.29 70.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.541 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.92 -17.84 27.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.738 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -90.92 -34.34 15.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.081 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.486 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.9 t -95.68 -14.03 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.335 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.486 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.1 m-85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.854 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.21 -44.48 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.696 0.284 . . . . 0.0 110.809 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.61 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 18.5 t70 -137.54 -100.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.272 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.23 -41.59 60.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.363 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.01 -25.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.27 0.557 . . . . 0.0 112.126 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.604 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 175.76 -53.81 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.12 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 39.4 Cg_exo -55.52 -24.56 44.98 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 121.596 1.531 . . . . 0.0 110.512 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.61 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.1 p-10 29.77 39.51 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.562 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 638' ' ' GLN . 7.7 pt20 41.56 94.29 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.931 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 158.52 -33.12 0.49 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.367 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.75 -23.04 10.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.691 0.282 . . . . 0.0 111.058 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -148.04 19.81 1.11 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.569 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -59.98 -22.91 63.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.877 0.37 . . . . 0.0 110.862 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -56.37 -20.2 18.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.635 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -48.53 -27.53 2.79 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.75 0.309 . . . . 0.0 111.244 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.27 22.82 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 5.6 t -159.3 25.5 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.279 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -143.4 -96.44 0.23 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.621 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.424 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 67.0 p-90 -62.59 -20.49 64.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.651 0.262 . . . . 0.0 111.209 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . 0.524 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 26.7 mtt180 -85.92 -14.69 44.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.912 0.387 . . . . 0.0 110.404 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -76.11 -14.07 60.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.505 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . 0.449 ' N ' ' CD1' ' A' ' 651' ' ' TRP . 1.6 p-90 -160.37 50.6 0.29 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.542 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 1.7 mt -67.68 -50.29 35.81 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.733 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 98.4 Cg_endo -84.49 5.6 6.21 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.777 2.318 . . . . 0.0 113.04 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 65.29 90.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.396 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.455 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.47 49.62 1.03 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.527 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.401 HG21 ' HA ' ' A' ' 651' ' ' TRP . 10.3 tp -114.44 -39.52 2.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.908 0.385 . . . . 0.0 111.338 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . 0.462 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -137.46 -60.95 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.563 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 3.4 p -59.73 -39.51 79.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.37 0.605 . . . . 0.0 109.759 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.519 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 31.8 m -117.7 -18.33 9.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.109 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -82.14 -48.1 5.86 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.55 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.462 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 75.6 t -82.76 -60.31 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.233 0.539 . . . . 0.0 110.56 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.477 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 63.5 t -42.0 -32.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.44 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.4 tt -79.02 -34.58 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.677 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.58 -27.75 34.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.327 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.477 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 1.7 p -84.47 -36.16 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.074 0.464 . . . . 0.0 110.275 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 670' ' ' ALA . 39.0 mt -76.44 -36.16 28.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.915 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.05 -32.93 0.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.384 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.1 tp -84.53 -63.1 1.4 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.87 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -54.01 -24.56 17.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.46 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 666' ' ' ILE . . . -71.0 -24.7 62.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.054 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 10.2 mt -84.45 -39.82 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.16 0.505 . . . . 0.0 110.886 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -57.52 -34.65 69.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.772 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.89 -17.84 27.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.835 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -89.28 -33.59 16.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.102 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.492 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.5 t -98.78 -14.07 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.228 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.492 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.774 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 2.2 m -110.6 -44.11 3.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.754 0.312 . . . . 0.0 110.748 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 43.7 t0 -140.51 -100.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.169 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -54.52 -44.64 72.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.389 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.15 -28.64 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.494 0.664 . . . . 0.0 111.977 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.592 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.5 OUTLIER 175.14 -53.26 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.851 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 31.4 Cg_exo -54.63 -24.43 36.95 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 121.654 1.569 . . . . 0.0 110.511 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.592 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 5.9 p-10 28.95 56.47 0.12 Allowed 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.451 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . 0.441 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 10.4 pt20 42.99 96.01 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.715 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -168.18 -40.81 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.416 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -111.05 -29.99 7.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.307 . . . . 0.0 110.982 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 0.6 OUTLIER -162.94 88.97 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.055 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 638' ' ' GLN . 2.8 p30 -102.81 -28.54 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.945 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -64.37 -24.91 67.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.993 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 1.4 p-90 -48.48 -32.08 7.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.719 0.295 . . . . 0.0 111.19 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -130.58 -13.3 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.981 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 4.8 t -132.39 34.49 3.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.81 0.338 . . . . 0.0 111.302 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -145.25 -96.31 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.447 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -72.05 -29.65 64.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 110.769 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 19.7 ttm-85 -86.34 -13.79 45.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.393 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -68.33 -12.89 61.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.385 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -162.31 45.58 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.747 0.308 . . . . 0.0 111.055 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.592 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 0.0 OUTLIER -86.17 -33.05 0.46 Allowed Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 63.1 Cg_endo -93.43 -4.49 3.0 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.512 2.142 . . . . 0.0 112.791 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 74.81 90.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.996 0.427 . . . . 0.0 110.585 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.456 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.15 46.15 1.38 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.444 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.466 ' CA ' ' HA3' ' A' ' 660' ' ' GLY . 9.3 tp -114.55 -39.5 2.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . . . . . . . . . . . -130.78 -58.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.883 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.39 -39.14 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.224 0.535 . . . . 0.0 109.985 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.513 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 5.6 m -119.11 -19.16 8.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.147 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . 0.466 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.33 -52.72 3.88 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.681 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 664' ' ' ALA . 76.5 t -82.39 -62.13 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.063 0.459 . . . . 0.0 110.964 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 24.5 t -42.37 -30.97 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.692 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.5 tp -76.62 -35.06 24.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.216 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.56 -24.57 36.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.894 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . . . . . . . . . 1.1 t -83.83 -45.64 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.465 0.65 . . . . 0.0 110.008 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 670' ' ' ALA . 23.2 mm -68.5 -35.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.491 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.77 -34.82 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.145 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.8 tp -84.7 -63.11 1.39 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.003 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.76 -24.65 9.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.655 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 666' ' ' ILE . . . -72.43 -25.02 61.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.26 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 10.2 mt -78.8 -41.2 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.093 0.473 . . . . 0.0 111.135 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -59.05 -33.82 71.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.7 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -17.95 26.95 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.635 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 11.0 t80 -86.67 -34.6 19.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.826 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.487 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 44.6 t -100.55 -18.51 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.487 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.779 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.546 -0.221 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.97 -41.77 11.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.726 0.298 . . . . 0.0 110.896 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.611 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.2 t0 -141.55 -92.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.354 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -58.98 -39.02 80.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.51 -27.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.421 0.629 . . . . 0.0 111.867 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.619 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 178.51 -54.56 0.0 OUTLIER Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.787 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 38.3 Cg_exo -55.48 -23.76 40.65 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.597 1.531 . . . . 0.0 110.375 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.611 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.5 p-10 28.8 49.77 0.04 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.519 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 42.94 65.47 0.94 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.507 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -126.97 -41.92 0.29 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.23 80.93 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.95 80.82 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.005 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -67.55 -26.83 66.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 648' ' ' TRP . 7.0 m120 -56.26 -22.03 27.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.488 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 648' ' ' TRP . 3.4 p-90 -48.55 -28.48 3.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.752 0.311 . . . . 0.0 111.2 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . 0.417 ' HA ' ' CE3' ' A' ' 645' ' ' TRP . 0.0 OUTLIER -144.93 19.6 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.2 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 5.9 t -156.82 25.03 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.698 0.285 . . . . 0.0 111.224 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -146.48 -109.4 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.462 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.427 ' CZ2' ' HA ' ' A' ' 644' ' ' TRP . 49.2 p-90 -59.32 -21.4 59.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 111.133 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . 0.482 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 2.7 ttt85 -86.45 -18.03 32.75 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.044 0.449 . . . . 0.0 110.2 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.25 -3.85 41.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.809 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . 0.42 ' HA ' HG21 ' A' ' 656' ' ' ILE . 5.3 p-90 -169.28 49.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.838 0.351 . . . . 0.0 110.959 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.558 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 1.7 mt -62.1 -56.71 28.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.076 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.558 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 34.1 Cg_endo -66.68 -74.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.208 1.939 . . . . 0.0 112.477 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 177.9 69.64 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.446 0.641 . . . . 0.0 110.359 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.47 ' CA ' HG12 ' A' ' 658' ' ' VAL . . . 103.78 35.37 3.51 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.989 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.539 ' O ' ' HA3' ' A' ' 660' ' ' GLY . 0.5 OUTLIER -73.54 -15.26 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.0 110.31 178.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . . . . . . . . . . . -108.36 -34.08 2.78 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . 0.47 HG12 ' CA ' ' A' ' 655' ' ' GLY . 14.5 p -82.03 -31.78 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 110.313 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.543 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 82.0 m -124.43 -21.24 4.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.801 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.22 -53.1 3.77 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.261 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 656' ' ' ILE . 54.1 t -82.69 -61.06 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.219 0.533 . . . . 0.0 110.837 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.455 ' HA ' HG23 ' A' ' 665' ' ' VAL . 39.1 t -42.07 -33.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.544 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.543 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.0 OUTLIER -75.16 -37.79 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.291 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.63 -24.66 36.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.184 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' A' ' 662' ' ' VAL . 3.3 m -84.4 -43.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.427 ' N ' ' CG2' ' A' ' 665' ' ' VAL . 19.7 mm -68.22 -35.42 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.383 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.34 -34.7 0.35 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.138 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 4.1 tp -84.87 -63.05 1.4 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.811 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.76 -26.9 10.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.612 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -67.96 -22.0 65.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.07 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 23.3 mm -85.26 -37.52 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.088 0.471 . . . . 0.0 111.142 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.49 -33.16 73.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.632 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -17.84 27.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.738 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -91.52 -34.3 14.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.482 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -94.86 -11.92 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.354 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.482 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.843 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 5.2 t -108.12 -43.65 4.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.59 0.233 . . . . 0.0 110.935 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.572 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 20.2 t70 -139.23 -102.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.278 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -49.61 -40.57 39.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.779 0.323 . . . . 0.0 111.373 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.5 -24.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.232 0.539 . . . . 0.0 111.928 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.3 tm? 176.78 -58.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.471 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 7.4 Cg_endo -53.9 -21.26 20.2 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.983 1.788 . . . . 0.0 111.077 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.572 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 7.0 p-10 25.18 60.94 0.06 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.707 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 39.18 68.89 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.727 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -123.21 -49.09 0.23 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -99.96 81.03 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.335 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.53 87.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -66.84 -27.83 67.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.04 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -56.86 -20.12 21.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.604 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -48.43 -30.04 4.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.818 0.342 . . . . 0.0 111.228 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -144.5 20.89 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 6.6 t -160.66 27.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.742 0.306 . . . . 0.0 111.125 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.59 -111.21 0.86 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.517 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -57.9 -22.25 47.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.121 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 23.9 ttt-85 -86.5 -20.16 28.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.049 0.452 . . . . 0.0 110.185 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -24.4 61.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.034 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . 0.454 ' CD1' ' N ' ' A' ' 651' ' ' TRP . 1.2 p-90 -165.58 61.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.732 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 1.5 tp -66.81 -33.87 6.78 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.197 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 35.0 Cg_endo -94.39 -73.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.681 2.254 . . . . 0.0 112.409 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 167.45 80.36 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.438 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.416 ' CA ' ' HB ' ' A' ' 659' ' ' THR . . . 103.57 45.3 1.56 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.361 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.454 HG23 ' HA ' ' A' ' 651' ' ' TRP . 3.0 tp -102.71 -34.51 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.041 0.448 . . . . 0.0 110.842 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 656' ' ' ILE . . . -114.07 -35.91 1.43 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.514 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . 0.416 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 14.7 p -81.24 -40.33 18.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.145 0.498 . . . . 0.0 110.081 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.538 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 43.6 m -117.63 -16.42 10.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.086 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 656' ' ' ILE . . . -82.39 -48.87 5.45 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.307 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.402 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 84.1 t -82.78 -60.72 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.168 0.508 . . . . 0.0 110.66 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.489 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 54.2 t -42.02 -32.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.529 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' A' ' 659' ' ' THR . 3.2 tp -78.65 -35.62 18.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.79 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.43 -26.97 34.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.37 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 1.9 p -84.81 -36.07 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.151 0.501 . . . . 0.0 110.261 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 25.1 mm -79.59 -37.56 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.195 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.33 -33.59 0.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.265 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.4 tp -84.77 -63.22 1.37 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.997 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -26.83 16.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.025 0.441 . . . . 0.0 110.43 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -65.72 -25.03 67.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.84 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 21.9 mm -86.1 -36.34 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.151 0.5 . . . . 0.0 110.939 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -59.8 -31.29 69.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.96 -17.86 27.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.638 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.87 -35.1 15.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.02 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.473 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.9 t -95.88 -16.51 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.351 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 676' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.828 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 3.1 m -131.72 -50.79 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.69 0.281 . . . . 0.0 110.799 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.535 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.7 t70 -136.87 -90.85 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -38.03 89.61 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.223 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 3.1 m -165.11 -32.4 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.599 0.714 . . . . 0.0 111.459 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.592 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.6 OUTLIER 175.0 -52.56 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.853 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 34.8 Cg_exo -55.27 -24.19 40.96 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.62 1.547 . . . . 0.0 110.45 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.535 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 5.7 p-10 30.45 51.3 0.1 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.286 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 42.94 97.26 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.873 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 157.23 -30.96 0.53 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.442 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -104.16 -29.06 11.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.712 0.292 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -166.17 41.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.307 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -61.34 -22.84 65.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.872 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -54.85 -22.9 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.702 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -49.02 -29.23 4.69 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.777 0.322 . . . . 0.0 111.296 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -144.7 21.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.199 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 6.2 t -160.77 27.3 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.792 0.33 . . . . 0.0 111.197 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -148.25 -88.72 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.398 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 37.5 p-90 -74.19 -24.1 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 0.0 110.795 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 29.7 ttt85 -86.24 -12.13 50.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.484 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -14.63 63.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.111 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . 0.425 ' N ' ' CD1' ' A' ' 651' ' ' TRP . 2.3 p-90 -169.17 51.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.876 0.37 . . . . 0.0 110.828 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 5.3 tt -82.97 -32.48 0.55 Allowed Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 44.4 Cg_endo -91.61 -75.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.301 2.001 . . . . 0.0 112.601 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 166.53 84.22 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.958 0.409 . . . . 0.0 110.316 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.58 39.9 2.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.295 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.549 ' O ' ' HA3' ' A' ' 660' ' ' GLY . 1.6 tp -101.85 -31.53 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.196 0.522 . . . . 0.0 110.676 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . 0.415 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -105.99 -37.02 2.61 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.25 -38.08 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.03 -0.585 . . . . 0.0 110.321 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.535 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 78.7 m -115.98 -20.08 10.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.746 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.29 -44.69 7.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.421 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.415 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 90.5 t -82.55 -61.53 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.149 0.5 . . . . 0.0 110.472 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.491 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 51.4 t -42.35 -32.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.402 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 659' ' ' THR . 0.2 OUTLIER -79.34 -34.2 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.701 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.45 -27.52 34.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.224 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.491 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 1.8 p -84.55 -34.38 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.264 0.554 . . . . 0.0 110.132 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 24.3 mm -82.06 -37.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.161 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.38 -32.41 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.453 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.19 -63.28 1.37 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.768 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . 0.401 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -53.67 -25.76 19.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.979 0.418 . . . . 0.0 110.325 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -68.76 -22.96 64.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.067 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 7.5 mt -86.07 -37.39 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.08 0.467 . . . . 0.0 111.164 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.92 -30.75 69.26 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.697 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.97 -17.85 27.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.831 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.2 OUTLIER -93.54 -33.51 13.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.243 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.49 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 41.9 t -94.93 -6.95 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.59 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.49 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.8 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.763 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.98 -41.11 3.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.617 0.246 . . . . 0.0 110.987 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.567 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 15.5 t70 -143.61 -99.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.481 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -50.34 -39.05 45.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.461 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.4 -24.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 0.0 112.124 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.473 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.2 tm? 177.14 -58.74 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.332 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 9.3 Cg_endo -56.42 -20.49 33.14 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.749 1.633 . . . . 0.0 110.688 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.567 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.9 p-10 29.78 53.46 0.12 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.518 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 42.8 66.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.543 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -135.13 -59.57 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.381 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.68 -28.31 23.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 0.0 110.781 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . 0.424 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 1.4 t-20 -153.55 88.68 1.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.709 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . 0.4 ' O ' ' CG2' ' A' ' 646' ' ' THR . 2.7 p30 -109.57 -29.95 8.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -53.55 -28.83 33.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.859 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . 0.424 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 5.6 p-90 -48.68 -27.5 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.386 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -151.23 26.73 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.459 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 646' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 642' ' ' ASP . 4.2 t -168.66 32.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.81 0.338 . . . . 0.0 111.159 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 651' ' ' TRP . . . -149.36 -93.31 0.11 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.321 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.425 ' CH2' ' HG3' ' A' ' 649' ' ' ARG . 47.0 p-90 -64.92 -21.03 66.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.691 0.282 . . . . 0.0 110.965 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . 0.458 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 3.9 mtp85 -86.33 -19.75 29.35 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.063 0.458 . . . . 0.0 110.112 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -71.21 -22.02 62.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.069 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 651' ' ' TRP . 1.5 p-90 -154.91 57.34 0.67 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.893 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.472 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 0.5 OUTLIER -66.0 -49.51 56.93 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.751 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 31.1 Cg_endo -94.39 -77.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.417 2.745 . . . . 0.0 112.581 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 167.24 98.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.566 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.7 39.72 2.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.466 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . . . . . . . . . 5.6 tp -114.26 -39.62 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 111.535 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . 0.448 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -137.69 -58.61 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 659' ' ' THR . 4.4 p -63.21 -41.18 91.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.369 0.604 . . . . 0.0 109.638 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.515 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 40.6 m -114.19 -17.52 11.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.854 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -82.11 -46.31 6.67 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.641 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.448 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 76.6 t -82.57 -60.67 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.169 0.509 . . . . 0.0 110.62 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.475 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 54.1 t -42.16 -32.67 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.324 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 659' ' ' THR . 0.3 OUTLIER -79.42 -34.97 16.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.662 -179.229 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.42 -27.33 34.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.431 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 2.0 p -84.61 -33.73 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.239 0.542 . . . . 0.0 110.146 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 25.3 mm -82.99 -36.76 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.132 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -42.2 -32.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.402 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.59 -63.32 1.36 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . 0.472 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.2 OUTLIER -52.61 -29.28 25.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.034 0.445 . . . . 0.0 110.134 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -65.48 -21.61 66.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.174 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 11.8 mt -80.54 -36.44 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 120.967 0.413 . . . . 0.0 111.942 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.13 69.31 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.43 0.633 . . . . 0.0 110.659 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.03 -17.77 27.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.905 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . 0.499 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.3 OUTLIER -99.18 -32.55 11.17 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.508 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.427 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 43.6 t -90.98 2.42 7.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.426 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 676' ' ' PHE . 4.7 m-85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 3.3 t -70.04 -42.02 73.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.623 0.249 . . . . 0.0 110.944 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.577 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 38.6 t70 -140.16 -102.53 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.444 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -44.31 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 111.371 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.75 -27.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.42 0.629 . . . . 0.0 111.934 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.617 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 176.89 -54.32 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.174 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.057 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 33.5 Cg_exo -54.77 -24.56 38.55 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.595 1.53 . . . . 0.0 110.502 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.577 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.1 p-10 29.38 41.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.561 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 42.6 67.54 0.6 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.571 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -142.63 -58.6 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.641 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.31 -49.59 16.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.01 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -159.54 90.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.02 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -86.99 -25.68 24.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.971 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -55.12 -22.03 15.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.554 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -48.54 -28.42 3.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.764 0.316 . . . . 0.0 111.24 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.43 19.08 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.147 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 5.8 t -155.99 25.6 0.37 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.818 0.342 . . . . 0.0 111.119 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.78 -89.52 0.14 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.912 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 36.7 p-90 -70.71 -21.29 62.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 110.423 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' A' ' 649' ' ' ARG . 1.2 ttt85 -86.05 -12.11 51.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.405 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . 0.418 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.0 OUTLIER -65.84 -11.84 49.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.325 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . 0.463 ' N ' ' CD1' ' A' ' 651' ' ' TRP . 1.2 p-90 -164.24 48.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 110.71 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.583 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 1.6 tp -97.1 -31.71 0.26 Allowed Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 63.7 Cg_endo -88.05 -7.97 5.93 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.229 1.953 . . . . 0.0 112.822 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 76.54 91.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.989 0.423 . . . . 0.0 110.504 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 104.33 42.0 1.96 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.458 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.451 ' HB ' ' HG2' ' A' ' 653' ' ' PRO . 10.2 tp -114.55 -39.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.912 0.387 . . . . 0.0 111.464 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . . . . . . . . . . . -141.64 -59.25 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . 0.4 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.2 p -62.8 -37.05 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.431 0.634 . . . . 0.0 109.595 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.545 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 54.2 m -118.04 -17.83 9.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.992 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -82.03 -56.82 2.8 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.768 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 664' ' ' ALA . 40.8 t -82.41 -60.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.096 0.474 . . . . 0.0 111.123 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 666' ' ' ILE . 24.9 t -43.2 -31.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.677 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 659' ' ' THR . 5.3 tt -72.9 -34.18 45.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.946 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.47 -24.88 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.472 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . . . . . . . . . 1.4 t -84.03 -45.63 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.374 0.607 . . . . 0.0 110.016 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 662' ' ' VAL . 19.0 mm -65.49 -34.81 72.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.337 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.7 -34.56 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.039 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.4 tp -84.75 -63.02 1.41 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.963 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -52.66 -25.19 10.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.736 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -71.25 -25.16 62.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.114 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 8.5 mt -82.95 -35.97 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.14 0.495 . . . . 0.0 110.999 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.47 78.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.469 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 -17.9 26.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -90.99 -34.05 15.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.228 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.473 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.2 t -95.82 -10.1 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.473 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.6 m-85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.774 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.48 -40.96 28.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.589 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.6 t0 -140.23 -92.99 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.83 0.347 . . . . 0.0 111.369 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -39.9 89.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.34 -24.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.284 0.564 . . . . 0.0 111.89 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.615 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 175.24 -53.42 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.995 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 35.3 Cg_exo -55.05 -24.11 38.65 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.686 1.59 . . . . 0.0 110.53 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.589 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.6 p-10 24.86 55.25 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.584 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 42.87 77.99 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.546 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -132.48 -46.16 0.12 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.418 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.12 77.77 1.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.344 . . . . 0.0 110.767 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.66 86.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -80.61 -19.92 44.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.218 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -53.98 -23.9 14.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.542 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -50.92 -28.25 9.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.202 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -144.07 19.0 1.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.268 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 5.7 t -156.83 25.53 0.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.824 0.345 . . . . 0.0 111.173 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.45 -93.19 0.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.277 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -76.52 -31.88 57.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 110.664 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -86.4 -12.08 50.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.561 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.72 -13.78 55.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.627 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -163.65 44.61 0.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.754 0.312 . . . . 0.0 111.146 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 2.7 tt -89.51 -31.73 0.37 Allowed Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 52.9 Cg_endo -92.32 -4.65 3.61 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.425 2.083 . . . . 0.0 112.904 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 74.62 89.49 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.957 0.408 . . . . 0.0 110.633 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.94 47.66 1.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.462 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.439 ' HB ' ' HG2' ' A' ' 653' ' ' PRO . 8.4 tp -114.58 -39.75 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.785 0.326 . . . . 0.0 111.725 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . 0.418 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -140.46 -61.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.505 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.24 -36.13 70.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.368 0.604 . . . . 0.0 109.679 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.495 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 54.8 m -118.85 -19.1 8.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.157 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -82.2 -52.95 3.83 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.944 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.418 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 57.6 t -82.57 -60.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.135 0.493 . . . . 0.0 110.979 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.468 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 42.2 t -42.03 -31.78 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.572 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 659' ' ' THR . 0.6 OUTLIER -79.02 -36.46 18.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.712 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.53 -27.05 34.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.571 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 2.0 p -84.65 -34.4 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.152 0.501 . . . . 0.0 110.397 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 39.0 mt -80.29 -37.99 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.285 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 671' ' ' ILE . . . -40.45 -33.3 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.287 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.69 -63.05 1.4 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.029 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -54.08 -24.57 17.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.578 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -73.07 -21.91 60.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.019 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 667' ' ' ALA . 4.9 mt -77.84 -55.33 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 121.322 0.582 . . . . 0.0 110.729 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . 0.443 ' HA ' ' HE1' ' A' ' 676' ' ' PHE . . . -46.82 -62.6 1.32 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.986 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -22.5 11.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.206 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -70.03 -51.08 35.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.061 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.08 -43.66 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.073 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.443 ' HE1' ' HA ' ' A' ' 672' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.825 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.35 -39.9 6.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.721 0.296 . . . . 0.0 110.95 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.642 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 23.1 t70 -139.8 -98.85 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.399 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -53.42 -42.06 66.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.312 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.94 -20.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.611 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 173.17 -53.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.975 179.242 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 39.5 Cg_exo -55.82 -23.51 42.38 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.706 1.604 . . . . 0.0 110.461 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.642 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.8 p-10 25.54 48.32 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.577 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 637' ' ' ASP . 0.2 OUTLIER 35.32 90.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.039 179.554 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -168.12 -52.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.452 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.62 -37.31 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.0 110.801 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.64 94.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -90.58 9.72 28.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.06 -20.43 53.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.457 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -49.26 -35.13 16.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.134 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -133.71 9.13 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.537 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 3.0 t -145.12 23.46 1.51 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.796 0.331 . . . . 0.0 111.072 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -131.62 -100.41 0.81 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.146 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -73.47 -27.29 61.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.735 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 30.1 ttm-85 -86.27 -11.94 50.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.435 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -72.09 -9.87 59.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.317 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . 0.4 ' HA ' ' CG2' ' A' ' 656' ' ' ILE . 0.1 OUTLIER -165.08 47.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.336 -179.367 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 1.7 tp -92.31 -31.86 0.33 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 57.5 Cg_endo -91.31 -7.41 3.56 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.386 2.058 . . . . 0.0 113.078 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 75.19 92.94 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.01 0.434 . . . . 0.0 110.363 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.49 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.38 42.01 1.96 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.272 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.478 ' HB ' ' HG2' ' A' ' 653' ' ' PRO . 9.1 tp -114.5 -39.46 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 111.543 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . . . . . . . . . . . -128.83 -57.81 0.11 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.917 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . 0.407 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.9 p -63.11 -39.82 86.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.282 0.563 . . . . 0.0 110.213 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.49 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 13.6 m -119.4 -18.42 8.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.138 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . 0.472 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.27 -58.71 2.39 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.649 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.406 ' CG1' HG11 ' A' ' 665' ' ' VAL . 92.7 t -82.28 -61.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.173 0.511 . . . . 0.0 110.998 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.424 ' HA ' HG21 ' A' ' 665' ' ' VAL . 40.1 t -41.81 -31.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.751 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.4 tt -77.09 -38.43 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.305 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.17 36.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.34 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.424 HG21 ' HA ' ' A' ' 662' ' ' VAL . 10.9 m -84.43 -44.29 17.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.269 0.557 . . . . 0.0 110.331 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 670' ' ' ALA . 37.4 mt -66.83 -36.4 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.371 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.75 -35.5 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.955 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 3.2 tp -84.87 -63.01 1.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.88 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . 0.407 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -52.16 -26.31 11.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.665 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 666' ' ' ILE . . . -70.92 -21.96 62.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.181 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 9.7 mt -86.07 -38.54 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.129 0.49 . . . . 0.0 111.041 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -58.99 -31.09 68.47 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.753 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.01 -17.83 27.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.839 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.1 OUTLIER -92.45 -34.23 14.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.166 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 40.8 t -94.62 -10.5 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.514 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.493 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.6 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.799 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.71 -43.2 8.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.685 0.279 . . . . 0.0 110.93 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.613 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 9.1 t0 -139.63 -93.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.9 0.381 . . . . 0.0 111.353 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.29 -41.18 79.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.012 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.31 -21.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.126 0.489 . . . . 0.0 112.2 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.2 tm? 177.47 -58.57 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.366 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 9.4 Cg_endo -56.53 -20.22 32.74 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.792 1.661 . . . . 0.0 110.76 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.613 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.0 p-10 27.0 50.16 0.02 OUTLIER 'General case' 0 C--O 1.23 0.072 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.564 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . 0.426 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 4.0 pt20 43.97 98.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.821 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -170.8 -51.89 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.661 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.37 -37.22 14.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.347 . . . . 0.0 111.013 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -170.43 94.41 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 638' ' ' GLN . 4.8 p-10 -99.59 -34.73 10.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.723 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -51.09 -24.62 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.846 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -48.68 -27.53 2.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.819 0.342 . . . . 0.0 111.191 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -150.71 24.51 0.77 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 646' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 642' ' ' ASP . 6.8 t -162.19 28.71 0.11 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.772 0.32 . . . . 0.0 111.193 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -151.19 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.328 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.41 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 59.6 p-90 -73.33 -21.54 60.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.788 0.328 . . . . 0.0 110.832 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . 0.41 ' HG3' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -86.21 -11.94 51.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.654 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -68.91 -7.54 35.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.867 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -166.92 41.39 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.71 0.291 . . . . 0.0 111.174 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.602 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 2.5 tp -89.63 -31.72 0.37 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 60.3 Cg_endo -91.65 -6.4 3.63 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.427 2.084 . . . . 0.0 112.856 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 74.98 91.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.99 0.424 . . . . 0.0 110.483 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.13 45.23 1.5 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.227 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.448 ' HB ' ' HG2' ' A' ' 653' ' ' PRO . 9.4 tp -114.53 -39.51 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . 0.427 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -135.23 -62.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.789 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.89 -38.21 75.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.321 0.582 . . . . 0.0 109.818 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 43.5 m -118.22 -19.37 9.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.233 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . 0.411 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.18 -47.88 5.94 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.682 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.427 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 74.1 t -82.52 -60.23 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 110.439 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.454 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 78.0 t -42.07 -31.76 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.307 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 659' ' ' THR . 5.2 tt -80.96 -34.51 13.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.616 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.59 -27.49 34.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.42 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 1.7 p -84.44 -35.09 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.224 0.535 . . . . 0.0 110.13 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 51.2 mt -79.6 -36.69 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.831 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.98 -32.93 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.398 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.8 tp -84.58 -62.96 1.42 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -53.4 -25.42 15.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.474 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -70.03 -23.93 63.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.138 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 17.9 mt -85.1 -40.53 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.097 0.475 . . . . 0.0 110.952 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -56.68 -32.17 65.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.818 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -17.92 27.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.922 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -92.17 -32.89 14.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.208 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.482 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.3 t -97.2 -10.9 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.489 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.482 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.837 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 631' ' ' SER . . . . . 0.429 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -127.89 -51.86 1.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.568 0.223 . . . . 0.0 111.001 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.541 ' CB ' ' HB2' ' A' ' 637' ' ' ASP . 9.9 t0 -132.04 -95.64 0.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.464 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -38.23 69.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.407 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.06 -26.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.238 0.542 . . . . 0.0 112.253 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.2 tm? 178.04 -58.75 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.436 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 11.1 Cg_endo -57.81 -20.15 42.23 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.752 1.634 . . . . 0.0 110.649 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 632' ' ' ASP . 2.0 p-10 33.48 36.97 0.01 OUTLIER 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.392 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 53.14 87.7 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.174 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -152.1 -46.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.404 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.45 -31.38 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 2.4 m120 -159.13 83.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . 0.409 ' O ' ' CG2' ' A' ' 646' ' ' THR . 7.8 p-10 -95.24 -26.89 15.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.04 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -65.29 -20.64 66.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.009 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 1.4 p-90 -48.44 -27.93 2.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.628 0.251 . . . . 0.0 111.421 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.04 27.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.637 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 646' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 642' ' ' ASP . 5.9 t -175.03 32.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.444 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -137.92 -88.57 0.2 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.594 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.448 ' CE2' ' HG3' ' A' ' 649' ' ' ARG . 50.2 p-90 -69.86 -29.54 66.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 0.0 111.154 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . 0.448 ' HG3' ' CE2' ' A' ' 648' ' ' TRP . 2.6 mtp-105 -86.43 -16.26 37.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 0.0 110.362 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -65.82 -24.13 66.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.085 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . 0.432 ' HA ' ' CG2' ' A' ' 656' ' ' ILE . 1.4 p-90 -160.74 56.72 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.133 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.608 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 9.5 tp -81.98 -32.61 0.61 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 62.9 Cg_endo -96.03 -5.27 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.715 2.277 . . . . 0.0 112.875 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 75.61 89.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.003 0.43 . . . . 0.0 110.465 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.46 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.05 48.44 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.351 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.439 ' HB ' ' HG2' ' A' ' 653' ' ' PRO . 10.4 tp -114.48 -39.77 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . . . . . . . . . . . -132.6 -59.43 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.939 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 3.5 p -61.68 -38.69 80.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.26 0.552 . . . . 0.0 110.012 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.507 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 29.9 m -119.91 -18.46 8.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.214 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . 0.434 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.32 -55.26 3.11 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.673 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 664' ' ' ALA . 93.8 t -82.51 -60.73 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.109 0.48 . . . . 0.0 111.011 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.406 ' HA ' HG23 ' A' ' 665' ' ' VAL . 38.3 t -42.44 -32.41 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.609 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.6 tp -76.14 -37.27 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.64 -24.38 36.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.134 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.429 ' CG2' ' N ' ' A' ' 666' ' ' ILE . 2.7 m -84.25 -41.98 16.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.335 0.588 . . . . 0.0 110.297 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.429 ' N ' ' CG2' ' A' ' 665' ' ' VAL . 43.4 mt -70.83 -36.63 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.321 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -39.94 -34.86 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.183 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 3.0 tp -84.74 -63.15 1.38 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.887 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . 0.403 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.2 OUTLIER -52.51 -25.59 10.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.675 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 666' ' ' ILE . . . -71.92 -24.57 61.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.045 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 11.6 mt -85.99 -37.85 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.117 0.484 . . . . 0.0 110.883 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -57.62 -32.43 67.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.652 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.88 -17.96 27.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.742 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.2 OUTLIER -89.25 -34.89 16.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.484 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 41.0 t -97.15 -15.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.406 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.484 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.733 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.27 -43.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.619 0.247 . . . . 0.0 111.005 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.603 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 67.2 t0 -137.86 -105.07 0.19 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.374 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -46.06 -44.06 15.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 0.0 111.547 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.8 -26.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.374 0.607 . . . . 0.0 112.049 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.602 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 174.35 -52.99 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.835 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 37.4 Cg_exo -56.06 -23.86 46.19 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.682 1.588 . . . . 0.0 110.363 178.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.603 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.9 p-10 31.45 40.01 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.314 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 42.98 69.25 0.41 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.515 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -131.9 -57.03 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.422 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.7 -28.92 19.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.361 . . . . 0.0 110.862 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 0.6 OUTLIER -159.43 93.58 1.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.83 179.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -102.57 -36.96 8.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -54.19 -22.54 11.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.592 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 7.4 p-90 -48.56 -28.22 3.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.788 0.327 . . . . 0.0 111.18 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -149.18 23.25 0.94 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.264 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 6.2 t -160.35 27.18 0.16 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.698 0.285 . . . . 0.0 111.264 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -150.36 -85.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.517 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.438 ' O ' HG13 ' A' ' 652' ' ' ILE . 69.3 p-90 -79.43 -21.27 45.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.62 0.248 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . 0.513 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 2.6 ttt85 -86.34 -15.8 39.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.063 0.458 . . . . 0.0 110.346 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -16.59 61.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.37 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . 0.441 ' CD1' ' N ' ' A' ' 651' ' ' TRP . 1.9 p-90 -162.7 54.86 0.21 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.693 0.282 . . . . 0.0 111.258 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.513 ' CG1' ' HA ' ' A' ' 649' ' ' ARG . 0.3 OUTLIER -69.63 -51.32 16.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 110.809 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 32.1 Cg_endo -95.13 -80.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.456 2.771 . . . . 0.0 112.628 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 170.35 105.94 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.722 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.79 35.44 3.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.612 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.4 ' CG2' ' HA ' ' A' ' 651' ' ' TRP . 0.6 OUTLIER -114.15 -39.58 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 0.0 111.454 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . 0.432 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -137.82 -58.09 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 4.6 p -64.59 -39.25 84.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.303 0.573 . . . . 0.0 109.638 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.526 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 20.5 m -115.08 -17.37 11.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.852 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -81.92 -46.18 6.81 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.53 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.432 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 99.5 t -82.6 -60.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.26 0.553 . . . . 0.0 110.448 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.498 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 53.8 t -42.0 -31.65 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.56 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 659' ' ' THR . 0.7 OUTLIER -79.66 -34.09 15.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.748 -179.154 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.48 -27.36 34.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.164 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.498 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 1.5 p -84.55 -36.0 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.131 0.491 . . . . 0.0 110.156 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 39.4 mt -78.91 -37.02 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.022 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.38 -32.96 0.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.481 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.6 -63.13 1.39 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.803 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -24.51 15.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 110.508 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -70.7 -22.47 62.45 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.168 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 6.8 mt -81.59 -51.9 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.172 0.511 . . . . 0.0 110.975 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -48.95 -33.4 10.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.699 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . 0.449 ' H ' ' HG3' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.8 -17.9 27.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.523 -179.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -96.35 -31.16 13.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.738 0.304 . . . . 0.0 111.385 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.456 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 41.1 t -94.66 -1.19 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.381 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.456 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 2.4 m-85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.801 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 631' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 637' ' ' ASP . 42.5 t 61.54 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.491 0.186 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.613 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 38.8 t70 -122.51 -99.76 0.42 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.745 0.307 . . . . 0.0 111.235 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -45.15 80.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.269 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.2 -24.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.133 0.492 . . . . 0.0 112.31 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.487 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.2 tm? 177.03 -58.66 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.425 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 9.2 Cg_endo -56.56 -20.53 34.28 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.775 1.65 . . . . 0.0 110.864 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.613 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.9 p-10 31.24 39.87 0.01 OUTLIER 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.38 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 52.95 97.96 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.189 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -171.68 -40.8 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.452 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -83.34 -34.79 25.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -168.01 47.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -51.16 -27.18 8.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.255 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -52.18 -20.56 2.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.94 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 -48.36 -28.85 3.44 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.786 0.327 . . . . 0.0 111.269 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.58 22.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.239 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 11.0 t -156.97 25.36 0.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.108 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.78 -111.97 0.89 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.235 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -60.4 -21.52 62.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.709 0.29 . . . . 0.0 110.926 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . 0.451 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 39.2 ttt85 -86.55 -19.13 29.9 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.33 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -26.97 64.23 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.861 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -153.29 58.9 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.083 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.491 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 1.9 mt -63.07 -47.56 85.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.698 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 29.5 Cg_endo -95.42 -76.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.458 2.772 . . . . 0.0 112.548 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 165.68 95.6 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.473 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.473 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.67 42.92 1.9 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.337 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.403 ' C ' ' HA3' ' A' ' 660' ' ' GLY . 10.3 tp -114.27 -39.55 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.821 0.344 . . . . 0.0 111.465 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . 0.447 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -135.23 -56.59 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 659' ' ' THR . 8.0 p -63.47 -42.72 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.345 0.593 . . . . 0.0 109.757 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.527 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 20.4 m -114.86 -16.96 11.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.867 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . 0.403 ' HA3' ' C ' ' A' ' 656' ' ' ILE . . . -82.24 -46.6 6.48 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.64 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.447 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 67.7 t -82.82 -59.12 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.108 0.48 . . . . 0.0 110.345 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.461 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 74.6 t -42.56 -32.33 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.078 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 659' ' ' THR . 0.5 OUTLIER -81.3 -34.37 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.566 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.51 -27.07 34.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.298 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 2.1 p -84.44 -34.71 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.215 0.531 . . . . 0.0 110.076 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 61.3 mt -81.61 -36.66 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.086 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . 0.428 ' O ' HG13 ' A' ' 671' ' ' ILE . . . -41.83 -32.2 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.413 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.57 -62.79 1.47 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.74 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -24.66 15.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.022 0.439 . . . . 0.0 110.388 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -73.65 -21.94 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.149 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.516 HG22 HD11 ' A' ' 671' ' ' ILE . 6.8 mt -75.37 -55.58 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 121.289 0.566 . . . . 0.0 111.012 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . 0.419 ' HA ' ' HE1' ' A' ' 676' ' ' PHE . . . -47.52 -62.62 1.35 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.795 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -21.94 18.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.154 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -65.5 -48.3 73.02 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.98 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . . . . . . . . . 20.7 t -101.7 -42.29 9.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.419 ' HE1' ' HA ' ' A' ' 672' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 631' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 637' ' ' ASP . 1.1 t -107.54 -40.85 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.631 0.253 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.578 ' HB2' ' HA ' ' A' ' 637' ' ' ASP . 1.1 m-20 -136.29 -99.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.86 0.362 . . . . 0.0 111.436 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -49.56 -44.37 46.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.509 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.9 -19.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.474 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.1 tm? 177.32 -58.89 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.384 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 10.3 Cg_endo -57.12 -20.72 39.13 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.754 1.636 . . . . 0.0 110.617 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.578 ' HA ' ' HB2' ' A' ' 632' ' ' ASP . 1.7 p-10 28.58 42.48 0.01 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.452 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 43.46 74.13 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.525 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -140.94 -55.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.463 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -93.96 -29.93 15.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.957 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.64 101.32 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -102.24 -33.92 9.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -52.89 -22.45 5.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.725 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -48.54 -28.05 3.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.714 0.292 . . . . 0.0 111.332 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -149.14 20.21 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.275 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 6.7 t -155.7 25.88 0.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 111.131 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -140.91 -98.55 0.35 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.24 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -66.61 -28.49 68.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -86.32 -12.08 50.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.509 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -12.88 61.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.484 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . 0.448 ' CD1' ' N ' ' A' ' 651' ' ' TRP . 1.6 p-90 -164.79 45.66 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.78 0.324 . . . . 0.0 111.193 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 4.3 tt -88.9 -31.78 0.38 Allowed Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 56.5 Cg_endo -92.6 -6.18 3.13 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.438 2.092 . . . . 0.0 112.983 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 75.74 91.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.97 0.414 . . . . 0.0 110.461 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.475 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.18 45.0 1.52 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.463 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.438 ' CA ' ' HA3' ' A' ' 660' ' ' GLY . 9.9 tp -114.58 -39.43 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . . . . . . . . . . . -132.92 -59.28 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.776 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 3.5 p -61.73 -38.91 81.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.283 0.563 . . . . 0.0 109.975 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.544 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 24.2 m -119.44 -18.37 8.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.108 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . 0.438 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.24 -53.31 3.7 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.605 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 664' ' ' ALA . 83.9 t -82.55 -60.87 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.074 0.464 . . . . 0.0 111.036 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.4 ' CG1' ' CD1' ' A' ' 666' ' ' ILE . 25.6 t -43.38 -31.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.656 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.5 tp -73.9 -34.47 39.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.992 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.64 -23.5 36.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.668 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . . . . . . . . . 1.8 t -83.8 -46.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.391 0.615 . . . . 0.0 109.917 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.4 ' CD1' ' CG1' ' A' ' 662' ' ' VAL . 60.6 mt -66.97 -35.06 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.186 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . 0.436 ' O ' HG12 ' A' ' 671' ' ' ILE . . . -41.59 -34.12 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.117 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.5 tp -84.81 -63.0 1.41 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.82 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -52.26 -26.35 11.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.595 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -69.33 -21.94 63.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.087 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 667' ' ' ALA . 20.5 mm -84.55 -40.31 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.104 0.478 . . . . 0.0 111.148 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.19 -31.75 69.3 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.808 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.88 -17.95 27.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.79 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -92.0 -34.28 14.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.483 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 44.0 t -94.39 -13.11 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.356 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.483 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.772 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.5 m -91.38 -48.87 6.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.675 0.274 . . . . 0.0 110.824 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.582 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 11.1 t70 -139.23 -95.17 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.354 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -57.58 -39.65 77.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.189 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.89 -25.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.342 0.591 . . . . 0.0 111.884 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.616 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 174.78 -53.47 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.858 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.616 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 38.0 Cg_exo -55.51 -24.02 42.18 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.691 1.594 . . . . 0.0 110.423 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.582 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.1 p-10 26.89 47.16 0.01 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.479 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 50.67 57.46 6.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.132 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -121.58 -44.4 0.38 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.411 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.92 74.96 2.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 110.734 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 60.74 82.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.27 -24.99 63.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -55.65 -19.66 11.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.782 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -48.48 -28.3 3.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.73 0.3 . . . . 0.0 111.294 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.8 20.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.314 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 7.4 t -157.29 26.24 0.3 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 111.126 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -142.54 -90.69 0.14 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.343 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.405 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 68.1 p-90 -71.92 -22.02 61.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.667 0.27 . . . . 0.0 110.999 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . 0.405 ' HG3' ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -86.17 -12.02 50.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.907 0.384 . . . . 0.0 110.474 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -15.06 62.46 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.201 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . 0.482 ' CD1' ' N ' ' A' ' 651' ' ' TRP . 0.6 OUTLIER -168.49 52.36 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.188 -179.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.597 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 4.2 tp -89.86 -31.9 0.37 Allowed Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 57.7 Cg_endo -91.84 -8.03 3.09 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.377 2.051 . . . . 0.0 112.976 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 76.06 92.51 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.953 0.406 . . . . 0.0 110.363 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.416 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.29 43.07 1.79 Allowed Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.249 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . 0.467 ' CG2' ' HA ' ' A' ' 651' ' ' TRP . 10.2 tp -114.5 -39.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.32 . . . . 0.0 111.525 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -136.08 -57.37 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.668 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.92 -38.12 81.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.275 0.56 . . . . 0.0 109.805 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.512 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 16.7 m -120.04 -18.33 8.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.018 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -82.14 -52.79 3.9 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.726 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 86.5 t -82.64 -59.63 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.146 0.498 . . . . 0.0 110.768 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.466 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 44.6 t -42.54 -31.64 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.383 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 659' ' ' THR . 0.2 OUTLIER -79.52 -36.0 17.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.71 -179.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.66 -27.01 34.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 2.0 p -84.76 -35.34 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.228 0.537 . . . . 0.0 110.336 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.425 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 26.9 mm -81.14 -37.86 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.284 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . 0.42 ' O ' HG12 ' A' ' 671' ' ' ILE . . . -41.27 -32.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.35 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.9 tp -84.69 -63.14 1.39 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.36 -25.79 16.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.051 0.453 . . . . 0.0 110.396 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -68.35 -21.87 64.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.037 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 667' ' ' ALA . 16.8 mm -84.73 -41.21 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.177 0.513 . . . . 0.0 111.214 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -58.61 -32.15 68.74 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.96 -17.87 27.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.974 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -94.21 -32.5 13.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.274 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.481 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.1 t -94.83 -4.66 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.42 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.481 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 2.4 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.837 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 631' ' ' SER . . . . . 0.427 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -117.88 -48.62 2.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.66 0.267 . . . . 0.0 110.899 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . 0.604 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 65.3 t0 -136.39 -93.79 0.24 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.857 0.36 . . . . 0.0 111.316 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -37.81 70.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.148 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.09 -27.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.414 0.626 . . . . 0.0 111.77 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.611 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 178.26 -54.27 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.904 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 636' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 39.5 Cg_exo -56.03 -23.95 46.38 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 121.586 1.524 . . . . 0.0 110.371 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 637' ' ' ASP . . . . . 0.604 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.2 p-10 30.33 40.58 0.01 OUTLIER 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.552 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 637' ' ' ASP . 2.9 pt20 36.35 73.82 0.08 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.054 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -162.77 -46.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.727 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.88 -38.54 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 111.103 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -153.33 46.32 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 642' ' ' ASP . . . . . 0.411 ' O ' ' CG2' ' A' ' 646' ' ' THR . 17.4 p-10 -64.78 -32.34 73.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -50.25 -25.58 3.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.725 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -48.71 -27.86 3.19 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.788 0.328 . . . . 0.0 111.272 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -148.86 22.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.323 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 646' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 642' ' ' ASP . 12.4 t -159.25 26.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 647' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 651' ' ' TRP . . . -143.51 -95.6 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.293 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.408 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 65.3 p-90 -65.07 -21.51 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.841 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 649' ' ' ARG . . . . . 0.614 ' HA ' HG12 ' A' ' 652' ' ' ILE . 19.9 mtp85 -86.61 -19.32 29.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.241 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.55 -12.83 61.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.68 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 651' ' ' TRP . . . . . 0.407 ' CD1' ' O ' ' A' ' 647' ' ' GLY . 2.3 p-90 -154.45 46.75 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.763 0.316 . . . . 0.0 111.136 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 652' ' ' ILE . . . . . 0.614 HG12 ' HA ' ' A' ' 649' ' ' ARG . 0.0 OUTLIER -71.55 -61.85 1.95 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.849 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.82 -2.39 12.16 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.739 2.293 . . . . 0.0 113.016 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 72.87 91.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.963 0.411 . . . . 0.0 110.405 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . 0.401 ' C ' ' CA ' ' A' ' 660' ' ' GLY . . . 104.01 49.15 1.1 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.077 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 656' ' ' ILE . . . . . . . . . . . . . 9.8 tp -114.51 -39.74 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.779 0.323 . . . . 0.0 111.733 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 657' ' ' GLY . . . . . . . . . . . . . . . -139.68 -61.33 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.591 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 1.9 p -62.33 -36.84 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.418 0.628 . . . . 0.0 109.656 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 659' ' ' THR . . . . . 0.508 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 47.0 m -117.75 -17.97 9.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.084 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 660' ' ' GLY . . . . . 0.401 ' CA ' ' C ' ' A' ' 655' ' ' GLY . . . -82.28 -57.32 2.66 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.977 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 664' ' ' ALA . 40.7 t -82.19 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.201 0.524 . . . . 0.0 111.144 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.415 ' HA ' HG21 ' A' ' 665' ' ' VAL . 24.4 t -43.13 -31.14 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.775 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.6 tt -75.19 -36.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.122 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 664' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.68 -24.81 36.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.115 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 665' ' ' VAL . . . . . 0.415 HG21 ' HA ' ' A' ' 662' ' ' VAL . 2.4 m -84.41 -41.17 15.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.32 0.581 . . . . 0.0 110.279 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 666' ' ' ILE . . . . . 0.41 ' N ' ' CG2' ' A' ' 665' ' ' VAL . 18.5 mm -70.3 -36.51 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.362 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.31 -34.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.146 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.77 -63.01 1.41 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.863 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 669' ' ' PHE . . . . . 0.4 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 34.7 t80 -52.78 -25.94 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -70.81 -24.28 62.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.182 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 10.3 mt -85.55 -33.24 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.124 0.488 . . . . 0.0 110.915 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -62.86 -33.81 76.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.379 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 673' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.13 -17.76 27.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.743 179.415 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -91.69 -33.98 14.83 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.069 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 675' ' ' VAL . . . . . 0.484 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.9 t -94.82 -12.05 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.309 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 676' ' ' PHE . . . . . 0.484 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.815 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' SER . . . . . 0.418 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -102.85 -48.51 4.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.688 0.28 . . . . 0.0 110.875 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.596 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 12.4 t70 -136.3 -96.85 0.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.861 0.362 . . . . 0.0 111.32 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.62 -41.39 63.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.24 -22.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.148 0.499 . . . . 0.0 112.288 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.491 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.1 tm? 177.66 -58.56 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.281 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 10.6 Cg_endo -57.64 -20.26 41.42 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.668 1.579 . . . . 0.0 110.585 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.596 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 1.9 p-10 30.52 40.64 0.01 OUTLIER 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.396 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 44.01 54.46 5.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.359 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -132.86 -46.18 0.12 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.4 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -99.52 -27.06 13.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 0.0 110.844 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 1.6 t-20 -148.05 69.74 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -94.8 -27.47 15.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.048 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.6 -21.05 66.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.096 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . 0.416 ' HA ' ' CE2' ' A' ' 648' ' ' TRP . 1.2 p-90 -48.43 -29.59 4.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.773 0.32 . . . . 0.0 111.242 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -137.03 14.64 3.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.595 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 3.6 t -156.57 24.76 0.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.715 0.293 . . . . 0.0 111.446 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -143.42 -90.52 0.13 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.307 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.42 ' O ' HG13 ' A' ' 652' ' ' ILE . 37.9 p-90 -73.0 -20.9 60.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.614 0.245 . . . . 0.0 111.043 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . 0.474 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 4.0 ttt-85 -85.79 -15.44 42.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 110.284 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -24.4 63.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.789 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -159.18 59.06 0.41 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.498 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 0.5 OUTLIER -65.45 -47.88 67.96 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.8 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 41.1 Cg_endo -89.02 -76.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.975 2.45 . . . . 0.0 112.732 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 167.95 88.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.577 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.53 47.71 1.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.552 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.517 ' CA ' ' HA3' ' A' ' 660' ' ' GLY . 10.2 tp -114.48 -33.86 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.327 . . . . 0.0 111.187 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . 0.413 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -131.37 -48.04 0.12 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.737 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . 0.425 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 10.7 p -69.54 -43.29 80.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.246 0.546 . . . . 0.0 109.892 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.577 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 22.3 m -118.6 -15.85 9.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.677 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . 0.517 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.4 -51.05 4.51 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.345 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.435 ' CG1' HG11 ' A' ' 665' ' ' VAL . 43.1 t -82.62 -61.72 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 110.775 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 658' ' ' VAL . 40.0 t -41.79 -33.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.591 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.3 tt -75.98 -37.54 34.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.545 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.49 -24.95 36.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.173 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.435 HG11 ' CG1' ' A' ' 661' ' ' VAL . 5.2 m -84.51 -43.41 17.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.313 0.577 . . . . 0.0 110.478 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.425 ' N ' ' CG2' ' A' ' 665' ' ' VAL . 18.9 mm -67.35 -36.71 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.565 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.22 -35.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.976 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 3.4 tp -84.9 -63.03 1.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.873 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -26.89 10.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.755 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -70.07 -23.71 63.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.983 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 11.4 mt -85.96 -35.35 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.158 0.504 . . . . 0.0 110.88 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -61.11 -32.97 72.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.509 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -17.9 27.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.566 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -88.59 -35.08 17.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.467 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 36.6 t -96.77 -19.21 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.354 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 676' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.848 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.08 -44.15 15.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 110.855 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.643 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 64.2 t0 -136.92 -97.91 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.405 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -42.96 63.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.469 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.32 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.47 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.2 tm? 178.9 -59.42 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.316 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 15.0 Cg_endo -59.36 -20.13 54.45 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.702 1.601 . . . . 0.0 110.283 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.643 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 0.4 OUTLIER 36.31 -160.4 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.152 178.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -108.36 76.96 1.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.044 0.449 . . . . 0.0 111.027 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 179.48 -35.15 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.348 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.88 -29.28 23.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.752 0.311 . . . . 0.0 110.925 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.2 42.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.219 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -56.84 -22.37 36.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.145 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . 0.427 ' HB3' ' CD1' ' A' ' 648' ' ' TRP . 92.4 m-20 -52.99 -19.83 2.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.039 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . 0.412 ' HA ' ' CD ' ' A' ' 649' ' ' ARG . 25.9 p-90 -48.27 -28.32 3.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.908 0.385 . . . . 0.0 111.126 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.97 24.84 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.982 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 6.3 t -156.21 21.58 0.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.427 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -149.77 -124.92 1.31 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.848 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.427 ' CD1' ' HB3' ' A' ' 643' ' ' ASN . 64.7 p-90 -61.89 -21.05 64.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.655 0.264 . . . . 0.0 111.445 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . 0.482 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 3.3 ttt180 -86.17 -15.93 39.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.876 0.369 . . . . 0.0 110.474 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -73.62 -14.64 61.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.509 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 651' ' ' TRP . 2.3 p-90 -158.9 50.84 0.38 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.687 0.28 . . . . 0.0 111.503 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.482 ' CG1' ' HA ' ' A' ' 649' ' ' ARG . 0.7 OUTLIER -63.89 -48.61 78.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.357 . . . . 0.0 110.552 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 30.6 Cg_endo -94.46 -76.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.488 2.792 . . . . 0.0 112.485 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 167.31 96.1 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.624 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.59 42.3 2.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.323 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.426 ' CA ' ' HA3' ' A' ' 660' ' ' GLY . 9.1 tp -114.48 -39.6 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.706 0.289 . . . . 0.0 111.696 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -134.06 -53.68 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.738 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.51 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.352 0.596 . . . . 0.0 109.843 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.499 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 23.3 m -119.68 -17.81 8.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.992 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . 0.426 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.28 -51.57 4.34 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.623 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.408 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 53.1 t -82.78 -59.65 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.093 0.473 . . . . 0.0 110.567 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.446 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 62.0 t -42.19 -31.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.417 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.7 tp -80.85 -35.98 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.648 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.6 -26.86 34.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.498 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 2.1 p -84.69 -34.3 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 121.122 0.487 . . . . 0.0 110.356 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 45.8 mt -81.46 -38.32 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.267 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.13 -32.41 0.26 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.398 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.57 -63.17 1.38 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.97 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -54.04 -25.96 24.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.06 0.457 . . . . 0.0 110.357 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -67.99 -22.08 65.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.932 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 7.2 mt -85.5 -37.1 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.134 0.492 . . . . 0.0 111.051 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.3 -31.77 71.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.563 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 -17.87 27.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.754 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -92.65 -34.17 14.09 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.155 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -94.15 -11.06 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.396 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.48 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.831 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' SER . . . . . 0.401 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.5 OUTLIER -119.59 -45.0 2.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.706 0.289 . . . . 0.0 110.889 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.595 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 18.8 t70 -137.99 -95.65 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.362 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -52.53 -42.14 64.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.189 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.52 -20.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.483 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.1 tm? 177.79 -58.93 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.364 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 11.2 Cg_endo -58.03 -20.51 45.74 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.724 1.616 . . . . 0.0 110.544 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.595 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 1.4 p-10 30.24 39.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.6 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 636' ' ' PRO . 9.0 mt-30 51.5 98.78 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.163 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -170.12 -40.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.337 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -80.85 -39.96 25.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 110.731 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -178.78 92.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.51 -19.09 62.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -53.88 -20.3 5.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.098 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -48.31 -28.89 3.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.791 0.329 . . . . 0.0 111.163 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -147.62 20.82 1.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 6.9 t -155.6 24.91 0.4 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.771 0.32 . . . . 0.0 111.212 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -151.82 -79.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.655 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -86.13 -21.46 27.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.587 0.232 . . . . 0.0 111.287 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . 0.424 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 1.3 ttp85 -86.44 -15.75 39.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.317 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -71.22 -18.23 62.47 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.177 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -167.54 59.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.591 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.554 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 2.1 mt -60.33 -54.88 50.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.771 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 37.5 Cg_endo -69.13 -64.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.265 1.977 . . . . 0.0 112.378 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 168.39 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.494 0.664 . . . . 0.0 110.281 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.453 ' HA2' ' CG1' ' A' ' 658' ' ' VAL . . . 103.64 38.35 2.8 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.705 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.552 ' O ' ' HA3' ' A' ' 660' ' ' GLY . 0.4 OUTLIER -73.5 -17.68 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.245 0.545 . . . . 0.0 110.515 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -106.52 -35.39 2.87 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . 0.453 ' CG1' ' HA2' ' A' ' 655' ' ' GLY . 13.9 p -82.29 -31.65 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.254 -0.473 . . . . 0.0 110.6 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.565 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 70.9 m -123.47 -20.26 5.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.755 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.2 -44.54 7.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.908 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 96.5 t -82.62 -62.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.205 0.526 . . . . 0.0 110.413 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.488 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 44.0 t -42.05 -32.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.543 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.565 ' HB ' ' O ' ' A' ' 659' ' ' THR . 0.3 OUTLIER -79.27 -34.87 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.689 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.0 -27.23 35.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.285 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.488 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 1.8 p -84.64 -33.98 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 121.285 0.565 . . . . 0.0 110.154 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 662' ' ' VAL . 25.4 mm -82.84 -37.97 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.341 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.13 -32.65 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.342 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.4 tp -84.53 -63.1 1.4 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.821 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -53.86 -25.2 18.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.516 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -69.08 -22.65 63.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 16.1 mt -86.01 -36.3 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.113 0.482 . . . . 0.0 111.082 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -61.44 -33.16 73.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.543 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -17.9 27.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.716 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -91.46 -34.23 14.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.164 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.494 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -95.19 -11.29 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.302 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.494 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.18 -0.915 . . . . 0.0 110.792 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.1 m -120.92 -40.85 2.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.61 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 16.3 t70 -141.88 -99.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.349 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -39.07 60.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.441 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.46 -23.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.236 0.541 . . . . 0.0 112.007 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.614 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 173.1 -52.98 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.923 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 35.8 Cg_exo -55.96 -23.54 43.7 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.714 1.609 . . . . 0.0 110.489 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.61 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.0 p-10 27.28 48.93 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.539 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 43.01 73.54 0.14 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.593 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -134.66 -44.53 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.554 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -97.22 69.03 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 110.986 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 3.4 t30 62.28 86.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -63.86 -23.82 67.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.19 -17.06 9.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.891 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -48.25 -40.27 24.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.724 0.297 . . . . 0.0 111.251 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -131.89 16.39 4.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.385 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 9.5 t -152.48 23.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.794 0.331 . . . . 0.0 111.093 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.41 -96.72 0.28 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.112 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.497 ' O ' ' HB ' ' A' ' 652' ' ' ILE . 57.8 p-90 -64.77 -22.04 66.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.092 0.473 . . . . 0.0 110.697 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.45 -24.07 25.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . 0.416 ' HB3' ' CD1' ' A' ' 651' ' ' TRP . 3.6 tt0 -91.38 -32.93 15.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.207 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . 0.42 ' O ' ' CE3' ' A' ' 651' ' ' TRP . 25.0 p-90 -175.4 67.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.03 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.574 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 9.1 tp -64.3 -33.14 8.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 33.3 Cg_endo -93.82 -74.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.536 2.158 . . . . 0.0 112.442 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 178.67 70.34 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.439 0.638 . . . . 0.0 110.317 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.454 ' CA ' HG13 ' A' ' 658' ' ' VAL . . . 103.62 45.04 1.59 Allowed Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.565 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.479 ' O ' ' HA3' ' A' ' 660' ' ' GLY . 0.4 OUTLIER -73.08 -18.6 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 110.102 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . 0.441 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -106.12 -33.87 3.34 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . 0.454 HG13 ' CA ' ' A' ' 655' ' ' GLY . 13.0 p -82.13 -30.55 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.999 0.428 . . . . 0.0 110.589 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.551 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 99.5 m -124.82 -23.38 4.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.931 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.14 -44.64 7.46 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.156 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.441 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 74.5 t -82.67 -61.67 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.191 0.52 . . . . 0.0 110.574 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.403 ' HA ' HG21 ' A' ' 665' ' ' VAL . 40.1 t -43.05 -33.2 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.461 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 659' ' ' THR . 5.0 tt -77.47 -35.5 22.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.176 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.63 -25.19 35.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.844 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 666' ' ' ILE . 2.8 m -84.38 -42.21 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.301 0.572 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.431 ' N ' ' CG2' ' A' ' 665' ' ' VAL . 45.0 mt -70.82 -37.09 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.437 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -39.85 -34.58 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.117 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.83 -63.15 1.38 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.88 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.15 -26.77 12.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.617 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -69.35 -24.7 63.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.971 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 16.8 mt -86.1 -36.06 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.124 0.487 . . . . 0.0 110.879 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.79 -32.29 70.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.541 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.92 -17.84 27.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.738 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -90.92 -34.34 15.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.081 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.486 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.9 t -95.68 -14.03 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.335 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.486 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.1 m-85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.854 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.21 -44.48 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.696 0.284 . . . . 0.0 110.809 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.61 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 18.5 t70 -137.54 -100.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.272 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.23 -41.59 60.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.363 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.01 -25.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.27 0.557 . . . . 0.0 112.126 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.604 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 175.76 -53.81 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.12 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 39.4 Cg_exo -55.52 -24.56 44.98 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 121.596 1.531 . . . . 0.0 110.512 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.61 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.1 p-10 29.77 39.51 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.562 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 638' ' ' GLN . 7.7 pt20 41.56 94.29 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.931 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 158.52 -33.12 0.49 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.367 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.75 -23.04 10.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.691 0.282 . . . . 0.0 111.058 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -148.04 19.81 1.11 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.569 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -59.98 -22.91 63.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.877 0.37 . . . . 0.0 110.862 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -56.37 -20.2 18.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.635 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -48.53 -27.53 2.79 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.75 0.309 . . . . 0.0 111.244 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.27 22.82 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 5.6 t -159.3 25.5 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.279 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -143.4 -96.44 0.23 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.621 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.424 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 67.0 p-90 -62.59 -20.49 64.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.651 0.262 . . . . 0.0 111.209 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . 0.524 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 26.7 mtt180 -85.92 -14.69 44.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.912 0.387 . . . . 0.0 110.404 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -76.11 -14.07 60.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.505 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . 0.449 ' N ' ' CD1' ' A' ' 651' ' ' TRP . 1.6 p-90 -160.37 50.6 0.29 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.542 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 1.7 mt -67.68 -50.29 35.81 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.733 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 98.4 Cg_endo -84.49 5.6 6.21 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.777 2.318 . . . . 0.0 113.04 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 65.29 90.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.396 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.455 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.47 49.62 1.03 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.527 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.401 HG21 ' HA ' ' A' ' 651' ' ' TRP . 10.3 tp -114.44 -39.52 2.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.908 0.385 . . . . 0.0 111.338 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . 0.462 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -137.46 -60.95 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.563 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 3.4 p -59.73 -39.51 79.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.37 0.605 . . . . 0.0 109.759 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.519 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 31.8 m -117.7 -18.33 9.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.109 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -82.14 -48.1 5.86 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.55 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.462 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 75.6 t -82.76 -60.31 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.233 0.539 . . . . 0.0 110.56 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.477 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 63.5 t -42.0 -32.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.44 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.4 tt -79.02 -34.58 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.677 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.58 -27.75 34.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.327 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.477 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 1.7 p -84.47 -36.16 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.074 0.464 . . . . 0.0 110.275 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 670' ' ' ALA . 39.0 mt -76.44 -36.16 28.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.915 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.05 -32.93 0.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.384 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.1 tp -84.53 -63.1 1.4 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.87 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -54.01 -24.56 17.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.46 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 666' ' ' ILE . . . -71.0 -24.7 62.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.054 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 10.2 mt -84.45 -39.82 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.16 0.505 . . . . 0.0 110.886 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -57.52 -34.65 69.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.772 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.89 -17.84 27.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.835 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -89.28 -33.59 16.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.102 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.492 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.5 t -98.78 -14.07 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.228 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.492 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.774 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 2.2 m -110.6 -44.11 3.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.754 0.312 . . . . 0.0 110.748 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 43.7 t0 -140.51 -100.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.169 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -54.52 -44.64 72.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.389 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.15 -28.64 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.494 0.664 . . . . 0.0 111.977 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.592 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.5 OUTLIER 175.14 -53.26 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.851 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 31.4 Cg_exo -54.63 -24.43 36.95 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 121.654 1.569 . . . . 0.0 110.511 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.592 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 5.9 p-10 28.95 56.47 0.12 Allowed 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.451 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . 0.441 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 10.4 pt20 42.99 96.01 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.715 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -168.18 -40.81 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.416 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -111.05 -29.99 7.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.307 . . . . 0.0 110.982 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 0.6 OUTLIER -162.94 88.97 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.055 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 638' ' ' GLN . 2.8 p30 -102.81 -28.54 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.945 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -64.37 -24.91 67.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.993 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 1.4 p-90 -48.48 -32.08 7.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.719 0.295 . . . . 0.0 111.19 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -130.58 -13.3 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.981 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 4.8 t -132.39 34.49 3.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.81 0.338 . . . . 0.0 111.302 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -145.25 -96.31 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.447 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -72.05 -29.65 64.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 110.769 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 19.7 ttm-85 -86.34 -13.79 45.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.393 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -68.33 -12.89 61.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.385 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -162.31 45.58 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.747 0.308 . . . . 0.0 111.055 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.592 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 0.0 OUTLIER -86.17 -33.05 0.46 Allowed Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 63.1 Cg_endo -93.43 -4.49 3.0 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.512 2.142 . . . . 0.0 112.791 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 74.81 90.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.996 0.427 . . . . 0.0 110.585 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.456 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.15 46.15 1.38 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.444 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.466 ' CA ' ' HA3' ' A' ' 660' ' ' GLY . 9.3 tp -114.55 -39.5 2.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . . . . . . . . . . . -130.78 -58.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.883 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.39 -39.14 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.224 0.535 . . . . 0.0 109.985 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.513 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 5.6 m -119.11 -19.16 8.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.147 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . 0.466 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.33 -52.72 3.88 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.681 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 664' ' ' ALA . 76.5 t -82.39 -62.13 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.063 0.459 . . . . 0.0 110.964 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 24.5 t -42.37 -30.97 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.692 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.5 tp -76.62 -35.06 24.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.216 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.56 -24.57 36.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.894 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . . . . . . . . . 1.1 t -83.83 -45.64 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.465 0.65 . . . . 0.0 110.008 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 670' ' ' ALA . 23.2 mm -68.5 -35.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.491 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.77 -34.82 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.145 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.8 tp -84.7 -63.11 1.39 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.003 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.76 -24.65 9.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.655 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 666' ' ' ILE . . . -72.43 -25.02 61.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.26 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 10.2 mt -78.8 -41.2 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.093 0.473 . . . . 0.0 111.135 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -59.05 -33.82 71.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.7 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -17.95 26.95 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.635 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 11.0 t80 -86.67 -34.6 19.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.826 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.487 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 44.6 t -100.55 -18.51 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.487 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.779 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.546 -0.221 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.97 -41.77 11.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.726 0.298 . . . . 0.0 110.896 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.611 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.2 t0 -141.55 -92.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.354 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -58.98 -39.02 80.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.51 -27.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.421 0.629 . . . . 0.0 111.867 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.619 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 178.51 -54.56 0.0 OUTLIER Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.787 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 38.3 Cg_exo -55.48 -23.76 40.65 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.597 1.531 . . . . 0.0 110.375 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.611 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.5 p-10 28.8 49.77 0.04 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.519 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 42.94 65.47 0.94 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.507 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -126.97 -41.92 0.29 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.23 80.93 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.95 80.82 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.005 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -67.55 -26.83 66.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 648' ' ' TRP . 7.0 m120 -56.26 -22.03 27.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.488 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 648' ' ' TRP . 3.4 p-90 -48.55 -28.48 3.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.752 0.311 . . . . 0.0 111.2 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . 0.417 ' HA ' ' CE3' ' A' ' 645' ' ' TRP . 0.0 OUTLIER -144.93 19.6 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.2 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 5.9 t -156.82 25.03 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.698 0.285 . . . . 0.0 111.224 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -146.48 -109.4 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.462 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.427 ' CZ2' ' HA ' ' A' ' 644' ' ' TRP . 49.2 p-90 -59.32 -21.4 59.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 111.133 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . 0.482 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 2.7 ttt85 -86.45 -18.03 32.75 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.044 0.449 . . . . 0.0 110.2 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.25 -3.85 41.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.809 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . 0.42 ' HA ' HG21 ' A' ' 656' ' ' ILE . 5.3 p-90 -169.28 49.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.838 0.351 . . . . 0.0 110.959 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.558 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 1.7 mt -62.1 -56.71 28.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.076 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.558 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 34.1 Cg_endo -66.68 -74.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.208 1.939 . . . . 0.0 112.477 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 177.9 69.64 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.446 0.641 . . . . 0.0 110.359 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.47 ' CA ' HG12 ' A' ' 658' ' ' VAL . . . 103.78 35.37 3.51 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.989 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.539 ' O ' ' HA3' ' A' ' 660' ' ' GLY . 0.5 OUTLIER -73.54 -15.26 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.0 110.31 178.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . . . . . . . . . . . -108.36 -34.08 2.78 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . 0.47 HG12 ' CA ' ' A' ' 655' ' ' GLY . 14.5 p -82.03 -31.78 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 110.313 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.543 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 82.0 m -124.43 -21.24 4.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.801 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.22 -53.1 3.77 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.261 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 656' ' ' ILE . 54.1 t -82.69 -61.06 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.219 0.533 . . . . 0.0 110.837 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.455 ' HA ' HG23 ' A' ' 665' ' ' VAL . 39.1 t -42.07 -33.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.544 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.543 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.0 OUTLIER -75.16 -37.79 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.291 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.63 -24.66 36.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.184 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' A' ' 662' ' ' VAL . 3.3 m -84.4 -43.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.427 ' N ' ' CG2' ' A' ' 665' ' ' VAL . 19.7 mm -68.22 -35.42 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.383 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.34 -34.7 0.35 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.138 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 4.1 tp -84.87 -63.05 1.4 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.811 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.76 -26.9 10.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.612 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -67.96 -22.0 65.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.07 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 23.3 mm -85.26 -37.52 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.088 0.471 . . . . 0.0 111.142 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.49 -33.16 73.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.632 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -17.84 27.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.738 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -91.52 -34.3 14.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.482 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -94.86 -11.92 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.354 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.482 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.843 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 5.2 t -108.12 -43.65 4.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.59 0.233 . . . . 0.0 110.935 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.572 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 20.2 t70 -139.23 -102.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.278 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -49.61 -40.57 39.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.779 0.323 . . . . 0.0 111.373 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.5 -24.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.232 0.539 . . . . 0.0 111.928 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.3 tm? 176.78 -58.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.471 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 7.4 Cg_endo -53.9 -21.26 20.2 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.983 1.788 . . . . 0.0 111.077 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.572 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 7.0 p-10 25.18 60.94 0.06 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.707 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 39.18 68.89 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.727 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -123.21 -49.09 0.23 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -99.96 81.03 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.335 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.53 87.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -66.84 -27.83 67.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.04 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -56.86 -20.12 21.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.604 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -48.43 -30.04 4.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.818 0.342 . . . . 0.0 111.228 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -144.5 20.89 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 6.6 t -160.66 27.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.742 0.306 . . . . 0.0 111.125 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.59 -111.21 0.86 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.517 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -57.9 -22.25 47.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.121 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 23.9 ttt-85 -86.5 -20.16 28.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.049 0.452 . . . . 0.0 110.185 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -24.4 61.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.034 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . 0.454 ' CD1' ' N ' ' A' ' 651' ' ' TRP . 1.2 p-90 -165.58 61.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.732 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 1.5 tp -66.81 -33.87 6.78 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.197 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 35.0 Cg_endo -94.39 -73.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.681 2.254 . . . . 0.0 112.409 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 167.45 80.36 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.438 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.416 ' CA ' ' HB ' ' A' ' 659' ' ' THR . . . 103.57 45.3 1.56 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.361 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.454 HG23 ' HA ' ' A' ' 651' ' ' TRP . 3.0 tp -102.71 -34.51 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.041 0.448 . . . . 0.0 110.842 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 656' ' ' ILE . . . -114.07 -35.91 1.43 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.514 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . 0.416 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 14.7 p -81.24 -40.33 18.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.145 0.498 . . . . 0.0 110.081 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.538 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 43.6 m -117.63 -16.42 10.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.086 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 656' ' ' ILE . . . -82.39 -48.87 5.45 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.307 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.402 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 84.1 t -82.78 -60.72 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.168 0.508 . . . . 0.0 110.66 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.489 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 54.2 t -42.02 -32.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.529 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' A' ' 659' ' ' THR . 3.2 tp -78.65 -35.62 18.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.79 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.43 -26.97 34.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.37 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 1.9 p -84.81 -36.07 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.151 0.501 . . . . 0.0 110.261 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 25.1 mm -79.59 -37.56 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.195 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.33 -33.59 0.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.265 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.4 tp -84.77 -63.22 1.37 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.997 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -26.83 16.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.025 0.441 . . . . 0.0 110.43 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -65.72 -25.03 67.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.84 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 21.9 mm -86.1 -36.34 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.151 0.5 . . . . 0.0 110.939 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -59.8 -31.29 69.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.96 -17.86 27.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.638 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.87 -35.1 15.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.02 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.473 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.9 t -95.88 -16.51 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.351 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 676' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.828 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 3.1 m -131.72 -50.79 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.69 0.281 . . . . 0.0 110.799 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.535 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.7 t70 -136.87 -90.85 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -38.03 89.61 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.223 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 3.1 m -165.11 -32.4 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.599 0.714 . . . . 0.0 111.459 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.592 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.6 OUTLIER 175.0 -52.56 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.853 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 34.8 Cg_exo -55.27 -24.19 40.96 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.62 1.547 . . . . 0.0 110.45 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.535 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 5.7 p-10 30.45 51.3 0.1 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.286 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 42.94 97.26 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.873 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 157.23 -30.96 0.53 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.442 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -104.16 -29.06 11.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.712 0.292 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -166.17 41.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.307 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -61.34 -22.84 65.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.872 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -54.85 -22.9 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.702 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -49.02 -29.23 4.69 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.777 0.322 . . . . 0.0 111.296 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -144.7 21.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.199 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 6.2 t -160.77 27.3 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.792 0.33 . . . . 0.0 111.197 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -148.25 -88.72 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.398 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 37.5 p-90 -74.19 -24.1 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 0.0 110.795 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 29.7 ttt85 -86.24 -12.13 50.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.484 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -14.63 63.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.111 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . 0.425 ' N ' ' CD1' ' A' ' 651' ' ' TRP . 2.3 p-90 -169.17 51.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.876 0.37 . . . . 0.0 110.828 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 5.3 tt -82.97 -32.48 0.55 Allowed Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 44.4 Cg_endo -91.61 -75.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.301 2.001 . . . . 0.0 112.601 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 166.53 84.22 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.958 0.409 . . . . 0.0 110.316 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.58 39.9 2.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.295 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.549 ' O ' ' HA3' ' A' ' 660' ' ' GLY . 1.6 tp -101.85 -31.53 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.196 0.522 . . . . 0.0 110.676 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . 0.415 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -105.99 -37.02 2.61 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.25 -38.08 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.03 -0.585 . . . . 0.0 110.321 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.535 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 78.7 m -115.98 -20.08 10.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.746 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.29 -44.69 7.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.421 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.415 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 90.5 t -82.55 -61.53 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.149 0.5 . . . . 0.0 110.472 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.491 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 51.4 t -42.35 -32.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.402 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 659' ' ' THR . 0.2 OUTLIER -79.34 -34.2 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.701 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.45 -27.52 34.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.224 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.491 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 1.8 p -84.55 -34.38 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.264 0.554 . . . . 0.0 110.132 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 24.3 mm -82.06 -37.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.161 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.38 -32.41 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.453 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.19 -63.28 1.37 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.768 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . 0.401 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -53.67 -25.76 19.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.979 0.418 . . . . 0.0 110.325 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -68.76 -22.96 64.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.067 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 7.5 mt -86.07 -37.39 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.08 0.467 . . . . 0.0 111.164 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.92 -30.75 69.26 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.697 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.97 -17.85 27.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.831 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.2 OUTLIER -93.54 -33.51 13.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.243 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.49 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 41.9 t -94.93 -6.95 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.59 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.49 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.8 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.763 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.98 -41.11 3.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.617 0.246 . . . . 0.0 110.987 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.567 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 15.5 t70 -143.61 -99.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.481 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -50.34 -39.05 45.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.461 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.4 -24.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 0.0 112.124 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.473 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.2 tm? 177.14 -58.74 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.332 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 9.3 Cg_endo -56.42 -20.49 33.14 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.749 1.633 . . . . 0.0 110.688 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.567 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.9 p-10 29.78 53.46 0.12 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.518 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 42.8 66.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.543 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -135.13 -59.57 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.381 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.68 -28.31 23.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 0.0 110.781 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . 0.424 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 1.4 t-20 -153.55 88.68 1.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.709 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . 0.4 ' O ' ' CG2' ' A' ' 646' ' ' THR . 2.7 p30 -109.57 -29.95 8.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -53.55 -28.83 33.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.859 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . 0.424 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 5.6 p-90 -48.68 -27.5 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.386 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -151.23 26.73 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.459 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 642' ' ' ASP . 4.2 t -168.66 32.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.81 0.338 . . . . 0.0 111.159 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 651' ' ' TRP . . . -149.36 -93.31 0.11 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.321 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.425 ' CH2' ' HG3' ' A' ' 649' ' ' ARG . 47.0 p-90 -64.92 -21.03 66.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.691 0.282 . . . . 0.0 110.965 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . 0.458 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 3.9 mtp85 -86.33 -19.75 29.35 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.063 0.458 . . . . 0.0 110.112 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -71.21 -22.02 62.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.069 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 651' ' ' TRP . 1.5 p-90 -154.91 57.34 0.67 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.893 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.472 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 0.5 OUTLIER -66.0 -49.51 56.93 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.751 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 31.1 Cg_endo -94.39 -77.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.417 2.745 . . . . 0.0 112.581 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 167.24 98.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.566 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.7 39.72 2.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.466 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . . . . . . . . . 5.6 tp -114.26 -39.62 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 111.535 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . 0.448 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -137.69 -58.61 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 659' ' ' THR . 4.4 p -63.21 -41.18 91.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.369 0.604 . . . . 0.0 109.638 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.515 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 40.6 m -114.19 -17.52 11.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.854 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -82.11 -46.31 6.67 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.641 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.448 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 76.6 t -82.57 -60.67 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.169 0.509 . . . . 0.0 110.62 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.475 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 54.1 t -42.16 -32.67 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.324 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 659' ' ' THR . 0.3 OUTLIER -79.42 -34.97 16.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.662 -179.229 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.42 -27.33 34.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.431 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 2.0 p -84.61 -33.73 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.239 0.542 . . . . 0.0 110.146 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 25.3 mm -82.99 -36.76 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.132 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -42.2 -32.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.402 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.59 -63.32 1.36 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . 0.472 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.2 OUTLIER -52.61 -29.28 25.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.034 0.445 . . . . 0.0 110.134 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -65.48 -21.61 66.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.174 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 11.8 mt -80.54 -36.44 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 120.967 0.413 . . . . 0.0 111.942 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.13 69.31 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.43 0.633 . . . . 0.0 110.659 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.03 -17.77 27.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.905 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . 0.499 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.3 OUTLIER -99.18 -32.55 11.17 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.508 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.427 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 43.6 t -90.98 2.42 7.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.426 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 676' ' ' PHE . 4.7 m-85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 3.3 t -70.04 -42.02 73.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.623 0.249 . . . . 0.0 110.944 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.577 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 38.6 t70 -140.16 -102.53 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.444 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -44.31 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 111.371 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.75 -27.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.42 0.629 . . . . 0.0 111.934 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.617 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 176.89 -54.32 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.174 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.057 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 33.5 Cg_exo -54.77 -24.56 38.55 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.595 1.53 . . . . 0.0 110.502 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.577 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.1 p-10 29.38 41.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.561 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 42.6 67.54 0.6 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.571 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -142.63 -58.6 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.641 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.31 -49.59 16.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.01 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -159.54 90.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.02 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -86.99 -25.68 24.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.971 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -55.12 -22.03 15.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.554 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -48.54 -28.42 3.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.764 0.316 . . . . 0.0 111.24 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.43 19.08 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.147 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 5.8 t -155.99 25.6 0.37 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.818 0.342 . . . . 0.0 111.119 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.78 -89.52 0.14 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.912 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 36.7 p-90 -70.71 -21.29 62.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 110.423 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' A' ' 649' ' ' ARG . 1.2 ttt85 -86.05 -12.11 51.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.405 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . 0.418 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.0 OUTLIER -65.84 -11.84 49.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.325 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . 0.463 ' N ' ' CD1' ' A' ' 651' ' ' TRP . 1.2 p-90 -164.24 48.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 110.71 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.583 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 1.6 tp -97.1 -31.71 0.26 Allowed Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 63.7 Cg_endo -88.05 -7.97 5.93 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.229 1.953 . . . . 0.0 112.822 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 76.54 91.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.989 0.423 . . . . 0.0 110.504 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 104.33 42.0 1.96 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.458 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.451 ' HB ' ' HG2' ' A' ' 653' ' ' PRO . 10.2 tp -114.55 -39.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.912 0.387 . . . . 0.0 111.464 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . . . . . . . . . . . -141.64 -59.25 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . 0.4 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.2 p -62.8 -37.05 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.431 0.634 . . . . 0.0 109.595 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.545 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 54.2 m -118.04 -17.83 9.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.992 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -82.03 -56.82 2.8 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.768 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 664' ' ' ALA . 40.8 t -82.41 -60.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.096 0.474 . . . . 0.0 111.123 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 666' ' ' ILE . 24.9 t -43.2 -31.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.677 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 659' ' ' THR . 5.3 tt -72.9 -34.18 45.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.946 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.47 -24.88 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.472 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . . . . . . . . . 1.4 t -84.03 -45.63 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.374 0.607 . . . . 0.0 110.016 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 662' ' ' VAL . 19.0 mm -65.49 -34.81 72.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.337 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.7 -34.56 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.039 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.4 tp -84.75 -63.02 1.41 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.963 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -52.66 -25.19 10.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.736 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -71.25 -25.16 62.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.114 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 8.5 mt -82.95 -35.97 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.14 0.495 . . . . 0.0 110.999 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.47 78.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.469 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 -17.9 26.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -90.99 -34.05 15.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.228 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.473 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.2 t -95.82 -10.1 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.473 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.6 m-85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.774 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.48 -40.96 28.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.589 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.6 t0 -140.23 -92.99 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.83 0.347 . . . . 0.0 111.369 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -39.9 89.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.34 -24.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.284 0.564 . . . . 0.0 111.89 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.615 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 175.24 -53.42 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.995 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 35.3 Cg_exo -55.05 -24.11 38.65 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.686 1.59 . . . . 0.0 110.53 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.589 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.6 p-10 24.86 55.25 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.584 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 42.87 77.99 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.546 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -132.48 -46.16 0.12 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.418 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.12 77.77 1.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.344 . . . . 0.0 110.767 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.66 86.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -80.61 -19.92 44.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.218 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -53.98 -23.9 14.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.542 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -50.92 -28.25 9.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.202 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -144.07 19.0 1.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.268 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 5.7 t -156.83 25.53 0.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.824 0.345 . . . . 0.0 111.173 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.45 -93.19 0.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.277 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -76.52 -31.88 57.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 110.664 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -86.4 -12.08 50.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.561 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.72 -13.78 55.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.627 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -163.65 44.61 0.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.754 0.312 . . . . 0.0 111.146 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 2.7 tt -89.51 -31.73 0.37 Allowed Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 52.9 Cg_endo -92.32 -4.65 3.61 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.425 2.083 . . . . 0.0 112.904 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 74.62 89.49 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.957 0.408 . . . . 0.0 110.633 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.94 47.66 1.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.462 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.439 ' HB ' ' HG2' ' A' ' 653' ' ' PRO . 8.4 tp -114.58 -39.75 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.785 0.326 . . . . 0.0 111.725 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . 0.418 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -140.46 -61.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.505 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.24 -36.13 70.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.368 0.604 . . . . 0.0 109.679 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.495 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 54.8 m -118.85 -19.1 8.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.157 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -82.2 -52.95 3.83 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.944 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.418 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 57.6 t -82.57 -60.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.135 0.493 . . . . 0.0 110.979 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.468 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 42.2 t -42.03 -31.78 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.572 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 659' ' ' THR . 0.6 OUTLIER -79.02 -36.46 18.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.712 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.53 -27.05 34.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.571 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 2.0 p -84.65 -34.4 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.152 0.501 . . . . 0.0 110.397 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 39.0 mt -80.29 -37.99 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.285 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 671' ' ' ILE . . . -40.45 -33.3 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.287 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.69 -63.05 1.4 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.029 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -54.08 -24.57 17.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.578 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -73.07 -21.91 60.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.019 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 667' ' ' ALA . 4.9 mt -77.84 -55.33 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 121.322 0.582 . . . . 0.0 110.729 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . 0.443 ' HA ' ' HE1' ' A' ' 676' ' ' PHE . . . -46.82 -62.6 1.32 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.986 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -22.5 11.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.206 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -70.03 -51.08 35.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.061 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.08 -43.66 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.073 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.443 ' HE1' ' HA ' ' A' ' 672' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.825 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.35 -39.9 6.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.721 0.296 . . . . 0.0 110.95 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.642 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 23.1 t70 -139.8 -98.85 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.399 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -53.42 -42.06 66.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.312 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.94 -20.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.611 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 173.17 -53.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.975 179.242 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 39.5 Cg_exo -55.82 -23.51 42.38 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.706 1.604 . . . . 0.0 110.461 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.642 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.8 p-10 25.54 48.32 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.577 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 637' ' ' ASP . 0.2 OUTLIER 35.32 90.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.039 179.554 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -168.12 -52.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.452 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.62 -37.31 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.0 110.801 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.64 94.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -90.58 9.72 28.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.06 -20.43 53.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.457 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -49.26 -35.13 16.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.134 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -133.71 9.13 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.537 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 3.0 t -145.12 23.46 1.51 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.796 0.331 . . . . 0.0 111.072 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -131.62 -100.41 0.81 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.146 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -73.47 -27.29 61.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.735 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 30.1 ttm-85 -86.27 -11.94 50.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.435 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -72.09 -9.87 59.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.317 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . 0.4 ' HA ' ' CG2' ' A' ' 656' ' ' ILE . 0.1 OUTLIER -165.08 47.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.336 -179.367 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 1.7 tp -92.31 -31.86 0.33 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 57.5 Cg_endo -91.31 -7.41 3.56 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.386 2.058 . . . . 0.0 113.078 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 75.19 92.94 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.01 0.434 . . . . 0.0 110.363 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.49 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.38 42.01 1.96 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.272 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.478 ' HB ' ' HG2' ' A' ' 653' ' ' PRO . 9.1 tp -114.5 -39.46 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 111.543 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . . . . . . . . . . . -128.83 -57.81 0.11 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.917 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . 0.407 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.9 p -63.11 -39.82 86.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.282 0.563 . . . . 0.0 110.213 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.49 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 13.6 m -119.4 -18.42 8.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.138 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . 0.472 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.27 -58.71 2.39 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.649 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.406 ' CG1' HG11 ' A' ' 665' ' ' VAL . 92.7 t -82.28 -61.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.173 0.511 . . . . 0.0 110.998 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.424 ' HA ' HG21 ' A' ' 665' ' ' VAL . 40.1 t -41.81 -31.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.751 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.4 tt -77.09 -38.43 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.305 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.17 36.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.34 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.424 HG21 ' HA ' ' A' ' 662' ' ' VAL . 10.9 m -84.43 -44.29 17.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.269 0.557 . . . . 0.0 110.331 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 670' ' ' ALA . 37.4 mt -66.83 -36.4 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.371 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.75 -35.5 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.955 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 3.2 tp -84.87 -63.01 1.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.88 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . 0.407 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -52.16 -26.31 11.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.665 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 666' ' ' ILE . . . -70.92 -21.96 62.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.181 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 9.7 mt -86.07 -38.54 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.129 0.49 . . . . 0.0 111.041 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -58.99 -31.09 68.47 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.753 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.01 -17.83 27.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.839 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.1 OUTLIER -92.45 -34.23 14.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.166 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 40.8 t -94.62 -10.5 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.514 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.493 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.6 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.799 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.71 -43.2 8.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.685 0.279 . . . . 0.0 110.93 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.613 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 9.1 t0 -139.63 -93.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.9 0.381 . . . . 0.0 111.353 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.29 -41.18 79.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.012 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.31 -21.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.126 0.489 . . . . 0.0 112.2 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.2 tm? 177.47 -58.57 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.366 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 9.4 Cg_endo -56.53 -20.22 32.74 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.792 1.661 . . . . 0.0 110.76 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.613 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.0 p-10 27.0 50.16 0.02 OUTLIER 'General case' 0 C--O 1.23 0.072 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.564 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . 0.426 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 4.0 pt20 43.97 98.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.821 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -170.8 -51.89 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.661 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.37 -37.22 14.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.347 . . . . 0.0 111.013 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -170.43 94.41 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 638' ' ' GLN . 4.8 p-10 -99.59 -34.73 10.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.723 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -51.09 -24.62 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.846 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -48.68 -27.53 2.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.819 0.342 . . . . 0.0 111.191 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -150.71 24.51 0.77 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 642' ' ' ASP . 6.8 t -162.19 28.71 0.11 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.772 0.32 . . . . 0.0 111.193 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -151.19 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.328 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.41 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 59.6 p-90 -73.33 -21.54 60.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.788 0.328 . . . . 0.0 110.832 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . 0.41 ' HG3' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -86.21 -11.94 51.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.654 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -68.91 -7.54 35.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.867 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -166.92 41.39 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.71 0.291 . . . . 0.0 111.174 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.602 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 2.5 tp -89.63 -31.72 0.37 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 60.3 Cg_endo -91.65 -6.4 3.63 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.427 2.084 . . . . 0.0 112.856 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 74.98 91.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.99 0.424 . . . . 0.0 110.483 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.13 45.23 1.5 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.227 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.448 ' HB ' ' HG2' ' A' ' 653' ' ' PRO . 9.4 tp -114.53 -39.51 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . 0.427 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -135.23 -62.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.789 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.89 -38.21 75.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.321 0.582 . . . . 0.0 109.818 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 43.5 m -118.22 -19.37 9.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.233 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . 0.411 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.18 -47.88 5.94 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.682 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.427 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 74.1 t -82.52 -60.23 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 110.439 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.454 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 78.0 t -42.07 -31.76 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.307 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 659' ' ' THR . 5.2 tt -80.96 -34.51 13.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.616 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.59 -27.49 34.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.42 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 1.7 p -84.44 -35.09 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.224 0.535 . . . . 0.0 110.13 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 51.2 mt -79.6 -36.69 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.831 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.98 -32.93 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.398 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.8 tp -84.58 -62.96 1.42 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -53.4 -25.42 15.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.474 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -70.03 -23.93 63.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.138 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 17.9 mt -85.1 -40.53 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.097 0.475 . . . . 0.0 110.952 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -56.68 -32.17 65.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.818 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -17.92 27.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.922 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -92.17 -32.89 14.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.208 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.482 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.3 t -97.2 -10.9 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.489 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.482 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.837 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 631' ' ' SER . . . . . 0.429 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -127.89 -51.86 1.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.568 0.223 . . . . 0.0 111.001 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.541 ' CB ' ' HB2' ' A' ' 637' ' ' ASP . 9.9 t0 -132.04 -95.64 0.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.464 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -38.23 69.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.407 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.06 -26.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.238 0.542 . . . . 0.0 112.253 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.2 tm? 178.04 -58.75 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.436 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 11.1 Cg_endo -57.81 -20.15 42.23 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.752 1.634 . . . . 0.0 110.649 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 632' ' ' ASP . 2.0 p-10 33.48 36.97 0.01 OUTLIER 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.392 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 53.14 87.7 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.174 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -152.1 -46.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.404 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.45 -31.38 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 2.4 m120 -159.13 83.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . 0.409 ' O ' ' CG2' ' A' ' 646' ' ' THR . 7.8 p-10 -95.24 -26.89 15.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.04 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -65.29 -20.64 66.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.009 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 1.4 p-90 -48.44 -27.93 2.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.628 0.251 . . . . 0.0 111.421 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.04 27.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.637 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 642' ' ' ASP . 5.9 t -175.03 32.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.444 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -137.92 -88.57 0.2 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.594 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.448 ' CE2' ' HG3' ' A' ' 649' ' ' ARG . 50.2 p-90 -69.86 -29.54 66.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 0.0 111.154 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . 0.448 ' HG3' ' CE2' ' A' ' 648' ' ' TRP . 2.6 mtp-105 -86.43 -16.26 37.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 0.0 110.362 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -65.82 -24.13 66.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.085 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . 0.432 ' HA ' ' CG2' ' A' ' 656' ' ' ILE . 1.4 p-90 -160.74 56.72 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.133 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.608 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 9.5 tp -81.98 -32.61 0.61 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 62.9 Cg_endo -96.03 -5.27 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.715 2.277 . . . . 0.0 112.875 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 75.61 89.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.003 0.43 . . . . 0.0 110.465 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.46 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.05 48.44 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.351 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.439 ' HB ' ' HG2' ' A' ' 653' ' ' PRO . 10.4 tp -114.48 -39.77 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . . . . . . . . . . . -132.6 -59.43 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.939 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 3.5 p -61.68 -38.69 80.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.26 0.552 . . . . 0.0 110.012 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.507 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 29.9 m -119.91 -18.46 8.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.214 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . 0.434 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.32 -55.26 3.11 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.673 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 664' ' ' ALA . 93.8 t -82.51 -60.73 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.109 0.48 . . . . 0.0 111.011 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.406 ' HA ' HG23 ' A' ' 665' ' ' VAL . 38.3 t -42.44 -32.41 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.609 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.6 tp -76.14 -37.27 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.64 -24.38 36.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.134 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.429 ' CG2' ' N ' ' A' ' 666' ' ' ILE . 2.7 m -84.25 -41.98 16.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.335 0.588 . . . . 0.0 110.297 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.429 ' N ' ' CG2' ' A' ' 665' ' ' VAL . 43.4 mt -70.83 -36.63 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.321 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -39.94 -34.86 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.183 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 3.0 tp -84.74 -63.15 1.38 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.887 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . 0.403 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.2 OUTLIER -52.51 -25.59 10.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.675 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 666' ' ' ILE . . . -71.92 -24.57 61.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.045 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 11.6 mt -85.99 -37.85 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.117 0.484 . . . . 0.0 110.883 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -57.62 -32.43 67.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.652 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.88 -17.96 27.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.742 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.2 OUTLIER -89.25 -34.89 16.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.484 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 41.0 t -97.15 -15.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.406 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.484 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.733 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.27 -43.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.619 0.247 . . . . 0.0 111.005 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.603 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 67.2 t0 -137.86 -105.07 0.19 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.374 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -46.06 -44.06 15.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 0.0 111.547 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.8 -26.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.374 0.607 . . . . 0.0 112.049 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.602 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 174.35 -52.99 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.835 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 37.4 Cg_exo -56.06 -23.86 46.19 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.682 1.588 . . . . 0.0 110.363 178.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.603 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.9 p-10 31.45 40.01 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.314 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 42.98 69.25 0.41 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.515 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -131.9 -57.03 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.422 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.7 -28.92 19.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.361 . . . . 0.0 110.862 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 0.6 OUTLIER -159.43 93.58 1.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.83 179.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -102.57 -36.96 8.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -54.19 -22.54 11.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.592 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 7.4 p-90 -48.56 -28.22 3.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.788 0.327 . . . . 0.0 111.18 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -149.18 23.25 0.94 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.264 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 6.2 t -160.35 27.18 0.16 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.698 0.285 . . . . 0.0 111.264 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -150.36 -85.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.517 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.438 ' O ' HG13 ' A' ' 652' ' ' ILE . 69.3 p-90 -79.43 -21.27 45.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.62 0.248 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . 0.513 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 2.6 ttt85 -86.34 -15.8 39.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.063 0.458 . . . . 0.0 110.346 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -16.59 61.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.37 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . 0.441 ' CD1' ' N ' ' A' ' 651' ' ' TRP . 1.9 p-90 -162.7 54.86 0.21 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.693 0.282 . . . . 0.0 111.258 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.513 ' CG1' ' HA ' ' A' ' 649' ' ' ARG . 0.3 OUTLIER -69.63 -51.32 16.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 110.809 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 32.1 Cg_endo -95.13 -80.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.456 2.771 . . . . 0.0 112.628 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 170.35 105.94 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.722 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.79 35.44 3.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.612 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.4 ' CG2' ' HA ' ' A' ' 651' ' ' TRP . 0.6 OUTLIER -114.15 -39.58 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 0.0 111.454 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . 0.432 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -137.82 -58.09 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 4.6 p -64.59 -39.25 84.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.303 0.573 . . . . 0.0 109.638 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.526 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 20.5 m -115.08 -17.37 11.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.852 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -81.92 -46.18 6.81 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.53 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.432 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 99.5 t -82.6 -60.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.26 0.553 . . . . 0.0 110.448 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.498 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 53.8 t -42.0 -31.65 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.56 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 659' ' ' THR . 0.7 OUTLIER -79.66 -34.09 15.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.748 -179.154 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.48 -27.36 34.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.164 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.498 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 1.5 p -84.55 -36.0 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.131 0.491 . . . . 0.0 110.156 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 39.4 mt -78.91 -37.02 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.022 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.38 -32.96 0.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.481 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.6 -63.13 1.39 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.803 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -24.51 15.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 110.508 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -70.7 -22.47 62.45 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.168 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 6.8 mt -81.59 -51.9 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.172 0.511 . . . . 0.0 110.975 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -48.95 -33.4 10.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.699 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . 0.449 ' H ' ' HG3' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.8 -17.9 27.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.523 -179.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -96.35 -31.16 13.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.738 0.304 . . . . 0.0 111.385 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.456 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 41.1 t -94.66 -1.19 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.381 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.456 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 2.4 m-85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.801 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 631' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 637' ' ' ASP . 42.5 t 61.54 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.491 0.186 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.613 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 38.8 t70 -122.51 -99.76 0.42 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.745 0.307 . . . . 0.0 111.235 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -45.15 80.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.269 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.2 -24.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.133 0.492 . . . . 0.0 112.31 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.487 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.2 tm? 177.03 -58.66 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.425 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 9.2 Cg_endo -56.56 -20.53 34.28 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.775 1.65 . . . . 0.0 110.864 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.613 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.9 p-10 31.24 39.87 0.01 OUTLIER 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.38 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 52.95 97.96 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.189 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -171.68 -40.8 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.452 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -83.34 -34.79 25.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -168.01 47.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -51.16 -27.18 8.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.255 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -52.18 -20.56 2.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.94 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 -48.36 -28.85 3.44 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.786 0.327 . . . . 0.0 111.269 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.58 22.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.239 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 11.0 t -156.97 25.36 0.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.108 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.78 -111.97 0.89 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.235 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -60.4 -21.52 62.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.709 0.29 . . . . 0.0 110.926 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . 0.451 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 39.2 ttt85 -86.55 -19.13 29.9 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.33 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -26.97 64.23 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.861 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -153.29 58.9 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.083 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.491 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 1.9 mt -63.07 -47.56 85.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.698 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 29.5 Cg_endo -95.42 -76.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.458 2.772 . . . . 0.0 112.548 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 165.68 95.6 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.473 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.473 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.67 42.92 1.9 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.337 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.403 ' C ' ' HA3' ' A' ' 660' ' ' GLY . 10.3 tp -114.27 -39.55 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.821 0.344 . . . . 0.0 111.465 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . 0.447 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -135.23 -56.59 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 659' ' ' THR . 8.0 p -63.47 -42.72 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.345 0.593 . . . . 0.0 109.757 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.527 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 20.4 m -114.86 -16.96 11.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.867 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . 0.403 ' HA3' ' C ' ' A' ' 656' ' ' ILE . . . -82.24 -46.6 6.48 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.64 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.447 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 67.7 t -82.82 -59.12 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.108 0.48 . . . . 0.0 110.345 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.461 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 74.6 t -42.56 -32.33 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.078 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 659' ' ' THR . 0.5 OUTLIER -81.3 -34.37 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.566 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.51 -27.07 34.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.298 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 2.1 p -84.44 -34.71 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.215 0.531 . . . . 0.0 110.076 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 61.3 mt -81.61 -36.66 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.086 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . 0.428 ' O ' HG13 ' A' ' 671' ' ' ILE . . . -41.83 -32.2 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.413 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.57 -62.79 1.47 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.74 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -24.66 15.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.022 0.439 . . . . 0.0 110.388 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -73.65 -21.94 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.149 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.516 HG22 HD11 ' A' ' 671' ' ' ILE . 6.8 mt -75.37 -55.58 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 121.289 0.566 . . . . 0.0 111.012 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . 0.419 ' HA ' ' HE1' ' A' ' 676' ' ' PHE . . . -47.52 -62.62 1.35 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.795 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -21.94 18.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.154 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -65.5 -48.3 73.02 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.98 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . . . . . . . . . 20.7 t -101.7 -42.29 9.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.419 ' HE1' ' HA ' ' A' ' 672' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 631' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 637' ' ' ASP . 1.1 t -107.54 -40.85 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.631 0.253 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.578 ' HB2' ' HA ' ' A' ' 637' ' ' ASP . 1.1 m-20 -136.29 -99.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.86 0.362 . . . . 0.0 111.436 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -49.56 -44.37 46.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.509 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.9 -19.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.474 ' N ' ' HD2' ' A' ' 636' ' ' PRO . 2.1 tm? 177.32 -58.89 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.384 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 10.3 Cg_endo -57.12 -20.72 39.13 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.754 1.636 . . . . 0.0 110.617 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.578 ' HA ' ' HB2' ' A' ' 632' ' ' ASP . 1.7 p-10 28.58 42.48 0.01 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.452 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 43.46 74.13 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.525 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -140.94 -55.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.463 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -93.96 -29.93 15.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.957 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.64 101.32 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -102.24 -33.92 9.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -52.89 -22.45 5.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.725 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -48.54 -28.05 3.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.714 0.292 . . . . 0.0 111.332 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -149.14 20.21 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.275 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 6.7 t -155.7 25.88 0.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 111.131 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -140.91 -98.55 0.35 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.24 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -66.61 -28.49 68.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -86.32 -12.08 50.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.509 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -12.88 61.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.484 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . 0.448 ' CD1' ' N ' ' A' ' 651' ' ' TRP . 1.6 p-90 -164.79 45.66 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.78 0.324 . . . . 0.0 111.193 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 4.3 tt -88.9 -31.78 0.38 Allowed Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 56.5 Cg_endo -92.6 -6.18 3.13 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.438 2.092 . . . . 0.0 112.983 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 75.74 91.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.97 0.414 . . . . 0.0 110.461 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.475 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.18 45.0 1.52 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.463 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.438 ' CA ' ' HA3' ' A' ' 660' ' ' GLY . 9.9 tp -114.58 -39.43 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . . . . . . . . . . . -132.92 -59.28 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.776 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 3.5 p -61.73 -38.91 81.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.283 0.563 . . . . 0.0 109.975 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.544 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 24.2 m -119.44 -18.37 8.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.108 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . 0.438 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.24 -53.31 3.7 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.605 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 664' ' ' ALA . 83.9 t -82.55 -60.87 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.074 0.464 . . . . 0.0 111.036 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.4 ' CG1' ' CD1' ' A' ' 666' ' ' ILE . 25.6 t -43.38 -31.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.656 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.5 tp -73.9 -34.47 39.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.992 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.64 -23.5 36.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.668 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . . . . . . . . . 1.8 t -83.8 -46.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.391 0.615 . . . . 0.0 109.917 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.4 ' CD1' ' CG1' ' A' ' 662' ' ' VAL . 60.6 mt -66.97 -35.06 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.186 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . 0.436 ' O ' HG12 ' A' ' 671' ' ' ILE . . . -41.59 -34.12 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.117 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.5 tp -84.81 -63.0 1.41 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.82 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -52.26 -26.35 11.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.595 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -69.33 -21.94 63.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.087 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 667' ' ' ALA . 20.5 mm -84.55 -40.31 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.104 0.478 . . . . 0.0 111.148 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.19 -31.75 69.3 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.808 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.88 -17.95 27.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.79 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -92.0 -34.28 14.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.483 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 44.0 t -94.39 -13.11 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.356 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.483 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.772 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.5 m -91.38 -48.87 6.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.675 0.274 . . . . 0.0 110.824 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.582 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 11.1 t70 -139.23 -95.17 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.354 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -57.58 -39.65 77.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.189 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.89 -25.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.342 0.591 . . . . 0.0 111.884 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.616 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 174.78 -53.47 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.858 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.616 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 38.0 Cg_exo -55.51 -24.02 42.18 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.691 1.594 . . . . 0.0 110.423 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.582 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.1 p-10 26.89 47.16 0.01 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.479 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 50.67 57.46 6.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.132 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -121.58 -44.4 0.38 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.411 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.92 74.96 2.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 110.734 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 60.74 82.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.27 -24.99 63.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -55.65 -19.66 11.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.782 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -48.48 -28.3 3.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.73 0.3 . . . . 0.0 111.294 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.8 20.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.314 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' THR . . . . . . . . . . . . . 7.4 t -157.29 26.24 0.3 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 111.126 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -142.54 -90.69 0.14 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.343 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.405 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 68.1 p-90 -71.92 -22.02 61.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.667 0.27 . . . . 0.0 110.999 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . 0.405 ' HG3' ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -86.17 -12.02 50.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.907 0.384 . . . . 0.0 110.474 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -15.06 62.46 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.201 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . 0.482 ' CD1' ' N ' ' A' ' 651' ' ' TRP . 0.6 OUTLIER -168.49 52.36 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.188 -179.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.597 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 4.2 tp -89.86 -31.9 0.37 Allowed Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 652' ' ' ILE . 57.7 Cg_endo -91.84 -8.03 3.09 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.377 2.051 . . . . 0.0 112.976 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 76.06 92.51 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.953 0.406 . . . . 0.0 110.363 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.416 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.29 43.07 1.79 Allowed Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.249 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . 0.467 ' CG2' ' HA ' ' A' ' 651' ' ' TRP . 10.2 tp -114.5 -39.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.32 . . . . 0.0 111.525 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 661' ' ' VAL . . . -136.08 -57.37 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.668 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.92 -38.12 81.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.275 0.56 . . . . 0.0 109.805 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.512 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 16.7 m -120.04 -18.33 8.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.018 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -82.14 -52.79 3.9 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.726 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' A' ' 657' ' ' GLY . 86.5 t -82.64 -59.63 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.146 0.498 . . . . 0.0 110.768 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.466 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 44.6 t -42.54 -31.64 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.383 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 659' ' ' THR . 0.2 OUTLIER -79.52 -36.0 17.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.71 -179.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.66 -27.01 34.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 662' ' ' VAL . 2.0 p -84.76 -35.34 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.228 0.537 . . . . 0.0 110.336 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.425 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 26.9 mm -81.14 -37.86 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.284 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . 0.42 ' O ' HG12 ' A' ' 671' ' ' ILE . . . -41.27 -32.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.35 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.9 tp -84.69 -63.14 1.39 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.36 -25.79 16.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.051 0.453 . . . . 0.0 110.396 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -68.35 -21.87 64.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.037 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 667' ' ' ALA . 16.8 mm -84.73 -41.21 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.177 0.513 . . . . 0.0 111.214 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -58.61 -32.15 68.74 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.96 -17.87 27.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.974 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -94.21 -32.5 13.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.274 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.481 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.1 t -94.83 -4.66 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.42 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.481 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 2.4 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.837 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 631' ' ' SER . . . . . 0.427 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -117.88 -48.62 2.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.66 0.267 . . . . 0.0 110.899 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . 0.604 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 65.3 t0 -136.39 -93.79 0.24 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.857 0.36 . . . . 0.0 111.316 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -37.81 70.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.148 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.09 -27.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.414 0.626 . . . . 0.0 111.77 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.611 ' HB3' ' HD3' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 178.26 -54.27 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.904 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 636' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 635' ' ' LEU . 39.5 Cg_exo -56.03 -23.95 46.38 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 121.586 1.524 . . . . 0.0 110.371 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 637' ' ' ASP . . . . . 0.604 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.2 p-10 30.33 40.58 0.01 OUTLIER 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.552 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 637' ' ' ASP . 2.9 pt20 36.35 73.82 0.08 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.054 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -162.77 -46.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.727 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.88 -38.54 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 111.103 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -153.33 46.32 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 642' ' ' ASP . . . . . 0.411 ' O ' ' CG2' ' A' ' 646' ' ' THR . 17.4 p-10 -64.78 -32.34 73.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -50.25 -25.58 3.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.725 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -48.71 -27.86 3.19 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.788 0.328 . . . . 0.0 111.272 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -148.86 22.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.323 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 642' ' ' ASP . 12.4 t -159.25 26.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 651' ' ' TRP . . . -143.51 -95.6 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.293 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.408 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 65.3 p-90 -65.07 -21.51 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.841 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' ARG . . . . . 0.614 ' HA ' HG12 ' A' ' 652' ' ' ILE . 19.9 mtp85 -86.61 -19.32 29.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.241 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.55 -12.83 61.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.68 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' TRP . . . . . 0.407 ' CD1' ' O ' ' A' ' 647' ' ' GLY . 2.3 p-90 -154.45 46.75 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.763 0.316 . . . . 0.0 111.136 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' ILE . . . . . 0.614 HG12 ' HA ' ' A' ' 649' ' ' ARG . 0.0 OUTLIER -71.55 -61.85 1.95 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.849 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.82 -2.39 12.16 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.739 2.293 . . . . 0.0 113.016 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 72.87 91.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.963 0.411 . . . . 0.0 110.405 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . 0.401 ' C ' ' CA ' ' A' ' 660' ' ' GLY . . . 104.01 49.15 1.1 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.077 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' ILE . . . . . . . . . . . . . 9.8 tp -114.51 -39.74 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.779 0.323 . . . . 0.0 111.733 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' GLY . . . . . . . . . . . . . . . -139.68 -61.33 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.591 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 1.9 p -62.33 -36.84 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.418 0.628 . . . . 0.0 109.656 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 659' ' ' THR . . . . . 0.508 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 47.0 m -117.75 -17.97 9.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.084 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . 0.401 ' CA ' ' C ' ' A' ' 655' ' ' GLY . . . -82.28 -57.32 2.66 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.977 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 664' ' ' ALA . 40.7 t -82.19 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.201 0.524 . . . . 0.0 111.144 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.415 ' HA ' HG21 ' A' ' 665' ' ' VAL . 24.4 t -43.13 -31.14 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.775 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.6 tt -75.19 -36.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.122 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 664' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.68 -24.81 36.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.115 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 665' ' ' VAL . . . . . 0.415 HG21 ' HA ' ' A' ' 662' ' ' VAL . 2.4 m -84.41 -41.17 15.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.32 0.581 . . . . 0.0 110.279 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 666' ' ' ILE . . . . . 0.41 ' N ' ' CG2' ' A' ' 665' ' ' VAL . 18.5 mm -70.3 -36.51 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.362 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.31 -34.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.146 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.77 -63.01 1.41 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.863 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 669' ' ' PHE . . . . . 0.4 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 34.7 t80 -52.78 -25.94 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -70.81 -24.28 62.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.182 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 10.3 mt -85.55 -33.24 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.124 0.488 . . . . 0.0 110.915 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -62.86 -33.81 76.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.379 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 673' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.13 -17.76 27.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.743 179.415 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -91.69 -33.98 14.83 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.069 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 675' ' ' VAL . . . . . 0.484 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.9 t -94.82 -12.05 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.309 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 676' ' ' PHE . . . . . 0.484 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.815 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.45 ' N ' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 631' ' ' SER . . . . . 0.429 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -102.85 -48.51 4.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.688 0.28 . . . . 0.0 110.875 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.606 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 12.4 t70 -136.3 -96.85 0.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.861 0.362 . . . . 0.0 111.32 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.62 -41.39 63.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.24 -22.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.148 0.499 . . . . 0.0 112.288 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.576 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.1 tm? 177.66 -58.56 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.281 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.513 ' N ' HD13 ' A' ' 635' ' ' LEU . 10.6 Cg_endo -57.64 -20.26 41.42 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.668 1.579 . . . . 0.0 110.585 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.606 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 1.9 p-10 30.52 40.64 0.01 OUTLIER 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.396 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 44.01 54.46 5.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.359 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -132.86 -46.18 0.12 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.4 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -99.52 -27.06 13.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 0.0 110.844 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 1.6 t-20 -148.05 69.74 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.93 ' O ' HG22 ' A' ' 646' ' ' THR . 11.1 p-10 -94.8 -27.47 15.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.048 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.6 -21.05 66.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.096 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 644' ' ' TRP . . . . . 0.429 ' HA ' ' CE2' ' A' ' 648' ' ' TRP . 1.2 p-90 -48.43 -29.59 4.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.773 0.32 . . . . 0.0 111.242 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -137.03 14.64 3.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.595 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.93 HG22 ' O ' ' A' ' 642' ' ' ASP . 3.6 t -156.57 24.76 0.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.715 0.293 . . . . 0.0 111.446 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -143.42 -90.52 0.13 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.307 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.444 ' O ' HG13 ' A' ' 652' ' ' ILE . 37.9 p-90 -73.0 -20.9 60.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.614 0.245 . . . . 0.0 111.043 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 649' ' ' ARG . . . . . 0.486 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 4.0 ttt-85 -85.79 -15.44 42.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 110.284 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -24.4 63.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.789 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.712 ' HA ' HG22 ' A' ' 656' ' ' ILE . 6.0 p-90 -159.18 59.06 0.41 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.498 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 0.5 OUTLIER -65.45 -47.88 67.96 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.8 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.561 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 41.1 Cg_endo -89.02 -76.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.975 2.45 . . . . 0.0 112.732 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.95 88.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.666 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.53 47.71 1.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.552 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.735 ' O ' HG23 ' A' ' 661' ' ' VAL . 10.2 tp -114.48 -33.86 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.327 . . . . 0.0 111.187 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.429 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -131.37 -48.04 0.12 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.737 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 658' ' ' VAL . . . . . 0.48 HG13 ' N ' ' A' ' 659' ' ' THR . 10.7 p -69.54 -43.29 80.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.246 0.546 . . . . 0.0 109.892 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.666 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 22.3 m -118.6 -15.85 9.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.677 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.518 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.4 -51.05 4.51 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.345 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 656' ' ' ILE . 43.1 t -82.62 -61.72 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 110.775 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.588 ' HA ' HG22 ' A' ' 665' ' ' VAL . 40.0 t -41.79 -33.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.591 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.3 tt -75.98 -37.54 34.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.545 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.49 -24.95 36.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.173 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 662' ' ' VAL . 5.2 m -84.51 -43.41 17.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.313 0.577 . . . . 0.0 110.478 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.453 ' N ' HG23 ' A' ' 665' ' ' VAL . 18.9 mm -67.35 -36.71 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.565 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.22 -35.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.976 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 668' ' ' LEU . . . . . 0.514 ' HA ' HD12 ' A' ' 671' ' ' ILE . 3.4 tp -84.9 -63.03 1.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.873 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 669' ' ' PHE . . . . . 0.421 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -51.79 -26.89 10.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.755 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.407 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.07 -23.71 63.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.983 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 668' ' ' LEU . 11.4 mt -85.96 -35.35 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.158 0.504 . . . . 0.0 110.88 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 672' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 676' ' ' PHE . . . -61.11 -32.97 72.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.509 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.99 -17.9 27.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.566 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -88.59 -35.08 17.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 36.6 t -96.77 -19.21 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.354 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.48 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.848 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 631' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.6 OUTLIER -83.08 -44.15 15.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 110.855 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.68 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 64.2 t0 -136.92 -97.91 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.405 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -42.96 63.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.469 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.32 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.555 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 178.9 -59.42 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.316 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.497 ' N ' HD13 ' A' ' 635' ' ' LEU . 15.0 Cg_endo -59.36 -20.13 54.45 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.702 1.601 . . . . 0.0 110.283 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.68 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 0.4 OUTLIER 36.31 -160.4 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.152 178.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -108.36 76.96 1.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.044 0.449 . . . . 0.0 111.027 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 179.48 -35.15 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.348 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.88 -29.28 23.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.752 0.311 . . . . 0.0 110.925 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.2 42.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.219 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.929 ' O ' HG22 ' A' ' 646' ' ' THR . 5.6 t0 -56.84 -22.37 36.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.145 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 643' ' ' ASN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 648' ' ' TRP . 92.4 m-20 -52.99 -19.83 2.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.039 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 644' ' ' TRP . . . . . 0.425 ' HA ' ' CD ' ' A' ' 649' ' ' ARG . 25.9 p-90 -48.27 -28.32 3.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.908 0.385 . . . . 0.0 111.126 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.97 24.84 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.982 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.929 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.3 t -156.21 21.58 0.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.427 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -149.77 -124.92 1.31 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.848 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 643' ' ' ASN . 64.7 p-90 -61.89 -21.05 64.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.655 0.264 . . . . 0.0 111.445 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 649' ' ' ARG . . . . . 0.497 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 3.3 ttt180 -86.17 -15.93 39.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.876 0.369 . . . . 0.0 110.474 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 650' ' ' GLN . . . . . 0.459 ' O ' HG23 ' A' ' 656' ' ' ILE . 3.6 mt-30 -73.62 -14.64 61.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.509 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.568 ' HA ' HG22 ' A' ' 656' ' ' ILE . 2.3 p-90 -158.9 50.84 0.38 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.687 0.28 . . . . 0.0 111.503 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.497 ' CG1' ' HA ' ' A' ' 649' ' ' ARG . 0.7 OUTLIER -63.89 -48.61 78.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.357 . . . . 0.0 110.552 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 30.6 Cg_endo -94.46 -76.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.488 2.792 . . . . 0.0 112.485 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.31 96.1 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.624 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.525 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.59 42.3 2.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.323 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.1 tp -114.48 -39.6 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.706 0.289 . . . . 0.0 111.696 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 662' ' ' VAL . . . -134.06 -53.68 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.738 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 658' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 659' ' ' THR . 9.9 p -64.51 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.352 0.596 . . . . 0.0 109.843 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.525 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 23.3 m -119.68 -17.81 8.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.992 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.463 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.28 -51.57 4.34 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.623 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.802 ' O ' HG12 ' A' ' 665' ' ' VAL . 53.1 t -82.78 -59.65 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.093 0.473 . . . . 0.0 110.567 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 657' ' ' GLY . 62.0 t -42.19 -31.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.417 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.614 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 1.7 tp -80.85 -35.98 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.648 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.6 -26.86 34.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.498 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.802 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.1 p -84.69 -34.3 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 121.122 0.487 . . . . 0.0 110.356 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.451 HD12 HG12 ' A' ' 662' ' ' VAL . 45.8 mt -81.46 -38.32 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.267 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 667' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.13 -32.41 0.26 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.398 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 668' ' ' LEU . . . . . 0.563 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.0 OUTLIER -84.57 -63.17 1.38 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.97 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 669' ' ' PHE . . . . . 0.406 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 76.8 t80 -54.04 -25.96 24.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.06 0.457 . . . . 0.0 110.357 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.432 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -67.99 -22.08 65.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.932 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 668' ' ' LEU . 7.2 mt -85.5 -37.1 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.134 0.492 . . . . 0.0 111.051 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.3 -31.77 71.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.563 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.449 ' H ' ' HG3' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -90.02 -17.87 27.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.754 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -92.65 -34.17 14.09 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.155 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.492 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -94.15 -11.06 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.396 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.492 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.831 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.428 ' N ' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 631' ' ' SER . . . . . 0.417 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.5 OUTLIER -119.59 -45.0 2.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.706 0.289 . . . . 0.0 110.889 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.612 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 18.8 t70 -137.99 -95.65 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.362 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -52.53 -42.14 64.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.189 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.52 -20.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.568 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.1 tm? 177.79 -58.93 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.364 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.517 ' N ' HD13 ' A' ' 635' ' ' LEU . 11.2 Cg_endo -58.03 -20.51 45.74 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.724 1.616 . . . . 0.0 110.544 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.612 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 1.4 p-10 30.24 39.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.6 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 638' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 636' ' ' PRO . 9.0 mt-30 51.5 98.78 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.163 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -170.12 -40.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.337 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -80.85 -39.96 25.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 110.731 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -178.78 92.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.921 ' O ' HG22 ' A' ' 646' ' ' THR . 4.2 m-20 -70.51 -19.09 62.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -53.88 -20.3 5.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.098 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -48.31 -28.89 3.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.791 0.329 . . . . 0.0 111.163 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -147.62 20.82 1.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.921 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.9 t -155.6 24.91 0.4 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.771 0.32 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -151.82 -79.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.655 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.425 ' O ' HG13 ' A' ' 652' ' ' ILE . 65.1 p-90 -86.13 -21.46 27.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.587 0.232 . . . . 0.0 111.287 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 649' ' ' ARG . . . . . 0.479 ' HG2' HD11 ' A' ' 652' ' ' ILE . 1.3 ttp85 -86.44 -15.75 39.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.317 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -71.22 -18.23 62.47 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.177 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.835 ' HA ' HG22 ' A' ' 656' ' ' ILE . 12.0 p-90 -167.54 59.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.591 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.59 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 2.1 mt -60.33 -54.88 50.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.771 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 37.5 Cg_endo -69.13 -64.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.265 1.977 . . . . 0.0 112.378 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 168.39 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.494 0.664 . . . . 0.0 110.281 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.877 ' HA2' HG12 ' A' ' 658' ' ' VAL . . . 103.64 38.35 2.8 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.705 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.835 HG22 ' HA ' ' A' ' 651' ' ' TRP . 0.4 OUTLIER -73.5 -17.68 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.245 0.545 . . . . 0.0 110.515 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.659 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -106.52 -35.39 2.87 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 658' ' ' VAL . . . . . 0.877 HG12 ' HA2' ' A' ' 655' ' ' GLY . 13.9 p -82.29 -31.65 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.254 -0.473 . . . . 0.0 110.6 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.575 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 70.9 m -123.47 -20.26 5.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.755 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.2 -44.54 7.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.908 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 665' ' ' VAL . 96.5 t -82.62 -62.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.205 0.526 . . . . 0.0 110.413 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.518 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 44.0 t -42.05 -32.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.543 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.3 OUTLIER -79.27 -34.87 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.689 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.0 -27.23 35.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.285 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.8 p -84.64 -33.98 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 121.285 0.565 . . . . 0.0 110.154 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 670' ' ' ALA . 25.4 mm -82.84 -37.97 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.341 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 667' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.13 -32.65 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.342 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.4 tp -84.53 -63.1 1.4 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.821 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 669' ' ' PHE . . . . . 0.411 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 1.4 t80 -53.86 -25.2 18.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.516 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.439 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -69.08 -22.65 63.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 16.1 mt -86.01 -36.3 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.113 0.482 . . . . 0.0 111.082 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.16 73.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.543 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.0 -17.9 27.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.716 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -91.46 -34.23 14.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.164 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -95.19 -11.29 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.302 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.506 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.18 -0.915 . . . . 0.0 110.792 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.1 m -120.92 -40.85 2.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.616 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 16.3 t70 -141.88 -99.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.349 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -39.07 60.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.441 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.46 -23.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.236 0.541 . . . . 0.0 112.007 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.676 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 173.1 -52.98 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.923 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.676 ' N ' HD13 ' A' ' 635' ' ' LEU . 35.8 Cg_exo -55.96 -23.54 43.7 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.714 1.609 . . . . 0.0 110.489 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.0 p-10 27.28 48.93 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.539 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 43.01 73.54 0.14 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.593 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -134.66 -44.53 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.554 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -97.22 69.03 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 110.986 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 62.28 86.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.902 ' O ' HG22 ' A' ' 646' ' ' THR . 5.7 p-10 -63.86 -23.82 67.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.19 -17.06 9.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.891 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -48.25 -40.27 24.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.724 0.297 . . . . 0.0 111.251 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -131.89 16.39 4.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.385 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.902 HG22 ' O ' ' A' ' 642' ' ' ASP . 9.5 t -152.48 23.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.794 0.331 . . . . 0.0 111.093 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.41 -96.72 0.28 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.112 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.885 ' HB3' HD13 ' A' ' 652' ' ' ILE . 57.8 p-90 -64.77 -22.04 66.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.092 0.473 . . . . 0.0 110.697 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.45 -24.07 25.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 650' ' ' GLN . . . . . 0.507 ' O ' HG22 ' A' ' 656' ' ' ILE . 3.6 tt0 -91.38 -32.93 15.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.207 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.543 ' HA ' HG22 ' A' ' 656' ' ' ILE . 25.0 p-90 -175.4 67.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.03 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.885 HD13 ' HB3' ' A' ' 648' ' ' TRP . 9.1 tp -64.3 -33.14 8.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.654 ' HG3' HD12 ' A' ' 656' ' ' ILE . 33.3 Cg_endo -93.82 -74.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.536 2.158 . . . . 0.0 112.442 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 178.67 70.34 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.439 0.638 . . . . 0.0 110.317 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.814 ' HA2' HG12 ' A' ' 658' ' ' VAL . . . 103.62 45.04 1.59 Allowed Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.565 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.654 HD12 ' HG3' ' A' ' 653' ' ' PRO . 0.4 OUTLIER -73.08 -18.6 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 110.102 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.549 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -106.12 -33.87 3.34 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 658' ' ' VAL . . . . . 0.814 HG12 ' HA2' ' A' ' 655' ' ' GLY . 13.0 p -82.13 -30.55 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.999 0.428 . . . . 0.0 110.589 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.564 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 99.5 m -124.82 -23.38 4.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.931 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.14 -44.64 7.46 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.156 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 665' ' ' VAL . 74.5 t -82.67 -61.67 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.191 0.52 . . . . 0.0 110.574 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 665' ' ' VAL . 40.1 t -43.05 -33.2 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.461 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 659' ' ' THR . 5.0 tt -77.47 -35.5 22.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.176 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.63 -25.19 35.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.844 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 661' ' ' VAL . 2.8 m -84.38 -42.21 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.301 0.572 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.46 HD12 HG12 ' A' ' 662' ' ' VAL . 45.0 mt -70.82 -37.09 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.437 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 667' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -39.85 -34.58 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.117 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.83 -63.15 1.38 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.88 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 669' ' ' PHE . . . . . 0.42 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -52.15 -26.77 12.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.617 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.419 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -69.35 -24.7 63.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.971 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 16.8 mt -86.1 -36.06 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.124 0.487 . . . . 0.0 110.879 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.79 -32.29 70.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.541 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.92 -17.84 27.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.738 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -90.92 -34.34 15.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.081 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.498 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.9 t -95.68 -14.03 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.335 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.498 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.1 m-85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.854 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.21 -44.48 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.696 0.284 . . . . 0.0 110.809 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.631 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 18.5 t70 -137.54 -100.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.272 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.23 -41.59 60.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.363 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.01 -25.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.27 0.557 . . . . 0.0 112.126 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.694 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 175.76 -53.81 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.12 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.694 ' N ' HD13 ' A' ' 635' ' ' LEU . 39.4 Cg_exo -55.52 -24.56 44.98 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 121.596 1.531 . . . . 0.0 110.512 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.631 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.1 p-10 29.77 39.51 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.562 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 638' ' ' GLN . . . . . 0.424 ' O ' ' HG3' ' A' ' 638' ' ' GLN . 7.7 pt20 41.56 94.29 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.931 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 158.52 -33.12 0.49 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.367 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.75 -23.04 10.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.691 0.282 . . . . 0.0 111.058 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -148.04 19.81 1.11 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.569 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.918 ' O ' HG22 ' A' ' 646' ' ' THR . 4.2 t0 -59.98 -22.91 63.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.877 0.37 . . . . 0.0 110.862 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -56.37 -20.2 18.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.635 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -48.53 -27.53 2.79 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.75 0.309 . . . . 0.0 111.244 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.27 22.82 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.918 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.6 t -159.3 25.5 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.279 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 647' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 650' ' ' GLN . . . -143.4 -96.44 0.23 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.621 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.448 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 67.0 p-90 -62.59 -20.49 64.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.651 0.262 . . . . 0.0 111.209 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 649' ' ' ARG . . . . . 0.538 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 26.7 mtt180 -85.92 -14.69 44.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.912 0.387 . . . . 0.0 110.404 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 650' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 647' ' ' GLY . 2.2 mt-30 -76.11 -14.07 60.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.505 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.787 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.6 p-90 -160.37 50.6 0.29 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.572 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 1.7 mt -67.68 -50.29 35.81 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.733 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.572 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 98.4 Cg_endo -84.49 5.6 6.21 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.777 2.318 . . . . 0.0 113.04 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 65.29 90.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.396 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.507 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.47 49.62 1.03 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.527 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.787 HG22 ' HA ' ' A' ' 651' ' ' TRP . 10.3 tp -114.44 -39.52 2.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.908 0.385 . . . . 0.0 111.338 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.715 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -137.46 -60.95 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.563 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 658' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 651' ' ' TRP . 3.4 p -59.73 -39.51 79.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.37 0.605 . . . . 0.0 109.759 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 31.8 m -117.7 -18.33 9.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.109 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.14 -48.1 5.86 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.55 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.773 ' O ' HG12 ' A' ' 665' ' ' VAL . 75.6 t -82.76 -60.31 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.233 0.539 . . . . 0.0 110.56 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.547 HG12 HD12 ' A' ' 666' ' ' ILE . 63.5 t -42.0 -32.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.44 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.4 tt -79.02 -34.58 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.677 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.58 -27.75 34.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.327 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.7 p -84.47 -36.16 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.074 0.464 . . . . 0.0 110.275 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.547 HD12 HG12 ' A' ' 662' ' ' VAL . 39.0 mt -76.44 -36.16 28.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.915 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 667' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.05 -32.93 0.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.384 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 668' ' ' LEU . . . . . 0.511 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.1 tp -84.53 -63.1 1.4 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.87 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -54.01 -24.56 17.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.46 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.422 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -71.0 -24.7 62.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.054 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 668' ' ' LEU . 10.2 mt -84.45 -39.82 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.16 0.505 . . . . 0.0 110.886 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -57.52 -34.65 69.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.772 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.444 ' H ' ' HG3' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.89 -17.84 27.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.835 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 674' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 9.2 t80 -89.28 -33.59 16.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.102 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.5 t -98.78 -14.07 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.228 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.503 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.774 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 2.2 m -110.6 -44.11 3.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.754 0.312 . . . . 0.0 110.748 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.601 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 43.7 t0 -140.51 -100.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.169 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -54.52 -44.64 72.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.389 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.15 -28.64 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.494 0.664 . . . . 0.0 111.977 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.709 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.5 OUTLIER 175.14 -53.26 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.851 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.709 ' N ' HD13 ' A' ' 635' ' ' LEU . 31.4 Cg_exo -54.63 -24.43 36.95 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 121.654 1.569 . . . . 0.0 110.511 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.601 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 5.9 p-10 28.95 56.47 0.12 Allowed 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.451 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 638' ' ' GLN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 10.4 pt20 42.99 96.01 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.715 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -168.18 -40.81 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.416 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -111.05 -29.99 7.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.307 . . . . 0.0 110.982 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 0.6 OUTLIER -162.94 88.97 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.055 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.882 ' O ' HG22 ' A' ' 646' ' ' THR . 2.8 p30 -102.81 -28.54 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.945 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -64.37 -24.91 67.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.993 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 644' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 1.4 p-90 -48.48 -32.08 7.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.719 0.295 . . . . 0.0 111.19 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -130.58 -13.3 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.981 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 642' ' ' ASP . 4.8 t -132.39 34.49 3.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.81 0.338 . . . . 0.0 111.302 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -145.25 -96.31 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.447 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -72.05 -29.65 64.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 110.769 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 19.7 ttm-85 -86.34 -13.79 45.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.393 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 650' ' ' GLN . . . . . 0.539 ' O ' HG23 ' A' ' 656' ' ' ILE . 29.9 tt0 -68.33 -12.89 61.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.385 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.601 ' HA ' HG22 ' A' ' 656' ' ' ILE . 38.7 p-90 -162.31 45.58 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.747 0.308 . . . . 0.0 111.055 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.849 HD13 ' O ' ' A' ' 652' ' ' ILE . 0.0 OUTLIER -86.17 -33.05 0.46 Allowed Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.697 ' HD3' HG22 ' A' ' 652' ' ' ILE . 63.1 Cg_endo -93.43 -4.49 3.0 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.512 2.142 . . . . 0.0 112.791 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 74.81 90.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.996 0.427 . . . . 0.0 110.585 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.522 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.15 46.15 1.38 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.444 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.774 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.3 tp -114.55 -39.5 2.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.45 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -130.78 -58.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.883 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.39 -39.14 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.224 0.535 . . . . 0.0 109.985 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.53 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 5.6 m -119.11 -19.16 8.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.147 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.33 -52.72 3.88 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.681 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 665' ' ' VAL . 76.5 t -82.39 -62.13 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.063 0.459 . . . . 0.0 110.964 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 24.5 t -42.37 -30.97 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.692 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.5 tp -76.62 -35.06 24.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.216 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 664' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.56 -24.57 36.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.894 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 661' ' ' VAL . 1.1 t -83.83 -45.64 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.465 0.65 . . . . 0.0 110.008 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 670' ' ' ALA . 23.2 mm -68.5 -35.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.491 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 667' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.77 -34.82 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.145 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 668' ' ' LEU . . . . . 0.634 ' HA ' HD12 ' A' ' 671' ' ' ILE . 2.8 tp -84.7 -63.11 1.39 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.003 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.76 -24.65 9.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.655 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -72.43 -25.02 61.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.26 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' A' ' 668' ' ' LEU . 10.2 mt -78.8 -41.2 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.093 0.473 . . . . 0.0 111.135 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 672' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 676' ' ' PHE . . . -59.05 -33.82 71.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.7 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.45 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.97 -17.95 26.95 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.635 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 674' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 11.0 t80 -86.67 -34.6 19.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.826 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.5 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 44.6 t -100.55 -18.51 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.5 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.779 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.546 -0.221 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.97 -41.77 11.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.726 0.298 . . . . 0.0 110.896 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.623 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.2 t0 -141.55 -92.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.354 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -58.98 -39.02 80.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.51 -27.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.421 0.629 . . . . 0.0 111.867 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 178.51 -54.56 0.0 OUTLIER Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.787 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.68 ' N ' HD13 ' A' ' 635' ' ' LEU . 38.3 Cg_exo -55.48 -23.76 40.65 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.597 1.531 . . . . 0.0 110.375 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.623 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.5 p-10 28.8 49.77 0.04 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.519 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 42.94 65.47 0.94 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.507 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -126.97 -41.92 0.29 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.23 80.93 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.95 80.82 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.005 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.925 ' O ' HG22 ' A' ' 646' ' ' THR . 5.4 p30 -67.55 -26.83 66.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 643' ' ' ASN . . . . . 0.436 ' HB3' ' CD1' ' A' ' 648' ' ' TRP . 7.0 m120 -56.26 -22.03 27.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.488 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 644' ' ' TRP . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 648' ' ' TRP . 3.4 p-90 -48.55 -28.48 3.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.752 0.311 . . . . 0.0 111.2 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 645' ' ' TRP . . . . . 0.424 ' HA ' ' CE3' ' A' ' 645' ' ' TRP . 0.0 OUTLIER -144.93 19.6 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.2 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.925 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.9 t -156.82 25.03 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.698 0.285 . . . . 0.0 111.224 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -146.48 -109.4 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.462 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 643' ' ' ASN . 49.2 p-90 -59.32 -21.4 59.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 111.133 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 649' ' ' ARG . . . . . 0.516 ' HG2' HD11 ' A' ' 652' ' ' ILE . 2.7 ttt85 -86.45 -18.03 32.75 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.044 0.449 . . . . 0.0 110.2 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.25 -3.85 41.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.809 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.927 ' HA ' HG22 ' A' ' 656' ' ' ILE . 5.3 p-90 -169.28 49.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.838 0.351 . . . . 0.0 110.959 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.597 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 1.7 mt -62.1 -56.71 28.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.076 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 34.1 Cg_endo -66.68 -74.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.208 1.939 . . . . 0.0 112.477 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 177.9 69.64 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.446 0.641 . . . . 0.0 110.359 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.894 ' HA2' HG12 ' A' ' 658' ' ' VAL . . . 103.78 35.37 3.51 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.989 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.927 HG22 ' HA ' ' A' ' 651' ' ' TRP . 0.5 OUTLIER -73.54 -15.26 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.0 110.31 178.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 662' ' ' VAL . . . -108.36 -34.08 2.78 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 658' ' ' VAL . . . . . 0.894 HG12 ' HA2' ' A' ' 655' ' ' GLY . 14.5 p -82.03 -31.78 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 110.313 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.556 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 82.0 m -124.43 -21.24 4.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.801 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.22 -53.1 3.77 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.261 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 665' ' ' VAL . 54.1 t -82.69 -61.06 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.219 0.533 . . . . 0.0 110.837 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 657' ' ' GLY . 39.1 t -42.07 -33.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.544 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.0 OUTLIER -75.16 -37.79 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.291 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.63 -24.66 36.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.184 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 661' ' ' VAL . 3.3 m -84.4 -43.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' ' 670' ' ' ALA . 19.7 mm -68.22 -35.42 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.383 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.34 -34.7 0.35 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.138 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 4.1 tp -84.87 -63.05 1.4 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.811 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.76 -26.9 10.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.612 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.46 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -67.96 -22.0 65.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.07 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 23.3 mm -85.26 -37.52 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.088 0.471 . . . . 0.0 111.142 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.49 -33.16 73.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.632 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.437 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.97 -17.84 27.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.738 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -91.52 -34.3 14.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -94.86 -11.92 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.354 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.495 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.843 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 5.2 t -108.12 -43.65 4.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.59 0.233 . . . . 0.0 110.935 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.57 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 20.2 t70 -139.23 -102.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.278 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -49.61 -40.57 39.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.779 0.323 . . . . 0.0 111.373 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.5 -24.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.232 0.539 . . . . 0.0 111.928 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.555 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.3 tm? 176.78 -58.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.471 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 7.4 Cg_endo -53.9 -21.26 20.2 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.983 1.788 . . . . 0.0 111.077 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.57 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 7.0 p-10 25.18 60.94 0.06 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.707 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 39.18 68.89 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.727 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -123.21 -49.09 0.23 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -99.96 81.03 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.335 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.53 87.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.935 ' O ' HG22 ' A' ' 646' ' ' THR . 15.0 t0 -66.84 -27.83 67.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.04 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -56.86 -20.12 21.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.604 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -48.43 -30.04 4.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.818 0.342 . . . . 0.0 111.228 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -144.5 20.89 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.935 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.6 t -160.66 27.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.742 0.306 . . . . 0.0 111.125 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.59 -111.21 0.86 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.517 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.487 ' HE3' HD13 ' A' ' 652' ' ' ILE . 65.7 p-90 -57.9 -22.25 47.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.121 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 23.9 ttt-85 -86.5 -20.16 28.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.049 0.452 . . . . 0.0 110.185 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -24.4 61.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.034 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.747 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.2 p-90 -165.58 61.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.732 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.655 HG22 ' HD3' ' A' ' 653' ' ' PRO . 1.5 tp -66.81 -33.87 6.78 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.197 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.655 ' HD3' HG22 ' A' ' 652' ' ' ILE . 35.0 Cg_endo -94.39 -73.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.681 2.254 . . . . 0.0 112.409 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.45 80.36 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.438 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.441 ' CA ' ' HB ' ' A' ' 659' ' ' THR . . . 103.57 45.3 1.56 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.361 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.747 HG22 ' HA ' ' A' ' 651' ' ' TRP . 3.0 tp -102.71 -34.51 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.041 0.448 . . . . 0.0 110.842 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.625 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -114.07 -35.91 1.43 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.514 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 658' ' ' VAL . . . . . 0.42 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 14.7 p -81.24 -40.33 18.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.145 0.498 . . . . 0.0 110.081 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.549 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 43.6 m -117.63 -16.42 10.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.086 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 656' ' ' ILE . . . -82.39 -48.87 5.45 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.307 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.773 ' O ' HG12 ' A' ' 665' ' ' VAL . 84.1 t -82.78 -60.72 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.168 0.508 . . . . 0.0 110.66 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.519 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 54.2 t -42.02 -32.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.529 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.647 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 3.2 tp -78.65 -35.62 18.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.79 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.43 -26.97 34.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.37 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.9 p -84.81 -36.07 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.151 0.501 . . . . 0.0 110.261 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 670' ' ' ALA . 25.1 mm -79.59 -37.56 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.195 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 667' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.33 -33.59 0.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.265 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.4 tp -84.77 -63.22 1.37 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.997 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 669' ' ' PHE . . . . . 0.403 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -52.89 -26.83 16.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.025 0.441 . . . . 0.0 110.43 179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.437 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -65.72 -25.03 67.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.84 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 21.9 mm -86.1 -36.34 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.151 0.5 . . . . 0.0 110.939 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 672' ' ' ALA . . . . . 0.411 ' HA ' ' CD1' ' A' ' 676' ' ' PHE . . . -59.8 -31.29 69.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.96 -17.86 27.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.638 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.87 -35.1 15.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.02 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.484 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.9 t -95.88 -16.51 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.351 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.484 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.828 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 3.1 m -131.72 -50.79 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.69 0.281 . . . . 0.0 110.799 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.544 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.7 t70 -136.87 -90.85 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.494 ' HB2' ' HZ2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -64.93 -38.03 89.61 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.223 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 3.1 m -165.11 -32.4 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.599 0.714 . . . . 0.0 111.459 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.6 OUTLIER 175.0 -52.56 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.853 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.703 ' N ' HD13 ' A' ' 635' ' ' LEU . 34.8 Cg_exo -55.27 -24.19 40.96 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.62 1.547 . . . . 0.0 110.45 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 5.7 p-10 30.45 51.3 0.1 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.286 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 42.94 97.26 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.873 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 157.23 -30.96 0.53 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.442 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -104.16 -29.06 11.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.712 0.292 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -166.17 41.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.307 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.931 ' O ' HG22 ' A' ' 646' ' ' THR . 4.7 t0 -61.34 -22.84 65.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.872 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -54.85 -22.9 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.702 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -49.02 -29.23 4.69 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.777 0.322 . . . . 0.0 111.296 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -144.7 21.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.199 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.931 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.2 t -160.77 27.3 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.792 0.33 . . . . 0.0 111.197 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -148.25 -88.72 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.398 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 37.5 p-90 -74.19 -24.1 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 0.0 110.795 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 29.7 ttt85 -86.24 -12.13 50.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.484 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -14.63 63.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.111 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.686 ' HA ' HG22 ' A' ' 656' ' ' ILE . 2.3 p-90 -169.17 51.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.876 0.37 . . . . 0.0 110.828 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.651 HG22 ' HD3' ' A' ' 653' ' ' PRO . 5.3 tt -82.97 -32.48 0.55 Allowed Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.651 ' HD3' HG22 ' A' ' 652' ' ' ILE . 44.4 Cg_endo -91.61 -75.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.301 2.001 . . . . 0.0 112.601 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 166.53 84.22 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.958 0.409 . . . . 0.0 110.316 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.58 39.9 2.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.295 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' A' ' 651' ' ' TRP . 1.6 tp -101.85 -31.53 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.196 0.522 . . . . 0.0 110.676 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.678 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -105.99 -37.02 2.61 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.25 -38.08 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.03 -0.585 . . . . 0.0 110.321 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.547 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 78.7 m -115.98 -20.08 10.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.746 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.29 -44.69 7.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.421 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.764 ' O ' HG12 ' A' ' 665' ' ' VAL . 90.5 t -82.55 -61.53 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.149 0.5 . . . . 0.0 110.472 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.521 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 51.4 t -42.35 -32.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.402 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.701 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.2 OUTLIER -79.34 -34.2 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.701 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.45 -27.52 34.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.224 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.8 p -84.55 -34.38 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.264 0.554 . . . . 0.0 110.132 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 24.3 mm -82.06 -37.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.161 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 667' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.38 -32.41 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.453 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 668' ' ' LEU . . . . . 0.546 ' HA ' HD12 ' A' ' 671' ' ' ILE . 2.9 tp -84.19 -63.28 1.37 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.768 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 669' ' ' PHE . . . . . 0.426 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -53.67 -25.76 19.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.979 0.418 . . . . 0.0 110.325 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.43 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -68.76 -22.96 64.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.067 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 668' ' ' LEU . 7.5 mt -86.07 -37.39 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.08 0.467 . . . . 0.0 111.164 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.92 -30.75 69.26 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.697 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.97 -17.85 27.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.831 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 674' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.2 OUTLIER -93.54 -33.51 13.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.243 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 41.9 t -94.93 -6.95 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.59 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.503 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.8 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.763 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.98 -41.11 3.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.617 0.246 . . . . 0.0 110.987 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.581 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 15.5 t70 -143.61 -99.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.481 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -50.34 -39.05 45.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.461 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.4 -24.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 0.0 112.124 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.564 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 177.14 -58.74 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.332 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.5 ' N ' HD13 ' A' ' 635' ' ' LEU . 9.3 Cg_endo -56.42 -20.49 33.14 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.749 1.633 . . . . 0.0 110.688 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.9 p-10 29.78 53.46 0.12 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.518 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 638' ' ' GLN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 22.9 pt20 42.8 66.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.543 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -135.13 -59.57 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.381 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.68 -28.31 23.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 0.0 110.781 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 641' ' ' ASN . . . . . 0.424 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 1.4 t-20 -153.55 88.68 1.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.709 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.917 ' O ' HG22 ' A' ' 646' ' ' THR . 2.7 p30 -109.57 -29.95 8.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -53.55 -28.83 33.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.859 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 644' ' ' TRP . . . . . 0.424 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 5.6 p-90 -48.68 -27.5 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.386 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -151.23 26.73 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.459 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.917 HG22 ' O ' ' A' ' 642' ' ' ASP . 4.2 t -168.66 32.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.81 0.338 . . . . 0.0 111.159 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 647' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 651' ' ' TRP . . . -149.36 -93.31 0.11 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.321 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.445 ' CH2' ' HG3' ' A' ' 649' ' ' ARG . 47.0 p-90 -64.92 -21.03 66.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.691 0.282 . . . . 0.0 110.965 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 649' ' ' ARG . . . . . 0.469 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 3.9 mtp85 -86.33 -19.75 29.35 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.063 0.458 . . . . 0.0 110.112 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 650' ' ' GLN . . . . . 0.587 ' O ' HG23 ' A' ' 656' ' ' ILE . 3.2 mm-40 -71.21 -22.02 62.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.069 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.569 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.5 p-90 -154.91 57.34 0.67 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.893 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.472 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 0.5 OUTLIER -66.0 -49.51 56.93 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.751 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.559 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 31.1 Cg_endo -94.39 -77.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.417 2.745 . . . . 0.0 112.581 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.24 98.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.566 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.7 39.72 2.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.466 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 650' ' ' GLN . 5.6 tp -114.26 -39.62 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 111.535 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.813 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -137.69 -58.61 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 658' ' ' VAL . . . . . 0.421 HG12 ' HB3' ' A' ' 651' ' ' TRP . 4.4 p -63.21 -41.18 91.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.369 0.604 . . . . 0.0 109.638 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 40.6 m -114.19 -17.52 11.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.854 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.463 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.11 -46.31 6.67 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.641 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.813 HG23 ' HA2' ' A' ' 657' ' ' GLY . 76.6 t -82.57 -60.67 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.169 0.509 . . . . 0.0 110.62 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.503 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 54.1 t -42.16 -32.67 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.324 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.69 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.3 OUTLIER -79.42 -34.97 16.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.662 -179.229 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.42 -27.33 34.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.431 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.0 p -84.61 -33.73 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.239 0.542 . . . . 0.0 110.146 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 25.3 mm -82.99 -36.76 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.132 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 667' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -42.2 -32.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.402 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.59 -63.32 1.36 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 669' ' ' PHE . . . . . 0.496 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.2 OUTLIER -52.61 -29.28 25.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.034 0.445 . . . . 0.0 110.134 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -65.48 -21.61 66.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.174 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.446 HG22 ' CG2' ' A' ' 675' ' ' VAL . 11.8 mt -80.54 -36.44 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 120.967 0.413 . . . . 0.0 111.942 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.13 69.31 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.43 0.633 . . . . 0.0 110.659 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.03 -17.77 27.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.905 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 674' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.3 OUTLIER -99.18 -32.55 11.17 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.508 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 675' ' ' VAL . 43.6 t -90.98 2.42 7.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.426 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 676' ' ' PHE . 4.7 m-85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 3.3 t -70.04 -42.02 73.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.623 0.249 . . . . 0.0 110.944 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.591 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 38.6 t70 -140.16 -102.53 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.444 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -44.31 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 111.371 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.75 -27.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.42 0.629 . . . . 0.0 111.934 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 176.89 -54.32 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.174 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.057 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.691 ' N ' HD13 ' A' ' 635' ' ' LEU . 33.5 Cg_exo -54.77 -24.56 38.55 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.595 1.53 . . . . 0.0 110.502 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.1 p-10 29.38 41.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.561 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 42.6 67.54 0.6 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.571 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -142.63 -58.6 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.641 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.31 -49.59 16.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.01 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -159.54 90.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.02 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.913 ' O ' HG22 ' A' ' 646' ' ' THR . 2.8 t0 -86.99 -25.68 24.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.971 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -55.12 -22.03 15.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.554 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -48.54 -28.42 3.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.764 0.316 . . . . 0.0 111.24 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 645' ' ' TRP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 649' ' ' ARG . 0.0 OUTLIER -146.43 19.08 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.147 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.913 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.8 t -155.99 25.6 0.37 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.818 0.342 . . . . 0.0 111.119 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.78 -89.52 0.14 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.912 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 36.7 p-90 -70.71 -21.29 62.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 110.423 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 649' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 645' ' ' TRP . 1.2 ttt85 -86.05 -12.11 51.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.405 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 650' ' ' GLN . . . . . 0.48 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.0 OUTLIER -65.84 -11.84 49.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.325 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.528 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.2 p-90 -164.24 48.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 110.71 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.603 HG22 ' HD3' ' A' ' 653' ' ' PRO . 1.6 tp -97.1 -31.71 0.26 Allowed Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.603 ' HD3' HG22 ' A' ' 652' ' ' ILE . 63.7 Cg_endo -88.05 -7.97 5.93 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.229 1.953 . . . . 0.0 112.822 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 76.54 91.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.989 0.423 . . . . 0.0 110.504 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 104.33 42.0 1.96 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.458 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 651' ' ' TRP . 10.2 tp -114.55 -39.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.912 0.387 . . . . 0.0 111.464 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.709 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -141.64 -59.25 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 658' ' ' VAL . . . . . 0.41 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.2 p -62.8 -37.05 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.431 0.634 . . . . 0.0 109.595 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.56 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 54.2 m -118.04 -17.83 9.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.992 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.543 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.03 -56.82 2.8 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.768 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 665' ' ' VAL . 40.8 t -82.41 -60.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.096 0.474 . . . . 0.0 111.123 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 666' ' ' ILE . 24.9 t -43.2 -31.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.677 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 659' ' ' THR . 5.3 tt -72.9 -34.18 45.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.946 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 664' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.47 -24.88 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.472 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 661' ' ' VAL . 1.4 t -84.03 -45.63 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.374 0.607 . . . . 0.0 110.016 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 670' ' ' ALA . 19.0 mm -65.49 -34.81 72.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.337 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.7 -34.56 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.039 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 668' ' ' LEU . . . . . 0.526 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.4 tp -84.75 -63.02 1.41 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.963 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -52.66 -25.19 10.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.736 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -71.25 -25.16 62.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.114 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 668' ' ' LEU . 8.5 mt -82.95 -35.97 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.14 0.495 . . . . 0.0 110.999 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.47 78.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.469 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 -17.9 26.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 674' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 14.8 t80 -90.99 -34.05 15.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.228 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.2 t -95.82 -10.1 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.485 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.6 m-85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.774 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.48 -40.96 28.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.609 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.6 t0 -140.23 -92.99 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.83 0.347 . . . . 0.0 111.369 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -39.9 89.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.34 -24.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.284 0.564 . . . . 0.0 111.89 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 175.24 -53.42 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.995 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.703 ' N ' HD13 ' A' ' 635' ' ' LEU . 35.3 Cg_exo -55.05 -24.11 38.65 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.686 1.59 . . . . 0.0 110.53 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.609 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.6 p-10 24.86 55.25 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.584 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 42.87 77.99 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.546 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -132.48 -46.16 0.12 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.418 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.12 77.77 1.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.344 . . . . 0.0 110.767 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.66 86.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.921 ' O ' HG22 ' A' ' 646' ' ' THR . 1.2 t0 -80.61 -19.92 44.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.218 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -53.98 -23.9 14.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.542 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -50.92 -28.25 9.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.202 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -144.07 19.0 1.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.268 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.921 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.7 t -156.83 25.53 0.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.824 0.345 . . . . 0.0 111.173 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.45 -93.19 0.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.277 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -76.52 -31.88 57.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 110.664 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -86.4 -12.08 50.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.561 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 650' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 656' ' ' ILE . 50.6 tt0 -64.72 -13.78 55.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.627 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.558 ' HA ' HG22 ' A' ' 656' ' ' ILE . 35.7 p-90 -163.65 44.61 0.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.754 0.312 . . . . 0.0 111.146 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.615 HG22 ' HD3' ' A' ' 653' ' ' PRO . 2.7 tt -89.51 -31.73 0.37 Allowed Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.615 ' HD3' HG22 ' A' ' 652' ' ' ILE . 52.9 Cg_endo -92.32 -4.65 3.61 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.425 2.083 . . . . 0.0 112.904 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 74.62 89.49 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.957 0.408 . . . . 0.0 110.633 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.94 47.66 1.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.462 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.558 HG22 ' HA ' ' A' ' 651' ' ' TRP . 8.4 tp -114.58 -39.75 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.785 0.326 . . . . 0.0 111.725 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.701 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -140.46 -61.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.505 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.24 -36.13 70.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.368 0.604 . . . . 0.0 109.679 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.507 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 54.8 m -118.85 -19.1 8.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.157 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.2 -52.95 3.83 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.944 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.779 ' O ' HG12 ' A' ' 665' ' ' VAL . 57.6 t -82.57 -60.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.135 0.493 . . . . 0.0 110.979 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.498 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 42.2 t -42.03 -31.78 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.572 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.6 OUTLIER -79.02 -36.46 18.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.712 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.53 -27.05 34.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.571 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.0 p -84.65 -34.4 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.152 0.501 . . . . 0.0 110.397 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.452 HD12 ' CG1' ' A' ' 662' ' ' VAL . 39.0 mt -80.29 -37.99 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.285 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 667' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.45 -33.3 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.287 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.69 -63.05 1.4 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.029 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -54.08 -24.57 17.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.578 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -73.07 -21.91 60.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.019 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 667' ' ' ALA . 4.9 mt -77.84 -55.33 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 121.322 0.582 . . . . 0.0 110.729 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 672' ' ' ALA . . . . . 0.449 ' HA ' ' HE1' ' A' ' 676' ' ' PHE . . . -46.82 -62.6 1.32 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.986 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -22.5 11.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.206 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -70.03 -51.08 35.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.061 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 675' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.08 -43.66 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.073 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.449 ' HE1' ' HA ' ' A' ' 672' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.825 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.35 -39.9 6.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.721 0.296 . . . . 0.0 110.95 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.654 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 23.1 t70 -139.8 -98.85 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.399 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -53.42 -42.06 66.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.312 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.94 -20.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.686 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 173.17 -53.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.975 179.242 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.686 ' N ' HD13 ' A' ' 635' ' ' LEU . 39.5 Cg_exo -55.82 -23.51 42.38 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.706 1.604 . . . . 0.0 110.461 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.654 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.8 p-10 25.54 48.32 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.577 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 638' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 637' ' ' ASP . 0.2 OUTLIER 35.32 90.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.039 179.554 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -168.12 -52.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.452 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.62 -37.31 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.0 110.801 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.64 94.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.866 ' O ' HG22 ' A' ' 646' ' ' THR . 8.6 t70 -90.58 9.72 28.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.06 -20.43 53.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.457 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -49.26 -35.13 16.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.134 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -133.71 9.13 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.537 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 642' ' ' ASP . 3.0 t -145.12 23.46 1.51 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.796 0.331 . . . . 0.0 111.072 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -131.62 -100.41 0.81 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.146 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -73.47 -27.29 61.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.735 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 30.1 ttm-85 -86.27 -11.94 50.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.435 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 650' ' ' GLN . . . . . 0.453 ' O ' HG23 ' A' ' 656' ' ' ILE . 4.1 tt0 -72.09 -9.87 59.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.317 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.538 ' HA ' HG22 ' A' ' 656' ' ' ILE . 0.1 OUTLIER -165.08 47.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.336 -179.367 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.642 HG22 ' HD3' ' A' ' 653' ' ' PRO . 1.7 tp -92.31 -31.86 0.33 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.642 ' HD3' HG22 ' A' ' 652' ' ' ILE . 57.5 Cg_endo -91.31 -7.41 3.56 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.386 2.058 . . . . 0.0 113.078 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 75.19 92.94 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.01 0.434 . . . . 0.0 110.363 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.565 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.38 42.01 1.96 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.272 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.959 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.1 tp -114.5 -39.46 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 111.543 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 662' ' ' VAL . . . -128.83 -57.81 0.11 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.917 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 658' ' ' VAL . . . . . 0.419 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.9 p -63.11 -39.82 86.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.282 0.563 . . . . 0.0 110.213 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.565 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 13.6 m -119.4 -18.42 8.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.138 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.474 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.27 -58.71 2.39 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.649 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.959 HG23 ' O ' ' A' ' 656' ' ' ILE . 92.7 t -82.28 -61.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.173 0.511 . . . . 0.0 110.998 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.597 ' HA ' HG22 ' A' ' 665' ' ' VAL . 40.1 t -41.81 -31.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.751 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.4 tt -77.09 -38.43 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.305 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.17 36.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.34 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 662' ' ' VAL . 10.9 m -84.43 -44.29 17.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.269 0.557 . . . . 0.0 110.331 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.479 ' N ' HG23 ' A' ' 665' ' ' VAL . 37.4 mt -66.83 -36.4 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.371 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.75 -35.5 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.955 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 668' ' ' LEU . . . . . 0.538 ' HA ' HD12 ' A' ' 671' ' ' ILE . 3.2 tp -84.87 -63.01 1.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.88 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 669' ' ' PHE . . . . . 0.432 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -52.16 -26.31 11.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.665 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 666' ' ' ILE . . . -70.92 -21.96 62.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.181 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 668' ' ' LEU . 9.7 mt -86.07 -38.54 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.129 0.49 . . . . 0.0 111.041 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -58.99 -31.09 68.47 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.753 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.01 -17.83 27.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.839 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 674' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.1 OUTLIER -92.45 -34.23 14.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.166 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.505 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 40.8 t -94.62 -10.5 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.514 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.6 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.799 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.71 -43.2 8.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.685 0.279 . . . . 0.0 110.93 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.622 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 9.1 t0 -139.63 -93.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.9 0.381 . . . . 0.0 111.353 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.29 -41.18 79.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.012 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.31 -21.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.126 0.489 . . . . 0.0 112.2 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.579 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 177.47 -58.57 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.366 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.515 ' N ' HD13 ' A' ' 635' ' ' LEU . 9.4 Cg_endo -56.53 -20.22 32.74 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.792 1.661 . . . . 0.0 110.76 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.622 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.0 p-10 27.0 50.16 0.02 OUTLIER 'General case' 0 C--O 1.23 0.072 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.564 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 638' ' ' GLN . . . . . 0.449 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 4.0 pt20 43.97 98.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.821 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -170.8 -51.89 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.661 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.37 -37.22 14.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.347 . . . . 0.0 111.013 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -170.43 94.41 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.949 ' O ' HG22 ' A' ' 646' ' ' THR . 4.8 p-10 -99.59 -34.73 10.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.723 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -51.09 -24.62 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.846 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -48.68 -27.53 2.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.819 0.342 . . . . 0.0 111.191 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -150.71 24.51 0.77 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.949 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.8 t -162.19 28.71 0.11 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.772 0.32 . . . . 0.0 111.193 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -151.19 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.328 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.418 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 59.6 p-90 -73.33 -21.54 60.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.788 0.328 . . . . 0.0 110.832 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 649' ' ' ARG . . . . . 0.418 ' HG3' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -86.21 -11.94 51.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.654 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 650' ' ' GLN . . . . . 0.491 ' O ' HG23 ' A' ' 656' ' ' ILE . 1.8 mm100 -68.91 -7.54 35.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.867 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.58 ' HA ' HG22 ' A' ' 656' ' ' ILE . 9.2 p-90 -166.92 41.39 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.71 0.291 . . . . 0.0 111.174 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.63 HG22 ' HD3' ' A' ' 653' ' ' PRO . 2.5 tp -89.63 -31.72 0.37 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.63 ' HD3' HG22 ' A' ' 652' ' ' ILE . 60.3 Cg_endo -91.65 -6.4 3.63 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.427 2.084 . . . . 0.0 112.856 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 74.98 91.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.99 0.424 . . . . 0.0 110.483 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.482 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.13 45.23 1.5 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.227 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 651' ' ' TRP . 9.4 tp -114.53 -39.51 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.669 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -135.23 -62.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.789 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.89 -38.21 75.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.321 0.582 . . . . 0.0 109.818 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.539 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 43.5 m -118.22 -19.37 9.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.233 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.18 -47.88 5.94 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.682 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.803 ' O ' HG12 ' A' ' 665' ' ' VAL . 74.1 t -82.52 -60.23 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 110.439 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.54 HG12 HD12 ' A' ' 666' ' ' ILE . 78.0 t -42.07 -31.76 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.307 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.628 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 5.2 tt -80.96 -34.51 13.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.616 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 664' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.59 -27.49 34.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.42 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.803 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.7 p -84.44 -35.09 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.224 0.535 . . . . 0.0 110.13 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.54 HD12 HG12 ' A' ' 662' ' ' VAL . 51.2 mt -79.6 -36.69 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.831 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 667' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.98 -32.93 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.398 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.8 tp -84.58 -62.96 1.42 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 669' ' ' PHE . . . . . 0.404 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 2.2 t80 -53.4 -25.42 15.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.474 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.426 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.03 -23.93 63.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.138 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 17.9 mt -85.1 -40.53 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.097 0.475 . . . . 0.0 110.952 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -56.68 -32.17 65.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.818 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.97 -17.92 27.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.922 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -92.17 -32.89 14.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.208 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.3 t -97.2 -10.9 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.489 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.495 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.837 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.431 ' HA2' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 631' ' ' SER . . . . . 0.446 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -127.89 -51.86 1.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.568 0.223 . . . . 0.0 111.001 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.559 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 9.9 t0 -132.04 -95.64 0.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.464 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -38.23 69.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.407 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.06 -26.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.238 0.542 . . . . 0.0 112.253 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.566 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 178.04 -58.75 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.436 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.508 ' N ' HD13 ' A' ' 635' ' ' LEU . 11.1 Cg_endo -57.81 -20.15 42.23 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.752 1.634 . . . . 0.0 110.649 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.0 p-10 33.48 36.97 0.01 OUTLIER 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.392 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 53.14 87.7 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.174 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -152.1 -46.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.404 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.45 -31.38 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 641' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 2.4 m120 -159.13 83.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.894 ' O ' HG22 ' A' ' 646' ' ' THR . 7.8 p-10 -95.24 -26.89 15.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.04 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 643' ' ' ASN . . . . . 0.404 ' CB ' ' HA3' ' A' ' 647' ' ' GLY . 29.9 p-10 -65.29 -20.64 66.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.009 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 644' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 1.4 p-90 -48.44 -27.93 2.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.628 0.251 . . . . 0.0 111.421 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.04 27.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.637 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.894 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.9 t -175.03 32.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.444 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 647' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 643' ' ' ASN . . . -137.92 -88.57 0.2 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.594 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.472 ' CE2' ' HG3' ' A' ' 649' ' ' ARG . 50.2 p-90 -69.86 -29.54 66.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 0.0 111.154 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 649' ' ' ARG . . . . . 0.472 ' HG3' ' CE2' ' A' ' 648' ' ' TRP . 2.6 mtp-105 -86.43 -16.26 37.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 0.0 110.362 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -65.82 -24.13 66.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.085 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.624 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.4 p-90 -160.74 56.72 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.133 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.685 HG22 ' HD3' ' A' ' 653' ' ' PRO . 9.5 tp -81.98 -32.61 0.61 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.685 ' HD3' HG22 ' A' ' 652' ' ' ILE . 62.9 Cg_endo -96.03 -5.27 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.715 2.277 . . . . 0.0 112.875 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 75.61 89.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.003 0.43 . . . . 0.0 110.465 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.518 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.05 48.44 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.351 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.827 ' O ' HG23 ' A' ' 661' ' ' VAL . 10.4 tp -114.48 -39.77 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 656' ' ' ILE . . . -132.6 -59.43 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.939 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 658' ' ' VAL . . . . . 0.402 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.5 p -61.68 -38.69 80.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.26 0.552 . . . . 0.0 110.012 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.52 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 29.9 m -119.91 -18.46 8.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.214 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.32 -55.26 3.11 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.673 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 656' ' ' ILE . 93.8 t -82.51 -60.73 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.109 0.48 . . . . 0.0 111.011 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.547 ' HA ' HG22 ' A' ' 665' ' ' VAL . 38.3 t -42.44 -32.41 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.609 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.6 tp -76.14 -37.27 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 664' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.64 -24.38 36.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.134 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 661' ' ' VAL . 2.7 m -84.25 -41.98 16.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.335 0.588 . . . . 0.0 110.297 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.449 HD12 HG12 ' A' ' 662' ' ' VAL . 43.4 mt -70.83 -36.63 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.321 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -39.94 -34.86 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.183 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 668' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 671' ' ' ILE . 3.0 tp -84.74 -63.15 1.38 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.887 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 669' ' ' PHE . . . . . 0.429 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.2 OUTLIER -52.51 -25.59 10.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.675 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -71.92 -24.57 61.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.045 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 668' ' ' LEU . 11.6 mt -85.99 -37.85 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.117 0.484 . . . . 0.0 110.883 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 672' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -57.62 -32.43 67.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.652 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.88 -17.96 27.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.742 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 674' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.2 OUTLIER -89.25 -34.89 16.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 41.0 t -97.15 -15.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.406 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.497 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.733 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.27 -43.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.619 0.247 . . . . 0.0 111.005 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.614 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 67.2 t0 -137.86 -105.07 0.19 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.374 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -46.06 -44.06 15.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 0.0 111.547 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.8 -26.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.374 0.607 . . . . 0.0 112.049 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.694 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 174.35 -52.99 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.835 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.694 ' N ' HD13 ' A' ' 635' ' ' LEU . 37.4 Cg_exo -56.06 -23.86 46.19 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.682 1.588 . . . . 0.0 110.363 178.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.614 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.9 p-10 31.45 40.01 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.314 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 638' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 16.1 pt20 42.98 69.25 0.41 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.515 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -131.9 -57.03 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.422 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.7 -28.92 19.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.361 . . . . 0.0 110.862 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 0.6 OUTLIER -159.43 93.58 1.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.83 179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.937 ' O ' HG22 ' A' ' 646' ' ' THR . 5.6 p-10 -102.57 -36.96 8.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -54.19 -22.54 11.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.592 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 644' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 7.4 p-90 -48.56 -28.22 3.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.788 0.327 . . . . 0.0 111.18 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -149.18 23.25 0.94 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.264 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.937 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.2 t -160.35 27.18 0.16 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.698 0.285 . . . . 0.0 111.264 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -150.36 -85.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.517 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.464 ' O ' HG13 ' A' ' 652' ' ' ILE . 69.3 p-90 -79.43 -21.27 45.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.62 0.248 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 649' ' ' ARG . . . . . 0.527 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 2.6 ttt85 -86.34 -15.8 39.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.063 0.458 . . . . 0.0 110.346 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 650' ' ' GLN . . . . . 0.56 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.1 OUTLIER -72.46 -16.59 61.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.37 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.453 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.9 p-90 -162.7 54.86 0.21 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.693 0.282 . . . . 0.0 111.258 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.609 HD12 ' HD3' ' A' ' 653' ' ' PRO . 0.3 OUTLIER -69.63 -51.32 16.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 110.809 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.609 ' HD3' HD12 ' A' ' 652' ' ' ILE . 32.1 Cg_endo -95.13 -80.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.456 2.771 . . . . 0.0 112.628 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 170.35 105.94 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.722 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.79 35.44 3.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.612 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 650' ' ' GLN . 0.6 OUTLIER -114.15 -39.58 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 0.0 111.454 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.823 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -137.82 -58.09 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 4.6 p -64.59 -39.25 84.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.303 0.573 . . . . 0.0 109.638 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.537 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 20.5 m -115.08 -17.37 11.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.852 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.499 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -81.92 -46.18 6.81 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.53 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.823 HG23 ' HA2' ' A' ' 657' ' ' GLY . 99.5 t -82.6 -60.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.26 0.553 . . . . 0.0 110.448 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.529 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 53.8 t -42.0 -31.65 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.56 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.7 OUTLIER -79.66 -34.09 15.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.748 -179.154 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 664' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.48 -27.36 34.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.164 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.5 p -84.55 -36.0 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.131 0.491 . . . . 0.0 110.156 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.517 HD12 HG12 ' A' ' 662' ' ' VAL . 39.4 mt -78.91 -37.02 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.022 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 667' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.38 -32.96 0.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.481 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 668' ' ' LEU . . . . . 0.627 ' HA ' HD12 ' A' ' 671' ' ' ILE . 2.9 tp -84.6 -63.13 1.39 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.803 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -24.51 15.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 110.508 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.7 -22.47 62.45 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 668' ' ' LEU . 6.8 mt -81.59 -51.9 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.172 0.511 . . . . 0.0 110.975 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -48.95 -33.4 10.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.699 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -17.9 27.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.523 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 674' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 12.1 t80 -96.35 -31.16 13.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.738 0.304 . . . . 0.0 111.385 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 675' ' ' VAL . 41.1 t -94.66 -1.19 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.381 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.467 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 2.4 m-85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.801 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 631' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 637' ' ' ASP . 42.5 t 61.54 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.491 0.186 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.627 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 38.8 t70 -122.51 -99.76 0.42 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.745 0.307 . . . . 0.0 111.235 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -45.15 80.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.269 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.2 -24.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.133 0.492 . . . . 0.0 112.31 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.57 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 177.03 -58.66 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.425 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.509 ' N ' HD13 ' A' ' 635' ' ' LEU . 9.2 Cg_endo -56.56 -20.53 34.28 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.775 1.65 . . . . 0.0 110.864 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.627 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.9 p-10 31.24 39.87 0.01 OUTLIER 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.38 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 52.95 97.96 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.189 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -171.68 -40.8 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.452 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -83.34 -34.79 25.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -168.01 47.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.923 ' O ' HG22 ' A' ' 646' ' ' THR . 32.2 p-10 -51.16 -27.18 8.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.255 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -52.18 -20.56 2.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.94 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 -48.36 -28.85 3.44 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.786 0.327 . . . . 0.0 111.269 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.58 22.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.239 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.923 HG22 ' O ' ' A' ' 642' ' ' ASP . 11.0 t -156.97 25.36 0.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.108 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.78 -111.97 0.89 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.235 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.414 ' O ' HG13 ' A' ' 652' ' ' ILE . 69.7 p-90 -60.4 -21.52 62.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.709 0.29 . . . . 0.0 110.926 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 649' ' ' ARG . . . . . 0.462 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 39.2 ttt85 -86.55 -19.13 29.9 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.33 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 650' ' ' GLN . . . . . 0.502 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.0 OUTLIER -70.09 -26.97 64.23 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.861 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.575 ' HA ' HG22 ' A' ' 656' ' ' ILE . 5.0 p-90 -153.29 58.9 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.083 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.491 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 1.9 mt -63.07 -47.56 85.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.698 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 29.5 Cg_endo -95.42 -76.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.458 2.772 . . . . 0.0 112.548 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 165.68 95.6 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.473 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.539 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.67 42.92 1.9 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.337 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.575 HG22 ' HA ' ' A' ' 651' ' ' TRP . 10.3 tp -114.27 -39.55 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.821 0.344 . . . . 0.0 111.465 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.738 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -135.23 -56.59 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 658' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' A' ' 651' ' ' TRP . 8.0 p -63.47 -42.72 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.345 0.593 . . . . 0.0 109.757 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.539 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 20.4 m -114.86 -16.96 11.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.867 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.24 -46.6 6.48 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.64 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.828 ' O ' HG12 ' A' ' 665' ' ' VAL . 67.7 t -82.82 -59.12 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.108 0.48 . . . . 0.0 110.345 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.544 HG12 HD12 ' A' ' 666' ' ' ILE . 74.6 t -42.56 -32.33 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.078 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.687 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.5 OUTLIER -81.3 -34.37 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.566 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 664' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.51 -27.07 34.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.298 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.1 p -84.44 -34.71 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.215 0.531 . . . . 0.0 110.076 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.544 HD12 HG12 ' A' ' 662' ' ' VAL . 61.3 mt -81.61 -36.66 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.086 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 667' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.83 -32.2 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.413 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.57 -62.79 1.47 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.74 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -24.66 15.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.022 0.439 . . . . 0.0 110.388 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -73.65 -21.94 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.149 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 667' ' ' ALA . 6.8 mt -75.37 -55.58 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 121.289 0.566 . . . . 0.0 111.012 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 672' ' ' ALA . . . . . 0.438 ' HA ' ' CE1' ' A' ' 676' ' ' PHE . . . -47.52 -62.62 1.35 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.795 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -21.94 18.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.154 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 674' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 11.8 t80 -65.5 -48.3 73.02 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.98 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 675' ' ' VAL . . . . . . . . . . . . . 20.7 t -101.7 -42.29 9.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 672' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.428 ' N ' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 631' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 637' ' ' ASP . 1.1 t -107.54 -40.85 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.631 0.253 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 637' ' ' ASP . 1.1 m-20 -136.29 -99.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.86 0.362 . . . . 0.0 111.436 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -49.56 -44.37 46.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.509 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.9 -19.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.564 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.1 tm? 177.32 -58.89 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.384 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.518 ' N ' HD13 ' A' ' 635' ' ' LEU . 10.3 Cg_endo -57.12 -20.72 39.13 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.754 1.636 . . . . 0.0 110.617 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 632' ' ' ASP . 1.7 p-10 28.58 42.48 0.01 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.452 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 638' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 12.4 pt20 43.46 74.13 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.525 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -140.94 -55.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.463 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -93.96 -29.93 15.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.957 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.64 101.32 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.919 ' O ' HG22 ' A' ' 646' ' ' THR . 2.8 p30 -102.24 -33.92 9.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -52.89 -22.45 5.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.725 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -48.54 -28.05 3.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.714 0.292 . . . . 0.0 111.332 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -149.14 20.21 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.275 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.919 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.7 t -155.7 25.88 0.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 111.131 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -140.91 -98.55 0.35 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.24 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -66.61 -28.49 68.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -86.32 -12.08 50.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.509 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 650' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.2 OUTLIER -67.2 -12.88 61.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.484 -179.568 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.606 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.6 p-90 -164.79 45.66 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.78 0.324 . . . . 0.0 111.193 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.633 HG22 ' HD3' ' A' ' 653' ' ' PRO . 4.3 tt -88.9 -31.78 0.38 Allowed Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.633 ' HD3' HG22 ' A' ' 652' ' ' ILE . 56.5 Cg_endo -92.6 -6.18 3.13 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.438 2.092 . . . . 0.0 112.983 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 75.74 91.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.97 0.414 . . . . 0.0 110.461 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.18 45.0 1.52 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.463 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.9 tp -114.58 -39.43 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.494 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -132.92 -59.28 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.776 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 658' ' ' VAL . . . . . 0.405 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.5 p -61.73 -38.91 81.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.283 0.563 . . . . 0.0 109.975 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.56 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 24.2 m -119.44 -18.37 8.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.108 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.559 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.24 -53.31 3.7 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.605 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.82 ' O ' HG23 ' A' ' 665' ' ' VAL . 83.9 t -82.55 -60.87 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.074 0.464 . . . . 0.0 111.036 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.514 HG12 HD12 ' A' ' 666' ' ' ILE . 25.6 t -43.38 -31.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.656 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.5 tp -73.9 -34.47 39.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.992 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 664' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.64 -23.5 36.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.668 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 661' ' ' VAL . 1.8 t -83.8 -46.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.391 0.615 . . . . 0.0 109.917 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.514 HD12 HG12 ' A' ' 662' ' ' VAL . 60.6 mt -66.97 -35.06 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.186 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 667' ' ' ALA . . . . . 0.443 ' O ' HG12 ' A' ' 671' ' ' ILE . . . -41.59 -34.12 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.117 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.5 tp -84.81 -63.0 1.41 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.82 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -52.26 -26.35 11.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.595 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.412 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -69.33 -21.94 63.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.087 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 667' ' ' ALA . 20.5 mm -84.55 -40.31 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.104 0.478 . . . . 0.0 111.148 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.19 -31.75 69.3 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.808 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.88 -17.95 27.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.79 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -92.0 -34.28 14.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 44.0 t -94.39 -13.11 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.356 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.495 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.772 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.5 m -91.38 -48.87 6.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.675 0.274 . . . . 0.0 110.824 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.585 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 11.1 t70 -139.23 -95.17 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.354 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -57.58 -39.65 77.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.189 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.89 -25.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.342 0.591 . . . . 0.0 111.884 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 174.78 -53.47 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.858 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.696 ' N ' HD13 ' A' ' 635' ' ' LEU . 38.0 Cg_exo -55.51 -24.02 42.18 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.691 1.594 . . . . 0.0 110.423 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.1 p-10 26.89 47.16 0.01 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.479 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 50.67 57.46 6.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.132 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -121.58 -44.4 0.38 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.411 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.92 74.96 2.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 110.734 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 60.74 82.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.931 ' O ' HG22 ' A' ' 646' ' ' THR . 1.2 p30 -59.27 -24.99 63.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -55.65 -19.66 11.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.782 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -48.48 -28.3 3.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.73 0.3 . . . . 0.0 111.294 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.8 20.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.314 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.931 HG22 ' O ' ' A' ' 642' ' ' ASP . 7.4 t -157.29 26.24 0.3 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 111.126 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -142.54 -90.69 0.14 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.343 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.416 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 68.1 p-90 -71.92 -22.02 61.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.667 0.27 . . . . 0.0 110.999 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 649' ' ' ARG . . . . . 0.416 ' HG3' ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -86.17 -12.02 50.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.907 0.384 . . . . 0.0 110.474 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -15.06 62.46 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.201 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.599 ' HA ' HG22 ' A' ' 656' ' ' ILE . 0.6 OUTLIER -168.49 52.36 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.188 -179.465 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.628 HG22 ' HD3' ' A' ' 653' ' ' PRO . 4.2 tp -89.86 -31.9 0.37 Allowed Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.628 ' HD3' HG22 ' A' ' 652' ' ' ILE . 57.7 Cg_endo -91.84 -8.03 3.09 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.377 2.051 . . . . 0.0 112.976 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 76.06 92.51 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.953 0.406 . . . . 0.0 110.363 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.469 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.29 43.07 1.79 Allowed Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.249 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 661' ' ' VAL . 10.2 tp -114.5 -39.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.32 . . . . 0.0 111.525 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.567 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -136.08 -57.37 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.668 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.92 -38.12 81.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.275 0.56 . . . . 0.0 109.805 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 16.7 m -120.04 -18.33 8.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.018 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.474 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.14 -52.79 3.9 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.726 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.807 ' O ' HG12 ' A' ' 665' ' ' VAL . 86.5 t -82.64 -59.63 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.146 0.498 . . . . 0.0 110.768 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.495 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 44.6 t -42.54 -31.64 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.383 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.668 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.2 OUTLIER -79.52 -36.0 17.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.71 -179.363 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.66 -27.01 34.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.807 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.0 p -84.76 -35.34 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.228 0.537 . . . . 0.0 110.336 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 26.9 mm -81.14 -37.86 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.284 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 667' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.27 -32.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.35 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.9 tp -84.69 -63.14 1.39 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.36 -25.79 16.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.051 0.453 . . . . 0.0 110.396 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -68.35 -21.87 64.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.037 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 667' ' ' ALA . 16.8 mm -84.73 -41.21 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.177 0.513 . . . . 0.0 111.214 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -58.61 -32.15 68.74 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.461 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.96 -17.87 27.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.974 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -94.21 -32.5 13.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.274 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 675' ' ' VAL . 46.1 t -94.83 -4.66 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.42 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.494 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 2.4 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.837 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 631' ' ' SER . . . . . 0.441 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -117.88 -48.62 2.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.66 0.267 . . . . 0.0 110.899 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 632' ' ' ASP . . . . . 0.625 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 65.3 t0 -136.39 -93.79 0.24 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.857 0.36 . . . . 0.0 111.316 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -37.81 70.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.148 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.09 -27.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.414 0.626 . . . . 0.0 111.77 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.677 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 178.26 -54.27 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.904 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 636' ' ' PRO . . . . . 0.677 ' N ' HD13 ' A' ' 635' ' ' LEU . 39.5 Cg_exo -56.03 -23.95 46.38 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 121.586 1.524 . . . . 0.0 110.371 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 637' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.2 p-10 30.33 40.58 0.01 OUTLIER 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.552 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 638' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 637' ' ' ASP . 2.9 pt20 36.35 73.82 0.08 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.054 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -162.77 -46.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.727 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.88 -38.54 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 111.103 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -153.33 46.32 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 642' ' ' ASP . . . . . 0.947 ' O ' HG22 ' A' ' 646' ' ' THR . 17.4 p-10 -64.78 -32.34 73.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -50.25 -25.58 3.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.725 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -48.71 -27.86 3.19 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.788 0.328 . . . . 0.0 111.272 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -148.86 22.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.323 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 646' ' ' THR . . . . . 0.947 HG22 ' O ' ' A' ' 642' ' ' ASP . 12.4 t -159.25 26.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 647' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 651' ' ' TRP . . . -143.51 -95.6 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.293 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.432 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 65.3 p-90 -65.07 -21.51 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.841 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 649' ' ' ARG . . . . . 0.615 ' HA ' HG12 ' A' ' 652' ' ' ILE . 19.9 mtp85 -86.61 -19.32 29.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.241 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 650' ' ' GLN . . . . . 0.402 ' HG3' ' HA ' ' A' ' 646' ' ' THR . 0.5 OUTLIER -69.55 -12.83 61.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.68 -179.357 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 651' ' ' TRP . . . . . 0.522 ' HA ' HG22 ' A' ' 656' ' ' ILE . 2.3 p-90 -154.45 46.75 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.763 0.316 . . . . 0.0 111.136 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 652' ' ' ILE . . . . . 0.615 HG12 ' HA ' ' A' ' 649' ' ' ARG . 0.0 OUTLIER -71.55 -61.85 1.95 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.849 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 653' ' ' PRO . . . . . 0.522 ' O ' ' HB3' ' A' ' 654' ' ' ALA . 64.8 Cg_endo -73.82 -2.39 12.16 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.739 2.293 . . . . 0.0 113.016 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 654' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 72.87 91.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.963 0.411 . . . . 0.0 110.405 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 655' ' ' GLY . . . . . 0.436 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.01 49.15 1.1 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.077 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 656' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 651' ' ' TRP . 9.8 tp -114.51 -39.74 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.779 0.323 . . . . 0.0 111.733 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 657' ' ' GLY . . . . . 0.698 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -139.68 -61.33 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.591 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 658' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' A' ' 651' ' ' TRP . 1.9 p -62.33 -36.84 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.418 0.628 . . . . 0.0 109.656 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 659' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 47.0 m -117.75 -17.97 9.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.084 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 660' ' ' GLY . . . . . 0.498 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.28 -57.32 2.66 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.977 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.698 HG23 ' HA2' ' A' ' 657' ' ' GLY . 40.7 t -82.19 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.201 0.524 . . . . 0.0 111.144 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.601 ' HA ' HG22 ' A' ' 665' ' ' VAL . 24.4 t -43.13 -31.14 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.775 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.6 tt -75.19 -36.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.122 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 664' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.68 -24.81 36.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.115 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 665' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 661' ' ' VAL . 2.4 m -84.41 -41.17 15.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.32 0.581 . . . . 0.0 110.279 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 666' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 670' ' ' ALA . 18.5 mm -70.3 -36.51 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.362 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.31 -34.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.146 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 668' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.3 tp -84.77 -63.01 1.41 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.863 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 669' ' ' PHE . . . . . 0.428 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 34.7 t80 -52.78 -25.94 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 670' ' ' ALA . . . . . 0.437 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.81 -24.28 62.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.182 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 668' ' ' LEU . 10.3 mt -85.55 -33.24 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.124 0.488 . . . . 0.0 110.915 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -62.86 -33.81 76.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.379 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 673' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.13 -17.76 27.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.743 179.415 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 674' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 5.1 t80 -91.69 -33.98 14.83 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.069 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 675' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.9 t -94.82 -12.05 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.309 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 676' ' ' PHE . . . . . 0.496 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.815 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.45 ' N ' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 631' ' ' SER . . . . . 0.429 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -102.85 -48.51 4.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.688 0.28 . . . . 0.0 110.875 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.606 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 12.4 t70 -136.3 -96.85 0.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.861 0.362 . . . . 0.0 111.32 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.62 -41.39 63.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.24 -22.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.148 0.499 . . . . 0.0 112.288 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.576 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.1 tm? 177.66 -58.56 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.281 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.513 ' N ' HD13 ' A' ' 635' ' ' LEU . 10.6 Cg_endo -57.64 -20.26 41.42 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.668 1.579 . . . . 0.0 110.585 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.606 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 1.9 p-10 30.52 40.64 0.01 OUTLIER 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.396 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 44.01 54.46 5.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.359 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -132.86 -46.18 0.12 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.4 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -99.52 -27.06 13.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 0.0 110.844 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 1.6 t-20 -148.05 69.74 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.93 ' O ' HG22 ' A' ' 646' ' ' THR . 11.1 p-10 -94.8 -27.47 15.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.048 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.6 -21.05 66.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.096 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 644' ' ' TRP . . . . . 0.429 ' HA ' ' CE2' ' A' ' 648' ' ' TRP . 1.2 p-90 -48.43 -29.59 4.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.773 0.32 . . . . 0.0 111.242 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -137.03 14.64 3.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.595 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.93 HG22 ' O ' ' A' ' 642' ' ' ASP . 3.6 t -156.57 24.76 0.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.715 0.293 . . . . 0.0 111.446 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -143.42 -90.52 0.13 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.307 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.444 ' O ' HG13 ' A' ' 652' ' ' ILE . 37.9 p-90 -73.0 -20.9 60.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.614 0.245 . . . . 0.0 111.043 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 649' ' ' ARG . . . . . 0.486 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 4.0 ttt-85 -85.79 -15.44 42.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 110.284 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -24.4 63.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.789 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.712 ' HA ' HG22 ' A' ' 656' ' ' ILE . 6.0 p-90 -159.18 59.06 0.41 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.498 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 0.5 OUTLIER -65.45 -47.88 67.96 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.8 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.561 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 41.1 Cg_endo -89.02 -76.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.975 2.45 . . . . 0.0 112.732 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.95 88.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.666 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.53 47.71 1.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.552 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.735 ' O ' HG23 ' A' ' 661' ' ' VAL . 10.2 tp -114.48 -33.86 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.327 . . . . 0.0 111.187 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.429 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -131.37 -48.04 0.12 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.737 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 658' ' ' VAL . . . . . 0.48 HG13 ' N ' ' A' ' 659' ' ' THR . 10.7 p -69.54 -43.29 80.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.246 0.546 . . . . 0.0 109.892 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.666 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 22.3 m -118.6 -15.85 9.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.677 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.518 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.4 -51.05 4.51 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.345 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 656' ' ' ILE . 43.1 t -82.62 -61.72 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 110.775 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.588 ' HA ' HG22 ' A' ' 665' ' ' VAL . 40.0 t -41.79 -33.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.591 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.3 tt -75.98 -37.54 34.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.545 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.49 -24.95 36.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.173 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 662' ' ' VAL . 5.2 m -84.51 -43.41 17.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.313 0.577 . . . . 0.0 110.478 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.453 ' N ' HG23 ' A' ' 665' ' ' VAL . 18.9 mm -67.35 -36.71 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.565 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.22 -35.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.976 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 668' ' ' LEU . . . . . 0.514 ' HA ' HD12 ' A' ' 671' ' ' ILE . 3.4 tp -84.9 -63.03 1.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.873 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 669' ' ' PHE . . . . . 0.421 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -51.79 -26.89 10.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.755 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.407 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.07 -23.71 63.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.983 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 668' ' ' LEU . 11.4 mt -85.96 -35.35 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.158 0.504 . . . . 0.0 110.88 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 672' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 676' ' ' PHE . . . -61.11 -32.97 72.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.509 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.99 -17.9 27.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.566 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -88.59 -35.08 17.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 36.6 t -96.77 -19.21 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.354 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.48 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.848 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 631' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.6 OUTLIER -83.08 -44.15 15.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 110.855 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.68 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 64.2 t0 -136.92 -97.91 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.405 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -42.96 63.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.469 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.32 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.555 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 178.9 -59.42 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.316 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.497 ' N ' HD13 ' A' ' 635' ' ' LEU . 15.0 Cg_endo -59.36 -20.13 54.45 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.702 1.601 . . . . 0.0 110.283 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.68 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 0.4 OUTLIER 36.31 -160.4 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.152 178.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -108.36 76.96 1.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.044 0.449 . . . . 0.0 111.027 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 179.48 -35.15 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.348 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.88 -29.28 23.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.752 0.311 . . . . 0.0 110.925 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.2 42.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.219 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.929 ' O ' HG22 ' A' ' 646' ' ' THR . 5.6 t0 -56.84 -22.37 36.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.145 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 643' ' ' ASN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 648' ' ' TRP . 92.4 m-20 -52.99 -19.83 2.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.039 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 644' ' ' TRP . . . . . 0.425 ' HA ' ' CD ' ' A' ' 649' ' ' ARG . 25.9 p-90 -48.27 -28.32 3.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.908 0.385 . . . . 0.0 111.126 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.97 24.84 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.982 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.929 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.3 t -156.21 21.58 0.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.427 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -149.77 -124.92 1.31 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.848 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 643' ' ' ASN . 64.7 p-90 -61.89 -21.05 64.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.655 0.264 . . . . 0.0 111.445 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 649' ' ' ARG . . . . . 0.497 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 3.3 ttt180 -86.17 -15.93 39.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.876 0.369 . . . . 0.0 110.474 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 650' ' ' GLN . . . . . 0.459 ' O ' HG23 ' A' ' 656' ' ' ILE . 3.6 mt-30 -73.62 -14.64 61.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.509 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.568 ' HA ' HG22 ' A' ' 656' ' ' ILE . 2.3 p-90 -158.9 50.84 0.38 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.687 0.28 . . . . 0.0 111.503 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.497 ' CG1' ' HA ' ' A' ' 649' ' ' ARG . 0.7 OUTLIER -63.89 -48.61 78.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.357 . . . . 0.0 110.552 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 30.6 Cg_endo -94.46 -76.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.488 2.792 . . . . 0.0 112.485 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.31 96.1 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.624 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.525 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.59 42.3 2.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.323 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.1 tp -114.48 -39.6 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.706 0.289 . . . . 0.0 111.696 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 662' ' ' VAL . . . -134.06 -53.68 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.738 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 658' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 659' ' ' THR . 9.9 p -64.51 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.352 0.596 . . . . 0.0 109.843 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.525 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 23.3 m -119.68 -17.81 8.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.992 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.463 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.28 -51.57 4.34 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.623 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.802 ' O ' HG12 ' A' ' 665' ' ' VAL . 53.1 t -82.78 -59.65 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.093 0.473 . . . . 0.0 110.567 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 657' ' ' GLY . 62.0 t -42.19 -31.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.417 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.614 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 1.7 tp -80.85 -35.98 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.648 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.6 -26.86 34.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.498 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.802 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.1 p -84.69 -34.3 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 121.122 0.487 . . . . 0.0 110.356 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.451 HD12 HG12 ' A' ' 662' ' ' VAL . 45.8 mt -81.46 -38.32 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.267 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 667' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.13 -32.41 0.26 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.398 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 668' ' ' LEU . . . . . 0.563 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.0 OUTLIER -84.57 -63.17 1.38 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.97 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 669' ' ' PHE . . . . . 0.406 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 76.8 t80 -54.04 -25.96 24.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.06 0.457 . . . . 0.0 110.357 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.432 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -67.99 -22.08 65.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.932 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 668' ' ' LEU . 7.2 mt -85.5 -37.1 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.134 0.492 . . . . 0.0 111.051 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.3 -31.77 71.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.563 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.449 ' H ' ' HG3' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -90.02 -17.87 27.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.754 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -92.65 -34.17 14.09 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.155 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.492 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -94.15 -11.06 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.396 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.492 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.831 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.428 ' N ' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 631' ' ' SER . . . . . 0.417 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.5 OUTLIER -119.59 -45.0 2.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.706 0.289 . . . . 0.0 110.889 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.612 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 18.8 t70 -137.99 -95.65 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.362 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -52.53 -42.14 64.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.189 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.52 -20.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.568 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.1 tm? 177.79 -58.93 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.364 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.517 ' N ' HD13 ' A' ' 635' ' ' LEU . 11.2 Cg_endo -58.03 -20.51 45.74 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.724 1.616 . . . . 0.0 110.544 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.612 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 1.4 p-10 30.24 39.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.6 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 638' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 636' ' ' PRO . 9.0 mt-30 51.5 98.78 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.163 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -170.12 -40.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.337 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -80.85 -39.96 25.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 110.731 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -178.78 92.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.921 ' O ' HG22 ' A' ' 646' ' ' THR . 4.2 m-20 -70.51 -19.09 62.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -53.88 -20.3 5.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.098 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -48.31 -28.89 3.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.791 0.329 . . . . 0.0 111.163 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -147.62 20.82 1.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.921 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.9 t -155.6 24.91 0.4 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.771 0.32 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -151.82 -79.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.655 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.425 ' O ' HG13 ' A' ' 652' ' ' ILE . 65.1 p-90 -86.13 -21.46 27.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.587 0.232 . . . . 0.0 111.287 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 649' ' ' ARG . . . . . 0.479 ' HG2' HD11 ' A' ' 652' ' ' ILE . 1.3 ttp85 -86.44 -15.75 39.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.317 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -71.22 -18.23 62.47 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.177 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.835 ' HA ' HG22 ' A' ' 656' ' ' ILE . 12.0 p-90 -167.54 59.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.591 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.59 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 2.1 mt -60.33 -54.88 50.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.771 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 37.5 Cg_endo -69.13 -64.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.265 1.977 . . . . 0.0 112.378 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 168.39 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.494 0.664 . . . . 0.0 110.281 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.877 ' HA2' HG12 ' A' ' 658' ' ' VAL . . . 103.64 38.35 2.8 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.705 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.835 HG22 ' HA ' ' A' ' 651' ' ' TRP . 0.4 OUTLIER -73.5 -17.68 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.245 0.545 . . . . 0.0 110.515 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.659 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -106.52 -35.39 2.87 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 658' ' ' VAL . . . . . 0.877 HG12 ' HA2' ' A' ' 655' ' ' GLY . 13.9 p -82.29 -31.65 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.254 -0.473 . . . . 0.0 110.6 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.575 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 70.9 m -123.47 -20.26 5.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.755 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.2 -44.54 7.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.908 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 665' ' ' VAL . 96.5 t -82.62 -62.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.205 0.526 . . . . 0.0 110.413 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.518 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 44.0 t -42.05 -32.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.543 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.3 OUTLIER -79.27 -34.87 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.689 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.0 -27.23 35.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.285 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.8 p -84.64 -33.98 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 121.285 0.565 . . . . 0.0 110.154 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 670' ' ' ALA . 25.4 mm -82.84 -37.97 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.341 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 667' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.13 -32.65 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.342 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.4 tp -84.53 -63.1 1.4 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.821 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 669' ' ' PHE . . . . . 0.411 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 1.4 t80 -53.86 -25.2 18.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.516 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.439 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -69.08 -22.65 63.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 16.1 mt -86.01 -36.3 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.113 0.482 . . . . 0.0 111.082 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.16 73.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.543 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.0 -17.9 27.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.716 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -91.46 -34.23 14.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.164 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -95.19 -11.29 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.302 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.506 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.18 -0.915 . . . . 0.0 110.792 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.1 m -120.92 -40.85 2.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.616 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 16.3 t70 -141.88 -99.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.349 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -39.07 60.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.441 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.46 -23.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.236 0.541 . . . . 0.0 112.007 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.676 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 173.1 -52.98 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.923 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.676 ' N ' HD13 ' A' ' 635' ' ' LEU . 35.8 Cg_exo -55.96 -23.54 43.7 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.714 1.609 . . . . 0.0 110.489 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.0 p-10 27.28 48.93 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.539 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 43.01 73.54 0.14 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.593 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -134.66 -44.53 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.554 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -97.22 69.03 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 110.986 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 62.28 86.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.902 ' O ' HG22 ' A' ' 646' ' ' THR . 5.7 p-10 -63.86 -23.82 67.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.19 -17.06 9.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.891 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -48.25 -40.27 24.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.724 0.297 . . . . 0.0 111.251 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -131.89 16.39 4.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.385 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.902 HG22 ' O ' ' A' ' 642' ' ' ASP . 9.5 t -152.48 23.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.794 0.331 . . . . 0.0 111.093 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.41 -96.72 0.28 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.112 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.885 ' HB3' HD13 ' A' ' 652' ' ' ILE . 57.8 p-90 -64.77 -22.04 66.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.092 0.473 . . . . 0.0 110.697 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.45 -24.07 25.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 650' ' ' GLN . . . . . 0.507 ' O ' HG22 ' A' ' 656' ' ' ILE . 3.6 tt0 -91.38 -32.93 15.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.207 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.543 ' HA ' HG22 ' A' ' 656' ' ' ILE . 25.0 p-90 -175.4 67.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.03 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.885 HD13 ' HB3' ' A' ' 648' ' ' TRP . 9.1 tp -64.3 -33.14 8.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.654 ' HG3' HD12 ' A' ' 656' ' ' ILE . 33.3 Cg_endo -93.82 -74.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.536 2.158 . . . . 0.0 112.442 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 178.67 70.34 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.439 0.638 . . . . 0.0 110.317 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.814 ' HA2' HG12 ' A' ' 658' ' ' VAL . . . 103.62 45.04 1.59 Allowed Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.565 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.654 HD12 ' HG3' ' A' ' 653' ' ' PRO . 0.4 OUTLIER -73.08 -18.6 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 110.102 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.549 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -106.12 -33.87 3.34 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 658' ' ' VAL . . . . . 0.814 HG12 ' HA2' ' A' ' 655' ' ' GLY . 13.0 p -82.13 -30.55 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.999 0.428 . . . . 0.0 110.589 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.564 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 99.5 m -124.82 -23.38 4.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.931 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.14 -44.64 7.46 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.156 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 665' ' ' VAL . 74.5 t -82.67 -61.67 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.191 0.52 . . . . 0.0 110.574 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 665' ' ' VAL . 40.1 t -43.05 -33.2 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.461 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 659' ' ' THR . 5.0 tt -77.47 -35.5 22.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.176 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.63 -25.19 35.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.844 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 661' ' ' VAL . 2.8 m -84.38 -42.21 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.301 0.572 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.46 HD12 HG12 ' A' ' 662' ' ' VAL . 45.0 mt -70.82 -37.09 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.437 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 667' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -39.85 -34.58 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.117 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.83 -63.15 1.38 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.88 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 669' ' ' PHE . . . . . 0.42 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -52.15 -26.77 12.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.617 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.419 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -69.35 -24.7 63.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.971 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 16.8 mt -86.1 -36.06 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.124 0.487 . . . . 0.0 110.879 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.79 -32.29 70.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.541 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.92 -17.84 27.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.738 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -90.92 -34.34 15.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.081 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.498 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.9 t -95.68 -14.03 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.335 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.498 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.1 m-85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.854 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.21 -44.48 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.696 0.284 . . . . 0.0 110.809 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.631 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 18.5 t70 -137.54 -100.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.272 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.23 -41.59 60.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.363 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.01 -25.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.27 0.557 . . . . 0.0 112.126 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.694 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 175.76 -53.81 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.12 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.694 ' N ' HD13 ' A' ' 635' ' ' LEU . 39.4 Cg_exo -55.52 -24.56 44.98 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 121.596 1.531 . . . . 0.0 110.512 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.631 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.1 p-10 29.77 39.51 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.562 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 638' ' ' GLN . . . . . 0.424 ' O ' ' HG3' ' A' ' 638' ' ' GLN . 7.7 pt20 41.56 94.29 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.931 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 158.52 -33.12 0.49 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.367 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.75 -23.04 10.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.691 0.282 . . . . 0.0 111.058 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -148.04 19.81 1.11 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.569 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.918 ' O ' HG22 ' A' ' 646' ' ' THR . 4.2 t0 -59.98 -22.91 63.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.877 0.37 . . . . 0.0 110.862 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -56.37 -20.2 18.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.635 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -48.53 -27.53 2.79 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.75 0.309 . . . . 0.0 111.244 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.27 22.82 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.918 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.6 t -159.3 25.5 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.279 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 647' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 650' ' ' GLN . . . -143.4 -96.44 0.23 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.621 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.448 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 67.0 p-90 -62.59 -20.49 64.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.651 0.262 . . . . 0.0 111.209 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 649' ' ' ARG . . . . . 0.538 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 26.7 mtt180 -85.92 -14.69 44.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.912 0.387 . . . . 0.0 110.404 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 650' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 647' ' ' GLY . 2.2 mt-30 -76.11 -14.07 60.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.505 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.787 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.6 p-90 -160.37 50.6 0.29 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.572 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 1.7 mt -67.68 -50.29 35.81 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.733 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.572 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 98.4 Cg_endo -84.49 5.6 6.21 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.777 2.318 . . . . 0.0 113.04 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 65.29 90.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.396 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.507 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.47 49.62 1.03 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.527 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.787 HG22 ' HA ' ' A' ' 651' ' ' TRP . 10.3 tp -114.44 -39.52 2.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.908 0.385 . . . . 0.0 111.338 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.715 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -137.46 -60.95 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.563 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 658' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 651' ' ' TRP . 3.4 p -59.73 -39.51 79.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.37 0.605 . . . . 0.0 109.759 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 31.8 m -117.7 -18.33 9.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.109 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.14 -48.1 5.86 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.55 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.773 ' O ' HG12 ' A' ' 665' ' ' VAL . 75.6 t -82.76 -60.31 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.233 0.539 . . . . 0.0 110.56 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.547 HG12 HD12 ' A' ' 666' ' ' ILE . 63.5 t -42.0 -32.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.44 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.4 tt -79.02 -34.58 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.677 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.58 -27.75 34.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.327 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.7 p -84.47 -36.16 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.074 0.464 . . . . 0.0 110.275 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.547 HD12 HG12 ' A' ' 662' ' ' VAL . 39.0 mt -76.44 -36.16 28.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.915 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 667' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.05 -32.93 0.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.384 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 668' ' ' LEU . . . . . 0.511 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.1 tp -84.53 -63.1 1.4 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.87 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -54.01 -24.56 17.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.46 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.422 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -71.0 -24.7 62.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.054 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 668' ' ' LEU . 10.2 mt -84.45 -39.82 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.16 0.505 . . . . 0.0 110.886 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -57.52 -34.65 69.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.772 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.444 ' H ' ' HG3' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.89 -17.84 27.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.835 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 674' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 9.2 t80 -89.28 -33.59 16.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.102 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.5 t -98.78 -14.07 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.228 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.503 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.774 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 2.2 m -110.6 -44.11 3.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.754 0.312 . . . . 0.0 110.748 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.601 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 43.7 t0 -140.51 -100.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.169 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -54.52 -44.64 72.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.389 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.15 -28.64 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.494 0.664 . . . . 0.0 111.977 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.709 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.5 OUTLIER 175.14 -53.26 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.851 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.709 ' N ' HD13 ' A' ' 635' ' ' LEU . 31.4 Cg_exo -54.63 -24.43 36.95 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 121.654 1.569 . . . . 0.0 110.511 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.601 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 5.9 p-10 28.95 56.47 0.12 Allowed 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.451 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 638' ' ' GLN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 10.4 pt20 42.99 96.01 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.715 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -168.18 -40.81 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.416 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -111.05 -29.99 7.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.307 . . . . 0.0 110.982 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 0.6 OUTLIER -162.94 88.97 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.055 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.882 ' O ' HG22 ' A' ' 646' ' ' THR . 2.8 p30 -102.81 -28.54 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.945 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -64.37 -24.91 67.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.993 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 644' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 1.4 p-90 -48.48 -32.08 7.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.719 0.295 . . . . 0.0 111.19 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -130.58 -13.3 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.981 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 642' ' ' ASP . 4.8 t -132.39 34.49 3.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.81 0.338 . . . . 0.0 111.302 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -145.25 -96.31 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.447 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -72.05 -29.65 64.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 110.769 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 19.7 ttm-85 -86.34 -13.79 45.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.393 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 650' ' ' GLN . . . . . 0.539 ' O ' HG23 ' A' ' 656' ' ' ILE . 29.9 tt0 -68.33 -12.89 61.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.385 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.601 ' HA ' HG22 ' A' ' 656' ' ' ILE . 38.7 p-90 -162.31 45.58 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.747 0.308 . . . . 0.0 111.055 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.849 HD13 ' O ' ' A' ' 652' ' ' ILE . 0.0 OUTLIER -86.17 -33.05 0.46 Allowed Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.697 ' HD3' HG22 ' A' ' 652' ' ' ILE . 63.1 Cg_endo -93.43 -4.49 3.0 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.512 2.142 . . . . 0.0 112.791 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 74.81 90.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.996 0.427 . . . . 0.0 110.585 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.522 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.15 46.15 1.38 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.444 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.774 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.3 tp -114.55 -39.5 2.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.45 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -130.78 -58.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.883 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.39 -39.14 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.224 0.535 . . . . 0.0 109.985 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.53 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 5.6 m -119.11 -19.16 8.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.147 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.33 -52.72 3.88 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.681 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 665' ' ' VAL . 76.5 t -82.39 -62.13 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.063 0.459 . . . . 0.0 110.964 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 24.5 t -42.37 -30.97 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.692 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.5 tp -76.62 -35.06 24.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.216 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 664' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.56 -24.57 36.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.894 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 661' ' ' VAL . 1.1 t -83.83 -45.64 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.465 0.65 . . . . 0.0 110.008 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 670' ' ' ALA . 23.2 mm -68.5 -35.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.491 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 667' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.77 -34.82 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.145 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 668' ' ' LEU . . . . . 0.634 ' HA ' HD12 ' A' ' 671' ' ' ILE . 2.8 tp -84.7 -63.11 1.39 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.003 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.76 -24.65 9.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.655 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -72.43 -25.02 61.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.26 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' A' ' 668' ' ' LEU . 10.2 mt -78.8 -41.2 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.093 0.473 . . . . 0.0 111.135 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 672' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 676' ' ' PHE . . . -59.05 -33.82 71.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.7 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.45 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.97 -17.95 26.95 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.635 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 674' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 11.0 t80 -86.67 -34.6 19.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.826 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.5 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 44.6 t -100.55 -18.51 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.5 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.779 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.546 -0.221 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.97 -41.77 11.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.726 0.298 . . . . 0.0 110.896 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.623 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.2 t0 -141.55 -92.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.354 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -58.98 -39.02 80.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.51 -27.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.421 0.629 . . . . 0.0 111.867 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 178.51 -54.56 0.0 OUTLIER Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.787 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.68 ' N ' HD13 ' A' ' 635' ' ' LEU . 38.3 Cg_exo -55.48 -23.76 40.65 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.597 1.531 . . . . 0.0 110.375 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.623 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.5 p-10 28.8 49.77 0.04 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.519 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 42.94 65.47 0.94 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.507 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -126.97 -41.92 0.29 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.23 80.93 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.95 80.82 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.005 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.925 ' O ' HG22 ' A' ' 646' ' ' THR . 5.4 p30 -67.55 -26.83 66.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 643' ' ' ASN . . . . . 0.436 ' HB3' ' CD1' ' A' ' 648' ' ' TRP . 7.0 m120 -56.26 -22.03 27.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.488 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 644' ' ' TRP . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 648' ' ' TRP . 3.4 p-90 -48.55 -28.48 3.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.752 0.311 . . . . 0.0 111.2 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 645' ' ' TRP . . . . . 0.424 ' HA ' ' CE3' ' A' ' 645' ' ' TRP . 0.0 OUTLIER -144.93 19.6 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.2 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.925 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.9 t -156.82 25.03 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.698 0.285 . . . . 0.0 111.224 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -146.48 -109.4 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.462 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 643' ' ' ASN . 49.2 p-90 -59.32 -21.4 59.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 111.133 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 649' ' ' ARG . . . . . 0.516 ' HG2' HD11 ' A' ' 652' ' ' ILE . 2.7 ttt85 -86.45 -18.03 32.75 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.044 0.449 . . . . 0.0 110.2 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.25 -3.85 41.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.809 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.927 ' HA ' HG22 ' A' ' 656' ' ' ILE . 5.3 p-90 -169.28 49.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.838 0.351 . . . . 0.0 110.959 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.597 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 1.7 mt -62.1 -56.71 28.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.076 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 34.1 Cg_endo -66.68 -74.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.208 1.939 . . . . 0.0 112.477 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 177.9 69.64 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.446 0.641 . . . . 0.0 110.359 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.894 ' HA2' HG12 ' A' ' 658' ' ' VAL . . . 103.78 35.37 3.51 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.989 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.927 HG22 ' HA ' ' A' ' 651' ' ' TRP . 0.5 OUTLIER -73.54 -15.26 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.0 110.31 178.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 662' ' ' VAL . . . -108.36 -34.08 2.78 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 658' ' ' VAL . . . . . 0.894 HG12 ' HA2' ' A' ' 655' ' ' GLY . 14.5 p -82.03 -31.78 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 110.313 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.556 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 82.0 m -124.43 -21.24 4.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.801 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.22 -53.1 3.77 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.261 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 665' ' ' VAL . 54.1 t -82.69 -61.06 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.219 0.533 . . . . 0.0 110.837 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 657' ' ' GLY . 39.1 t -42.07 -33.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.544 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.0 OUTLIER -75.16 -37.79 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.291 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.63 -24.66 36.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.184 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 661' ' ' VAL . 3.3 m -84.4 -43.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' ' 670' ' ' ALA . 19.7 mm -68.22 -35.42 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.383 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.34 -34.7 0.35 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.138 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 4.1 tp -84.87 -63.05 1.4 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.811 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.76 -26.9 10.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.612 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.46 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -67.96 -22.0 65.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.07 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 23.3 mm -85.26 -37.52 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.088 0.471 . . . . 0.0 111.142 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.49 -33.16 73.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.632 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.437 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.97 -17.84 27.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.738 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -91.52 -34.3 14.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -94.86 -11.92 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.354 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.495 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.843 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 5.2 t -108.12 -43.65 4.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.59 0.233 . . . . 0.0 110.935 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.57 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 20.2 t70 -139.23 -102.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.278 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -49.61 -40.57 39.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.779 0.323 . . . . 0.0 111.373 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.5 -24.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.232 0.539 . . . . 0.0 111.928 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.555 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.3 tm? 176.78 -58.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.471 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 7.4 Cg_endo -53.9 -21.26 20.2 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.983 1.788 . . . . 0.0 111.077 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.57 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 7.0 p-10 25.18 60.94 0.06 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.707 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 39.18 68.89 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.727 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -123.21 -49.09 0.23 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -99.96 81.03 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.335 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.53 87.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.935 ' O ' HG22 ' A' ' 646' ' ' THR . 15.0 t0 -66.84 -27.83 67.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.04 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -56.86 -20.12 21.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.604 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -48.43 -30.04 4.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.818 0.342 . . . . 0.0 111.228 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -144.5 20.89 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.935 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.6 t -160.66 27.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.742 0.306 . . . . 0.0 111.125 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.59 -111.21 0.86 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.517 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.487 ' HE3' HD13 ' A' ' 652' ' ' ILE . 65.7 p-90 -57.9 -22.25 47.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.121 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 23.9 ttt-85 -86.5 -20.16 28.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.049 0.452 . . . . 0.0 110.185 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -24.4 61.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.034 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.747 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.2 p-90 -165.58 61.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.732 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.655 HG22 ' HD3' ' A' ' 653' ' ' PRO . 1.5 tp -66.81 -33.87 6.78 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.197 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.655 ' HD3' HG22 ' A' ' 652' ' ' ILE . 35.0 Cg_endo -94.39 -73.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.681 2.254 . . . . 0.0 112.409 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.45 80.36 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.438 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.441 ' CA ' ' HB ' ' A' ' 659' ' ' THR . . . 103.57 45.3 1.56 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.361 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.747 HG22 ' HA ' ' A' ' 651' ' ' TRP . 3.0 tp -102.71 -34.51 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.041 0.448 . . . . 0.0 110.842 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.625 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -114.07 -35.91 1.43 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.514 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 658' ' ' VAL . . . . . 0.42 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 14.7 p -81.24 -40.33 18.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.145 0.498 . . . . 0.0 110.081 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.549 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 43.6 m -117.63 -16.42 10.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.086 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 656' ' ' ILE . . . -82.39 -48.87 5.45 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.307 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.773 ' O ' HG12 ' A' ' 665' ' ' VAL . 84.1 t -82.78 -60.72 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.168 0.508 . . . . 0.0 110.66 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.519 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 54.2 t -42.02 -32.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.529 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.647 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 3.2 tp -78.65 -35.62 18.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.79 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.43 -26.97 34.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.37 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.9 p -84.81 -36.07 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.151 0.501 . . . . 0.0 110.261 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 670' ' ' ALA . 25.1 mm -79.59 -37.56 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.195 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 667' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.33 -33.59 0.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.265 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.4 tp -84.77 -63.22 1.37 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.997 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 669' ' ' PHE . . . . . 0.403 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -52.89 -26.83 16.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.025 0.441 . . . . 0.0 110.43 179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.437 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -65.72 -25.03 67.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.84 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 21.9 mm -86.1 -36.34 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.151 0.5 . . . . 0.0 110.939 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 672' ' ' ALA . . . . . 0.411 ' HA ' ' CD1' ' A' ' 676' ' ' PHE . . . -59.8 -31.29 69.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.96 -17.86 27.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.638 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.87 -35.1 15.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.02 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.484 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.9 t -95.88 -16.51 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.351 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.484 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.828 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 3.1 m -131.72 -50.79 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.69 0.281 . . . . 0.0 110.799 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.544 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.7 t70 -136.87 -90.85 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.494 ' HB2' ' HZ2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -64.93 -38.03 89.61 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.223 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 3.1 m -165.11 -32.4 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.599 0.714 . . . . 0.0 111.459 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.6 OUTLIER 175.0 -52.56 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.853 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.703 ' N ' HD13 ' A' ' 635' ' ' LEU . 34.8 Cg_exo -55.27 -24.19 40.96 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.62 1.547 . . . . 0.0 110.45 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 5.7 p-10 30.45 51.3 0.1 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.286 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 42.94 97.26 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.873 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 157.23 -30.96 0.53 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.442 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -104.16 -29.06 11.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.712 0.292 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -166.17 41.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.307 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.931 ' O ' HG22 ' A' ' 646' ' ' THR . 4.7 t0 -61.34 -22.84 65.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.872 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -54.85 -22.9 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.702 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -49.02 -29.23 4.69 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.777 0.322 . . . . 0.0 111.296 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -144.7 21.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.199 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.931 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.2 t -160.77 27.3 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.792 0.33 . . . . 0.0 111.197 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -148.25 -88.72 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.398 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 37.5 p-90 -74.19 -24.1 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 0.0 110.795 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 29.7 ttt85 -86.24 -12.13 50.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.484 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -14.63 63.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.111 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.686 ' HA ' HG22 ' A' ' 656' ' ' ILE . 2.3 p-90 -169.17 51.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.876 0.37 . . . . 0.0 110.828 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.651 HG22 ' HD3' ' A' ' 653' ' ' PRO . 5.3 tt -82.97 -32.48 0.55 Allowed Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.651 ' HD3' HG22 ' A' ' 652' ' ' ILE . 44.4 Cg_endo -91.61 -75.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.301 2.001 . . . . 0.0 112.601 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 166.53 84.22 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.958 0.409 . . . . 0.0 110.316 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.58 39.9 2.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.295 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' A' ' 651' ' ' TRP . 1.6 tp -101.85 -31.53 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.196 0.522 . . . . 0.0 110.676 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.678 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -105.99 -37.02 2.61 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.25 -38.08 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.03 -0.585 . . . . 0.0 110.321 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.547 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 78.7 m -115.98 -20.08 10.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.746 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.29 -44.69 7.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.421 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.764 ' O ' HG12 ' A' ' 665' ' ' VAL . 90.5 t -82.55 -61.53 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.149 0.5 . . . . 0.0 110.472 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.521 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 51.4 t -42.35 -32.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.402 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.701 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.2 OUTLIER -79.34 -34.2 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.701 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.45 -27.52 34.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.224 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.8 p -84.55 -34.38 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.264 0.554 . . . . 0.0 110.132 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 24.3 mm -82.06 -37.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.161 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 667' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.38 -32.41 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.453 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 668' ' ' LEU . . . . . 0.546 ' HA ' HD12 ' A' ' 671' ' ' ILE . 2.9 tp -84.19 -63.28 1.37 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.768 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 669' ' ' PHE . . . . . 0.426 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -53.67 -25.76 19.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.979 0.418 . . . . 0.0 110.325 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.43 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -68.76 -22.96 64.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.067 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 668' ' ' LEU . 7.5 mt -86.07 -37.39 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.08 0.467 . . . . 0.0 111.164 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.92 -30.75 69.26 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.697 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.97 -17.85 27.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.831 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 674' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.2 OUTLIER -93.54 -33.51 13.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.243 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 41.9 t -94.93 -6.95 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.59 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.503 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.8 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.763 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.98 -41.11 3.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.617 0.246 . . . . 0.0 110.987 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.581 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 15.5 t70 -143.61 -99.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.481 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -50.34 -39.05 45.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.461 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.4 -24.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 0.0 112.124 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.564 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 177.14 -58.74 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.332 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.5 ' N ' HD13 ' A' ' 635' ' ' LEU . 9.3 Cg_endo -56.42 -20.49 33.14 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.749 1.633 . . . . 0.0 110.688 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.9 p-10 29.78 53.46 0.12 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.518 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 638' ' ' GLN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 22.9 pt20 42.8 66.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.543 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -135.13 -59.57 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.381 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.68 -28.31 23.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 0.0 110.781 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 641' ' ' ASN . . . . . 0.424 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 1.4 t-20 -153.55 88.68 1.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.709 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.917 ' O ' HG22 ' A' ' 646' ' ' THR . 2.7 p30 -109.57 -29.95 8.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -53.55 -28.83 33.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.859 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 644' ' ' TRP . . . . . 0.424 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 5.6 p-90 -48.68 -27.5 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.386 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -151.23 26.73 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.459 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.917 HG22 ' O ' ' A' ' 642' ' ' ASP . 4.2 t -168.66 32.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.81 0.338 . . . . 0.0 111.159 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 647' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 651' ' ' TRP . . . -149.36 -93.31 0.11 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.321 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.445 ' CH2' ' HG3' ' A' ' 649' ' ' ARG . 47.0 p-90 -64.92 -21.03 66.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.691 0.282 . . . . 0.0 110.965 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 649' ' ' ARG . . . . . 0.469 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 3.9 mtp85 -86.33 -19.75 29.35 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.063 0.458 . . . . 0.0 110.112 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 650' ' ' GLN . . . . . 0.587 ' O ' HG23 ' A' ' 656' ' ' ILE . 3.2 mm-40 -71.21 -22.02 62.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.069 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.569 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.5 p-90 -154.91 57.34 0.67 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.893 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.472 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 0.5 OUTLIER -66.0 -49.51 56.93 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.751 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.559 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 31.1 Cg_endo -94.39 -77.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.417 2.745 . . . . 0.0 112.581 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.24 98.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.566 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.7 39.72 2.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.466 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 650' ' ' GLN . 5.6 tp -114.26 -39.62 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 111.535 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.813 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -137.69 -58.61 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 658' ' ' VAL . . . . . 0.421 HG12 ' HB3' ' A' ' 651' ' ' TRP . 4.4 p -63.21 -41.18 91.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.369 0.604 . . . . 0.0 109.638 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 40.6 m -114.19 -17.52 11.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.854 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.463 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.11 -46.31 6.67 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.641 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.813 HG23 ' HA2' ' A' ' 657' ' ' GLY . 76.6 t -82.57 -60.67 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.169 0.509 . . . . 0.0 110.62 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.503 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 54.1 t -42.16 -32.67 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.324 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.69 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.3 OUTLIER -79.42 -34.97 16.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.662 -179.229 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.42 -27.33 34.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.431 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.0 p -84.61 -33.73 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.239 0.542 . . . . 0.0 110.146 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 25.3 mm -82.99 -36.76 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.132 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 667' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -42.2 -32.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.402 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.59 -63.32 1.36 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 669' ' ' PHE . . . . . 0.496 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.2 OUTLIER -52.61 -29.28 25.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.034 0.445 . . . . 0.0 110.134 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -65.48 -21.61 66.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.174 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.446 HG22 ' CG2' ' A' ' 675' ' ' VAL . 11.8 mt -80.54 -36.44 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 120.967 0.413 . . . . 0.0 111.942 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.13 69.31 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.43 0.633 . . . . 0.0 110.659 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.03 -17.77 27.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.905 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 674' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.3 OUTLIER -99.18 -32.55 11.17 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.508 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 675' ' ' VAL . 43.6 t -90.98 2.42 7.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.426 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 676' ' ' PHE . 4.7 m-85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 3.3 t -70.04 -42.02 73.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.623 0.249 . . . . 0.0 110.944 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.591 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 38.6 t70 -140.16 -102.53 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.444 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -44.31 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 111.371 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.75 -27.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.42 0.629 . . . . 0.0 111.934 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 176.89 -54.32 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.174 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.057 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.691 ' N ' HD13 ' A' ' 635' ' ' LEU . 33.5 Cg_exo -54.77 -24.56 38.55 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.595 1.53 . . . . 0.0 110.502 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.1 p-10 29.38 41.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.561 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 42.6 67.54 0.6 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.571 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -142.63 -58.6 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.641 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.31 -49.59 16.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.01 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -159.54 90.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.02 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.913 ' O ' HG22 ' A' ' 646' ' ' THR . 2.8 t0 -86.99 -25.68 24.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.971 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -55.12 -22.03 15.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.554 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -48.54 -28.42 3.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.764 0.316 . . . . 0.0 111.24 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 645' ' ' TRP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 649' ' ' ARG . 0.0 OUTLIER -146.43 19.08 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.147 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.913 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.8 t -155.99 25.6 0.37 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.818 0.342 . . . . 0.0 111.119 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.78 -89.52 0.14 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.912 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 36.7 p-90 -70.71 -21.29 62.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 110.423 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 649' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 645' ' ' TRP . 1.2 ttt85 -86.05 -12.11 51.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.405 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 650' ' ' GLN . . . . . 0.48 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.0 OUTLIER -65.84 -11.84 49.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.325 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.528 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.2 p-90 -164.24 48.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 110.71 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.603 HG22 ' HD3' ' A' ' 653' ' ' PRO . 1.6 tp -97.1 -31.71 0.26 Allowed Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.603 ' HD3' HG22 ' A' ' 652' ' ' ILE . 63.7 Cg_endo -88.05 -7.97 5.93 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.229 1.953 . . . . 0.0 112.822 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 76.54 91.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.989 0.423 . . . . 0.0 110.504 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 104.33 42.0 1.96 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.458 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 651' ' ' TRP . 10.2 tp -114.55 -39.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.912 0.387 . . . . 0.0 111.464 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.709 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -141.64 -59.25 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 658' ' ' VAL . . . . . 0.41 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.2 p -62.8 -37.05 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.431 0.634 . . . . 0.0 109.595 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.56 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 54.2 m -118.04 -17.83 9.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.992 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.543 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.03 -56.82 2.8 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.768 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 665' ' ' VAL . 40.8 t -82.41 -60.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.096 0.474 . . . . 0.0 111.123 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 666' ' ' ILE . 24.9 t -43.2 -31.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.677 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 659' ' ' THR . 5.3 tt -72.9 -34.18 45.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.946 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 664' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.47 -24.88 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.472 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 661' ' ' VAL . 1.4 t -84.03 -45.63 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.374 0.607 . . . . 0.0 110.016 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 670' ' ' ALA . 19.0 mm -65.49 -34.81 72.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.337 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.7 -34.56 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.039 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 668' ' ' LEU . . . . . 0.526 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.4 tp -84.75 -63.02 1.41 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.963 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -52.66 -25.19 10.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.736 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -71.25 -25.16 62.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.114 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 668' ' ' LEU . 8.5 mt -82.95 -35.97 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.14 0.495 . . . . 0.0 110.999 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.47 78.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.469 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 -17.9 26.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 674' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 14.8 t80 -90.99 -34.05 15.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.228 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.2 t -95.82 -10.1 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.485 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.6 m-85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.774 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.48 -40.96 28.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.609 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.6 t0 -140.23 -92.99 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.83 0.347 . . . . 0.0 111.369 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -39.9 89.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.34 -24.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.284 0.564 . . . . 0.0 111.89 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 175.24 -53.42 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.995 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.703 ' N ' HD13 ' A' ' 635' ' ' LEU . 35.3 Cg_exo -55.05 -24.11 38.65 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.686 1.59 . . . . 0.0 110.53 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.609 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.6 p-10 24.86 55.25 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.584 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 42.87 77.99 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.546 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -132.48 -46.16 0.12 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.418 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.12 77.77 1.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.344 . . . . 0.0 110.767 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.66 86.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.921 ' O ' HG22 ' A' ' 646' ' ' THR . 1.2 t0 -80.61 -19.92 44.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.218 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -53.98 -23.9 14.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.542 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -50.92 -28.25 9.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.202 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -144.07 19.0 1.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.268 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.921 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.7 t -156.83 25.53 0.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.824 0.345 . . . . 0.0 111.173 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.45 -93.19 0.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.277 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -76.52 -31.88 57.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 110.664 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -86.4 -12.08 50.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.561 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 650' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 656' ' ' ILE . 50.6 tt0 -64.72 -13.78 55.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.627 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.558 ' HA ' HG22 ' A' ' 656' ' ' ILE . 35.7 p-90 -163.65 44.61 0.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.754 0.312 . . . . 0.0 111.146 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.615 HG22 ' HD3' ' A' ' 653' ' ' PRO . 2.7 tt -89.51 -31.73 0.37 Allowed Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.615 ' HD3' HG22 ' A' ' 652' ' ' ILE . 52.9 Cg_endo -92.32 -4.65 3.61 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.425 2.083 . . . . 0.0 112.904 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 74.62 89.49 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.957 0.408 . . . . 0.0 110.633 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.94 47.66 1.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.462 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.558 HG22 ' HA ' ' A' ' 651' ' ' TRP . 8.4 tp -114.58 -39.75 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.785 0.326 . . . . 0.0 111.725 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.701 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -140.46 -61.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.505 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.24 -36.13 70.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.368 0.604 . . . . 0.0 109.679 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.507 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 54.8 m -118.85 -19.1 8.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.157 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.2 -52.95 3.83 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.944 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.779 ' O ' HG12 ' A' ' 665' ' ' VAL . 57.6 t -82.57 -60.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.135 0.493 . . . . 0.0 110.979 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.498 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 42.2 t -42.03 -31.78 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.572 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.6 OUTLIER -79.02 -36.46 18.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.712 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.53 -27.05 34.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.571 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.0 p -84.65 -34.4 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.152 0.501 . . . . 0.0 110.397 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.452 HD12 ' CG1' ' A' ' 662' ' ' VAL . 39.0 mt -80.29 -37.99 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.285 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 667' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.45 -33.3 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.287 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.69 -63.05 1.4 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.029 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -54.08 -24.57 17.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.578 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -73.07 -21.91 60.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.019 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 667' ' ' ALA . 4.9 mt -77.84 -55.33 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 121.322 0.582 . . . . 0.0 110.729 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 672' ' ' ALA . . . . . 0.449 ' HA ' ' HE1' ' A' ' 676' ' ' PHE . . . -46.82 -62.6 1.32 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.986 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -22.5 11.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.206 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -70.03 -51.08 35.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.061 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 675' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.08 -43.66 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.073 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.449 ' HE1' ' HA ' ' A' ' 672' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.825 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.35 -39.9 6.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.721 0.296 . . . . 0.0 110.95 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.654 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 23.1 t70 -139.8 -98.85 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.399 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -53.42 -42.06 66.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.312 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.94 -20.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.686 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 173.17 -53.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.975 179.242 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.686 ' N ' HD13 ' A' ' 635' ' ' LEU . 39.5 Cg_exo -55.82 -23.51 42.38 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.706 1.604 . . . . 0.0 110.461 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.654 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.8 p-10 25.54 48.32 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.577 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 638' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 637' ' ' ASP . 0.2 OUTLIER 35.32 90.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.039 179.554 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -168.12 -52.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.452 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.62 -37.31 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.0 110.801 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.64 94.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.866 ' O ' HG22 ' A' ' 646' ' ' THR . 8.6 t70 -90.58 9.72 28.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.06 -20.43 53.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.457 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -49.26 -35.13 16.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.134 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -133.71 9.13 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.537 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 642' ' ' ASP . 3.0 t -145.12 23.46 1.51 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.796 0.331 . . . . 0.0 111.072 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -131.62 -100.41 0.81 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.146 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -73.47 -27.29 61.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.735 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 30.1 ttm-85 -86.27 -11.94 50.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.435 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 650' ' ' GLN . . . . . 0.453 ' O ' HG23 ' A' ' 656' ' ' ILE . 4.1 tt0 -72.09 -9.87 59.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.317 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.538 ' HA ' HG22 ' A' ' 656' ' ' ILE . 0.1 OUTLIER -165.08 47.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.336 -179.367 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.642 HG22 ' HD3' ' A' ' 653' ' ' PRO . 1.7 tp -92.31 -31.86 0.33 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.642 ' HD3' HG22 ' A' ' 652' ' ' ILE . 57.5 Cg_endo -91.31 -7.41 3.56 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.386 2.058 . . . . 0.0 113.078 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 75.19 92.94 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.01 0.434 . . . . 0.0 110.363 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.565 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.38 42.01 1.96 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.272 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.959 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.1 tp -114.5 -39.46 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 111.543 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 662' ' ' VAL . . . -128.83 -57.81 0.11 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.917 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 658' ' ' VAL . . . . . 0.419 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.9 p -63.11 -39.82 86.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.282 0.563 . . . . 0.0 110.213 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.565 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 13.6 m -119.4 -18.42 8.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.138 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.474 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.27 -58.71 2.39 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.649 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.959 HG23 ' O ' ' A' ' 656' ' ' ILE . 92.7 t -82.28 -61.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.173 0.511 . . . . 0.0 110.998 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.597 ' HA ' HG22 ' A' ' 665' ' ' VAL . 40.1 t -41.81 -31.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.751 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.4 tt -77.09 -38.43 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.305 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.17 36.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.34 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 662' ' ' VAL . 10.9 m -84.43 -44.29 17.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.269 0.557 . . . . 0.0 110.331 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.479 ' N ' HG23 ' A' ' 665' ' ' VAL . 37.4 mt -66.83 -36.4 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.371 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.75 -35.5 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.955 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 668' ' ' LEU . . . . . 0.538 ' HA ' HD12 ' A' ' 671' ' ' ILE . 3.2 tp -84.87 -63.01 1.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.88 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 669' ' ' PHE . . . . . 0.432 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -52.16 -26.31 11.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.665 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 666' ' ' ILE . . . -70.92 -21.96 62.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.181 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 668' ' ' LEU . 9.7 mt -86.07 -38.54 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.129 0.49 . . . . 0.0 111.041 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -58.99 -31.09 68.47 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.753 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.01 -17.83 27.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.839 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 674' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.1 OUTLIER -92.45 -34.23 14.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.166 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.505 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 40.8 t -94.62 -10.5 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.514 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.6 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.799 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.71 -43.2 8.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.685 0.279 . . . . 0.0 110.93 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.622 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 9.1 t0 -139.63 -93.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.9 0.381 . . . . 0.0 111.353 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.29 -41.18 79.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.012 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.31 -21.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.126 0.489 . . . . 0.0 112.2 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.579 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 177.47 -58.57 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.366 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.515 ' N ' HD13 ' A' ' 635' ' ' LEU . 9.4 Cg_endo -56.53 -20.22 32.74 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.792 1.661 . . . . 0.0 110.76 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.622 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.0 p-10 27.0 50.16 0.02 OUTLIER 'General case' 0 C--O 1.23 0.072 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.564 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 638' ' ' GLN . . . . . 0.449 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 4.0 pt20 43.97 98.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.821 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -170.8 -51.89 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.661 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.37 -37.22 14.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.347 . . . . 0.0 111.013 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -170.43 94.41 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.949 ' O ' HG22 ' A' ' 646' ' ' THR . 4.8 p-10 -99.59 -34.73 10.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.723 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -51.09 -24.62 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.846 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -48.68 -27.53 2.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.819 0.342 . . . . 0.0 111.191 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -150.71 24.51 0.77 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.949 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.8 t -162.19 28.71 0.11 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.772 0.32 . . . . 0.0 111.193 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -151.19 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.328 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.418 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 59.6 p-90 -73.33 -21.54 60.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.788 0.328 . . . . 0.0 110.832 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 649' ' ' ARG . . . . . 0.418 ' HG3' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -86.21 -11.94 51.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.654 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 650' ' ' GLN . . . . . 0.491 ' O ' HG23 ' A' ' 656' ' ' ILE . 1.8 mm100 -68.91 -7.54 35.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.867 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.58 ' HA ' HG22 ' A' ' 656' ' ' ILE . 9.2 p-90 -166.92 41.39 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.71 0.291 . . . . 0.0 111.174 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.63 HG22 ' HD3' ' A' ' 653' ' ' PRO . 2.5 tp -89.63 -31.72 0.37 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.63 ' HD3' HG22 ' A' ' 652' ' ' ILE . 60.3 Cg_endo -91.65 -6.4 3.63 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.427 2.084 . . . . 0.0 112.856 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 74.98 91.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.99 0.424 . . . . 0.0 110.483 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.482 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.13 45.23 1.5 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.227 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 651' ' ' TRP . 9.4 tp -114.53 -39.51 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.669 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -135.23 -62.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.789 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.89 -38.21 75.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.321 0.582 . . . . 0.0 109.818 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.539 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 43.5 m -118.22 -19.37 9.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.233 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.18 -47.88 5.94 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.682 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.803 ' O ' HG12 ' A' ' 665' ' ' VAL . 74.1 t -82.52 -60.23 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 110.439 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.54 HG12 HD12 ' A' ' 666' ' ' ILE . 78.0 t -42.07 -31.76 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.307 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.628 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 5.2 tt -80.96 -34.51 13.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.616 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 664' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.59 -27.49 34.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.42 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.803 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.7 p -84.44 -35.09 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.224 0.535 . . . . 0.0 110.13 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.54 HD12 HG12 ' A' ' 662' ' ' VAL . 51.2 mt -79.6 -36.69 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.831 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 667' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.98 -32.93 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.398 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.8 tp -84.58 -62.96 1.42 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 669' ' ' PHE . . . . . 0.404 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 2.2 t80 -53.4 -25.42 15.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.474 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.426 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.03 -23.93 63.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.138 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 17.9 mt -85.1 -40.53 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.097 0.475 . . . . 0.0 110.952 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -56.68 -32.17 65.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.818 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.97 -17.92 27.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.922 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -92.17 -32.89 14.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.208 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.3 t -97.2 -10.9 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.489 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.495 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.837 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.431 ' HA2' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 631' ' ' SER . . . . . 0.446 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -127.89 -51.86 1.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.568 0.223 . . . . 0.0 111.001 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.559 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 9.9 t0 -132.04 -95.64 0.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.464 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -38.23 69.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.407 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.06 -26.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.238 0.542 . . . . 0.0 112.253 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.566 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 178.04 -58.75 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.436 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.508 ' N ' HD13 ' A' ' 635' ' ' LEU . 11.1 Cg_endo -57.81 -20.15 42.23 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.752 1.634 . . . . 0.0 110.649 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.0 p-10 33.48 36.97 0.01 OUTLIER 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.392 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 53.14 87.7 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.174 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -152.1 -46.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.404 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.45 -31.38 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 641' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 2.4 m120 -159.13 83.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.894 ' O ' HG22 ' A' ' 646' ' ' THR . 7.8 p-10 -95.24 -26.89 15.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.04 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 643' ' ' ASN . . . . . 0.404 ' CB ' ' HA3' ' A' ' 647' ' ' GLY . 29.9 p-10 -65.29 -20.64 66.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.009 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 644' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 1.4 p-90 -48.44 -27.93 2.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.628 0.251 . . . . 0.0 111.421 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.04 27.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.637 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.894 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.9 t -175.03 32.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.444 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 647' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 643' ' ' ASN . . . -137.92 -88.57 0.2 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.594 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.472 ' CE2' ' HG3' ' A' ' 649' ' ' ARG . 50.2 p-90 -69.86 -29.54 66.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 0.0 111.154 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 649' ' ' ARG . . . . . 0.472 ' HG3' ' CE2' ' A' ' 648' ' ' TRP . 2.6 mtp-105 -86.43 -16.26 37.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 0.0 110.362 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -65.82 -24.13 66.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.085 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.624 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.4 p-90 -160.74 56.72 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.133 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.685 HG22 ' HD3' ' A' ' 653' ' ' PRO . 9.5 tp -81.98 -32.61 0.61 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.685 ' HD3' HG22 ' A' ' 652' ' ' ILE . 62.9 Cg_endo -96.03 -5.27 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.715 2.277 . . . . 0.0 112.875 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 75.61 89.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.003 0.43 . . . . 0.0 110.465 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.518 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.05 48.44 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.351 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.827 ' O ' HG23 ' A' ' 661' ' ' VAL . 10.4 tp -114.48 -39.77 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 656' ' ' ILE . . . -132.6 -59.43 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.939 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 658' ' ' VAL . . . . . 0.402 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.5 p -61.68 -38.69 80.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.26 0.552 . . . . 0.0 110.012 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.52 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 29.9 m -119.91 -18.46 8.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.214 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.32 -55.26 3.11 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.673 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 656' ' ' ILE . 93.8 t -82.51 -60.73 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.109 0.48 . . . . 0.0 111.011 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.547 ' HA ' HG22 ' A' ' 665' ' ' VAL . 38.3 t -42.44 -32.41 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.609 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.6 tp -76.14 -37.27 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 664' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.64 -24.38 36.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.134 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 661' ' ' VAL . 2.7 m -84.25 -41.98 16.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.335 0.588 . . . . 0.0 110.297 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.449 HD12 HG12 ' A' ' 662' ' ' VAL . 43.4 mt -70.83 -36.63 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.321 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -39.94 -34.86 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.183 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 668' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 671' ' ' ILE . 3.0 tp -84.74 -63.15 1.38 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.887 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 669' ' ' PHE . . . . . 0.429 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.2 OUTLIER -52.51 -25.59 10.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.675 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -71.92 -24.57 61.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.045 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 668' ' ' LEU . 11.6 mt -85.99 -37.85 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.117 0.484 . . . . 0.0 110.883 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 672' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -57.62 -32.43 67.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.652 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.88 -17.96 27.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.742 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 674' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.2 OUTLIER -89.25 -34.89 16.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 41.0 t -97.15 -15.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.406 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.497 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.733 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.27 -43.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.619 0.247 . . . . 0.0 111.005 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.614 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 67.2 t0 -137.86 -105.07 0.19 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.374 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -46.06 -44.06 15.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 0.0 111.547 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.8 -26.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.374 0.607 . . . . 0.0 112.049 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.694 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 174.35 -52.99 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.835 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.694 ' N ' HD13 ' A' ' 635' ' ' LEU . 37.4 Cg_exo -56.06 -23.86 46.19 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.682 1.588 . . . . 0.0 110.363 178.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.614 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.9 p-10 31.45 40.01 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.314 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 638' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 16.1 pt20 42.98 69.25 0.41 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.515 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -131.9 -57.03 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.422 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.7 -28.92 19.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.361 . . . . 0.0 110.862 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 0.6 OUTLIER -159.43 93.58 1.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.83 179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.937 ' O ' HG22 ' A' ' 646' ' ' THR . 5.6 p-10 -102.57 -36.96 8.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -54.19 -22.54 11.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.592 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 644' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 7.4 p-90 -48.56 -28.22 3.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.788 0.327 . . . . 0.0 111.18 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -149.18 23.25 0.94 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.264 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.937 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.2 t -160.35 27.18 0.16 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.698 0.285 . . . . 0.0 111.264 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -150.36 -85.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.517 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.464 ' O ' HG13 ' A' ' 652' ' ' ILE . 69.3 p-90 -79.43 -21.27 45.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.62 0.248 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 649' ' ' ARG . . . . . 0.527 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 2.6 ttt85 -86.34 -15.8 39.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.063 0.458 . . . . 0.0 110.346 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 650' ' ' GLN . . . . . 0.56 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.1 OUTLIER -72.46 -16.59 61.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.37 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.453 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.9 p-90 -162.7 54.86 0.21 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.693 0.282 . . . . 0.0 111.258 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.609 HD12 ' HD3' ' A' ' 653' ' ' PRO . 0.3 OUTLIER -69.63 -51.32 16.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 110.809 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.609 ' HD3' HD12 ' A' ' 652' ' ' ILE . 32.1 Cg_endo -95.13 -80.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.456 2.771 . . . . 0.0 112.628 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 170.35 105.94 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.722 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.79 35.44 3.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.612 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 650' ' ' GLN . 0.6 OUTLIER -114.15 -39.58 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 0.0 111.454 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.823 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -137.82 -58.09 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 4.6 p -64.59 -39.25 84.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.303 0.573 . . . . 0.0 109.638 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.537 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 20.5 m -115.08 -17.37 11.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.852 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.499 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -81.92 -46.18 6.81 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.53 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.823 HG23 ' HA2' ' A' ' 657' ' ' GLY . 99.5 t -82.6 -60.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.26 0.553 . . . . 0.0 110.448 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.529 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 53.8 t -42.0 -31.65 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.56 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.7 OUTLIER -79.66 -34.09 15.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.748 -179.154 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 664' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.48 -27.36 34.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.164 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.5 p -84.55 -36.0 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.131 0.491 . . . . 0.0 110.156 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.517 HD12 HG12 ' A' ' 662' ' ' VAL . 39.4 mt -78.91 -37.02 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.022 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 667' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.38 -32.96 0.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.481 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 668' ' ' LEU . . . . . 0.627 ' HA ' HD12 ' A' ' 671' ' ' ILE . 2.9 tp -84.6 -63.13 1.39 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.803 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -24.51 15.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 110.508 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.7 -22.47 62.45 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 668' ' ' LEU . 6.8 mt -81.59 -51.9 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.172 0.511 . . . . 0.0 110.975 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -48.95 -33.4 10.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.699 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -17.9 27.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.523 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 674' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 12.1 t80 -96.35 -31.16 13.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.738 0.304 . . . . 0.0 111.385 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 675' ' ' VAL . 41.1 t -94.66 -1.19 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.381 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.467 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 2.4 m-85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.801 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 631' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 637' ' ' ASP . 42.5 t 61.54 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.491 0.186 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.627 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 38.8 t70 -122.51 -99.76 0.42 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.745 0.307 . . . . 0.0 111.235 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -45.15 80.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.269 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.2 -24.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.133 0.492 . . . . 0.0 112.31 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.57 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 177.03 -58.66 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.425 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.509 ' N ' HD13 ' A' ' 635' ' ' LEU . 9.2 Cg_endo -56.56 -20.53 34.28 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.775 1.65 . . . . 0.0 110.864 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.627 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.9 p-10 31.24 39.87 0.01 OUTLIER 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.38 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 52.95 97.96 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.189 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -171.68 -40.8 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.452 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -83.34 -34.79 25.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -168.01 47.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.923 ' O ' HG22 ' A' ' 646' ' ' THR . 32.2 p-10 -51.16 -27.18 8.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.255 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -52.18 -20.56 2.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.94 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 -48.36 -28.85 3.44 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.786 0.327 . . . . 0.0 111.269 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.58 22.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.239 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.923 HG22 ' O ' ' A' ' 642' ' ' ASP . 11.0 t -156.97 25.36 0.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.108 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.78 -111.97 0.89 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.235 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.414 ' O ' HG13 ' A' ' 652' ' ' ILE . 69.7 p-90 -60.4 -21.52 62.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.709 0.29 . . . . 0.0 110.926 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 649' ' ' ARG . . . . . 0.462 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 39.2 ttt85 -86.55 -19.13 29.9 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.33 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 650' ' ' GLN . . . . . 0.502 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.0 OUTLIER -70.09 -26.97 64.23 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.861 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.575 ' HA ' HG22 ' A' ' 656' ' ' ILE . 5.0 p-90 -153.29 58.9 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.083 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.491 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 1.9 mt -63.07 -47.56 85.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.698 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 29.5 Cg_endo -95.42 -76.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.458 2.772 . . . . 0.0 112.548 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 165.68 95.6 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.473 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.539 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.67 42.92 1.9 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.337 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.575 HG22 ' HA ' ' A' ' 651' ' ' TRP . 10.3 tp -114.27 -39.55 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.821 0.344 . . . . 0.0 111.465 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.738 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -135.23 -56.59 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 658' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' A' ' 651' ' ' TRP . 8.0 p -63.47 -42.72 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.345 0.593 . . . . 0.0 109.757 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.539 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 20.4 m -114.86 -16.96 11.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.867 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.24 -46.6 6.48 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.64 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.828 ' O ' HG12 ' A' ' 665' ' ' VAL . 67.7 t -82.82 -59.12 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.108 0.48 . . . . 0.0 110.345 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.544 HG12 HD12 ' A' ' 666' ' ' ILE . 74.6 t -42.56 -32.33 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.078 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.687 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.5 OUTLIER -81.3 -34.37 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.566 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 664' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.51 -27.07 34.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.298 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.1 p -84.44 -34.71 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.215 0.531 . . . . 0.0 110.076 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.544 HD12 HG12 ' A' ' 662' ' ' VAL . 61.3 mt -81.61 -36.66 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.086 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 667' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.83 -32.2 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.413 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.57 -62.79 1.47 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.74 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -24.66 15.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.022 0.439 . . . . 0.0 110.388 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -73.65 -21.94 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.149 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 667' ' ' ALA . 6.8 mt -75.37 -55.58 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 121.289 0.566 . . . . 0.0 111.012 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 672' ' ' ALA . . . . . 0.438 ' HA ' ' CE1' ' A' ' 676' ' ' PHE . . . -47.52 -62.62 1.35 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.795 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -21.94 18.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.154 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 674' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 11.8 t80 -65.5 -48.3 73.02 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.98 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 675' ' ' VAL . . . . . . . . . . . . . 20.7 t -101.7 -42.29 9.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 672' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.428 ' N ' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 631' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 637' ' ' ASP . 1.1 t -107.54 -40.85 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.631 0.253 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 637' ' ' ASP . 1.1 m-20 -136.29 -99.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.86 0.362 . . . . 0.0 111.436 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -49.56 -44.37 46.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.509 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.9 -19.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.564 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.1 tm? 177.32 -58.89 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.384 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.518 ' N ' HD13 ' A' ' 635' ' ' LEU . 10.3 Cg_endo -57.12 -20.72 39.13 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.754 1.636 . . . . 0.0 110.617 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 632' ' ' ASP . 1.7 p-10 28.58 42.48 0.01 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.452 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 638' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 12.4 pt20 43.46 74.13 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.525 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -140.94 -55.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.463 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -93.96 -29.93 15.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.957 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.64 101.32 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.919 ' O ' HG22 ' A' ' 646' ' ' THR . 2.8 p30 -102.24 -33.92 9.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -52.89 -22.45 5.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.725 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -48.54 -28.05 3.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.714 0.292 . . . . 0.0 111.332 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -149.14 20.21 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.275 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.919 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.7 t -155.7 25.88 0.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 111.131 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -140.91 -98.55 0.35 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.24 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -66.61 -28.49 68.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -86.32 -12.08 50.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.509 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 650' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.2 OUTLIER -67.2 -12.88 61.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.484 -179.568 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.606 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.6 p-90 -164.79 45.66 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.78 0.324 . . . . 0.0 111.193 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.633 HG22 ' HD3' ' A' ' 653' ' ' PRO . 4.3 tt -88.9 -31.78 0.38 Allowed Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.633 ' HD3' HG22 ' A' ' 652' ' ' ILE . 56.5 Cg_endo -92.6 -6.18 3.13 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.438 2.092 . . . . 0.0 112.983 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 75.74 91.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.97 0.414 . . . . 0.0 110.461 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.18 45.0 1.52 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.463 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.9 tp -114.58 -39.43 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.494 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -132.92 -59.28 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.776 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 658' ' ' VAL . . . . . 0.405 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.5 p -61.73 -38.91 81.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.283 0.563 . . . . 0.0 109.975 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.56 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 24.2 m -119.44 -18.37 8.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.108 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.559 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.24 -53.31 3.7 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.605 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.82 ' O ' HG23 ' A' ' 665' ' ' VAL . 83.9 t -82.55 -60.87 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.074 0.464 . . . . 0.0 111.036 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.514 HG12 HD12 ' A' ' 666' ' ' ILE . 25.6 t -43.38 -31.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.656 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.5 tp -73.9 -34.47 39.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.992 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 664' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.64 -23.5 36.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.668 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 661' ' ' VAL . 1.8 t -83.8 -46.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.391 0.615 . . . . 0.0 109.917 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.514 HD12 HG12 ' A' ' 662' ' ' VAL . 60.6 mt -66.97 -35.06 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.186 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 667' ' ' ALA . . . . . 0.443 ' O ' HG12 ' A' ' 671' ' ' ILE . . . -41.59 -34.12 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.117 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.5 tp -84.81 -63.0 1.41 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.82 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -52.26 -26.35 11.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.595 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.412 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -69.33 -21.94 63.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.087 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 667' ' ' ALA . 20.5 mm -84.55 -40.31 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.104 0.478 . . . . 0.0 111.148 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.19 -31.75 69.3 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.808 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.88 -17.95 27.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.79 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -92.0 -34.28 14.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 44.0 t -94.39 -13.11 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.356 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.495 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.772 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.5 m -91.38 -48.87 6.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.675 0.274 . . . . 0.0 110.824 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.585 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 11.1 t70 -139.23 -95.17 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.354 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -57.58 -39.65 77.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.189 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.89 -25.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.342 0.591 . . . . 0.0 111.884 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 174.78 -53.47 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.858 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.696 ' N ' HD13 ' A' ' 635' ' ' LEU . 38.0 Cg_exo -55.51 -24.02 42.18 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.691 1.594 . . . . 0.0 110.423 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.1 p-10 26.89 47.16 0.01 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.479 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 50.67 57.46 6.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.132 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -121.58 -44.4 0.38 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.411 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.92 74.96 2.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 110.734 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 60.74 82.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.931 ' O ' HG22 ' A' ' 646' ' ' THR . 1.2 p30 -59.27 -24.99 63.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -55.65 -19.66 11.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.782 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -48.48 -28.3 3.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.73 0.3 . . . . 0.0 111.294 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.8 20.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.314 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.931 HG22 ' O ' ' A' ' 642' ' ' ASP . 7.4 t -157.29 26.24 0.3 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 111.126 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -142.54 -90.69 0.14 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.343 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.416 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 68.1 p-90 -71.92 -22.02 61.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.667 0.27 . . . . 0.0 110.999 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 649' ' ' ARG . . . . . 0.416 ' HG3' ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -86.17 -12.02 50.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.907 0.384 . . . . 0.0 110.474 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -15.06 62.46 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.201 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.599 ' HA ' HG22 ' A' ' 656' ' ' ILE . 0.6 OUTLIER -168.49 52.36 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.188 -179.465 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.628 HG22 ' HD3' ' A' ' 653' ' ' PRO . 4.2 tp -89.86 -31.9 0.37 Allowed Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.628 ' HD3' HG22 ' A' ' 652' ' ' ILE . 57.7 Cg_endo -91.84 -8.03 3.09 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.377 2.051 . . . . 0.0 112.976 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 76.06 92.51 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.953 0.406 . . . . 0.0 110.363 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.469 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.29 43.07 1.79 Allowed Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.249 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 661' ' ' VAL . 10.2 tp -114.5 -39.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.32 . . . . 0.0 111.525 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.567 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -136.08 -57.37 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.668 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.92 -38.12 81.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.275 0.56 . . . . 0.0 109.805 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 16.7 m -120.04 -18.33 8.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.018 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.474 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.14 -52.79 3.9 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.726 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.807 ' O ' HG12 ' A' ' 665' ' ' VAL . 86.5 t -82.64 -59.63 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.146 0.498 . . . . 0.0 110.768 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.495 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 44.6 t -42.54 -31.64 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.383 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.668 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.2 OUTLIER -79.52 -36.0 17.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.71 -179.363 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.66 -27.01 34.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.807 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.0 p -84.76 -35.34 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.228 0.537 . . . . 0.0 110.336 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 26.9 mm -81.14 -37.86 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.284 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 667' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.27 -32.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.35 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.9 tp -84.69 -63.14 1.39 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.36 -25.79 16.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.051 0.453 . . . . 0.0 110.396 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -68.35 -21.87 64.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.037 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 667' ' ' ALA . 16.8 mm -84.73 -41.21 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.177 0.513 . . . . 0.0 111.214 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -58.61 -32.15 68.74 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.461 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.96 -17.87 27.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.974 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -94.21 -32.5 13.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.274 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 675' ' ' VAL . 46.1 t -94.83 -4.66 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.42 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.494 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 2.4 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.837 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 631' ' ' SER . . . . . 0.441 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -117.88 -48.62 2.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.66 0.267 . . . . 0.0 110.899 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 632' ' ' ASP . . . . . 0.625 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 65.3 t0 -136.39 -93.79 0.24 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.857 0.36 . . . . 0.0 111.316 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -37.81 70.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.148 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.09 -27.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.414 0.626 . . . . 0.0 111.77 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.677 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 178.26 -54.27 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.904 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 636' ' ' PRO . . . . . 0.677 ' N ' HD13 ' A' ' 635' ' ' LEU . 39.5 Cg_exo -56.03 -23.95 46.38 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 121.586 1.524 . . . . 0.0 110.371 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 637' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.2 p-10 30.33 40.58 0.01 OUTLIER 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.552 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 638' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 637' ' ' ASP . 2.9 pt20 36.35 73.82 0.08 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.054 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -162.77 -46.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.727 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.88 -38.54 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 111.103 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -153.33 46.32 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 642' ' ' ASP . . . . . 0.947 ' O ' HG22 ' A' ' 646' ' ' THR . 17.4 p-10 -64.78 -32.34 73.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -50.25 -25.58 3.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.725 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -48.71 -27.86 3.19 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.788 0.328 . . . . 0.0 111.272 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -148.86 22.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.323 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 646' ' ' THR . . . . . 0.947 HG22 ' O ' ' A' ' 642' ' ' ASP . 12.4 t -159.25 26.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 647' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 651' ' ' TRP . . . -143.51 -95.6 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.293 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.432 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 65.3 p-90 -65.07 -21.51 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.841 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 649' ' ' ARG . . . . . 0.615 ' HA ' HG12 ' A' ' 652' ' ' ILE . 19.9 mtp85 -86.61 -19.32 29.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.241 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 650' ' ' GLN . . . . . 0.402 ' HG3' ' HA ' ' A' ' 646' ' ' THR . 0.5 OUTLIER -69.55 -12.83 61.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.68 -179.357 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 651' ' ' TRP . . . . . 0.522 ' HA ' HG22 ' A' ' 656' ' ' ILE . 2.3 p-90 -154.45 46.75 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.763 0.316 . . . . 0.0 111.136 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 652' ' ' ILE . . . . . 0.615 HG12 ' HA ' ' A' ' 649' ' ' ARG . 0.0 OUTLIER -71.55 -61.85 1.95 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.849 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.522 ' O ' ' HB3' ' A' ' 654' ' ' ALA . 64.8 Cg_endo -73.82 -2.39 12.16 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.739 2.293 . . . . 0.0 113.016 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 654' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 72.87 91.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.963 0.411 . . . . 0.0 110.405 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 655' ' ' GLY . . . . . 0.436 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.01 49.15 1.1 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.077 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 656' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 651' ' ' TRP . 9.8 tp -114.51 -39.74 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.779 0.323 . . . . 0.0 111.733 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 657' ' ' GLY . . . . . 0.698 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -139.68 -61.33 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.591 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 658' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' A' ' 651' ' ' TRP . 1.9 p -62.33 -36.84 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.418 0.628 . . . . 0.0 109.656 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 659' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 47.0 m -117.75 -17.97 9.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.084 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 660' ' ' GLY . . . . . 0.498 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.28 -57.32 2.66 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.977 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.698 HG23 ' HA2' ' A' ' 657' ' ' GLY . 40.7 t -82.19 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.201 0.524 . . . . 0.0 111.144 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.601 ' HA ' HG22 ' A' ' 665' ' ' VAL . 24.4 t -43.13 -31.14 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.775 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.6 tt -75.19 -36.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.122 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 664' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.68 -24.81 36.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.115 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 665' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 661' ' ' VAL . 2.4 m -84.41 -41.17 15.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.32 0.581 . . . . 0.0 110.279 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 666' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 670' ' ' ALA . 18.5 mm -70.3 -36.51 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.362 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.31 -34.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.146 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 668' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.3 tp -84.77 -63.01 1.41 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.863 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 669' ' ' PHE . . . . . 0.428 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 34.7 t80 -52.78 -25.94 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 670' ' ' ALA . . . . . 0.437 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.81 -24.28 62.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.182 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 668' ' ' LEU . 10.3 mt -85.55 -33.24 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.124 0.488 . . . . 0.0 110.915 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -62.86 -33.81 76.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.379 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 673' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.13 -17.76 27.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.743 179.415 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 674' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 5.1 t80 -91.69 -33.98 14.83 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.069 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 675' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.9 t -94.82 -12.05 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.309 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 676' ' ' PHE . . . . . 0.496 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.815 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.45 ' N ' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . 0.429 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -102.85 -48.51 4.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.688 0.28 . . . . 0.0 110.875 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.606 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 12.4 t70 -136.3 -96.85 0.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.861 0.362 . . . . 0.0 111.32 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.62 -41.39 63.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.24 -22.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.148 0.499 . . . . 0.0 112.288 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.576 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.1 tm? 177.66 -58.56 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.281 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.513 ' N ' HD13 ' A' ' 635' ' ' LEU . 10.6 Cg_endo -57.64 -20.26 41.42 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.668 1.579 . . . . 0.0 110.585 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.606 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 1.9 p-10 30.52 40.64 0.01 OUTLIER 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.396 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 44.01 54.46 5.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.359 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -132.86 -46.18 0.12 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.4 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -99.52 -27.06 13.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 0.0 110.844 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 1.6 t-20 -148.05 69.74 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.93 ' O ' HG22 ' A' ' 646' ' ' THR . 11.1 p-10 -94.8 -27.47 15.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.048 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.6 -21.05 66.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.096 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . 0.429 ' HA ' ' CE2' ' A' ' 648' ' ' TRP . 1.2 p-90 -48.43 -29.59 4.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.773 0.32 . . . . 0.0 111.242 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -137.03 14.64 3.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.595 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.93 HG22 ' O ' ' A' ' 642' ' ' ASP . 3.6 t -156.57 24.76 0.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.715 0.293 . . . . 0.0 111.446 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -143.42 -90.52 0.13 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.307 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.444 ' O ' HG13 ' A' ' 652' ' ' ILE . 37.9 p-90 -73.0 -20.9 60.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.614 0.245 . . . . 0.0 111.043 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . 0.486 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 4.0 ttt-85 -85.79 -15.44 42.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 110.284 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -24.4 63.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.789 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.712 ' HA ' HG22 ' A' ' 656' ' ' ILE . 6.0 p-90 -159.18 59.06 0.41 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.498 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 0.5 OUTLIER -65.45 -47.88 67.96 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.8 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.561 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 41.1 Cg_endo -89.02 -76.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.975 2.45 . . . . 0.0 112.732 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.95 88.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.666 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.53 47.71 1.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.552 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.735 ' O ' HG23 ' A' ' 661' ' ' VAL . 10.2 tp -114.48 -33.86 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.327 . . . . 0.0 111.187 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.429 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -131.37 -48.04 0.12 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.737 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . 0.48 HG13 ' N ' ' A' ' 659' ' ' THR . 10.7 p -69.54 -43.29 80.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.246 0.546 . . . . 0.0 109.892 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.666 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 22.3 m -118.6 -15.85 9.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.677 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.518 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.4 -51.05 4.51 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.345 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 656' ' ' ILE . 43.1 t -82.62 -61.72 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 110.775 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.588 ' HA ' HG22 ' A' ' 665' ' ' VAL . 40.0 t -41.79 -33.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.591 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.3 tt -75.98 -37.54 34.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.545 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.49 -24.95 36.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.173 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 662' ' ' VAL . 5.2 m -84.51 -43.41 17.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.313 0.577 . . . . 0.0 110.478 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.453 ' N ' HG23 ' A' ' 665' ' ' VAL . 18.9 mm -67.35 -36.71 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.565 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.22 -35.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.976 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . 0.514 ' HA ' HD12 ' A' ' 671' ' ' ILE . 3.4 tp -84.9 -63.03 1.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.873 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . 0.421 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -51.79 -26.89 10.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.755 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.407 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.07 -23.71 63.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.983 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 668' ' ' LEU . 11.4 mt -85.96 -35.35 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.158 0.504 . . . . 0.0 110.88 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 676' ' ' PHE . . . -61.11 -32.97 72.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.509 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.99 -17.9 27.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.566 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -88.59 -35.08 17.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 36.6 t -96.77 -19.21 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.354 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.48 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.848 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.6 OUTLIER -83.08 -44.15 15.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 110.855 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.68 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 64.2 t0 -136.92 -97.91 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.405 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -42.96 63.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.469 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.32 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.555 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 178.9 -59.42 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.316 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.497 ' N ' HD13 ' A' ' 635' ' ' LEU . 15.0 Cg_endo -59.36 -20.13 54.45 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.702 1.601 . . . . 0.0 110.283 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.68 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 0.4 OUTLIER 36.31 -160.4 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.152 178.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -108.36 76.96 1.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.044 0.449 . . . . 0.0 111.027 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 179.48 -35.15 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.348 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.88 -29.28 23.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.752 0.311 . . . . 0.0 110.925 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.2 42.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.219 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.929 ' O ' HG22 ' A' ' 646' ' ' THR . 5.6 t0 -56.84 -22.37 36.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.145 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 648' ' ' TRP . 92.4 m-20 -52.99 -19.83 2.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.039 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . 0.425 ' HA ' ' CD ' ' A' ' 649' ' ' ARG . 25.9 p-90 -48.27 -28.32 3.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.908 0.385 . . . . 0.0 111.126 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.97 24.84 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.982 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.929 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.3 t -156.21 21.58 0.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.427 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -149.77 -124.92 1.31 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.848 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 643' ' ' ASN . 64.7 p-90 -61.89 -21.05 64.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.655 0.264 . . . . 0.0 111.445 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . 0.497 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 3.3 ttt180 -86.17 -15.93 39.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.876 0.369 . . . . 0.0 110.474 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . 0.459 ' O ' HG23 ' A' ' 656' ' ' ILE . 3.6 mt-30 -73.62 -14.64 61.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.509 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.568 ' HA ' HG22 ' A' ' 656' ' ' ILE . 2.3 p-90 -158.9 50.84 0.38 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.687 0.28 . . . . 0.0 111.503 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.497 ' CG1' ' HA ' ' A' ' 649' ' ' ARG . 0.7 OUTLIER -63.89 -48.61 78.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.357 . . . . 0.0 110.552 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 30.6 Cg_endo -94.46 -76.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.488 2.792 . . . . 0.0 112.485 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.31 96.1 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.624 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.525 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.59 42.3 2.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.323 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.1 tp -114.48 -39.6 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.706 0.289 . . . . 0.0 111.696 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 662' ' ' VAL . . . -134.06 -53.68 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.738 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 659' ' ' THR . 9.9 p -64.51 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.352 0.596 . . . . 0.0 109.843 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.525 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 23.3 m -119.68 -17.81 8.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.992 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.463 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.28 -51.57 4.34 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.623 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.802 ' O ' HG12 ' A' ' 665' ' ' VAL . 53.1 t -82.78 -59.65 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.093 0.473 . . . . 0.0 110.567 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 657' ' ' GLY . 62.0 t -42.19 -31.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.417 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.614 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 1.7 tp -80.85 -35.98 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.648 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.6 -26.86 34.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.498 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.802 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.1 p -84.69 -34.3 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 121.122 0.487 . . . . 0.0 110.356 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.451 HD12 HG12 ' A' ' 662' ' ' VAL . 45.8 mt -81.46 -38.32 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.267 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.13 -32.41 0.26 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.398 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . 0.563 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.0 OUTLIER -84.57 -63.17 1.38 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.97 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . 0.406 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 76.8 t80 -54.04 -25.96 24.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.06 0.457 . . . . 0.0 110.357 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.432 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -67.99 -22.08 65.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.932 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 668' ' ' LEU . 7.2 mt -85.5 -37.1 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.134 0.492 . . . . 0.0 111.051 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.3 -31.77 71.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.563 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.449 ' H ' ' HG3' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -90.02 -17.87 27.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.754 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -92.65 -34.17 14.09 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.155 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.492 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -94.15 -11.06 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.396 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.492 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.831 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.428 ' N ' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . 0.417 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.5 OUTLIER -119.59 -45.0 2.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.706 0.289 . . . . 0.0 110.889 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.612 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 18.8 t70 -137.99 -95.65 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.362 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -52.53 -42.14 64.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.189 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.52 -20.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.568 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.1 tm? 177.79 -58.93 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.364 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.517 ' N ' HD13 ' A' ' 635' ' ' LEU . 11.2 Cg_endo -58.03 -20.51 45.74 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.724 1.616 . . . . 0.0 110.544 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.612 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 1.4 p-10 30.24 39.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.6 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 636' ' ' PRO . 9.0 mt-30 51.5 98.78 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.163 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -170.12 -40.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.337 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -80.85 -39.96 25.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 110.731 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -178.78 92.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.921 ' O ' HG22 ' A' ' 646' ' ' THR . 4.2 m-20 -70.51 -19.09 62.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -53.88 -20.3 5.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.098 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -48.31 -28.89 3.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.791 0.329 . . . . 0.0 111.163 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -147.62 20.82 1.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.921 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.9 t -155.6 24.91 0.4 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.771 0.32 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -151.82 -79.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.655 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.425 ' O ' HG13 ' A' ' 652' ' ' ILE . 65.1 p-90 -86.13 -21.46 27.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.587 0.232 . . . . 0.0 111.287 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . 0.479 ' HG2' HD11 ' A' ' 652' ' ' ILE . 1.3 ttp85 -86.44 -15.75 39.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.317 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -71.22 -18.23 62.47 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.177 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.835 ' HA ' HG22 ' A' ' 656' ' ' ILE . 12.0 p-90 -167.54 59.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.591 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.59 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 2.1 mt -60.33 -54.88 50.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.771 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 37.5 Cg_endo -69.13 -64.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.265 1.977 . . . . 0.0 112.378 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 168.39 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.494 0.664 . . . . 0.0 110.281 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.877 ' HA2' HG12 ' A' ' 658' ' ' VAL . . . 103.64 38.35 2.8 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.705 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.835 HG22 ' HA ' ' A' ' 651' ' ' TRP . 0.4 OUTLIER -73.5 -17.68 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.245 0.545 . . . . 0.0 110.515 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.659 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -106.52 -35.39 2.87 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . 0.877 HG12 ' HA2' ' A' ' 655' ' ' GLY . 13.9 p -82.29 -31.65 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.254 -0.473 . . . . 0.0 110.6 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.575 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 70.9 m -123.47 -20.26 5.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.755 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.2 -44.54 7.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.908 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 665' ' ' VAL . 96.5 t -82.62 -62.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.205 0.526 . . . . 0.0 110.413 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.518 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 44.0 t -42.05 -32.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.543 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.3 OUTLIER -79.27 -34.87 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.689 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.0 -27.23 35.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.285 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.8 p -84.64 -33.98 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 121.285 0.565 . . . . 0.0 110.154 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 670' ' ' ALA . 25.4 mm -82.84 -37.97 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.341 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.13 -32.65 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.342 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.4 tp -84.53 -63.1 1.4 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.821 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . 0.411 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 1.4 t80 -53.86 -25.2 18.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.516 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.439 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -69.08 -22.65 63.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 16.1 mt -86.01 -36.3 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.113 0.482 . . . . 0.0 111.082 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.16 73.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.543 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.0 -17.9 27.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.716 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -91.46 -34.23 14.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.164 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -95.19 -11.29 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.302 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.506 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.18 -0.915 . . . . 0.0 110.792 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.1 m -120.92 -40.85 2.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.616 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 16.3 t70 -141.88 -99.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.349 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -39.07 60.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.441 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.46 -23.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.236 0.541 . . . . 0.0 112.007 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.676 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 173.1 -52.98 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.923 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.676 ' N ' HD13 ' A' ' 635' ' ' LEU . 35.8 Cg_exo -55.96 -23.54 43.7 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.714 1.609 . . . . 0.0 110.489 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.0 p-10 27.28 48.93 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.539 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 43.01 73.54 0.14 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.593 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -134.66 -44.53 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.554 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -97.22 69.03 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 110.986 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 3.4 t30 62.28 86.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.902 ' O ' HG22 ' A' ' 646' ' ' THR . 5.7 p-10 -63.86 -23.82 67.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.19 -17.06 9.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.891 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -48.25 -40.27 24.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.724 0.297 . . . . 0.0 111.251 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -131.89 16.39 4.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.385 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.902 HG22 ' O ' ' A' ' 642' ' ' ASP . 9.5 t -152.48 23.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.794 0.331 . . . . 0.0 111.093 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.41 -96.72 0.28 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.112 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.885 ' HB3' HD13 ' A' ' 652' ' ' ILE . 57.8 p-90 -64.77 -22.04 66.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.092 0.473 . . . . 0.0 110.697 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.45 -24.07 25.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . 0.507 ' O ' HG22 ' A' ' 656' ' ' ILE . 3.6 tt0 -91.38 -32.93 15.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.207 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.543 ' HA ' HG22 ' A' ' 656' ' ' ILE . 25.0 p-90 -175.4 67.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.03 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.885 HD13 ' HB3' ' A' ' 648' ' ' TRP . 9.1 tp -64.3 -33.14 8.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.654 ' HG3' HD12 ' A' ' 656' ' ' ILE . 33.3 Cg_endo -93.82 -74.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.536 2.158 . . . . 0.0 112.442 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 178.67 70.34 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.439 0.638 . . . . 0.0 110.317 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.814 ' HA2' HG12 ' A' ' 658' ' ' VAL . . . 103.62 45.04 1.59 Allowed Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.565 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.654 HD12 ' HG3' ' A' ' 653' ' ' PRO . 0.4 OUTLIER -73.08 -18.6 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 110.102 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.549 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -106.12 -33.87 3.34 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . 0.814 HG12 ' HA2' ' A' ' 655' ' ' GLY . 13.0 p -82.13 -30.55 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.999 0.428 . . . . 0.0 110.589 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.564 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 99.5 m -124.82 -23.38 4.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.931 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.14 -44.64 7.46 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.156 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 665' ' ' VAL . 74.5 t -82.67 -61.67 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.191 0.52 . . . . 0.0 110.574 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 665' ' ' VAL . 40.1 t -43.05 -33.2 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.461 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 659' ' ' THR . 5.0 tt -77.47 -35.5 22.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.176 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.63 -25.19 35.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.844 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 661' ' ' VAL . 2.8 m -84.38 -42.21 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.301 0.572 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.46 HD12 HG12 ' A' ' 662' ' ' VAL . 45.0 mt -70.82 -37.09 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.437 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -39.85 -34.58 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.117 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.83 -63.15 1.38 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.88 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . 0.42 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -52.15 -26.77 12.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.617 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.419 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -69.35 -24.7 63.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.971 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 16.8 mt -86.1 -36.06 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.124 0.487 . . . . 0.0 110.879 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.79 -32.29 70.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.541 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.92 -17.84 27.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.738 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -90.92 -34.34 15.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.081 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.498 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.9 t -95.68 -14.03 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.335 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.498 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.1 m-85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.854 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.21 -44.48 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.696 0.284 . . . . 0.0 110.809 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.631 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 18.5 t70 -137.54 -100.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.272 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.23 -41.59 60.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.363 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.01 -25.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.27 0.557 . . . . 0.0 112.126 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.694 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 175.76 -53.81 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.12 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.694 ' N ' HD13 ' A' ' 635' ' ' LEU . 39.4 Cg_exo -55.52 -24.56 44.98 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 121.596 1.531 . . . . 0.0 110.512 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.631 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.1 p-10 29.77 39.51 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.562 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . 0.424 ' O ' ' HG3' ' A' ' 638' ' ' GLN . 7.7 pt20 41.56 94.29 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.931 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 158.52 -33.12 0.49 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.367 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.75 -23.04 10.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.691 0.282 . . . . 0.0 111.058 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -148.04 19.81 1.11 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.569 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.918 ' O ' HG22 ' A' ' 646' ' ' THR . 4.2 t0 -59.98 -22.91 63.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.877 0.37 . . . . 0.0 110.862 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -56.37 -20.2 18.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.635 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -48.53 -27.53 2.79 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.75 0.309 . . . . 0.0 111.244 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.27 22.82 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.918 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.6 t -159.3 25.5 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.279 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 650' ' ' GLN . . . -143.4 -96.44 0.23 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.621 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.448 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 67.0 p-90 -62.59 -20.49 64.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.651 0.262 . . . . 0.0 111.209 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . 0.538 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 26.7 mtt180 -85.92 -14.69 44.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.912 0.387 . . . . 0.0 110.404 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 647' ' ' GLY . 2.2 mt-30 -76.11 -14.07 60.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.505 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.787 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.6 p-90 -160.37 50.6 0.29 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.572 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 1.7 mt -67.68 -50.29 35.81 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.733 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.572 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 98.4 Cg_endo -84.49 5.6 6.21 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.777 2.318 . . . . 0.0 113.04 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 65.29 90.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.396 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.507 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.47 49.62 1.03 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.527 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.787 HG22 ' HA ' ' A' ' 651' ' ' TRP . 10.3 tp -114.44 -39.52 2.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.908 0.385 . . . . 0.0 111.338 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.715 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -137.46 -60.95 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.563 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 651' ' ' TRP . 3.4 p -59.73 -39.51 79.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.37 0.605 . . . . 0.0 109.759 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 31.8 m -117.7 -18.33 9.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.109 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.14 -48.1 5.86 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.55 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.773 ' O ' HG12 ' A' ' 665' ' ' VAL . 75.6 t -82.76 -60.31 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.233 0.539 . . . . 0.0 110.56 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.547 HG12 HD12 ' A' ' 666' ' ' ILE . 63.5 t -42.0 -32.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.44 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.4 tt -79.02 -34.58 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.677 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.58 -27.75 34.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.327 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.7 p -84.47 -36.16 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.074 0.464 . . . . 0.0 110.275 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.547 HD12 HG12 ' A' ' 662' ' ' VAL . 39.0 mt -76.44 -36.16 28.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.915 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.05 -32.93 0.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.384 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . 0.511 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.1 tp -84.53 -63.1 1.4 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.87 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -54.01 -24.56 17.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.46 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.422 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -71.0 -24.7 62.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.054 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 668' ' ' LEU . 10.2 mt -84.45 -39.82 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.16 0.505 . . . . 0.0 110.886 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -57.52 -34.65 69.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.772 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.444 ' H ' ' HG3' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.89 -17.84 27.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.835 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 9.2 t80 -89.28 -33.59 16.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.102 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.5 t -98.78 -14.07 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.228 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.503 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.774 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 2.2 m -110.6 -44.11 3.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.754 0.312 . . . . 0.0 110.748 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.601 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 43.7 t0 -140.51 -100.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.169 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -54.52 -44.64 72.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.389 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.15 -28.64 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.494 0.664 . . . . 0.0 111.977 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.709 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.5 OUTLIER 175.14 -53.26 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.851 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.709 ' N ' HD13 ' A' ' 635' ' ' LEU . 31.4 Cg_exo -54.63 -24.43 36.95 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 121.654 1.569 . . . . 0.0 110.511 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.601 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 5.9 p-10 28.95 56.47 0.12 Allowed 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.451 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 10.4 pt20 42.99 96.01 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.715 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -168.18 -40.81 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.416 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -111.05 -29.99 7.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.307 . . . . 0.0 110.982 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 0.6 OUTLIER -162.94 88.97 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.055 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.882 ' O ' HG22 ' A' ' 646' ' ' THR . 2.8 p30 -102.81 -28.54 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.945 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -64.37 -24.91 67.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.993 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 1.4 p-90 -48.48 -32.08 7.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.719 0.295 . . . . 0.0 111.19 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -130.58 -13.3 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.981 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 642' ' ' ASP . 4.8 t -132.39 34.49 3.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.81 0.338 . . . . 0.0 111.302 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -145.25 -96.31 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.447 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -72.05 -29.65 64.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 110.769 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 19.7 ttm-85 -86.34 -13.79 45.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.393 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . 0.539 ' O ' HG23 ' A' ' 656' ' ' ILE . 29.9 tt0 -68.33 -12.89 61.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.385 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.601 ' HA ' HG22 ' A' ' 656' ' ' ILE . 38.7 p-90 -162.31 45.58 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.747 0.308 . . . . 0.0 111.055 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.849 HD13 ' O ' ' A' ' 652' ' ' ILE . 0.0 OUTLIER -86.17 -33.05 0.46 Allowed Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.697 ' HD3' HG22 ' A' ' 652' ' ' ILE . 63.1 Cg_endo -93.43 -4.49 3.0 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.512 2.142 . . . . 0.0 112.791 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 74.81 90.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.996 0.427 . . . . 0.0 110.585 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.522 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.15 46.15 1.38 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.444 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.774 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.3 tp -114.55 -39.5 2.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.45 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -130.78 -58.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.883 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.39 -39.14 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.224 0.535 . . . . 0.0 109.985 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.53 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 5.6 m -119.11 -19.16 8.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.147 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.33 -52.72 3.88 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.681 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 665' ' ' VAL . 76.5 t -82.39 -62.13 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.063 0.459 . . . . 0.0 110.964 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 24.5 t -42.37 -30.97 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.692 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.5 tp -76.62 -35.06 24.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.216 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.56 -24.57 36.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.894 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 661' ' ' VAL . 1.1 t -83.83 -45.64 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.465 0.65 . . . . 0.0 110.008 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 670' ' ' ALA . 23.2 mm -68.5 -35.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.491 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.77 -34.82 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.145 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . 0.634 ' HA ' HD12 ' A' ' 671' ' ' ILE . 2.8 tp -84.7 -63.11 1.39 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.003 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.76 -24.65 9.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.655 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -72.43 -25.02 61.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.26 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' A' ' 668' ' ' LEU . 10.2 mt -78.8 -41.2 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.093 0.473 . . . . 0.0 111.135 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 676' ' ' PHE . . . -59.05 -33.82 71.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.7 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.45 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.97 -17.95 26.95 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.635 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 11.0 t80 -86.67 -34.6 19.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.826 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.5 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 44.6 t -100.55 -18.51 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.5 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.779 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.546 -0.221 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.97 -41.77 11.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.726 0.298 . . . . 0.0 110.896 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.623 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.2 t0 -141.55 -92.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.354 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -58.98 -39.02 80.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.51 -27.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.421 0.629 . . . . 0.0 111.867 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 178.51 -54.56 0.0 OUTLIER Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.787 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.68 ' N ' HD13 ' A' ' 635' ' ' LEU . 38.3 Cg_exo -55.48 -23.76 40.65 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.597 1.531 . . . . 0.0 110.375 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.623 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.5 p-10 28.8 49.77 0.04 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.519 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 42.94 65.47 0.94 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.507 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -126.97 -41.92 0.29 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.23 80.93 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.95 80.82 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.005 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.925 ' O ' HG22 ' A' ' 646' ' ' THR . 5.4 p30 -67.55 -26.83 66.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . 0.436 ' HB3' ' CD1' ' A' ' 648' ' ' TRP . 7.0 m120 -56.26 -22.03 27.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.488 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 648' ' ' TRP . 3.4 p-90 -48.55 -28.48 3.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.752 0.311 . . . . 0.0 111.2 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . 0.424 ' HA ' ' CE3' ' A' ' 645' ' ' TRP . 0.0 OUTLIER -144.93 19.6 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.2 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.925 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.9 t -156.82 25.03 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.698 0.285 . . . . 0.0 111.224 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -146.48 -109.4 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.462 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 643' ' ' ASN . 49.2 p-90 -59.32 -21.4 59.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 111.133 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . 0.516 ' HG2' HD11 ' A' ' 652' ' ' ILE . 2.7 ttt85 -86.45 -18.03 32.75 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.044 0.449 . . . . 0.0 110.2 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.25 -3.85 41.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.809 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.927 ' HA ' HG22 ' A' ' 656' ' ' ILE . 5.3 p-90 -169.28 49.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.838 0.351 . . . . 0.0 110.959 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.597 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 1.7 mt -62.1 -56.71 28.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.076 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 34.1 Cg_endo -66.68 -74.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.208 1.939 . . . . 0.0 112.477 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 177.9 69.64 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.446 0.641 . . . . 0.0 110.359 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.894 ' HA2' HG12 ' A' ' 658' ' ' VAL . . . 103.78 35.37 3.51 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.989 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.927 HG22 ' HA ' ' A' ' 651' ' ' TRP . 0.5 OUTLIER -73.54 -15.26 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.0 110.31 178.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 662' ' ' VAL . . . -108.36 -34.08 2.78 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . 0.894 HG12 ' HA2' ' A' ' 655' ' ' GLY . 14.5 p -82.03 -31.78 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 110.313 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.556 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 82.0 m -124.43 -21.24 4.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.801 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.22 -53.1 3.77 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.261 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 665' ' ' VAL . 54.1 t -82.69 -61.06 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.219 0.533 . . . . 0.0 110.837 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 657' ' ' GLY . 39.1 t -42.07 -33.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.544 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.0 OUTLIER -75.16 -37.79 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.291 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.63 -24.66 36.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.184 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 661' ' ' VAL . 3.3 m -84.4 -43.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' ' 670' ' ' ALA . 19.7 mm -68.22 -35.42 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.383 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.34 -34.7 0.35 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.138 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 4.1 tp -84.87 -63.05 1.4 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.811 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.76 -26.9 10.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.612 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.46 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -67.96 -22.0 65.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.07 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 23.3 mm -85.26 -37.52 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.088 0.471 . . . . 0.0 111.142 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.49 -33.16 73.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.632 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.437 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.97 -17.84 27.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.738 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -91.52 -34.3 14.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -94.86 -11.92 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.354 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.495 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.843 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 5.2 t -108.12 -43.65 4.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.59 0.233 . . . . 0.0 110.935 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.57 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 20.2 t70 -139.23 -102.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.278 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -49.61 -40.57 39.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.779 0.323 . . . . 0.0 111.373 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.5 -24.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.232 0.539 . . . . 0.0 111.928 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.555 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.3 tm? 176.78 -58.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.471 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 7.4 Cg_endo -53.9 -21.26 20.2 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.983 1.788 . . . . 0.0 111.077 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.57 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 7.0 p-10 25.18 60.94 0.06 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.707 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 39.18 68.89 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.727 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -123.21 -49.09 0.23 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -99.96 81.03 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.335 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.53 87.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.935 ' O ' HG22 ' A' ' 646' ' ' THR . 15.0 t0 -66.84 -27.83 67.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.04 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -56.86 -20.12 21.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.604 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -48.43 -30.04 4.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.818 0.342 . . . . 0.0 111.228 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -144.5 20.89 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.935 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.6 t -160.66 27.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.742 0.306 . . . . 0.0 111.125 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.59 -111.21 0.86 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.517 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.487 ' HE3' HD13 ' A' ' 652' ' ' ILE . 65.7 p-90 -57.9 -22.25 47.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.121 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 23.9 ttt-85 -86.5 -20.16 28.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.049 0.452 . . . . 0.0 110.185 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -24.4 61.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.034 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.747 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.2 p-90 -165.58 61.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.732 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.655 HG22 ' HD3' ' A' ' 653' ' ' PRO . 1.5 tp -66.81 -33.87 6.78 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.197 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.655 ' HD3' HG22 ' A' ' 652' ' ' ILE . 35.0 Cg_endo -94.39 -73.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.681 2.254 . . . . 0.0 112.409 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.45 80.36 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.438 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.441 ' CA ' ' HB ' ' A' ' 659' ' ' THR . . . 103.57 45.3 1.56 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.361 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.747 HG22 ' HA ' ' A' ' 651' ' ' TRP . 3.0 tp -102.71 -34.51 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.041 0.448 . . . . 0.0 110.842 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.625 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -114.07 -35.91 1.43 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.514 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . 0.42 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 14.7 p -81.24 -40.33 18.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.145 0.498 . . . . 0.0 110.081 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.549 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 43.6 m -117.63 -16.42 10.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.086 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 656' ' ' ILE . . . -82.39 -48.87 5.45 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.307 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.773 ' O ' HG12 ' A' ' 665' ' ' VAL . 84.1 t -82.78 -60.72 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.168 0.508 . . . . 0.0 110.66 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.519 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 54.2 t -42.02 -32.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.529 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.647 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 3.2 tp -78.65 -35.62 18.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.79 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.43 -26.97 34.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.37 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.9 p -84.81 -36.07 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.151 0.501 . . . . 0.0 110.261 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 670' ' ' ALA . 25.1 mm -79.59 -37.56 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.195 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.33 -33.59 0.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.265 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.4 tp -84.77 -63.22 1.37 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.997 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . 0.403 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -52.89 -26.83 16.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.025 0.441 . . . . 0.0 110.43 179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.437 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -65.72 -25.03 67.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.84 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 21.9 mm -86.1 -36.34 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.151 0.5 . . . . 0.0 110.939 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . 0.411 ' HA ' ' CD1' ' A' ' 676' ' ' PHE . . . -59.8 -31.29 69.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.96 -17.86 27.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.638 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.87 -35.1 15.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.02 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.484 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.9 t -95.88 -16.51 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.351 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.484 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.828 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 3.1 m -131.72 -50.79 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.69 0.281 . . . . 0.0 110.799 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.544 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.7 t70 -136.87 -90.85 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.494 ' HB2' ' HZ2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -64.93 -38.03 89.61 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.223 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 3.1 m -165.11 -32.4 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.599 0.714 . . . . 0.0 111.459 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.6 OUTLIER 175.0 -52.56 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.853 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.703 ' N ' HD13 ' A' ' 635' ' ' LEU . 34.8 Cg_exo -55.27 -24.19 40.96 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.62 1.547 . . . . 0.0 110.45 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 5.7 p-10 30.45 51.3 0.1 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.286 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 42.94 97.26 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.873 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 157.23 -30.96 0.53 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.442 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -104.16 -29.06 11.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.712 0.292 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -166.17 41.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.307 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.931 ' O ' HG22 ' A' ' 646' ' ' THR . 4.7 t0 -61.34 -22.84 65.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.872 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -54.85 -22.9 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.702 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -49.02 -29.23 4.69 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.777 0.322 . . . . 0.0 111.296 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -144.7 21.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.199 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.931 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.2 t -160.77 27.3 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.792 0.33 . . . . 0.0 111.197 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -148.25 -88.72 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.398 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 37.5 p-90 -74.19 -24.1 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 0.0 110.795 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 29.7 ttt85 -86.24 -12.13 50.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.484 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -14.63 63.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.111 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.686 ' HA ' HG22 ' A' ' 656' ' ' ILE . 2.3 p-90 -169.17 51.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.876 0.37 . . . . 0.0 110.828 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.651 HG22 ' HD3' ' A' ' 653' ' ' PRO . 5.3 tt -82.97 -32.48 0.55 Allowed Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.651 ' HD3' HG22 ' A' ' 652' ' ' ILE . 44.4 Cg_endo -91.61 -75.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.301 2.001 . . . . 0.0 112.601 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 166.53 84.22 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.958 0.409 . . . . 0.0 110.316 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.58 39.9 2.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.295 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' A' ' 651' ' ' TRP . 1.6 tp -101.85 -31.53 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.196 0.522 . . . . 0.0 110.676 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.678 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -105.99 -37.02 2.61 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.25 -38.08 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.03 -0.585 . . . . 0.0 110.321 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.547 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 78.7 m -115.98 -20.08 10.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.746 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.29 -44.69 7.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.421 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.764 ' O ' HG12 ' A' ' 665' ' ' VAL . 90.5 t -82.55 -61.53 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.149 0.5 . . . . 0.0 110.472 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.521 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 51.4 t -42.35 -32.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.402 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.701 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.2 OUTLIER -79.34 -34.2 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.701 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.45 -27.52 34.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.224 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.8 p -84.55 -34.38 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.264 0.554 . . . . 0.0 110.132 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 24.3 mm -82.06 -37.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.161 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.38 -32.41 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.453 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . 0.546 ' HA ' HD12 ' A' ' 671' ' ' ILE . 2.9 tp -84.19 -63.28 1.37 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.768 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . 0.426 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -53.67 -25.76 19.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.979 0.418 . . . . 0.0 110.325 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.43 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -68.76 -22.96 64.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.067 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 668' ' ' LEU . 7.5 mt -86.07 -37.39 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.08 0.467 . . . . 0.0 111.164 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.92 -30.75 69.26 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.697 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.97 -17.85 27.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.831 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.2 OUTLIER -93.54 -33.51 13.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.243 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 41.9 t -94.93 -6.95 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.59 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.503 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.8 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.763 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.98 -41.11 3.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.617 0.246 . . . . 0.0 110.987 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.581 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 15.5 t70 -143.61 -99.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.481 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -50.34 -39.05 45.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.461 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.4 -24.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 0.0 112.124 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.564 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 177.14 -58.74 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.332 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.5 ' N ' HD13 ' A' ' 635' ' ' LEU . 9.3 Cg_endo -56.42 -20.49 33.14 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.749 1.633 . . . . 0.0 110.688 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.9 p-10 29.78 53.46 0.12 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.518 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 22.9 pt20 42.8 66.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.543 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -135.13 -59.57 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.381 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.68 -28.31 23.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 0.0 110.781 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . 0.424 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 1.4 t-20 -153.55 88.68 1.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.709 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.917 ' O ' HG22 ' A' ' 646' ' ' THR . 2.7 p30 -109.57 -29.95 8.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -53.55 -28.83 33.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.859 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . 0.424 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 5.6 p-90 -48.68 -27.5 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.386 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -151.23 26.73 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.459 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.917 HG22 ' O ' ' A' ' 642' ' ' ASP . 4.2 t -168.66 32.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.81 0.338 . . . . 0.0 111.159 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 651' ' ' TRP . . . -149.36 -93.31 0.11 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.321 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.445 ' CH2' ' HG3' ' A' ' 649' ' ' ARG . 47.0 p-90 -64.92 -21.03 66.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.691 0.282 . . . . 0.0 110.965 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . 0.469 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 3.9 mtp85 -86.33 -19.75 29.35 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.063 0.458 . . . . 0.0 110.112 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . 0.587 ' O ' HG23 ' A' ' 656' ' ' ILE . 3.2 mm-40 -71.21 -22.02 62.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.069 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.569 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.5 p-90 -154.91 57.34 0.67 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.893 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.472 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 0.5 OUTLIER -66.0 -49.51 56.93 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.751 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.559 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 31.1 Cg_endo -94.39 -77.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.417 2.745 . . . . 0.0 112.581 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.24 98.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.566 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.7 39.72 2.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.466 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 650' ' ' GLN . 5.6 tp -114.26 -39.62 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 111.535 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.813 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -137.69 -58.61 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . 0.421 HG12 ' HB3' ' A' ' 651' ' ' TRP . 4.4 p -63.21 -41.18 91.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.369 0.604 . . . . 0.0 109.638 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 40.6 m -114.19 -17.52 11.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.854 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.463 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.11 -46.31 6.67 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.641 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.813 HG23 ' HA2' ' A' ' 657' ' ' GLY . 76.6 t -82.57 -60.67 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.169 0.509 . . . . 0.0 110.62 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.503 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 54.1 t -42.16 -32.67 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.324 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.69 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.3 OUTLIER -79.42 -34.97 16.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.662 -179.229 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.42 -27.33 34.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.431 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.0 p -84.61 -33.73 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.239 0.542 . . . . 0.0 110.146 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 25.3 mm -82.99 -36.76 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.132 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -42.2 -32.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.402 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.59 -63.32 1.36 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . 0.496 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.2 OUTLIER -52.61 -29.28 25.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.034 0.445 . . . . 0.0 110.134 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -65.48 -21.61 66.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.174 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.446 HG22 ' CG2' ' A' ' 675' ' ' VAL . 11.8 mt -80.54 -36.44 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 120.967 0.413 . . . . 0.0 111.942 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.13 69.31 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.43 0.633 . . . . 0.0 110.659 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.03 -17.77 27.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.905 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.3 OUTLIER -99.18 -32.55 11.17 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.508 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 675' ' ' VAL . 43.6 t -90.98 2.42 7.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.426 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 676' ' ' PHE . 4.7 m-85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 3.3 t -70.04 -42.02 73.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.623 0.249 . . . . 0.0 110.944 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.591 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 38.6 t70 -140.16 -102.53 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.444 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -44.31 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 111.371 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.75 -27.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.42 0.629 . . . . 0.0 111.934 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 176.89 -54.32 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.174 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.057 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.691 ' N ' HD13 ' A' ' 635' ' ' LEU . 33.5 Cg_exo -54.77 -24.56 38.55 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.595 1.53 . . . . 0.0 110.502 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.1 p-10 29.38 41.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.561 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 42.6 67.54 0.6 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.571 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -142.63 -58.6 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.641 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.31 -49.59 16.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.01 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -159.54 90.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.02 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.913 ' O ' HG22 ' A' ' 646' ' ' THR . 2.8 t0 -86.99 -25.68 24.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.971 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -55.12 -22.03 15.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.554 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -48.54 -28.42 3.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.764 0.316 . . . . 0.0 111.24 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 649' ' ' ARG . 0.0 OUTLIER -146.43 19.08 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.147 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.913 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.8 t -155.99 25.6 0.37 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.818 0.342 . . . . 0.0 111.119 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.78 -89.52 0.14 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.912 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 36.7 p-90 -70.71 -21.29 62.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 110.423 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 645' ' ' TRP . 1.2 ttt85 -86.05 -12.11 51.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.405 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . 0.48 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.0 OUTLIER -65.84 -11.84 49.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.325 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.528 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.2 p-90 -164.24 48.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 110.71 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.603 HG22 ' HD3' ' A' ' 653' ' ' PRO . 1.6 tp -97.1 -31.71 0.26 Allowed Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.603 ' HD3' HG22 ' A' ' 652' ' ' ILE . 63.7 Cg_endo -88.05 -7.97 5.93 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.229 1.953 . . . . 0.0 112.822 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 76.54 91.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.989 0.423 . . . . 0.0 110.504 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 104.33 42.0 1.96 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.458 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 651' ' ' TRP . 10.2 tp -114.55 -39.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.912 0.387 . . . . 0.0 111.464 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.709 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -141.64 -59.25 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . 0.41 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.2 p -62.8 -37.05 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.431 0.634 . . . . 0.0 109.595 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.56 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 54.2 m -118.04 -17.83 9.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.992 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.543 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.03 -56.82 2.8 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.768 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 665' ' ' VAL . 40.8 t -82.41 -60.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.096 0.474 . . . . 0.0 111.123 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 666' ' ' ILE . 24.9 t -43.2 -31.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.677 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 659' ' ' THR . 5.3 tt -72.9 -34.18 45.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.946 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.47 -24.88 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.472 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 661' ' ' VAL . 1.4 t -84.03 -45.63 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.374 0.607 . . . . 0.0 110.016 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 670' ' ' ALA . 19.0 mm -65.49 -34.81 72.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.337 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.7 -34.56 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.039 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . 0.526 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.4 tp -84.75 -63.02 1.41 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.963 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -52.66 -25.19 10.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.736 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -71.25 -25.16 62.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.114 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 668' ' ' LEU . 8.5 mt -82.95 -35.97 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.14 0.495 . . . . 0.0 110.999 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.47 78.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.469 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 -17.9 26.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 14.8 t80 -90.99 -34.05 15.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.228 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.2 t -95.82 -10.1 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.485 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.6 m-85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.774 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.48 -40.96 28.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.609 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.6 t0 -140.23 -92.99 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.83 0.347 . . . . 0.0 111.369 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -39.9 89.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.34 -24.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.284 0.564 . . . . 0.0 111.89 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 175.24 -53.42 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.995 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.703 ' N ' HD13 ' A' ' 635' ' ' LEU . 35.3 Cg_exo -55.05 -24.11 38.65 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.686 1.59 . . . . 0.0 110.53 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.609 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.6 p-10 24.86 55.25 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.584 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 42.87 77.99 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.546 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -132.48 -46.16 0.12 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.418 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.12 77.77 1.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.344 . . . . 0.0 110.767 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.66 86.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.921 ' O ' HG22 ' A' ' 646' ' ' THR . 1.2 t0 -80.61 -19.92 44.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.218 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -53.98 -23.9 14.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.542 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -50.92 -28.25 9.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.202 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -144.07 19.0 1.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.268 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.921 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.7 t -156.83 25.53 0.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.824 0.345 . . . . 0.0 111.173 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.45 -93.19 0.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.277 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -76.52 -31.88 57.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 110.664 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -86.4 -12.08 50.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.561 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 656' ' ' ILE . 50.6 tt0 -64.72 -13.78 55.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.627 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.558 ' HA ' HG22 ' A' ' 656' ' ' ILE . 35.7 p-90 -163.65 44.61 0.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.754 0.312 . . . . 0.0 111.146 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.615 HG22 ' HD3' ' A' ' 653' ' ' PRO . 2.7 tt -89.51 -31.73 0.37 Allowed Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.615 ' HD3' HG22 ' A' ' 652' ' ' ILE . 52.9 Cg_endo -92.32 -4.65 3.61 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.425 2.083 . . . . 0.0 112.904 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 74.62 89.49 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.957 0.408 . . . . 0.0 110.633 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.94 47.66 1.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.462 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.558 HG22 ' HA ' ' A' ' 651' ' ' TRP . 8.4 tp -114.58 -39.75 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.785 0.326 . . . . 0.0 111.725 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.701 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -140.46 -61.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.505 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.24 -36.13 70.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.368 0.604 . . . . 0.0 109.679 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.507 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 54.8 m -118.85 -19.1 8.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.157 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.2 -52.95 3.83 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.944 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.779 ' O ' HG12 ' A' ' 665' ' ' VAL . 57.6 t -82.57 -60.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.135 0.493 . . . . 0.0 110.979 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.498 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 42.2 t -42.03 -31.78 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.572 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.6 OUTLIER -79.02 -36.46 18.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.712 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.53 -27.05 34.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.571 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.0 p -84.65 -34.4 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.152 0.501 . . . . 0.0 110.397 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.452 HD12 ' CG1' ' A' ' 662' ' ' VAL . 39.0 mt -80.29 -37.99 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.285 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.45 -33.3 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.287 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.69 -63.05 1.4 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.029 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -54.08 -24.57 17.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.578 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -73.07 -21.91 60.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.019 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 667' ' ' ALA . 4.9 mt -77.84 -55.33 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 121.322 0.582 . . . . 0.0 110.729 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . 0.449 ' HA ' ' HE1' ' A' ' 676' ' ' PHE . . . -46.82 -62.6 1.32 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.986 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -22.5 11.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.206 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -70.03 -51.08 35.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.061 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.08 -43.66 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.073 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.449 ' HE1' ' HA ' ' A' ' 672' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.825 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.35 -39.9 6.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.721 0.296 . . . . 0.0 110.95 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.654 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 23.1 t70 -139.8 -98.85 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.399 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -53.42 -42.06 66.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.312 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.94 -20.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.686 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 173.17 -53.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.975 179.242 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.686 ' N ' HD13 ' A' ' 635' ' ' LEU . 39.5 Cg_exo -55.82 -23.51 42.38 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.706 1.604 . . . . 0.0 110.461 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.654 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.8 p-10 25.54 48.32 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.577 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 637' ' ' ASP . 0.2 OUTLIER 35.32 90.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.039 179.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -168.12 -52.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.452 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.62 -37.31 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.0 110.801 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.64 94.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.866 ' O ' HG22 ' A' ' 646' ' ' THR . 8.6 t70 -90.58 9.72 28.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.06 -20.43 53.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.457 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -49.26 -35.13 16.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.134 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -133.71 9.13 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.537 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 642' ' ' ASP . 3.0 t -145.12 23.46 1.51 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.796 0.331 . . . . 0.0 111.072 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -131.62 -100.41 0.81 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.146 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -73.47 -27.29 61.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.735 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 30.1 ttm-85 -86.27 -11.94 50.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.435 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . 0.453 ' O ' HG23 ' A' ' 656' ' ' ILE . 3.8 tt0 -72.09 -9.87 59.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.317 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.538 ' HA ' HG22 ' A' ' 656' ' ' ILE . 0.1 OUTLIER -165.08 47.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.336 -179.367 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.642 HG22 ' HD3' ' A' ' 653' ' ' PRO . 1.7 tp -92.31 -31.86 0.33 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.642 ' HD3' HG22 ' A' ' 652' ' ' ILE . 57.5 Cg_endo -91.31 -7.41 3.56 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.386 2.058 . . . . 0.0 113.078 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 75.19 92.94 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.01 0.434 . . . . 0.0 110.363 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.565 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.38 42.01 1.96 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.272 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.959 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.1 tp -114.5 -39.46 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 111.543 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 662' ' ' VAL . . . -128.83 -57.81 0.11 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.917 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . 0.419 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.9 p -63.11 -39.82 86.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.282 0.563 . . . . 0.0 110.213 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.565 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 13.6 m -119.4 -18.42 8.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.138 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.474 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.27 -58.71 2.39 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.649 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.959 HG23 ' O ' ' A' ' 656' ' ' ILE . 92.7 t -82.28 -61.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.173 0.511 . . . . 0.0 110.998 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.597 ' HA ' HG22 ' A' ' 665' ' ' VAL . 40.1 t -41.81 -31.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.751 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.4 tt -77.09 -38.43 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.305 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.17 36.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.34 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 662' ' ' VAL . 10.9 m -84.43 -44.29 17.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.269 0.557 . . . . 0.0 110.331 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.479 ' N ' HG23 ' A' ' 665' ' ' VAL . 37.4 mt -66.83 -36.4 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.371 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.75 -35.5 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.955 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . 0.538 ' HA ' HD12 ' A' ' 671' ' ' ILE . 3.2 tp -84.87 -63.01 1.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.88 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . 0.432 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -52.16 -26.31 11.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.665 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 666' ' ' ILE . . . -70.92 -21.96 62.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.181 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 668' ' ' LEU . 9.7 mt -86.07 -38.54 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.129 0.49 . . . . 0.0 111.041 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -58.99 -31.09 68.47 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.753 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.01 -17.83 27.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.839 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.1 OUTLIER -92.45 -34.23 14.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.166 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.505 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 40.8 t -94.62 -10.5 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.514 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.6 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.799 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.71 -43.2 8.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.685 0.279 . . . . 0.0 110.93 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.622 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 9.1 t0 -139.63 -93.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.9 0.381 . . . . 0.0 111.353 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.29 -41.18 79.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.012 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.31 -21.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.126 0.489 . . . . 0.0 112.2 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.579 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 177.47 -58.57 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.366 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.515 ' N ' HD13 ' A' ' 635' ' ' LEU . 9.4 Cg_endo -56.53 -20.22 32.74 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.792 1.661 . . . . 0.0 110.76 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.622 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.0 p-10 27.0 50.16 0.02 OUTLIER 'General case' 0 C--O 1.23 0.072 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.564 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . 0.449 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 4.0 pt20 43.97 98.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.821 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -170.8 -51.89 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.661 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.37 -37.22 14.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.347 . . . . 0.0 111.013 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -170.43 94.41 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.949 ' O ' HG22 ' A' ' 646' ' ' THR . 4.8 p-10 -99.59 -34.73 10.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.723 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -51.09 -24.62 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.846 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -48.68 -27.53 2.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.819 0.342 . . . . 0.0 111.191 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -150.71 24.51 0.77 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.949 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.8 t -162.19 28.71 0.11 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.772 0.32 . . . . 0.0 111.193 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -151.19 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.328 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.418 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 59.6 p-90 -73.33 -21.54 60.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.788 0.328 . . . . 0.0 110.832 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . 0.418 ' HG3' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -86.21 -11.94 51.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.654 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . 0.491 ' O ' HG23 ' A' ' 656' ' ' ILE . 1.8 mm100 -68.91 -7.54 35.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.867 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.58 ' HA ' HG22 ' A' ' 656' ' ' ILE . 9.2 p-90 -166.92 41.39 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.71 0.291 . . . . 0.0 111.174 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.63 HG22 ' HD3' ' A' ' 653' ' ' PRO . 2.5 tp -89.63 -31.72 0.37 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.63 ' HD3' HG22 ' A' ' 652' ' ' ILE . 60.3 Cg_endo -91.65 -6.4 3.63 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.427 2.084 . . . . 0.0 112.856 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 74.98 91.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.99 0.424 . . . . 0.0 110.483 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.482 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.13 45.23 1.5 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.227 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 651' ' ' TRP . 9.4 tp -114.53 -39.51 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.669 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -135.23 -62.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.789 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.89 -38.21 75.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.321 0.582 . . . . 0.0 109.818 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.539 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 43.5 m -118.22 -19.37 9.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.233 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.18 -47.88 5.94 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.682 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.803 ' O ' HG12 ' A' ' 665' ' ' VAL . 74.1 t -82.52 -60.23 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 110.439 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.54 HG12 HD12 ' A' ' 666' ' ' ILE . 78.0 t -42.07 -31.76 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.307 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.628 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 5.2 tt -80.96 -34.51 13.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.616 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.59 -27.49 34.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.42 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.803 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.7 p -84.44 -35.09 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.224 0.535 . . . . 0.0 110.13 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.54 HD12 HG12 ' A' ' 662' ' ' VAL . 51.2 mt -79.6 -36.69 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.831 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.98 -32.93 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.398 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.8 tp -84.58 -62.96 1.42 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . 0.404 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 2.2 t80 -53.4 -25.42 15.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.474 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.426 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.03 -23.93 63.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.138 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 17.9 mt -85.1 -40.53 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.097 0.475 . . . . 0.0 110.952 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -56.68 -32.17 65.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.818 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.97 -17.92 27.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.922 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -92.17 -32.89 14.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.208 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.3 t -97.2 -10.9 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.489 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.495 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.837 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.431 ' HA2' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . 0.446 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -127.89 -51.86 1.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.568 0.223 . . . . 0.0 111.001 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.559 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 9.9 t0 -132.04 -95.64 0.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.464 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -38.23 69.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.407 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.06 -26.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.238 0.542 . . . . 0.0 112.253 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.566 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 178.04 -58.75 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.436 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.508 ' N ' HD13 ' A' ' 635' ' ' LEU . 11.1 Cg_endo -57.81 -20.15 42.23 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.752 1.634 . . . . 0.0 110.649 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.0 p-10 33.48 36.97 0.01 OUTLIER 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.392 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 53.14 87.7 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.174 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -152.1 -46.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.404 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.45 -31.38 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 2.4 m120 -159.13 83.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.894 ' O ' HG22 ' A' ' 646' ' ' THR . 7.8 p-10 -95.24 -26.89 15.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.04 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . 0.404 ' CB ' ' HA3' ' A' ' 647' ' ' GLY . 29.9 p-10 -65.29 -20.64 66.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.009 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 1.4 p-90 -48.44 -27.93 2.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.628 0.251 . . . . 0.0 111.421 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.04 27.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.637 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.894 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.9 t -175.03 32.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.444 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 643' ' ' ASN . . . -137.92 -88.57 0.2 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.594 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.472 ' CE2' ' HG3' ' A' ' 649' ' ' ARG . 50.2 p-90 -69.86 -29.54 66.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 0.0 111.154 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . 0.472 ' HG3' ' CE2' ' A' ' 648' ' ' TRP . 2.6 mtp-105 -86.43 -16.26 37.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 0.0 110.362 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -65.82 -24.13 66.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.085 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.624 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.4 p-90 -160.74 56.72 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.133 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.685 HG22 ' HD3' ' A' ' 653' ' ' PRO . 9.5 tp -81.98 -32.61 0.61 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.685 ' HD3' HG22 ' A' ' 652' ' ' ILE . 62.9 Cg_endo -96.03 -5.27 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.715 2.277 . . . . 0.0 112.875 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 75.61 89.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.003 0.43 . . . . 0.0 110.465 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.518 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.05 48.44 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.351 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.827 ' O ' HG23 ' A' ' 661' ' ' VAL . 10.4 tp -114.48 -39.77 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 656' ' ' ILE . . . -132.6 -59.43 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.939 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . 0.402 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.5 p -61.68 -38.69 80.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.26 0.552 . . . . 0.0 110.012 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.52 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 29.9 m -119.91 -18.46 8.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.214 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.32 -55.26 3.11 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.673 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 656' ' ' ILE . 93.8 t -82.51 -60.73 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.109 0.48 . . . . 0.0 111.011 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.547 ' HA ' HG22 ' A' ' 665' ' ' VAL . 38.3 t -42.44 -32.41 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.609 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.6 tp -76.14 -37.27 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.64 -24.38 36.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.134 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 661' ' ' VAL . 2.7 m -84.25 -41.98 16.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.335 0.588 . . . . 0.0 110.297 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.449 HD12 HG12 ' A' ' 662' ' ' VAL . 43.4 mt -70.83 -36.63 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.321 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -39.94 -34.86 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.183 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 671' ' ' ILE . 3.0 tp -84.74 -63.15 1.38 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.887 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . 0.429 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.2 OUTLIER -52.51 -25.59 10.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.675 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -71.92 -24.57 61.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.045 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 668' ' ' LEU . 11.6 mt -85.99 -37.85 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.117 0.484 . . . . 0.0 110.883 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -57.62 -32.43 67.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.652 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.88 -17.96 27.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.742 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.2 OUTLIER -89.25 -34.89 16.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 41.0 t -97.15 -15.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.406 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.497 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.733 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.27 -43.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.619 0.247 . . . . 0.0 111.005 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.614 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 67.2 t0 -137.86 -105.07 0.19 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.374 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -46.06 -44.06 15.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 0.0 111.547 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.8 -26.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.374 0.607 . . . . 0.0 112.049 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.694 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 174.35 -52.99 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.835 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.694 ' N ' HD13 ' A' ' 635' ' ' LEU . 37.4 Cg_exo -56.06 -23.86 46.19 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.682 1.588 . . . . 0.0 110.363 178.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.614 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.9 p-10 31.45 40.01 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.314 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 16.1 pt20 42.98 69.25 0.41 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.515 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -131.9 -57.03 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.422 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.7 -28.92 19.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.361 . . . . 0.0 110.862 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 0.6 OUTLIER -159.43 93.58 1.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.83 179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.937 ' O ' HG22 ' A' ' 646' ' ' THR . 5.6 p-10 -102.57 -36.96 8.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -54.19 -22.54 11.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.592 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 7.4 p-90 -48.56 -28.22 3.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.788 0.327 . . . . 0.0 111.18 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -149.18 23.25 0.94 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.264 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.937 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.2 t -160.35 27.18 0.16 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.698 0.285 . . . . 0.0 111.264 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -150.36 -85.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.517 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.464 ' O ' HG13 ' A' ' 652' ' ' ILE . 69.3 p-90 -79.43 -21.27 45.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.62 0.248 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . 0.527 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 2.6 ttt85 -86.34 -15.8 39.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.063 0.458 . . . . 0.0 110.346 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . 0.56 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.1 OUTLIER -72.46 -16.59 61.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.37 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.453 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.9 p-90 -162.7 54.86 0.21 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.693 0.282 . . . . 0.0 111.258 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.609 HD12 ' HD3' ' A' ' 653' ' ' PRO . 0.3 OUTLIER -69.63 -51.32 16.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 110.809 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.609 ' HD3' HD12 ' A' ' 652' ' ' ILE . 32.1 Cg_endo -95.13 -80.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.456 2.771 . . . . 0.0 112.628 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 170.35 105.94 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.722 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.79 35.44 3.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.612 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 650' ' ' GLN . 0.6 OUTLIER -114.15 -39.58 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 0.0 111.454 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.823 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -137.82 -58.09 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 4.6 p -64.59 -39.25 84.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.303 0.573 . . . . 0.0 109.638 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.537 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 20.5 m -115.08 -17.37 11.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.852 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.499 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -81.92 -46.18 6.81 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.53 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.823 HG23 ' HA2' ' A' ' 657' ' ' GLY . 99.5 t -82.6 -60.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.26 0.553 . . . . 0.0 110.448 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.529 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 53.8 t -42.0 -31.65 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.56 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.7 OUTLIER -79.66 -34.09 15.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.748 -179.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.48 -27.36 34.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.164 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.5 p -84.55 -36.0 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.131 0.491 . . . . 0.0 110.156 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.517 HD12 HG12 ' A' ' 662' ' ' VAL . 39.4 mt -78.91 -37.02 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.022 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.38 -32.96 0.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.481 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . 0.627 ' HA ' HD12 ' A' ' 671' ' ' ILE . 2.9 tp -84.6 -63.13 1.39 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.803 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -24.51 15.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 110.508 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.7 -22.47 62.45 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 668' ' ' LEU . 6.8 mt -81.59 -51.9 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.172 0.511 . . . . 0.0 110.975 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -48.95 -33.4 10.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.699 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -17.9 27.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.523 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 12.1 t80 -96.35 -31.16 13.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.738 0.304 . . . . 0.0 111.385 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 675' ' ' VAL . 41.1 t -94.66 -1.19 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.381 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.467 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 2.4 m-85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.801 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 637' ' ' ASP . 42.5 t 61.54 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.491 0.186 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.627 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 38.8 t70 -122.51 -99.76 0.42 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.745 0.307 . . . . 0.0 111.235 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -45.15 80.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.269 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.2 -24.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.133 0.492 . . . . 0.0 112.31 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.57 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 177.03 -58.66 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.425 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.509 ' N ' HD13 ' A' ' 635' ' ' LEU . 9.2 Cg_endo -56.56 -20.53 34.28 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.775 1.65 . . . . 0.0 110.864 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.627 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.9 p-10 31.24 39.87 0.01 OUTLIER 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.38 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 52.95 97.96 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.189 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -171.68 -40.8 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.452 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -83.34 -34.79 25.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -168.01 47.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.923 ' O ' HG22 ' A' ' 646' ' ' THR . 32.2 p-10 -51.16 -27.18 8.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.255 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -52.18 -20.56 2.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.94 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 -48.36 -28.85 3.44 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.786 0.327 . . . . 0.0 111.269 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.58 22.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.239 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.923 HG22 ' O ' ' A' ' 642' ' ' ASP . 11.0 t -156.97 25.36 0.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.108 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.78 -111.97 0.89 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.235 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.414 ' O ' HG13 ' A' ' 652' ' ' ILE . 69.7 p-90 -60.4 -21.52 62.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.709 0.29 . . . . 0.0 110.926 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . 0.462 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 39.2 ttt85 -86.55 -19.13 29.9 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.33 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . 0.502 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.0 OUTLIER -70.09 -26.97 64.23 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.861 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.575 ' HA ' HG22 ' A' ' 656' ' ' ILE . 5.0 p-90 -153.29 58.9 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.083 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.491 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 1.9 mt -63.07 -47.56 85.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.698 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 29.5 Cg_endo -95.42 -76.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.458 2.772 . . . . 0.0 112.548 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 165.68 95.6 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.473 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.539 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.67 42.92 1.9 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.337 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.575 HG22 ' HA ' ' A' ' 651' ' ' TRP . 10.3 tp -114.27 -39.55 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.821 0.344 . . . . 0.0 111.465 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.738 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -135.23 -56.59 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' A' ' 651' ' ' TRP . 8.0 p -63.47 -42.72 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.345 0.593 . . . . 0.0 109.757 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.539 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 20.4 m -114.86 -16.96 11.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.867 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.24 -46.6 6.48 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.64 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.828 ' O ' HG12 ' A' ' 665' ' ' VAL . 67.7 t -82.82 -59.12 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.108 0.48 . . . . 0.0 110.345 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.544 HG12 HD12 ' A' ' 666' ' ' ILE . 74.6 t -42.56 -32.33 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.078 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.687 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.5 OUTLIER -81.3 -34.37 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.566 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.51 -27.07 34.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.298 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.1 p -84.44 -34.71 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.215 0.531 . . . . 0.0 110.076 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.544 HD12 HG12 ' A' ' 662' ' ' VAL . 61.3 mt -81.61 -36.66 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.086 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.83 -32.2 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.413 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.57 -62.79 1.47 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.74 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -24.66 15.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.022 0.439 . . . . 0.0 110.388 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -73.65 -21.94 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.149 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 667' ' ' ALA . 6.8 mt -75.37 -55.58 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 121.289 0.566 . . . . 0.0 111.012 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . 0.438 ' HA ' ' CE1' ' A' ' 676' ' ' PHE . . . -47.52 -62.62 1.35 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.795 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -21.94 18.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.154 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 11.8 t80 -65.5 -48.3 73.02 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.98 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . . . . . . . . . 20.7 t -101.7 -42.29 9.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 672' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.428 ' N ' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 637' ' ' ASP . 1.1 t -107.54 -40.85 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.631 0.253 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 637' ' ' ASP . 1.1 m-20 -136.29 -99.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.86 0.362 . . . . 0.0 111.436 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -49.56 -44.37 46.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.509 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.9 -19.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.564 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.1 tm? 177.32 -58.89 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.384 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.518 ' N ' HD13 ' A' ' 635' ' ' LEU . 10.3 Cg_endo -57.12 -20.72 39.13 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.754 1.636 . . . . 0.0 110.617 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 632' ' ' ASP . 1.7 p-10 28.58 42.48 0.01 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.452 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 12.4 pt20 43.46 74.13 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.525 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -140.94 -55.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.463 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -93.96 -29.93 15.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.957 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.64 101.32 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.919 ' O ' HG22 ' A' ' 646' ' ' THR . 2.8 p30 -102.24 -33.92 9.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -52.89 -22.45 5.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.725 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -48.54 -28.05 3.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.714 0.292 . . . . 0.0 111.332 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -149.14 20.21 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.275 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.919 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.7 t -155.7 25.88 0.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 111.131 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -140.91 -98.55 0.35 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.24 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -66.61 -28.49 68.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -86.32 -12.08 50.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.509 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.2 OUTLIER -67.2 -12.88 61.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.484 -179.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.606 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.6 p-90 -164.79 45.66 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.78 0.324 . . . . 0.0 111.193 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.633 HG22 ' HD3' ' A' ' 653' ' ' PRO . 4.3 tt -88.9 -31.78 0.38 Allowed Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.633 ' HD3' HG22 ' A' ' 652' ' ' ILE . 56.5 Cg_endo -92.6 -6.18 3.13 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.438 2.092 . . . . 0.0 112.983 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 75.74 91.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.97 0.414 . . . . 0.0 110.461 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.18 45.0 1.52 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.463 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.9 tp -114.58 -39.43 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.494 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -132.92 -59.28 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.776 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . 0.405 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.5 p -61.73 -38.91 81.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.283 0.563 . . . . 0.0 109.975 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.56 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 24.2 m -119.44 -18.37 8.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.108 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.559 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.24 -53.31 3.7 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.605 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.82 ' O ' HG23 ' A' ' 665' ' ' VAL . 83.9 t -82.55 -60.87 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.074 0.464 . . . . 0.0 111.036 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.514 HG12 HD12 ' A' ' 666' ' ' ILE . 25.6 t -43.38 -31.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.656 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.5 tp -73.9 -34.47 39.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.992 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.64 -23.5 36.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.668 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 661' ' ' VAL . 1.8 t -83.8 -46.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.391 0.615 . . . . 0.0 109.917 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.514 HD12 HG12 ' A' ' 662' ' ' VAL . 60.6 mt -66.97 -35.06 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.186 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . 0.443 ' O ' HG12 ' A' ' 671' ' ' ILE . . . -41.59 -34.12 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.117 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.5 tp -84.81 -63.0 1.41 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.82 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -52.26 -26.35 11.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.595 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.412 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -69.33 -21.94 63.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.087 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 667' ' ' ALA . 20.5 mm -84.55 -40.31 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.104 0.478 . . . . 0.0 111.148 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.19 -31.75 69.3 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.808 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.88 -17.95 27.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.79 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -92.0 -34.28 14.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 44.0 t -94.39 -13.11 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.356 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.495 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.772 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.5 m -91.38 -48.87 6.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.675 0.274 . . . . 0.0 110.824 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.585 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 11.1 t70 -139.23 -95.17 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.354 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -57.58 -39.65 77.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.189 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.89 -25.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.342 0.591 . . . . 0.0 111.884 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 174.78 -53.47 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.858 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.696 ' N ' HD13 ' A' ' 635' ' ' LEU . 38.0 Cg_exo -55.51 -24.02 42.18 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.691 1.594 . . . . 0.0 110.423 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.1 p-10 26.89 47.16 0.01 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.479 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . 0.407 ' NE2' HG21 ' A' ' 646' ' ' THR . 7.5 mt-30 50.67 57.46 6.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.132 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -121.58 -44.4 0.38 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.411 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.92 74.96 2.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 110.734 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 60.74 82.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.931 ' O ' HG22 ' A' ' 646' ' ' THR . 1.2 p30 -59.27 -24.99 63.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -55.65 -19.66 11.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.782 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -48.48 -28.3 3.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.73 0.3 . . . . 0.0 111.294 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.8 20.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.314 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.931 HG22 ' O ' ' A' ' 642' ' ' ASP . 7.4 t -157.29 26.24 0.3 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 111.126 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -142.54 -90.69 0.14 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.343 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.416 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 68.1 p-90 -71.92 -22.02 61.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.667 0.27 . . . . 0.0 110.999 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . 0.416 ' HG3' ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -86.17 -12.02 50.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.907 0.384 . . . . 0.0 110.474 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -15.06 62.46 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.201 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.599 ' HA ' HG22 ' A' ' 656' ' ' ILE . 0.6 OUTLIER -168.49 52.36 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.188 -179.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.628 HG22 ' HD3' ' A' ' 653' ' ' PRO . 4.2 tp -89.86 -31.9 0.37 Allowed Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.628 ' HD3' HG22 ' A' ' 652' ' ' ILE . 57.7 Cg_endo -91.84 -8.03 3.09 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.377 2.051 . . . . 0.0 112.976 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 76.06 92.51 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.953 0.406 . . . . 0.0 110.363 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.469 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.29 43.07 1.79 Allowed Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.249 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 661' ' ' VAL . 10.2 tp -114.5 -39.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.32 . . . . 0.0 111.525 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.567 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -136.08 -57.37 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.668 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.92 -38.12 81.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.275 0.56 . . . . 0.0 109.805 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 16.7 m -120.04 -18.33 8.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.018 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.474 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.14 -52.79 3.9 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.726 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.807 ' O ' HG12 ' A' ' 665' ' ' VAL . 86.5 t -82.64 -59.63 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.146 0.498 . . . . 0.0 110.768 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.495 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 44.6 t -42.54 -31.64 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.383 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.668 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.2 OUTLIER -79.52 -36.0 17.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.71 -179.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.66 -27.01 34.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.807 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.0 p -84.76 -35.34 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.228 0.537 . . . . 0.0 110.336 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 26.9 mm -81.14 -37.86 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.284 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.27 -32.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.35 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.9 tp -84.69 -63.14 1.39 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.36 -25.79 16.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.051 0.453 . . . . 0.0 110.396 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -68.35 -21.87 64.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.037 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 667' ' ' ALA . 16.8 mm -84.73 -41.21 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.177 0.513 . . . . 0.0 111.214 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -58.61 -32.15 68.74 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.461 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.96 -17.87 27.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.974 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -94.21 -32.5 13.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.274 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 675' ' ' VAL . 46.1 t -94.83 -4.66 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.42 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.494 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 2.4 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.837 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 631' ' ' SER . . . . . 0.441 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -117.88 -48.62 2.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.66 0.267 . . . . 0.0 110.899 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . 0.625 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 65.3 t0 -136.39 -93.79 0.24 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.857 0.36 . . . . 0.0 111.316 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -37.81 70.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.148 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.09 -27.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.414 0.626 . . . . 0.0 111.77 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.677 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 178.26 -54.27 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.904 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 636' ' ' PRO . . . . . 0.677 ' N ' HD13 ' A' ' 635' ' ' LEU . 39.5 Cg_exo -56.03 -23.95 46.38 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 121.586 1.524 . . . . 0.0 110.371 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 637' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.2 p-10 30.33 40.58 0.01 OUTLIER 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.552 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 637' ' ' ASP . 2.9 pt20 36.35 73.82 0.08 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.054 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -162.77 -46.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.727 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.88 -38.54 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 111.103 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -153.33 46.32 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 642' ' ' ASP . . . . . 0.947 ' O ' HG22 ' A' ' 646' ' ' THR . 17.4 p-10 -64.78 -32.34 73.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -50.25 -25.58 3.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.725 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -48.71 -27.86 3.19 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.788 0.328 . . . . 0.0 111.272 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -148.86 22.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.323 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 646' ' ' THR . . . . . 0.947 HG22 ' O ' ' A' ' 642' ' ' ASP . 12.4 t -159.25 26.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 647' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 651' ' ' TRP . . . -143.51 -95.6 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.293 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.432 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 65.3 p-90 -65.07 -21.51 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.841 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 649' ' ' ARG . . . . . 0.615 ' HA ' HG12 ' A' ' 652' ' ' ILE . 19.9 mtp85 -86.61 -19.32 29.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.241 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 650' ' ' GLN . . . . . 0.402 ' HG3' ' HA ' ' A' ' 646' ' ' THR . 0.5 OUTLIER -69.55 -12.83 61.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.68 -179.357 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 651' ' ' TRP . . . . . 0.522 ' HA ' HG22 ' A' ' 656' ' ' ILE . 2.3 p-90 -154.45 46.75 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.763 0.316 . . . . 0.0 111.136 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 652' ' ' ILE . . . . . 0.615 HG12 ' HA ' ' A' ' 649' ' ' ARG . 0.0 OUTLIER -71.55 -61.85 1.95 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.849 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 653' ' ' PRO . . . . . 0.522 ' O ' ' HB3' ' A' ' 654' ' ' ALA . 64.8 Cg_endo -73.82 -2.39 12.16 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.739 2.293 . . . . 0.0 113.016 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 654' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 72.87 91.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.963 0.411 . . . . 0.0 110.405 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . 0.436 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.01 49.15 1.1 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.077 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 656' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 651' ' ' TRP . 9.8 tp -114.51 -39.74 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.779 0.323 . . . . 0.0 111.733 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 657' ' ' GLY . . . . . 0.698 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -139.68 -61.33 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.591 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 658' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' A' ' 651' ' ' TRP . 1.9 p -62.33 -36.84 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.418 0.628 . . . . 0.0 109.656 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 659' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 47.0 m -117.75 -17.97 9.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.084 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 660' ' ' GLY . . . . . 0.498 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.28 -57.32 2.66 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.977 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.698 HG23 ' HA2' ' A' ' 657' ' ' GLY . 40.7 t -82.19 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.201 0.524 . . . . 0.0 111.144 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.601 ' HA ' HG22 ' A' ' 665' ' ' VAL . 24.4 t -43.13 -31.14 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.775 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.6 tt -75.19 -36.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.122 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 664' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.68 -24.81 36.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.115 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 665' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 661' ' ' VAL . 2.4 m -84.41 -41.17 15.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.32 0.581 . . . . 0.0 110.279 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 666' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 670' ' ' ALA . 18.5 mm -70.3 -36.51 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.362 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.31 -34.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.146 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.3 tp -84.77 -63.01 1.41 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.863 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 669' ' ' PHE . . . . . 0.428 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 34.7 t80 -52.78 -25.94 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 670' ' ' ALA . . . . . 0.437 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.81 -24.28 62.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.182 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 668' ' ' LEU . 10.3 mt -85.55 -33.24 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.124 0.488 . . . . 0.0 110.915 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -62.86 -33.81 76.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.379 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 673' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.13 -17.76 27.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.743 179.415 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 674' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 5.1 t80 -91.69 -33.98 14.83 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.069 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 675' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.9 t -94.82 -12.05 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.309 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 676' ' ' PHE . . . . . 0.496 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.815 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.45 ' N ' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . 0.429 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -102.85 -48.51 4.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.688 0.28 . . . . 0.0 110.875 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.606 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 12.4 t70 -136.3 -96.85 0.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.861 0.362 . . . . 0.0 111.32 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.62 -41.39 63.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.24 -22.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.148 0.499 . . . . 0.0 112.288 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.576 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.1 tm? 177.66 -58.56 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.281 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.513 ' N ' HD13 ' A' ' 635' ' ' LEU . 10.6 Cg_endo -57.64 -20.26 41.42 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.668 1.579 . . . . 0.0 110.585 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.606 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 1.9 p-10 30.52 40.64 0.01 OUTLIER 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.396 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 44.01 54.46 5.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.359 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -132.86 -46.18 0.12 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.4 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -99.52 -27.06 13.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 0.0 110.844 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 1.6 t-20 -148.05 69.74 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.93 ' O ' HG22 ' A' ' 646' ' ' THR . 11.1 p-10 -94.8 -27.47 15.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.048 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.6 -21.05 66.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.096 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . 0.429 ' HA ' ' CE2' ' A' ' 648' ' ' TRP . 1.2 p-90 -48.43 -29.59 4.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.773 0.32 . . . . 0.0 111.242 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -137.03 14.64 3.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.595 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.93 HG22 ' O ' ' A' ' 642' ' ' ASP . 3.6 t -156.57 24.76 0.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.715 0.293 . . . . 0.0 111.446 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -143.42 -90.52 0.13 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.307 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.444 ' O ' HG13 ' A' ' 652' ' ' ILE . 37.9 p-90 -73.0 -20.9 60.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.614 0.245 . . . . 0.0 111.043 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . 0.486 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 4.0 ttt-85 -85.79 -15.44 42.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 110.284 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -24.4 63.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.789 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.712 ' HA ' HG22 ' A' ' 656' ' ' ILE . 6.0 p-90 -159.18 59.06 0.41 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.498 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 0.5 OUTLIER -65.45 -47.88 67.96 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.8 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.561 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 41.1 Cg_endo -89.02 -76.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.975 2.45 . . . . 0.0 112.732 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.95 88.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.666 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.53 47.71 1.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.552 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.735 ' O ' HG23 ' A' ' 661' ' ' VAL . 10.2 tp -114.48 -33.86 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.327 . . . . 0.0 111.187 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.429 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -131.37 -48.04 0.12 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.737 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . 0.48 HG13 ' N ' ' A' ' 659' ' ' THR . 10.7 p -69.54 -43.29 80.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.246 0.546 . . . . 0.0 109.892 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.666 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 22.3 m -118.6 -15.85 9.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.677 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.518 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.4 -51.05 4.51 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.345 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 656' ' ' ILE . 43.1 t -82.62 -61.72 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 110.775 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.588 ' HA ' HG22 ' A' ' 665' ' ' VAL . 40.0 t -41.79 -33.28 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.591 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.3 tt -75.98 -37.54 34.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.545 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.49 -24.95 36.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.173 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 662' ' ' VAL . 5.2 m -84.51 -43.41 17.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.313 0.577 . . . . 0.0 110.478 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.453 ' N ' HG23 ' A' ' 665' ' ' VAL . 18.9 mm -67.35 -36.71 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.565 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.22 -35.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.976 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . 0.514 ' HA ' HD12 ' A' ' 671' ' ' ILE . 3.4 tp -84.9 -63.03 1.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.873 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . 0.421 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -51.79 -26.89 10.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.755 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.407 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.07 -23.71 63.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.983 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 668' ' ' LEU . 11.4 mt -85.96 -35.35 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.158 0.504 . . . . 0.0 110.88 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 676' ' ' PHE . . . -61.11 -32.97 72.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.509 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.99 -17.9 27.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.566 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -88.59 -35.08 17.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 36.6 t -96.77 -19.21 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.354 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.48 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.848 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.6 OUTLIER -83.08 -44.15 15.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.631 0.253 . . . . 0.0 110.855 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.68 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 64.2 t0 -136.92 -97.91 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.405 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -42.96 63.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.469 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.32 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.555 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 178.9 -59.42 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.316 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.497 ' N ' HD13 ' A' ' 635' ' ' LEU . 15.0 Cg_endo -59.36 -20.13 54.45 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.702 1.601 . . . . 0.0 110.283 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.68 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 0.4 OUTLIER 36.31 -160.4 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.152 178.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -108.36 76.96 1.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.044 0.449 . . . . 0.0 111.027 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 179.48 -35.15 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.348 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.88 -29.28 23.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.752 0.311 . . . . 0.0 110.925 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.2 42.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.219 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.929 ' O ' HG22 ' A' ' 646' ' ' THR . 5.6 t0 -56.84 -22.37 36.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.145 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 648' ' ' TRP . 92.4 m-20 -52.99 -19.83 2.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.039 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . 0.425 ' HA ' ' CD ' ' A' ' 649' ' ' ARG . 25.9 p-90 -48.27 -28.32 3.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.908 0.385 . . . . 0.0 111.126 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.97 24.84 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.982 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.929 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.3 t -156.21 21.58 0.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.427 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -149.77 -124.92 1.31 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.848 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 643' ' ' ASN . 64.7 p-90 -61.89 -21.05 64.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.655 0.264 . . . . 0.0 111.445 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . 0.497 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 3.3 ttt180 -86.17 -15.93 39.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.876 0.369 . . . . 0.0 110.474 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . 0.459 ' O ' HG23 ' A' ' 656' ' ' ILE . 3.6 mt-30 -73.62 -14.64 61.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.509 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.568 ' HA ' HG22 ' A' ' 656' ' ' ILE . 2.3 p-90 -158.9 50.84 0.38 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.687 0.28 . . . . 0.0 111.503 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.497 ' CG1' ' HA ' ' A' ' 649' ' ' ARG . 0.7 OUTLIER -63.89 -48.61 78.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.357 . . . . 0.0 110.552 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 30.6 Cg_endo -94.46 -76.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.488 2.792 . . . . 0.0 112.485 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.31 96.1 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.624 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.525 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.59 42.3 2.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.323 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.1 tp -114.48 -39.6 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.706 0.289 . . . . 0.0 111.696 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 662' ' ' VAL . . . -134.06 -53.68 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.738 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 659' ' ' THR . 9.9 p -64.51 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.352 0.596 . . . . 0.0 109.843 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.525 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 23.3 m -119.68 -17.81 8.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.992 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.463 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.28 -51.57 4.34 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.623 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.802 ' O ' HG12 ' A' ' 665' ' ' VAL . 53.1 t -82.78 -59.65 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.093 0.473 . . . . 0.0 110.567 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 657' ' ' GLY . 62.0 t -42.19 -31.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.417 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.614 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 1.7 tp -80.85 -35.98 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.648 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.6 -26.86 34.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.498 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.802 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.1 p -84.69 -34.3 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 121.122 0.487 . . . . 0.0 110.356 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.451 HD12 HG12 ' A' ' 662' ' ' VAL . 45.8 mt -81.46 -38.32 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.267 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.13 -32.41 0.26 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.398 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . 0.563 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.0 OUTLIER -84.57 -63.17 1.38 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.97 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . 0.406 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 76.8 t80 -54.04 -25.96 24.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.06 0.457 . . . . 0.0 110.357 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.432 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -67.99 -22.08 65.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.932 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 668' ' ' LEU . 7.2 mt -85.5 -37.1 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.134 0.492 . . . . 0.0 111.051 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.3 -31.77 71.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.563 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.449 ' H ' ' HG3' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -90.02 -17.87 27.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.754 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -92.65 -34.17 14.09 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.155 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.492 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -94.15 -11.06 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.396 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.492 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.831 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.428 ' N ' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . 0.417 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.5 OUTLIER -119.59 -45.0 2.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.706 0.289 . . . . 0.0 110.889 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.612 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 18.8 t70 -137.99 -95.65 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.362 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -52.53 -42.14 64.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.189 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.52 -20.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.568 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.1 tm? 177.79 -58.93 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.364 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.517 ' N ' HD13 ' A' ' 635' ' ' LEU . 11.2 Cg_endo -58.03 -20.51 45.74 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.724 1.616 . . . . 0.0 110.544 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.612 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 1.4 p-10 30.24 39.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.6 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 636' ' ' PRO . 9.0 mt-30 51.5 98.78 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.163 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -170.12 -40.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.337 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -80.85 -39.96 25.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 110.731 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -178.78 92.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.921 ' O ' HG22 ' A' ' 646' ' ' THR . 4.2 m-20 -70.51 -19.09 62.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -53.88 -20.3 5.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.098 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -48.31 -28.89 3.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.791 0.329 . . . . 0.0 111.163 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -147.62 20.82 1.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.207 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.921 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.9 t -155.6 24.91 0.4 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.771 0.32 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -151.82 -79.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.655 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.425 ' O ' HG13 ' A' ' 652' ' ' ILE . 65.1 p-90 -86.13 -21.46 27.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.587 0.232 . . . . 0.0 111.287 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . 0.479 ' HG2' HD11 ' A' ' 652' ' ' ILE . 1.3 ttp85 -86.44 -15.75 39.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.317 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -71.22 -18.23 62.47 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.177 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.835 ' HA ' HG22 ' A' ' 656' ' ' ILE . 12.0 p-90 -167.54 59.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.591 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.59 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 2.1 mt -60.33 -54.88 50.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.771 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 37.5 Cg_endo -69.13 -64.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.265 1.977 . . . . 0.0 112.378 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 168.39 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.494 0.664 . . . . 0.0 110.281 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.877 ' HA2' HG12 ' A' ' 658' ' ' VAL . . . 103.64 38.35 2.8 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.705 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.835 HG22 ' HA ' ' A' ' 651' ' ' TRP . 0.4 OUTLIER -73.5 -17.68 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.245 0.545 . . . . 0.0 110.515 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.659 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -106.52 -35.39 2.87 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . 0.877 HG12 ' HA2' ' A' ' 655' ' ' GLY . 13.9 p -82.29 -31.65 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.254 -0.473 . . . . 0.0 110.6 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.575 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 70.9 m -123.47 -20.26 5.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.755 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.2 -44.54 7.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.908 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 665' ' ' VAL . 96.5 t -82.62 -62.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.205 0.526 . . . . 0.0 110.413 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.518 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 44.0 t -42.05 -32.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.543 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.3 OUTLIER -79.27 -34.87 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.689 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.0 -27.23 35.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.285 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.8 p -84.64 -33.98 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 121.285 0.565 . . . . 0.0 110.154 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 670' ' ' ALA . 25.4 mm -82.84 -37.97 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.341 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.13 -32.65 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.342 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.4 tp -84.53 -63.1 1.4 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.821 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . 0.411 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 1.4 t80 -53.86 -25.2 18.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.516 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.439 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -69.08 -22.65 63.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 16.1 mt -86.01 -36.3 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.113 0.482 . . . . 0.0 111.082 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.16 73.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.543 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.0 -17.9 27.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.716 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -91.46 -34.23 14.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.164 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -95.19 -11.29 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.302 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.506 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.18 -0.915 . . . . 0.0 110.792 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.1 m -120.92 -40.85 2.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.616 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 16.3 t70 -141.88 -99.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.349 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -39.07 60.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.441 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.46 -23.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.236 0.541 . . . . 0.0 112.007 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.676 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 173.1 -52.98 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.923 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.676 ' N ' HD13 ' A' ' 635' ' ' LEU . 35.8 Cg_exo -55.96 -23.54 43.7 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.714 1.609 . . . . 0.0 110.489 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.0 p-10 27.28 48.93 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.539 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 43.01 73.54 0.14 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.593 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -134.66 -44.53 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.554 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -97.22 69.03 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 110.986 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 3.4 t30 62.28 86.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.902 ' O ' HG22 ' A' ' 646' ' ' THR . 5.7 p-10 -63.86 -23.82 67.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.19 -17.06 9.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.891 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -48.25 -40.27 24.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.724 0.297 . . . . 0.0 111.251 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -131.89 16.39 4.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.385 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.902 HG22 ' O ' ' A' ' 642' ' ' ASP . 9.5 t -152.48 23.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.794 0.331 . . . . 0.0 111.093 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.41 -96.72 0.28 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.112 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.885 ' HB3' HD13 ' A' ' 652' ' ' ILE . 57.8 p-90 -64.77 -22.04 66.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.092 0.473 . . . . 0.0 110.697 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.45 -24.07 25.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . 0.507 ' O ' HG22 ' A' ' 656' ' ' ILE . 3.6 tt0 -91.38 -32.93 15.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.207 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.543 ' HA ' HG22 ' A' ' 656' ' ' ILE . 25.0 p-90 -175.4 67.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.03 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.885 HD13 ' HB3' ' A' ' 648' ' ' TRP . 9.1 tp -64.3 -33.14 8.5 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.654 ' HG3' HD12 ' A' ' 656' ' ' ILE . 33.3 Cg_endo -93.82 -74.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.536 2.158 . . . . 0.0 112.442 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 178.67 70.34 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.439 0.638 . . . . 0.0 110.317 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.814 ' HA2' HG12 ' A' ' 658' ' ' VAL . . . 103.62 45.04 1.59 Allowed Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.565 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.654 HD12 ' HG3' ' A' ' 653' ' ' PRO . 0.4 OUTLIER -73.08 -18.6 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 110.102 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.549 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -106.12 -33.87 3.34 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . 0.814 HG12 ' HA2' ' A' ' 655' ' ' GLY . 13.0 p -82.13 -30.55 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.999 0.428 . . . . 0.0 110.589 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.564 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 99.5 m -124.82 -23.38 4.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.931 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.14 -44.64 7.46 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.156 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 665' ' ' VAL . 74.5 t -82.67 -61.67 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.191 0.52 . . . . 0.0 110.574 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 665' ' ' VAL . 40.1 t -43.05 -33.2 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.461 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 659' ' ' THR . 5.0 tt -77.47 -35.5 22.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.176 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.63 -25.19 35.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.844 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 661' ' ' VAL . 2.8 m -84.38 -42.21 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.301 0.572 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.46 HD12 HG12 ' A' ' 662' ' ' VAL . 45.0 mt -70.82 -37.09 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.437 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -39.85 -34.58 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.117 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.83 -63.15 1.38 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.88 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . 0.42 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -52.15 -26.77 12.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.617 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.419 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -69.35 -24.7 63.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.971 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 16.8 mt -86.1 -36.06 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.124 0.487 . . . . 0.0 110.879 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.79 -32.29 70.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.541 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.92 -17.84 27.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.738 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -90.92 -34.34 15.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.081 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.498 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.9 t -95.68 -14.03 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.335 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.498 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.1 m-85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.854 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.21 -44.48 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.696 0.284 . . . . 0.0 110.809 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.631 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 18.5 t70 -137.54 -100.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.272 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.23 -41.59 60.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.363 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.01 -25.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.27 0.557 . . . . 0.0 112.126 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.694 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 175.76 -53.81 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.12 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.694 ' N ' HD13 ' A' ' 635' ' ' LEU . 39.4 Cg_exo -55.52 -24.56 44.98 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 121.596 1.531 . . . . 0.0 110.512 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.631 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.1 p-10 29.77 39.51 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.562 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . 0.424 ' O ' ' HG3' ' A' ' 638' ' ' GLN . 7.7 pt20 41.56 94.29 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.931 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 158.52 -33.12 0.49 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.367 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.75 -23.04 10.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.691 0.282 . . . . 0.0 111.058 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -148.04 19.81 1.11 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.569 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.918 ' O ' HG22 ' A' ' 646' ' ' THR . 4.2 t0 -59.98 -22.91 63.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.877 0.37 . . . . 0.0 110.862 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -56.37 -20.2 18.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.635 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -48.53 -27.53 2.79 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.75 0.309 . . . . 0.0 111.244 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.27 22.82 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.918 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.6 t -159.3 25.5 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.279 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 650' ' ' GLN . . . -143.4 -96.44 0.23 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.621 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.448 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 67.0 p-90 -62.59 -20.49 64.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.651 0.262 . . . . 0.0 111.209 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . 0.538 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 26.7 mtt180 -85.92 -14.69 44.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.912 0.387 . . . . 0.0 110.404 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 647' ' ' GLY . 2.2 mt-30 -76.11 -14.07 60.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.505 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.787 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.6 p-90 -160.37 50.6 0.29 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.572 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 1.7 mt -67.68 -50.29 35.81 Favored Pre-proline 0 C--N 1.332 -0.18 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.733 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.572 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 98.4 Cg_endo -84.49 5.6 6.21 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.777 2.318 . . . . 0.0 113.04 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . . . . . . . . . . . 65.29 90.71 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 110.396 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.507 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.47 49.62 1.03 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.527 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.787 HG22 ' HA ' ' A' ' 651' ' ' TRP . 10.3 tp -114.44 -39.52 2.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.908 0.385 . . . . 0.0 111.338 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.715 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -137.46 -60.95 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.563 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 651' ' ' TRP . 3.4 p -59.73 -39.51 79.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.37 0.605 . . . . 0.0 109.759 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 31.8 m -117.7 -18.33 9.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.109 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.14 -48.1 5.86 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.55 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.773 ' O ' HG12 ' A' ' 665' ' ' VAL . 75.6 t -82.76 -60.31 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.233 0.539 . . . . 0.0 110.56 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.547 HG12 HD12 ' A' ' 666' ' ' ILE . 63.5 t -42.0 -32.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.44 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.4 tt -79.02 -34.58 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.677 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.58 -27.75 34.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.327 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.7 p -84.47 -36.16 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.074 0.464 . . . . 0.0 110.275 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.547 HD12 HG12 ' A' ' 662' ' ' VAL . 39.0 mt -76.44 -36.16 28.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.915 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.05 -32.93 0.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.384 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . 0.511 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.1 tp -84.53 -63.1 1.4 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.87 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -54.01 -24.56 17.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.46 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.422 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -71.0 -24.7 62.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.054 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 668' ' ' LEU . 10.2 mt -84.45 -39.82 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.16 0.505 . . . . 0.0 110.886 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -57.52 -34.65 69.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.772 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.444 ' H ' ' HG3' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.89 -17.84 27.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.835 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 9.2 t80 -89.28 -33.59 16.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.102 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.5 t -98.78 -14.07 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.228 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.503 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.774 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 2.2 m -110.6 -44.11 3.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.754 0.312 . . . . 0.0 110.748 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.601 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 43.7 t0 -140.51 -100.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.169 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -54.52 -44.64 72.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.389 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.15 -28.64 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.494 0.664 . . . . 0.0 111.977 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.709 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.5 OUTLIER 175.14 -53.26 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.851 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.709 ' N ' HD13 ' A' ' 635' ' ' LEU . 31.4 Cg_exo -54.63 -24.43 36.95 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 121.654 1.569 . . . . 0.0 110.511 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.601 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 5.9 p-10 28.95 56.47 0.12 Allowed 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.451 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 10.4 pt20 42.99 96.01 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.715 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -168.18 -40.81 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.416 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -111.05 -29.99 7.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.307 . . . . 0.0 110.982 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 0.6 OUTLIER -162.94 88.97 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.055 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.882 ' O ' HG22 ' A' ' 646' ' ' THR . 2.8 p30 -102.81 -28.54 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.945 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -64.37 -24.91 67.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.993 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 1.4 p-90 -48.48 -32.08 7.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.719 0.295 . . . . 0.0 111.19 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -130.58 -13.3 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.981 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 642' ' ' ASP . 4.8 t -132.39 34.49 3.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.81 0.338 . . . . 0.0 111.302 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -145.25 -96.31 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.447 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -72.05 -29.65 64.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 110.769 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 19.7 ttm-85 -86.34 -13.79 45.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.393 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . 0.539 ' O ' HG23 ' A' ' 656' ' ' ILE . 29.9 tt0 -68.33 -12.89 61.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.385 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.601 ' HA ' HG22 ' A' ' 656' ' ' ILE . 38.7 p-90 -162.31 45.58 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.747 0.308 . . . . 0.0 111.055 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.849 HD13 ' O ' ' A' ' 652' ' ' ILE . 0.0 OUTLIER -86.17 -33.05 0.46 Allowed Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.697 ' HD3' HG22 ' A' ' 652' ' ' ILE . 63.1 Cg_endo -93.43 -4.49 3.0 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.512 2.142 . . . . 0.0 112.791 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 74.81 90.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.996 0.427 . . . . 0.0 110.585 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.522 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.15 46.15 1.38 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.444 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.774 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.3 tp -114.55 -39.5 2.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.45 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -130.78 -58.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.883 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.39 -39.14 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.224 0.535 . . . . 0.0 109.985 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.53 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 5.6 m -119.11 -19.16 8.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.147 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.33 -52.72 3.88 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.681 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.819 ' O ' HG23 ' A' ' 665' ' ' VAL . 76.5 t -82.39 -62.13 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.063 0.459 . . . . 0.0 110.964 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 24.5 t -42.37 -30.97 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.692 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.5 tp -76.62 -35.06 24.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.216 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.56 -24.57 36.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.894 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 661' ' ' VAL . 1.1 t -83.83 -45.64 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.465 0.65 . . . . 0.0 110.008 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 670' ' ' ALA . 23.2 mm -68.5 -35.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.491 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.77 -34.82 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.145 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . 0.634 ' HA ' HD12 ' A' ' 671' ' ' ILE . 2.8 tp -84.7 -63.11 1.39 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.003 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.76 -24.65 9.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.655 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -72.43 -25.02 61.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.26 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' A' ' 668' ' ' LEU . 10.2 mt -78.8 -41.2 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.093 0.473 . . . . 0.0 111.135 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 676' ' ' PHE . . . -59.05 -33.82 71.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.7 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.45 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.97 -17.95 26.95 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.635 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 11.0 t80 -86.67 -34.6 19.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.826 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.5 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 44.6 t -100.55 -18.51 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.5 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.779 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.546 -0.221 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.97 -41.77 11.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.726 0.298 . . . . 0.0 110.896 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.623 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.2 t0 -141.55 -92.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.354 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -58.98 -39.02 80.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.51 -27.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.421 0.629 . . . . 0.0 111.867 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 178.51 -54.56 0.0 OUTLIER Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.787 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.68 ' N ' HD13 ' A' ' 635' ' ' LEU . 38.3 Cg_exo -55.48 -23.76 40.65 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.597 1.531 . . . . 0.0 110.375 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.623 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.5 p-10 28.8 49.77 0.04 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.519 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 42.94 65.47 0.94 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.507 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -126.97 -41.92 0.29 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.456 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.23 80.93 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 61.95 80.82 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.005 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.925 ' O ' HG22 ' A' ' 646' ' ' THR . 5.4 p30 -67.55 -26.83 66.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . 0.436 ' HB3' ' CD1' ' A' ' 648' ' ' TRP . 7.0 m120 -56.26 -22.03 27.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.488 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 648' ' ' TRP . 3.4 p-90 -48.55 -28.48 3.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.752 0.311 . . . . 0.0 111.2 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . 0.424 ' HA ' ' CE3' ' A' ' 645' ' ' TRP . 0.0 OUTLIER -144.93 19.6 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.2 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.925 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.9 t -156.82 25.03 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.698 0.285 . . . . 0.0 111.224 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -146.48 -109.4 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.462 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 643' ' ' ASN . 49.2 p-90 -59.32 -21.4 59.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 111.133 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . 0.516 ' HG2' HD11 ' A' ' 652' ' ' ILE . 2.7 ttt85 -86.45 -18.03 32.75 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.044 0.449 . . . . 0.0 110.2 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.25 -3.85 41.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.809 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.927 ' HA ' HG22 ' A' ' 656' ' ' ILE . 5.3 p-90 -169.28 49.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.838 0.351 . . . . 0.0 110.959 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.597 ' HB ' ' HD3' ' A' ' 653' ' ' PRO . 1.7 mt -62.1 -56.71 28.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.076 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 652' ' ' ILE . 34.1 Cg_endo -66.68 -74.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.208 1.939 . . . . 0.0 112.477 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 177.9 69.64 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.446 0.641 . . . . 0.0 110.359 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.894 ' HA2' HG12 ' A' ' 658' ' ' VAL . . . 103.78 35.37 3.51 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.989 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.927 HG22 ' HA ' ' A' ' 651' ' ' TRP . 0.5 OUTLIER -73.54 -15.26 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.0 110.31 178.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.648 ' O ' HG23 ' A' ' 662' ' ' VAL . . . -108.36 -34.08 2.78 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . 0.894 HG12 ' HA2' ' A' ' 655' ' ' GLY . 14.5 p -82.03 -31.78 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 110.313 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.556 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 82.0 m -124.43 -21.24 4.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.801 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.22 -53.1 3.77 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.261 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 665' ' ' VAL . 54.1 t -82.69 -61.06 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.219 0.533 . . . . 0.0 110.837 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 657' ' ' GLY . 39.1 t -42.07 -33.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.544 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.0 OUTLIER -75.16 -37.79 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.291 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.63 -24.66 36.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.184 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 661' ' ' VAL . 3.3 m -84.4 -43.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.328 0.585 . . . . 0.0 110.439 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' ' 670' ' ' ALA . 19.7 mm -68.22 -35.42 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.383 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.34 -34.7 0.35 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.138 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 4.1 tp -84.87 -63.05 1.4 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.811 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.76 -26.9 10.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.612 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.46 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -67.96 -22.0 65.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.07 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 23.3 mm -85.26 -37.52 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.088 0.471 . . . . 0.0 111.142 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -61.49 -33.16 73.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.632 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.437 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.97 -17.84 27.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.738 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -91.52 -34.3 14.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.7 t -94.86 -11.92 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.354 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.495 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.843 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 5.2 t -108.12 -43.65 4.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.59 0.233 . . . . 0.0 110.935 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.57 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 20.2 t70 -139.23 -102.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.278 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -49.61 -40.57 39.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.779 0.323 . . . . 0.0 111.373 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.5 -24.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.232 0.539 . . . . 0.0 111.928 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.555 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.3 tm? 176.78 -58.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.471 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 635' ' ' LEU . 7.4 Cg_endo -53.9 -21.26 20.2 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.983 1.788 . . . . 0.0 111.077 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.57 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 7.0 p-10 25.18 60.94 0.06 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.707 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 39.18 68.89 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.727 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -123.21 -49.09 0.23 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -99.96 81.03 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.335 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.53 87.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.935 ' O ' HG22 ' A' ' 646' ' ' THR . 15.0 t0 -66.84 -27.83 67.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.04 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -56.86 -20.12 21.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.604 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -48.43 -30.04 4.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.818 0.342 . . . . 0.0 111.228 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -144.5 20.89 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.153 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.935 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.6 t -160.66 27.85 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.742 0.306 . . . . 0.0 111.125 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.59 -111.21 0.86 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.517 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.487 ' HE3' HD13 ' A' ' 652' ' ' ILE . 65.7 p-90 -57.9 -22.25 47.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.121 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 23.9 ttt-85 -86.5 -20.16 28.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.049 0.452 . . . . 0.0 110.185 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -24.4 61.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.034 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.747 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.2 p-90 -165.58 61.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.732 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.655 HG22 ' HD3' ' A' ' 653' ' ' PRO . 1.5 tp -66.81 -33.87 6.78 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.197 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.655 ' HD3' HG22 ' A' ' 652' ' ' ILE . 35.0 Cg_endo -94.39 -73.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.681 2.254 . . . . 0.0 112.409 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.45 80.36 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.438 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.441 ' CA ' ' HB ' ' A' ' 659' ' ' THR . . . 103.57 45.3 1.56 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.361 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.747 HG22 ' HA ' ' A' ' 651' ' ' TRP . 3.0 tp -102.71 -34.51 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.041 0.448 . . . . 0.0 110.842 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.625 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -114.07 -35.91 1.43 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.514 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . 0.42 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 14.7 p -81.24 -40.33 18.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.145 0.498 . . . . 0.0 110.081 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.549 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 43.6 m -117.63 -16.42 10.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.086 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 656' ' ' ILE . . . -82.39 -48.87 5.45 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.307 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.773 ' O ' HG12 ' A' ' 665' ' ' VAL . 84.1 t -82.78 -60.72 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.168 0.508 . . . . 0.0 110.66 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.519 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 54.2 t -42.02 -32.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.529 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.647 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 3.2 tp -78.65 -35.62 18.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.79 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.43 -26.97 34.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.37 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.9 p -84.81 -36.07 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.151 0.501 . . . . 0.0 110.261 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 670' ' ' ALA . 25.1 mm -79.59 -37.56 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.195 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.33 -33.59 0.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.265 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.4 tp -84.77 -63.22 1.37 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.997 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . 0.403 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -52.89 -26.83 16.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.025 0.441 . . . . 0.0 110.43 179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.437 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -65.72 -25.03 67.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.84 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 21.9 mm -86.1 -36.34 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.151 0.5 . . . . 0.0 110.939 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . 0.411 ' HA ' ' CD1' ' A' ' 676' ' ' PHE . . . -59.8 -31.29 69.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.96 -17.86 27.12 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.638 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.87 -35.1 15.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.02 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.484 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.9 t -95.88 -16.51 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.351 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.484 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.828 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 3.1 m -131.72 -50.79 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.69 0.281 . . . . 0.0 110.799 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.544 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.7 t70 -136.87 -90.85 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.494 ' HB2' ' HZ2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -64.93 -38.03 89.61 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.223 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 3.1 m -165.11 -32.4 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.599 0.714 . . . . 0.0 111.459 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.6 OUTLIER 175.0 -52.56 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.853 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.703 ' N ' HD13 ' A' ' 635' ' ' LEU . 34.8 Cg_exo -55.27 -24.19 40.96 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.62 1.547 . . . . 0.0 110.45 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 5.7 p-10 30.45 51.3 0.1 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.286 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 42.94 97.26 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.873 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . 157.23 -30.96 0.53 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.442 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -104.16 -29.06 11.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.712 0.292 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -166.17 41.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.307 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.931 ' O ' HG22 ' A' ' 646' ' ' THR . 4.7 t0 -61.34 -22.84 65.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.872 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -54.85 -22.9 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.702 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -49.02 -29.23 4.69 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.777 0.322 . . . . 0.0 111.296 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -144.7 21.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.199 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.931 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.2 t -160.77 27.3 0.15 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.792 0.33 . . . . 0.0 111.197 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -148.25 -88.72 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.398 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 37.5 p-90 -74.19 -24.1 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 0.0 110.795 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 29.7 ttt85 -86.24 -12.13 50.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.484 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -14.63 63.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.111 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.686 ' HA ' HG22 ' A' ' 656' ' ' ILE . 2.3 p-90 -169.17 51.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.876 0.37 . . . . 0.0 110.828 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.651 HG22 ' HD3' ' A' ' 653' ' ' PRO . 5.3 tt -82.97 -32.48 0.55 Allowed Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.651 ' HD3' HG22 ' A' ' 652' ' ' ILE . 44.4 Cg_endo -91.61 -75.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.301 2.001 . . . . 0.0 112.601 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 166.53 84.22 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.958 0.409 . . . . 0.0 110.316 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.58 39.9 2.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.295 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' A' ' 651' ' ' TRP . 1.6 tp -101.85 -31.53 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.196 0.522 . . . . 0.0 110.676 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.678 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -105.99 -37.02 2.61 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.25 -38.08 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.03 -0.585 . . . . 0.0 110.321 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.547 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 78.7 m -115.98 -20.08 10.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.746 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 656' ' ' ILE . . . -82.29 -44.69 7.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.421 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.764 ' O ' HG12 ' A' ' 665' ' ' VAL . 90.5 t -82.55 -61.53 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.149 0.5 . . . . 0.0 110.472 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.521 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 51.4 t -42.35 -32.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.402 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.701 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.2 OUTLIER -79.34 -34.2 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.701 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.45 -27.52 34.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.224 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.8 p -84.55 -34.38 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.264 0.554 . . . . 0.0 110.132 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 24.3 mm -82.06 -37.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.161 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.38 -32.41 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.453 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . 0.546 ' HA ' HD12 ' A' ' 671' ' ' ILE . 2.9 tp -84.19 -63.28 1.37 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.768 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . 0.426 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -53.67 -25.76 19.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.979 0.418 . . . . 0.0 110.325 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.43 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -68.76 -22.96 64.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.067 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 668' ' ' LEU . 7.5 mt -86.07 -37.39 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.08 0.467 . . . . 0.0 111.164 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.92 -30.75 69.26 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.697 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.97 -17.85 27.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.831 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.2 OUTLIER -93.54 -33.51 13.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.243 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 41.9 t -94.93 -6.95 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.59 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.503 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.8 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.763 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.98 -41.11 3.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.617 0.246 . . . . 0.0 110.987 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.581 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 15.5 t70 -143.61 -99.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.481 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -50.34 -39.05 45.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.461 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.4 -24.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.214 0.53 . . . . 0.0 112.124 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.564 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 177.14 -58.74 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.332 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.5 ' N ' HD13 ' A' ' 635' ' ' LEU . 9.3 Cg_endo -56.42 -20.49 33.14 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.749 1.633 . . . . 0.0 110.688 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.9 p-10 29.78 53.46 0.12 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.518 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 22.9 pt20 42.8 66.7 0.72 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.543 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -135.13 -59.57 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.381 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.68 -28.31 23.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 0.0 110.781 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . 0.424 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 1.4 t-20 -153.55 88.68 1.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.709 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.917 ' O ' HG22 ' A' ' 646' ' ' THR . 2.7 p30 -109.57 -29.95 8.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -53.55 -28.83 33.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.859 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . 0.424 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 5.6 p-90 -48.68 -27.5 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.386 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -151.23 26.73 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.459 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.917 HG22 ' O ' ' A' ' 642' ' ' ASP . 4.2 t -168.66 32.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.81 0.338 . . . . 0.0 111.159 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 651' ' ' TRP . . . -149.36 -93.31 0.11 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.321 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.445 ' CH2' ' HG3' ' A' ' 649' ' ' ARG . 47.0 p-90 -64.92 -21.03 66.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.691 0.282 . . . . 0.0 110.965 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . 0.469 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 3.9 mtp85 -86.33 -19.75 29.35 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.063 0.458 . . . . 0.0 110.112 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . 0.587 ' O ' HG23 ' A' ' 656' ' ' ILE . 3.2 mm-40 -71.21 -22.02 62.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.069 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.569 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.5 p-90 -154.91 57.34 0.67 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.893 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.472 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 0.5 OUTLIER -66.0 -49.51 56.93 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.751 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.559 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 31.1 Cg_endo -94.39 -77.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.417 2.745 . . . . 0.0 112.581 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 167.24 98.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.566 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.7 39.72 2.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.466 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 650' ' ' GLN . 5.6 tp -114.26 -39.62 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 111.535 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.813 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -137.69 -58.61 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . 0.421 HG12 ' HB3' ' A' ' 651' ' ' TRP . 4.4 p -63.21 -41.18 91.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.369 0.604 . . . . 0.0 109.638 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 40.6 m -114.19 -17.52 11.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.854 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.463 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.11 -46.31 6.67 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.641 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.813 HG23 ' HA2' ' A' ' 657' ' ' GLY . 76.6 t -82.57 -60.67 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.169 0.509 . . . . 0.0 110.62 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.503 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 54.1 t -42.16 -32.67 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.324 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.69 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.3 OUTLIER -79.42 -34.97 16.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.662 -179.229 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.42 -27.33 34.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.431 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.0 p -84.61 -33.73 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.239 0.542 . . . . 0.0 110.146 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 25.3 mm -82.99 -36.76 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.132 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -42.2 -32.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.402 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.59 -63.32 1.36 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.864 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . 0.496 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.2 OUTLIER -52.61 -29.28 25.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.034 0.445 . . . . 0.0 110.134 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -65.48 -21.61 66.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.174 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.446 HG22 ' CG2' ' A' ' 675' ' ' VAL . 11.8 mt -80.54 -36.44 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 120.967 0.413 . . . . 0.0 111.942 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.13 69.31 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.43 0.633 . . . . 0.0 110.659 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.03 -17.77 27.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.905 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.3 OUTLIER -99.18 -32.55 11.17 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.508 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 675' ' ' VAL . 43.6 t -90.98 2.42 7.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.426 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 676' ' ' PHE . 4.7 m-85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 3.3 t -70.04 -42.02 73.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.623 0.249 . . . . 0.0 110.944 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.591 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 38.6 t70 -140.16 -102.53 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.444 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -44.31 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 111.371 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.75 -27.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.42 0.629 . . . . 0.0 111.934 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 176.89 -54.32 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.174 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.057 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.691 ' N ' HD13 ' A' ' 635' ' ' LEU . 33.5 Cg_exo -54.77 -24.56 38.55 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.595 1.53 . . . . 0.0 110.502 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.1 p-10 29.38 41.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.561 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 42.6 67.54 0.6 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.571 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -142.63 -58.6 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.641 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.31 -49.59 16.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.01 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -159.54 90.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.02 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.913 ' O ' HG22 ' A' ' 646' ' ' THR . 2.8 t0 -86.99 -25.68 24.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.971 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -55.12 -22.03 15.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.554 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -48.54 -28.42 3.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.764 0.316 . . . . 0.0 111.24 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 649' ' ' ARG . 0.0 OUTLIER -146.43 19.08 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.147 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.913 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.8 t -155.99 25.6 0.37 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.818 0.342 . . . . 0.0 111.119 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.78 -89.52 0.14 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.912 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 36.7 p-90 -70.71 -21.29 62.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 110.423 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 645' ' ' TRP . 1.2 ttt85 -86.05 -12.11 51.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.405 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . 0.48 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.0 OUTLIER -65.84 -11.84 49.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.325 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.528 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.2 p-90 -164.24 48.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 110.71 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.603 HG22 ' HD3' ' A' ' 653' ' ' PRO . 1.6 tp -97.1 -31.71 0.26 Allowed Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.603 ' HD3' HG22 ' A' ' 652' ' ' ILE . 63.7 Cg_endo -88.05 -7.97 5.93 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.229 1.953 . . . . 0.0 112.822 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 76.54 91.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.989 0.423 . . . . 0.0 110.504 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 104.33 42.0 1.96 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.458 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 651' ' ' TRP . 10.2 tp -114.55 -39.91 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.912 0.387 . . . . 0.0 111.464 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.709 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -141.64 -59.25 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . 0.41 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.2 p -62.8 -37.05 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.431 0.634 . . . . 0.0 109.595 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.56 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 54.2 m -118.04 -17.83 9.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.992 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.543 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.03 -56.82 2.8 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.768 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 665' ' ' VAL . 40.8 t -82.41 -60.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.096 0.474 . . . . 0.0 111.123 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 666' ' ' ILE . 24.9 t -43.2 -31.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.677 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 659' ' ' THR . 5.3 tt -72.9 -34.18 45.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.946 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.47 -24.88 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.472 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 661' ' ' VAL . 1.4 t -84.03 -45.63 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.374 0.607 . . . . 0.0 110.016 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 670' ' ' ALA . 19.0 mm -65.49 -34.81 72.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.337 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -41.7 -34.56 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.039 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . 0.526 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.4 tp -84.75 -63.02 1.41 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.963 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -52.66 -25.19 10.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.736 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -71.25 -25.16 62.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.114 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 668' ' ' LEU . 8.5 mt -82.95 -35.97 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.14 0.495 . . . . 0.0 110.999 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.47 78.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.469 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 -17.9 26.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 14.8 t80 -90.99 -34.05 15.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.228 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 47.2 t -95.82 -10.1 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.485 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.6 m-85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.774 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.48 -40.96 28.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.677 0.275 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.609 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 8.6 t0 -140.23 -92.99 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.83 0.347 . . . . 0.0 111.369 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -39.9 89.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.34 -24.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.284 0.564 . . . . 0.0 111.89 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 175.24 -53.42 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.995 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.703 ' N ' HD13 ' A' ' 635' ' ' LEU . 35.3 Cg_exo -55.05 -24.11 38.65 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.686 1.59 . . . . 0.0 110.53 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.609 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.6 p-10 24.86 55.25 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.584 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 42.87 77.99 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.546 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -132.48 -46.16 0.12 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.418 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.12 77.77 1.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.344 . . . . 0.0 110.767 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.66 86.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.921 ' O ' HG22 ' A' ' 646' ' ' THR . 1.2 t0 -80.61 -19.92 44.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.218 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -53.98 -23.9 14.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.542 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -50.92 -28.25 9.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.807 0.337 . . . . 0.0 111.202 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -144.07 19.0 1.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.268 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.921 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.7 t -156.83 25.53 0.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.824 0.345 . . . . 0.0 111.173 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.45 -93.19 0.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.277 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -76.52 -31.88 57.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 110.664 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -86.4 -12.08 50.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.561 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 656' ' ' ILE . 50.6 tt0 -64.72 -13.78 55.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.627 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.558 ' HA ' HG22 ' A' ' 656' ' ' ILE . 35.7 p-90 -163.65 44.61 0.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.754 0.312 . . . . 0.0 111.146 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.615 HG22 ' HD3' ' A' ' 653' ' ' PRO . 2.7 tt -89.51 -31.73 0.37 Allowed Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.615 ' HD3' HG22 ' A' ' 652' ' ' ILE . 52.9 Cg_endo -92.32 -4.65 3.61 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.425 2.083 . . . . 0.0 112.904 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 74.62 89.49 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.957 0.408 . . . . 0.0 110.633 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.94 47.66 1.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.462 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.558 HG22 ' HA ' ' A' ' 651' ' ' TRP . 8.4 tp -114.58 -39.75 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.785 0.326 . . . . 0.0 111.725 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.701 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -140.46 -61.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.505 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.24 -36.13 70.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.368 0.604 . . . . 0.0 109.679 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.507 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 54.8 m -118.85 -19.1 8.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.157 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.2 -52.95 3.83 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.944 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.779 ' O ' HG12 ' A' ' 665' ' ' VAL . 57.6 t -82.57 -60.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.135 0.493 . . . . 0.0 110.979 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.498 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 42.2 t -42.03 -31.78 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.572 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.6 OUTLIER -79.02 -36.46 18.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.712 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.53 -27.05 34.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.571 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.0 p -84.65 -34.4 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.152 0.501 . . . . 0.0 110.397 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.452 HD12 ' CG1' ' A' ' 662' ' ' VAL . 39.0 mt -80.29 -37.99 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.285 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.45 -33.3 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.287 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.69 -63.05 1.4 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.029 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -54.08 -24.57 17.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.578 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . . . . . . . . . . . -73.07 -21.91 60.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.019 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 667' ' ' ALA . 4.9 mt -77.84 -55.33 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 121.322 0.582 . . . . 0.0 110.729 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . 0.449 ' HA ' ' HE1' ' A' ' 676' ' ' PHE . . . -46.82 -62.6 1.32 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.986 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -22.5 11.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.206 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -70.03 -51.08 35.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.061 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.08 -43.66 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.073 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.449 ' HE1' ' HA ' ' A' ' 672' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.825 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.35 -39.9 6.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.721 0.296 . . . . 0.0 110.95 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.654 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 23.1 t70 -139.8 -98.85 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.399 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -53.42 -42.06 66.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.312 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.94 -20.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.686 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 173.17 -53.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.975 179.242 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.686 ' N ' HD13 ' A' ' 635' ' ' LEU . 39.5 Cg_exo -55.82 -23.51 42.38 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 121.706 1.604 . . . . 0.0 110.461 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.654 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.8 p-10 25.54 48.32 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.577 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 637' ' ' ASP . 0.2 OUTLIER 35.32 90.88 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.039 179.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -168.12 -52.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.452 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.62 -37.31 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.0 110.801 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.64 94.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.866 ' O ' HG22 ' A' ' 646' ' ' THR . 8.6 t70 -90.58 9.72 28.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.06 -20.43 53.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.457 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -49.26 -35.13 16.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.134 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -133.71 9.13 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.537 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 642' ' ' ASP . 3.0 t -145.12 23.46 1.51 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.796 0.331 . . . . 0.0 111.072 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -131.62 -100.41 0.81 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.146 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -73.47 -27.29 61.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.735 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 30.1 ttm-85 -86.27 -11.94 50.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.435 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . 0.453 ' O ' HG23 ' A' ' 656' ' ' ILE . 3.8 tt0 -72.09 -9.87 59.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.317 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.538 ' HA ' HG22 ' A' ' 656' ' ' ILE . 0.1 OUTLIER -165.08 47.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.336 -179.367 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.642 HG22 ' HD3' ' A' ' 653' ' ' PRO . 1.7 tp -92.31 -31.86 0.33 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.642 ' HD3' HG22 ' A' ' 652' ' ' ILE . 57.5 Cg_endo -91.31 -7.41 3.56 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.386 2.058 . . . . 0.0 113.078 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 75.19 92.94 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.01 0.434 . . . . 0.0 110.363 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.565 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.38 42.01 1.96 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.272 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.959 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.1 tp -114.5 -39.46 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 111.543 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 662' ' ' VAL . . . -128.83 -57.81 0.11 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.917 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . 0.419 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.9 p -63.11 -39.82 86.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.282 0.563 . . . . 0.0 110.213 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.565 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 13.6 m -119.4 -18.42 8.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.138 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.474 ' HA3' ' CA ' ' A' ' 656' ' ' ILE . . . -82.27 -58.71 2.39 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.649 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.959 HG23 ' O ' ' A' ' 656' ' ' ILE . 92.7 t -82.28 -61.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.173 0.511 . . . . 0.0 110.998 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.597 ' HA ' HG22 ' A' ' 665' ' ' VAL . 40.1 t -41.81 -31.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.751 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.4 tt -77.09 -38.43 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.305 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.17 36.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.34 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 662' ' ' VAL . 10.9 m -84.43 -44.29 17.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.269 0.557 . . . . 0.0 110.331 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.479 ' N ' HG23 ' A' ' 665' ' ' VAL . 37.4 mt -66.83 -36.4 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.371 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.75 -35.5 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.955 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . 0.538 ' HA ' HD12 ' A' ' 671' ' ' ILE . 3.2 tp -84.87 -63.01 1.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.88 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . 0.432 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.1 OUTLIER -52.16 -26.31 11.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.665 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 666' ' ' ILE . . . -70.92 -21.96 62.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.181 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 668' ' ' LEU . 9.7 mt -86.07 -38.54 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.129 0.49 . . . . 0.0 111.041 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -58.99 -31.09 68.47 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.753 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.01 -17.83 27.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.839 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.1 OUTLIER -92.45 -34.23 14.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.166 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.505 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 40.8 t -94.62 -10.5 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.514 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.6 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.799 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.71 -43.2 8.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.685 0.279 . . . . 0.0 110.93 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.622 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 9.1 t0 -139.63 -93.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.9 0.381 . . . . 0.0 111.353 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.29 -41.18 79.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.012 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.31 -21.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.126 0.489 . . . . 0.0 112.2 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.579 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 177.47 -58.57 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.366 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.515 ' N ' HD13 ' A' ' 635' ' ' LEU . 9.4 Cg_endo -56.53 -20.22 32.74 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.792 1.661 . . . . 0.0 110.76 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.622 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.0 p-10 27.0 50.16 0.02 OUTLIER 'General case' 0 C--O 1.23 0.072 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.564 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . 0.449 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 4.0 pt20 43.97 98.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.821 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -170.8 -51.89 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.661 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.37 -37.22 14.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.347 . . . . 0.0 111.013 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -170.43 94.41 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.949 ' O ' HG22 ' A' ' 646' ' ' THR . 4.8 p-10 -99.59 -34.73 10.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.723 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -51.09 -24.62 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.846 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -48.68 -27.53 2.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.819 0.342 . . . . 0.0 111.191 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -150.71 24.51 0.77 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.949 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.8 t -162.19 28.71 0.11 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.772 0.32 . . . . 0.0 111.193 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -151.19 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.328 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.418 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 59.6 p-90 -73.33 -21.54 60.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.788 0.328 . . . . 0.0 110.832 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . 0.418 ' HG3' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -86.21 -11.94 51.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.654 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . 0.491 ' O ' HG23 ' A' ' 656' ' ' ILE . 1.8 mm100 -68.91 -7.54 35.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.867 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.58 ' HA ' HG22 ' A' ' 656' ' ' ILE . 9.2 p-90 -166.92 41.39 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.71 0.291 . . . . 0.0 111.174 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.63 HG22 ' HD3' ' A' ' 653' ' ' PRO . 2.5 tp -89.63 -31.72 0.37 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.63 ' HD3' HG22 ' A' ' 652' ' ' ILE . 60.3 Cg_endo -91.65 -6.4 3.63 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.427 2.084 . . . . 0.0 112.856 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 74.98 91.51 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.99 0.424 . . . . 0.0 110.483 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.482 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.13 45.23 1.5 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.227 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 651' ' ' TRP . 9.4 tp -114.53 -39.51 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.669 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -135.23 -62.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.789 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.89 -38.21 75.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.321 0.582 . . . . 0.0 109.818 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.539 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 43.5 m -118.22 -19.37 9.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.233 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.18 -47.88 5.94 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.682 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.803 ' O ' HG12 ' A' ' 665' ' ' VAL . 74.1 t -82.52 -60.23 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 110.439 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.54 HG12 HD12 ' A' ' 666' ' ' ILE . 78.0 t -42.07 -31.76 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.307 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.628 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 5.2 tt -80.96 -34.51 13.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.616 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.59 -27.49 34.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.42 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.803 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.7 p -84.44 -35.09 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.224 0.535 . . . . 0.0 110.13 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.54 HD12 HG12 ' A' ' 662' ' ' VAL . 51.2 mt -79.6 -36.69 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.831 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.98 -32.93 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.398 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.8 tp -84.58 -62.96 1.42 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . 0.404 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 2.2 t80 -53.4 -25.42 15.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.474 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.426 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.03 -23.93 63.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.138 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . . . . . . . . . 17.9 mt -85.1 -40.53 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.097 0.475 . . . . 0.0 110.952 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -56.68 -32.17 65.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.818 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.97 -17.92 27.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.922 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -92.17 -32.89 14.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.208 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.3 t -97.2 -10.9 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.489 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.495 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.837 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.431 ' HA2' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . 0.446 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -127.89 -51.86 1.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.568 0.223 . . . . 0.0 111.001 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.559 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 9.9 t0 -132.04 -95.64 0.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.464 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -38.23 69.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.407 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.06 -26.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.238 0.542 . . . . 0.0 112.253 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.566 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 178.04 -58.75 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.436 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.508 ' N ' HD13 ' A' ' 635' ' ' LEU . 11.1 Cg_endo -57.81 -20.15 42.23 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.752 1.634 . . . . 0.0 110.649 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.0 p-10 33.48 36.97 0.01 OUTLIER 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.392 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 53.14 87.7 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.174 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -152.1 -46.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.404 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.45 -31.38 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . 0.405 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 2.4 m120 -159.13 83.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.894 ' O ' HG22 ' A' ' 646' ' ' THR . 7.8 p-10 -95.24 -26.89 15.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.04 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . 0.404 ' CB ' ' HA3' ' A' ' 647' ' ' GLY . 29.9 p-10 -65.29 -20.64 66.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.009 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 1.4 p-90 -48.44 -27.93 2.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.628 0.251 . . . . 0.0 111.421 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.04 27.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.637 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.894 HG22 ' O ' ' A' ' 642' ' ' ASP . 5.9 t -175.03 32.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.635 0.255 . . . . 0.0 111.444 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 643' ' ' ASN . . . -137.92 -88.57 0.2 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.594 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.472 ' CE2' ' HG3' ' A' ' 649' ' ' ARG . 50.2 p-90 -69.86 -29.54 66.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 0.0 111.154 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . 0.472 ' HG3' ' CE2' ' A' ' 648' ' ' TRP . 2.6 mtp-105 -86.43 -16.26 37.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 0.0 110.362 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -65.82 -24.13 66.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.085 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.624 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.4 p-90 -160.74 56.72 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.133 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.685 HG22 ' HD3' ' A' ' 653' ' ' PRO . 9.5 tp -81.98 -32.61 0.61 Allowed Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.685 ' HD3' HG22 ' A' ' 652' ' ' ILE . 62.9 Cg_endo -96.03 -5.27 1.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.715 2.277 . . . . 0.0 112.875 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 75.61 89.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.003 0.43 . . . . 0.0 110.465 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.518 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.05 48.44 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.351 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.827 ' O ' HG23 ' A' ' 661' ' ' VAL . 10.4 tp -114.48 -39.77 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 656' ' ' ILE . . . -132.6 -59.43 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.939 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . 0.402 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.5 p -61.68 -38.69 80.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.26 0.552 . . . . 0.0 110.012 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.52 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 29.9 m -119.91 -18.46 8.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.214 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.32 -55.26 3.11 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.673 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 656' ' ' ILE . 93.8 t -82.51 -60.73 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.109 0.48 . . . . 0.0 111.011 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.547 ' HA ' HG22 ' A' ' 665' ' ' VAL . 38.3 t -42.44 -32.41 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.609 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.6 tp -76.14 -37.27 32.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.64 -24.38 36.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.134 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 661' ' ' VAL . 2.7 m -84.25 -41.98 16.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.335 0.588 . . . . 0.0 110.297 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.449 HD12 HG12 ' A' ' 662' ' ' VAL . 43.4 mt -70.83 -36.63 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.321 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -39.94 -34.86 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.183 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 671' ' ' ILE . 3.0 tp -84.74 -63.15 1.38 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.887 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . 0.429 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 0.2 OUTLIER -52.51 -25.59 10.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.675 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -71.92 -24.57 61.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.045 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 668' ' ' LEU . 11.6 mt -85.99 -37.85 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.117 0.484 . . . . 0.0 110.883 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 676' ' ' PHE . . . -57.62 -32.43 67.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.652 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -89.88 -17.96 27.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.742 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 0.2 OUTLIER -89.25 -34.89 16.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 41.0 t -97.15 -15.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.406 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.497 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.733 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.27 -43.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.619 0.247 . . . . 0.0 111.005 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.614 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 67.2 t0 -137.86 -105.07 0.19 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.374 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -46.06 -44.06 15.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 0.0 111.547 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.8 -26.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.374 0.607 . . . . 0.0 112.049 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.694 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 174.35 -52.99 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.835 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.694 ' N ' HD13 ' A' ' 635' ' ' LEU . 37.4 Cg_exo -56.06 -23.86 46.19 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.682 1.588 . . . . 0.0 110.363 178.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.614 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 3.9 p-10 31.45 40.01 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.314 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 16.1 pt20 42.98 69.25 0.41 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.515 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -131.9 -57.03 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.422 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.7 -28.92 19.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.361 . . . . 0.0 110.862 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' TRP . 0.6 OUTLIER -159.43 93.58 1.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.83 179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.937 ' O ' HG22 ' A' ' 646' ' ' THR . 5.6 p-10 -102.57 -36.96 8.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -54.19 -22.54 11.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.592 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 641' ' ' ASN . 7.4 p-90 -48.56 -28.22 3.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.788 0.327 . . . . 0.0 111.18 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -149.18 23.25 0.94 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.264 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.937 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.2 t -160.35 27.18 0.16 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.698 0.285 . . . . 0.0 111.264 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -150.36 -85.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.517 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.464 ' O ' HG13 ' A' ' 652' ' ' ILE . 69.3 p-90 -79.43 -21.27 45.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.62 0.248 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . 0.527 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 2.6 ttt85 -86.34 -15.8 39.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.063 0.458 . . . . 0.0 110.346 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . 0.56 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.1 OUTLIER -72.46 -16.59 61.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.37 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.453 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.9 p-90 -162.7 54.86 0.21 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.693 0.282 . . . . 0.0 111.258 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.609 HD12 ' HD3' ' A' ' 653' ' ' PRO . 0.3 OUTLIER -69.63 -51.32 16.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 110.809 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.609 ' HD3' HD12 ' A' ' 652' ' ' ILE . 32.1 Cg_endo -95.13 -80.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.456 2.771 . . . . 0.0 112.628 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 170.35 105.94 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.722 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 103.79 35.44 3.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.612 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 650' ' ' GLN . 0.6 OUTLIER -114.15 -39.58 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 0.0 111.454 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.823 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -137.82 -58.09 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 4.6 p -64.59 -39.25 84.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.303 0.573 . . . . 0.0 109.638 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.537 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 20.5 m -115.08 -17.37 11.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.852 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.499 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -81.92 -46.18 6.81 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.53 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.823 HG23 ' HA2' ' A' ' 657' ' ' GLY . 99.5 t -82.6 -60.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.26 0.553 . . . . 0.0 110.448 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.529 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 53.8 t -42.0 -31.65 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.56 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.7 OUTLIER -79.66 -34.09 15.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.748 -179.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.48 -27.36 34.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.164 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 661' ' ' VAL . 1.5 p -84.55 -36.0 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.131 0.491 . . . . 0.0 110.156 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.517 HD12 HG12 ' A' ' 662' ' ' VAL . 39.4 mt -78.91 -37.02 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.022 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -40.38 -32.96 0.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.481 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . 0.627 ' HA ' HD12 ' A' ' 671' ' ' ILE . 2.9 tp -84.6 -63.13 1.39 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.803 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -24.51 15.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 110.508 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.7 -22.47 62.45 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 668' ' ' LEU . 6.8 mt -81.59 -51.9 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.172 0.511 . . . . 0.0 110.975 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -48.95 -33.4 10.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.699 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -17.9 27.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.523 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 12.1 t80 -96.35 -31.16 13.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.738 0.304 . . . . 0.0 111.385 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 675' ' ' VAL . 41.1 t -94.66 -1.19 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.381 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.467 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 2.4 m-85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.801 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 637' ' ' ASP . 42.5 t 61.54 -83.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.491 0.186 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.627 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 38.8 t70 -122.51 -99.76 0.42 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.745 0.307 . . . . 0.0 111.235 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -45.15 80.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.269 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.2 -24.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.133 0.492 . . . . 0.0 112.31 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.57 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.2 tm? 177.03 -58.66 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.425 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.509 ' N ' HD13 ' A' ' 635' ' ' LEU . 9.2 Cg_endo -56.56 -20.53 34.28 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.775 1.65 . . . . 0.0 110.864 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.627 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.9 p-10 31.24 39.87 0.01 OUTLIER 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.38 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 52.95 97.96 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.189 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -171.68 -40.8 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.452 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -83.34 -34.79 25.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.761 0.315 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -168.01 47.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.923 ' O ' HG22 ' A' ' 646' ' ' THR . 32.2 p-10 -51.16 -27.18 8.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.255 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -52.18 -20.56 2.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.94 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 -48.36 -28.85 3.44 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.786 0.327 . . . . 0.0 111.269 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.58 22.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.239 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.923 HG22 ' O ' ' A' ' 642' ' ' ASP . 11.0 t -156.97 25.36 0.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.108 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -141.78 -111.97 0.89 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.235 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.414 ' O ' HG13 ' A' ' 652' ' ' ILE . 69.7 p-90 -60.4 -21.52 62.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.709 0.29 . . . . 0.0 110.926 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . 0.462 ' HA ' ' CG1' ' A' ' 652' ' ' ILE . 39.2 ttt85 -86.55 -19.13 29.9 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.33 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . 0.502 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.0 OUTLIER -70.09 -26.97 64.23 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.861 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.575 ' HA ' HG22 ' A' ' 656' ' ' ILE . 5.0 p-90 -153.29 58.9 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.083 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.491 ' N ' ' CD ' ' A' ' 653' ' ' PRO . 1.9 mt -63.07 -47.56 85.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.698 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 654' ' ' ALA . 29.5 Cg_endo -95.42 -76.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.458 2.772 . . . . 0.0 112.548 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 653' ' ' PRO . . . 165.68 95.6 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.473 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.539 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 103.67 42.92 1.9 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.337 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.575 HG22 ' HA ' ' A' ' 651' ' ' TRP . 10.3 tp -114.27 -39.55 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.821 0.344 . . . . 0.0 111.465 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.738 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -135.23 -56.59 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' A' ' 651' ' ' TRP . 8.0 p -63.47 -42.72 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.345 0.593 . . . . 0.0 109.757 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.539 ' HB ' ' HA2' ' A' ' 655' ' ' GLY . 20.4 m -114.86 -16.96 11.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.867 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.24 -46.6 6.48 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.64 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.828 ' O ' HG12 ' A' ' 665' ' ' VAL . 67.7 t -82.82 -59.12 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.108 0.48 . . . . 0.0 110.345 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.544 HG12 HD12 ' A' ' 666' ' ' ILE . 74.6 t -42.56 -32.33 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.078 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.687 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.5 OUTLIER -81.3 -34.37 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.566 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.51 -27.07 34.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.298 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.1 p -84.44 -34.71 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.215 0.531 . . . . 0.0 110.076 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.544 HD12 HG12 ' A' ' 662' ' ' VAL . 61.3 mt -81.61 -36.66 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.086 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.83 -32.2 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.413 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.57 -62.79 1.47 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.74 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -24.66 15.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.022 0.439 . . . . 0.0 110.388 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 674' ' ' PHE . . . -73.65 -21.94 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.149 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 667' ' ' ALA . 6.8 mt -75.37 -55.58 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 121.289 0.566 . . . . 0.0 111.012 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . 0.438 ' HA ' ' CE1' ' A' ' 676' ' ' PHE . . . -47.52 -62.62 1.35 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.795 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -21.94 18.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.154 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 11.8 t80 -65.5 -48.3 73.02 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.98 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . . . . . . . . . 20.7 t -101.7 -42.29 9.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 672' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.818 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.428 ' N ' HD23 ' A' ' 635' ' ' LEU . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 637' ' ' ASP . 1.1 t -107.54 -40.85 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.631 0.253 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 637' ' ' ASP . 1.1 m-20 -136.29 -99.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.86 0.362 . . . . 0.0 111.436 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -49.56 -44.37 46.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.509 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.9 -19.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.564 ' C ' HD13 ' A' ' 635' ' ' LEU . 2.1 tm? 177.32 -58.89 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.384 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.518 ' N ' HD13 ' A' ' 635' ' ' LEU . 10.3 Cg_endo -57.12 -20.72 39.13 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.754 1.636 . . . . 0.0 110.617 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 632' ' ' ASP . 1.7 p-10 28.58 42.48 0.01 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.452 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 642' ' ' ASP . 12.4 pt20 43.46 74.13 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.525 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -140.94 -55.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.463 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -93.96 -29.93 15.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.957 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.64 101.32 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.919 ' O ' HG22 ' A' ' 646' ' ' THR . 2.8 p30 -102.24 -33.92 9.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -52.89 -22.45 5.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.725 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -48.54 -28.05 3.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.714 0.292 . . . . 0.0 111.332 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -149.14 20.21 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.275 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.919 HG22 ' O ' ' A' ' 642' ' ' ASP . 6.7 t -155.7 25.88 0.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 111.131 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -140.91 -98.55 0.35 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.24 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -66.61 -28.49 68.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -86.32 -12.08 50.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.509 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 656' ' ' ILE . 0.2 OUTLIER -67.2 -12.88 61.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.484 -179.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.606 ' HA ' HG22 ' A' ' 656' ' ' ILE . 1.6 p-90 -164.79 45.66 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.78 0.324 . . . . 0.0 111.193 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.633 HG22 ' HD3' ' A' ' 653' ' ' PRO . 4.3 tt -88.9 -31.78 0.38 Allowed Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.633 ' HD3' HG22 ' A' ' 652' ' ' ILE . 56.5 Cg_endo -92.6 -6.18 3.13 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.438 2.092 . . . . 0.0 112.983 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 75.74 91.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.97 0.414 . . . . 0.0 110.461 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.18 45.0 1.52 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.463 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.715 ' O ' HG23 ' A' ' 661' ' ' VAL . 9.9 tp -114.58 -39.43 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.494 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -132.92 -59.28 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.776 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . 0.405 ' O ' ' HB ' ' A' ' 662' ' ' VAL . 3.5 p -61.73 -38.91 81.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.283 0.563 . . . . 0.0 109.975 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.56 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 24.2 m -119.44 -18.37 8.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.108 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.559 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.24 -53.31 3.7 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.605 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.82 ' O ' HG23 ' A' ' 665' ' ' VAL . 83.9 t -82.55 -60.87 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.074 0.464 . . . . 0.0 111.036 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.514 HG12 HD12 ' A' ' 666' ' ' ILE . 25.6 t -43.38 -31.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.656 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 659' ' ' THR . 4.5 tp -73.9 -34.47 39.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.992 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.64 -23.5 36.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.668 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 661' ' ' VAL . 1.8 t -83.8 -46.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.391 0.615 . . . . 0.0 109.917 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.514 HD12 HG12 ' A' ' 662' ' ' VAL . 60.6 mt -66.97 -35.06 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.186 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . 0.443 ' O ' HG12 ' A' ' 671' ' ' ILE . . . -41.59 -34.12 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.117 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.5 tp -84.81 -63.0 1.41 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.82 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -52.26 -26.35 11.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.595 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.412 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -69.33 -21.94 63.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.087 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 667' ' ' ALA . 20.5 mm -84.55 -40.31 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.104 0.478 . . . . 0.0 111.148 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -59.19 -31.75 69.3 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.808 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.88 -17.95 27.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.79 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -92.0 -34.28 14.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 44.0 t -94.39 -13.11 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.356 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.495 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.4 m-85 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.772 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 1.5 m -91.38 -48.87 6.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.675 0.274 . . . . 0.0 110.824 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.585 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 11.1 t70 -139.23 -95.17 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.354 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -57.58 -39.65 77.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.189 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.89 -25.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.342 0.591 . . . . 0.0 111.884 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.7 OUTLIER 174.78 -53.47 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.858 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.696 ' N ' HD13 ' A' ' 635' ' ' LEU . 38.0 Cg_exo -55.51 -24.02 42.18 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.691 1.594 . . . . 0.0 110.423 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 4.1 p-10 26.89 47.16 0.01 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.479 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . 0.407 ' NE2' HG21 ' A' ' 646' ' ' THR . 7.5 mt-30 50.67 57.46 6.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.132 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -121.58 -44.4 0.38 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.411 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.92 74.96 2.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 110.734 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 60.74 82.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.931 ' O ' HG22 ' A' ' 646' ' ' THR . 1.2 p30 -59.27 -24.99 63.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -55.65 -19.66 11.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.782 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -48.48 -28.3 3.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.73 0.3 . . . . 0.0 111.294 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.8 20.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.314 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.931 HG22 ' O ' ' A' ' 642' ' ' ASP . 7.4 t -157.29 26.24 0.3 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 111.126 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -142.54 -90.69 0.14 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.343 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.416 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 68.1 p-90 -71.92 -22.02 61.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.667 0.27 . . . . 0.0 110.999 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . 0.416 ' HG3' ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -86.17 -12.02 50.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.907 0.384 . . . . 0.0 110.474 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -15.06 62.46 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.201 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.599 ' HA ' HG22 ' A' ' 656' ' ' ILE . 0.6 OUTLIER -168.49 52.36 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.188 -179.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.628 HG22 ' HD3' ' A' ' 653' ' ' PRO . 4.2 tp -89.86 -31.9 0.37 Allowed Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.628 ' HD3' HG22 ' A' ' 652' ' ' ILE . 57.7 Cg_endo -91.84 -8.03 3.09 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.377 2.051 . . . . 0.0 112.976 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 76.06 92.51 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.953 0.406 . . . . 0.0 110.363 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.469 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.29 43.07 1.79 Allowed Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.249 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 661' ' ' VAL . 10.2 tp -114.5 -39.73 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.32 . . . . 0.0 111.525 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.567 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -136.08 -57.37 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.668 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.92 -38.12 81.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.275 0.56 . . . . 0.0 109.805 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 16.7 m -120.04 -18.33 8.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.018 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.474 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.14 -52.79 3.9 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.726 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.807 ' O ' HG12 ' A' ' 665' ' ' VAL . 86.5 t -82.64 -59.63 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.146 0.498 . . . . 0.0 110.768 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.495 ' HA ' ' CG1' ' A' ' 665' ' ' VAL . 44.6 t -42.54 -31.64 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.383 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.668 ' O ' ' HB2' ' A' ' 667' ' ' ALA . 0.2 OUTLIER -79.52 -36.0 17.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.71 -179.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . . . . . . . . . . . -81.66 -27.01 34.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.807 HG12 ' O ' ' A' ' 661' ' ' VAL . 2.0 p -84.76 -35.34 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.228 0.537 . . . . 0.0 110.336 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 662' ' ' VAL . 26.9 mm -81.14 -37.86 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.284 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 663' ' ' ILE . . . -41.27 -32.61 0.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.35 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 1.9 tp -84.69 -63.14 1.39 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.36 -25.79 16.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.051 0.453 . . . . 0.0 110.396 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -68.35 -21.87 64.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.037 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 667' ' ' ALA . 16.8 mm -84.73 -41.21 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.177 0.513 . . . . 0.0 111.214 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -58.61 -32.15 68.74 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.461 ' HG3' ' H ' ' A' ' 673' ' ' LYS . 0.0 OUTLIER -89.96 -17.87 27.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.974 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -94.21 -32.5 13.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.274 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 675' ' ' VAL . 46.1 t -94.83 -4.66 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.42 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.494 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 2.4 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.837 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . 0.441 ' CB ' ' HB3' ' A' ' 637' ' ' ASP . 0.4 OUTLIER -117.88 -48.62 2.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.66 0.267 . . . . 0.0 110.899 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . 0.625 ' HB3' ' HA ' ' A' ' 637' ' ' ASP . 65.3 t0 -136.39 -93.79 0.24 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.857 0.36 . . . . 0.0 111.316 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -37.81 70.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.148 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.09 -27.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.414 0.626 . . . . 0.0 111.77 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.677 HD13 ' N ' ' A' ' 636' ' ' PRO . 0.8 OUTLIER 178.26 -54.27 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.904 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 636' ' ' PRO . . . . . 0.677 ' N ' HD13 ' A' ' 635' ' ' LEU . 39.5 Cg_exo -56.03 -23.95 46.38 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 121.586 1.524 . . . . 0.0 110.371 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 637' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 632' ' ' ASP . 2.2 p-10 30.33 40.58 0.01 OUTLIER 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.552 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 637' ' ' ASP . 2.9 pt20 36.35 73.82 0.08 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.054 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . . . . . . . . . . . -162.77 -46.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.727 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 640' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.88 -38.54 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.801 0.334 . . . . 0.0 111.103 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 641' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -153.33 46.32 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 642' ' ' ASP . . . . . 0.947 ' O ' HG22 ' A' ' 646' ' ' THR . 17.4 p-10 -64.78 -32.34 73.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 643' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -50.25 -25.58 3.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.725 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -48.71 -27.86 3.19 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.788 0.328 . . . . 0.0 111.272 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -148.86 22.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.323 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' THR . . . . . 0.947 HG22 ' O ' ' A' ' 642' ' ' ASP . 12.4 t -159.25 26.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 651' ' ' TRP . . . -143.51 -95.6 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.293 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.432 ' CZ3' ' HG3' ' A' ' 649' ' ' ARG . 65.3 p-90 -65.07 -21.51 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.841 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' ARG . . . . . 0.615 ' HA ' HG12 ' A' ' 652' ' ' ILE . 19.9 mtp85 -86.61 -19.32 29.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.241 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' GLN . . . . . 0.402 ' HG3' ' HA ' ' A' ' 646' ' ' THR . 0.5 OUTLIER -69.55 -12.83 61.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.68 -179.357 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' TRP . . . . . 0.522 ' HA ' HG22 ' A' ' 656' ' ' ILE . 2.3 p-90 -154.45 46.75 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.763 0.316 . . . . 0.0 111.136 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' ILE . . . . . 0.615 HG12 ' HA ' ' A' ' 649' ' ' ARG . 0.0 OUTLIER -71.55 -61.85 1.95 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.849 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.522 ' O ' ' HB3' ' A' ' 654' ' ' ALA . 64.8 Cg_endo -73.82 -2.39 12.16 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.739 2.293 . . . . 0.0 113.016 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 653' ' ' PRO . . . 72.87 91.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.963 0.411 . . . . 0.0 110.405 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . 0.436 ' HA2' ' HB ' ' A' ' 659' ' ' THR . . . 104.01 49.15 1.1 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.077 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 651' ' ' TRP . 9.8 tp -114.51 -39.74 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.779 0.323 . . . . 0.0 111.733 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' GLY . . . . . 0.698 ' HA2' HG23 ' A' ' 661' ' ' VAL . . . -139.68 -61.33 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.591 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 658' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' A' ' 651' ' ' TRP . 1.9 p -62.33 -36.84 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.418 0.628 . . . . 0.0 109.656 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 659' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' A' ' 663' ' ' ILE . 47.0 m -117.75 -17.97 9.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.084 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . 0.498 ' O ' HG22 ' A' ' 663' ' ' ILE . . . -82.28 -57.32 2.66 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.977 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.698 HG23 ' HA2' ' A' ' 657' ' ' GLY . 40.7 t -82.19 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.201 0.524 . . . . 0.0 111.144 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.601 ' HA ' HG22 ' A' ' 665' ' ' VAL . 24.4 t -43.13 -31.14 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.775 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 659' ' ' THR . 1.6 tt -75.19 -36.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.122 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 664' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 661' ' ' VAL . . . -81.68 -24.81 36.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.115 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 665' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 661' ' ' VAL . 2.4 m -84.41 -41.17 15.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.32 0.581 . . . . 0.0 110.279 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 666' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 670' ' ' ALA . 18.5 mm -70.3 -36.51 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.362 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 667' ' ' ALA . . . . . . . . . . . . . . . -40.31 -34.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.146 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 671' ' ' ILE . 1.3 tp -84.77 -63.01 1.41 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.863 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 669' ' ' PHE . . . . . 0.428 ' O ' ' HG2' ' A' ' 673' ' ' LYS . 34.7 t80 -52.78 -25.94 12.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 670' ' ' ALA . . . . . 0.437 ' HB2' HG22 ' A' ' 666' ' ' ILE . . . -70.81 -24.28 62.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.182 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 668' ' ' LEU . 10.3 mt -85.55 -33.24 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.124 0.488 . . . . 0.0 110.915 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 672' ' ' ALA . . . . . . . . . . . . . . . -62.86 -33.81 76.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.379 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 673' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 669' ' ' PHE . 0.0 OUTLIER -90.13 -17.76 27.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.743 179.415 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 674' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 670' ' ' ALA . 5.1 t80 -91.69 -33.98 14.83 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.069 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 675' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 676' ' ' PHE . 46.9 t -94.82 -12.05 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.309 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 676' ' ' PHE . . . . . 0.496 ' CE1' ' HB ' ' A' ' 675' ' ' VAL . 1.5 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.815 179.764 . . . . . . . . 1 1 . 1 stop_ save_